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Identification and Evolution of New Orthogonal Aminoacyl-tRNA
Synthetase/tRNA Pairs for Genetic Code Expansion
by Daniele Cervettini
Genetic code expansion is the branch of molecular biology aiming to expand the repertoire of amino
acids  which can be incorporated into proteins  in vivo. A central challenge in expanding the genetic
code of cells to incorporate non-canonical amino acids is the scalable discovery of aminoacyl-tRNA
synthetase (aaRS)–tRNA pairs (the components of the cellular translational machinery which specify
the  matching  between  codons  and  amino  acids)  that  are  orthogonal in  their  aminoacylation
specificity. An orthogonal pair is composed of an aaRS which can interact with its partner tRNA, but
not with any other tRNAs in the host, and a tRNA which is substrate to its partner aaRS, but not to
any other  aaRS in  the  host.  In  this  research,   candidate  orthogonal  tRNAs were  identified  from
millions of sequences by implementing a computational analysis which scored their likelihood to be
recognised by the endogenous aaRSs in E. coli, our model organism. I then developed a rapid, scalable
new in vitro approach, named tRNA Extension (tREX), to determine the in vivo aminoacylation status
of tRNAs. Using tREX, 243 candidate tRNAs were tested in  E. coli  and 71 orthogonal tRNAs were
identified, covering 16 isoacceptor classes. 23 of those formed functional orthogonal tRNA–cognate
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aaRS  pairs.  By  performing  additional  characterisation  and  molecular  evolution  of  these  newly
identified functional pairs, we discovered 5 orthogonal pairs, 3 of which displayed high activity in
amber  suppression,  the  technique  of  choice  used  to  implement  genetic  code expansion in  model
organisms. I additionally evolved new amino acid substrate specificities for two pairs. Finally, I use
tREX to characterize a matrix of 64 orthogonal synthetase-orthogonal tRNA specificities. This work
expanded the number of orthogonal pairs available for genetic code expansion, provided a robust
pipeline for the discovery of additional orthogonal pairs, and established a foundation for encoding
the cellular synthesis of non-canonical biopolymers.
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Protein Translation
Proteins represent the most versatile biological polymer and constitute an essential class of molecules
which is  necessary for  any form of life.  In spite of the variety of functions they fulfil  and of the
diversity of organisms in which they are found, all proteins consist of the same 20 building blocks, the
set  of  proteinogenic  amino acids.  These  monomers  can  be  polymerised  to form linear  molecules
thanks to the presence of a carboxylic acid and of an amine moieties in their structure, which can be
condensed to form a peptide bond. Organisms store their genetic information, which includes the
linear  sequence for  their  proteins,  by means of nucleic  acid sequences,  most  commonly DNA, as
elucidated thanks  to famous  experiments  by  Avery–MacLeod–McCarty1 first  and Hershey-Chase2
later.
The set of rules which define the correspondence between the genetic information contained into
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DNA  and the  distinctive  sequence  of  proteins  is  named  genetic  code,  and  the  set  of  molecular
processes involved in the relay of such information have been elucidated by memorable experiments
during the second half of the 20th century.
Immediately after the discovery of the DNA structure by Watson&Crick3, hypotheses were brought
forward about the mechanism by which genetic information is interpreted to produce proteins in the
cells. In a famous symposium4 Crick postulated in 1958 that the primary sequence of DNA should be
a simple code for the amino acid sequence of a particular protein and that an adaptor molecule should
exist, perhaps made of RNA, which should carry the amino acids to the template and mediate the
transfer of information from nucleic acids to proteins. Furthermore, he theorised that enzymes could
be responsible to join a specific amino acid to a specific adaptor or set of adaptors.
In the following years,  all  of Crick's suppositions were confirmed to be true. Nirenberg and co-
workers first showed that a stretch of poly-uracil can guide the synthesis of a poly-phenylalanine
peptide, highlighting the role of RNA in the protein synthesis process5, then cracked the triplet-based
genetic code6. The identity of the adaptor molecules was identified by Zamecnik and co-workers, who
showed that some soluble RNA (sRNA) molecules were covalently bound to 14C-labelled amino acids
in the presence of ATP and amino acid-activating enzymes7, in a crucial step for protein synthesis8, 9.
The connection between the genetic information stored in the DNA and the RNA used to synthesise
protein  was  found  when  the  key  enzyme,  RNA  polymerase,  was  purified  by  S.  Weiss  and  L.
Gladstone from mammalian cell extracts10, 11.
From the studies listed above, we now know that the DNA information is first copied into RNA in a
process known as  transcription, and that RNA is directly used as a template for protein synthesis.
Groups of three letters of RNA, known as codon, uniquely correspond to a specific amino acid and
the sRNA adaptor molecules which mediate this matching between codons and amino acids are now
known  as  tRNAs.  These  adaptors  are  recognised  specifically  by  a  family  of  activating  enzymes
known as  aminoacyl-tRNA synthetases, or aaRSs, which are responsible to ensure that the correct
amino acid is chemically bound to the right tRNA.
In the cell, the molecular machinery responsible to coordinate the conversion of genetic information
to functional protein is the ribosome. It consist of a multi-molecular complex composed of RNAs and
proteins which moves along mRNAs by one codon at the time, ensuring the correct matching between
codons and tRNAs to guarantee high fidelity in the protein synthesis process, known as translation12.
In the next sections I will describe in more detail the structure and function of tRNAs and aaRSs,
how they interact with each other and how ribosomal protein translation is carried out.
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tRNAs
In all organisms tRNAs are key molecules responsible to guarantee the correct flow of information
between  DNA  and  proteins.  They  consist  of  highly  modified  and  strongly  structured  RNA
molecules13 whose length varies between 70 to 130 nt. tRNA primary structure is characterised by a
high degree of divergence, both within an organism and among different organisms14. In spite of this
divergence  in  sequence,  tRNAs  present  a  common  secondary  structure,  which  is  best  known  as
cloverleaf structure. The characteristic features of the vast majority of tRNAs can be described taking
E. coli tRNAs as an example15 (Figure 1.1a): 
i) the two ends of tRNAs come together to form the acceptor stem;
ii)  the three nucleotides at the 3'-end are universally conserved and have sequence 5'-CCA-3'; 
iii) the  three  nucleotides  responsible  for  the  interaction  with  codons  in  mRNAs,  known  as
anticodon, are present in the middle of a 7 nt loop (anticodon loop) connected to a 5 bp stem
(anticodon stem). Together, the anticodon stem and the anticodon loop form the  anticodon
arm; 
iv) a structure composed of 3 to 4 bp stem and a loop of variable length is present upstream of the
anticodon arm. This structure is called  D arm due to the presence of dehydrouridine in the
loop16; 
v) a variable loop of length varying between 3 and 21 nt is present downstream of the anticodon
arm and is called variable arm. This structure may or may not fold in a double-stranded stem; 
vi) downstream of the variable arm, the last secondary structure element is represented by a 5 nt
long stem terminating in a 7 nt loop containing the conserved TΨC motif and is hence called
TΨC arm, where Ψ stands for pseudouridine.
Using the secondary structure as a reference,  E. coli tRNAs can be aligned to a standard prototype
whose nucleotides are numbered to define the canonical numbering scheme, as indicated below15:
1→7 Acceptor stem, first strand 39→43 Anticodon stem, second strand
8→9 Unpaired bases 44→48 Variable loop
10→13 D stem, first strand 49→53 TΨC stem, first strand
14→21 D loop 54→60 TΨC loop
22→25 D stem, second strand 61→65 TΨC stem, second strand
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26 Unpaired base 66→72 Acceptor stem, second strand
27→31 Anticodon stem, first strand 73 Discriminator base
32→38 Anticodon loop 74→76 CCA end
In  E. coli some positions are conserved among all  tRNAs15 (Figure 1.1a).  These include canonical
positions 8 which is always U, and positions 74→76, which have sequence CCA. Furthermore, the D
loop always contain two Gs which define positions 18 and 19, while the TΨC loop begins with the
conserved triplet TTC, which defines positions 54→56 (Figure 1.1a).
In  addition  to  possessing  well  defined  secondary structure  elements,  tRNAs adopt  a  conserved
tertiary structure18. In particular, the D arm and the TΨC fold back to establish mutual interactions
which confer a characteristic L shape to tRNAs (Figure 1.1b). This three-dimensional conformation is
approximately retained even in tRNAs where the secondary structure differs from the canonical one
described, and guarantees that tRNAs can be recognised correctly by the ribosome19.
Overall,  divergence  at  the  primary  structure  allows  different  tRNAs  to  possess  a  distinctive
fingerprint, which is necessary for specific interactions to occur20. As an example, aminoacyl-tRNA
synthetases, which are responsible for chemically linking tRNAs with their corresponding amino acid,
take advantage of this divergence to engage a specific subset of the cellular tRNA pool20. Conversely,
the existence of a conserved tertiary structure ensures that distinct tRNAs can establish interactions
8
Figure 1.1: a) Schematic representation of tRNA secondary structure with canonical numbering scheme. Conserved positions
among E. coli tRNAs are indicated. b) Tertiary structure of tRNAPhe from S. cerevisiae (PDB 1ehz17) adopts the canonical L
shapes. Secondary structures are colour coded as in a).
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with common partners involved in the translational apparatus.
Aminoacyl-tRNA Synthetases
tRNAs can fulfil  their role of adaptors between the codes of nucleic acid and amino acids if,  in
addition to displaying a solvent-exposed anticodon able to base-pair with a codon in an mRNA, they
can be uniquely linked to a specific amino acid. In the cell, a set of 20 enzymes is responsible for
catalysing the ATP-dependent esterification of an amino acid's carboxylic moiety onto one of the two
hydroxyl groups at the 3'-end of tRNAs. By discriminating a specific  subset of tRNAs within the
cellular pool, and being able to use only one amino acid as a substrate, these enzymes, the aminoacyl-
tRNA synthetases (aaRSs), are responsible to establish the correspondence between the alphabet of
DNA and the alphabet of proteins, which defines the genetic code of an organism. Individually, these
enzymes are indicated by the three letter code for their amino acid substrate (e.g.: AlaRS: alanyl-tRNA
synthetase).
aaRSs catalyse a reaction which proceeds in two steps: first, the carboxylic acid attached to the  α-
carbon of amino acids is activated to form an aminoacyl-AMP intermediate. In the second step, the
activated carboxylic acid is transferred to either the 2'-OH or 3'-OH of the terminal adenine of the
tRNA and the products are released21. While protein synthesis requires aminoacylation on the 3'-OH,
rapid trans-esterification occurs which causes co-existence of both species for all tRNAs22.
Based on structural features, aaRSs are commonly divided in two classes21. Class I synthetases are
defined by the presence of a Rossmann fold, a structural element involved in ATP binding, containing
two conserved motifs with sequence “HIGH” and “KMSKS”. These aaRSs are mostly monomeric,
with few exceptions which form dimers, they approach the acceptor stem of their substrate tRNA
from the minor groove and charge its 2'-hydroxyl group. Conversely, class II synthetases lack the
Rossmann fold and instead present a 7-stranded  β-sheet fold involved in ATP  binding, are mostly
dimeric or tetrameric and charge the 3'-hydroxyl group (with the exception of phenylalanyl-tRNA
synthetase).
aaRSs ensure high fidelity of protein synthesis by preventing charging of the wrong amino acid onto
their substrate tRNAs. The low error rate of aminoacylation (of the order of 10-4)23 is maintained by
means of two strategies. Firstly, synthetases have evolved to establish specific interactions with only
one amino acid24.  For charged and polar amino acids,  for example, a  distinctive hydrogen bonds
network can only be established between the enzyme and the side chain of one amino acid, ensuring
binding of a specific substrate for catalysis. For hydrophobic amino acids, non-polar interactions in
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combination with size exclusion of substrates with the incorrect side chain can provide specificity. In
certain cases, however, these strategies are not enough to provide a significant difference in binding
energy among different substrates. As an example, isoleucyl-tRNA synthetase (IleRS) must prevent
mis-charging of tRNAIle by valine25.  As both amino acids  are  small  and hydrophobic,  no specific
hydrogen bond patterns can discriminate between them. Furthermore, IleRS cannot exclude valine by
size because valine is one methyl group smaller than isoleucine. In these cases, aaRSs exploit a post-
transfer  correction  mechanism  known  as  editing,  which   hydrolyses  incorrect  aminoacyl-tRNA
complexes25. In fact, as isoleucine, being larger than valine, can be actively excluded from the active
site  of  the  editing  domain  of  IleRS  by  size25,  Val-tRNAIle  can  be  selectively  hydrolysed  while
preserving the pool of Ile-tRNAIle.
Aminoacyl-tRNA Synthetase Interactions with tRNAs
In addition to showing selectivity for one amino acid, aaRSs must be able to recognise only a subset
of  the cellular  tRNAs. tRNAs which are  recognised by the same aaRS are known as  isoacceptor
tRNAs, as they get charged with the same amino acid. Isoacceptor tRNAs are indicated with the
three-letter  code  of  the  amino  acid  which  they  encode  and  in  addition  their  anticodon  can  be
indicated  (e.g.:  tRNAAla is  one  of  the  alanyl  isoacceptor  tRNAs,  tRNAGGC
Ala  indicates  the  alanyl
isoacceptor tRNA with anticodon GGC). To ensure precise correspondence between anticodons and
amino acids, and consequently a precise matching between genetic information and protein sequence,
each tRNA must be substrate for one and only one aaRS. In spite of the high levels of conservation of
their three-dimensional shape, tRNAs diverge at their primary sequence15, resulting in heterogeneity
in the chemical moieties exposed to the solvent through in the major and minor groove, as well as in
the nucleotides not engaged in base pairing. As a result, aaRSs can effectively test the identity of a
tRNAs by sampling a discrete number of spots along their interaction surface20. If a tRNA displays the
correct  pattern  of  chemical  moieties  at  those  locations,  correct  binding  occurs  and  catalysis  is
favoured. Conversely, tRNAs which don't establish the correct set of interactions with an aaRS do not
get effectively aminoacylated.
For each tRNA, the nucleotides that are specifically recognised by its aaRS and which mediate their
interaction are known as  identity elements20. Understandably, these positions tend to be conserved
among tRNAs belonging to the same isoacceptor class within an organism and among closely related
species26. A key feature which guarantees fidelity of the genetic code is the difference in the identity
elements recognised by different aaRSs. As an example, PheRS is the only one which recognises the
top part of the anticodon stem and some nucleotides in the TΨC arm , while LeuRS is among the few
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which recognise features of the variable arm20.  For those positions which are identity elements to
multiple  aaRS,  different  enzymes  recognise  different  sequences.  As  an  example,  the  anticodon
represent  a  key  interaction  partner  for  17  out  of  20  aaRSs20 (AlaRS,  LeuRS  and SerRS being  the
exception), however, each of those synthetases is highly specific for the anticodon of its isoacceptor
tRNAs, such that variations at those positions are poorly tolerated. Being in close proximity to the
catalytic  site,  the  acceptor  stem  contains  identity  elements  for  a  large  number  of  aaRSs.  Some
synthetases also recognise the presence of a variable arm which forms a stem-loop structure (e.g.:
SerRS) or other unusual features, like the presence of one extra nucleotide at the 5'-end of the tRNA
which base pairs with canonical position 73, which is usually unpaired (e.g: HisRS)20.
The existence of a variety of interaction points distributed along the whole tRNA body is responsible
for the affinity of each aaRS for tRNAs belonging to its isoacceptor class and not others. In addition,
the coexistence of all aaRSs in the cell generate a competition for their respective substrates. Taken
together,  these  mechanisms  guarantee  fidelity  of  tRNAs  aminoacylation,  a  key  requirement  for
accurate protein synthesis.
Ribosomal protein synthesis
Aminoacylated tRNAs are the building blocks for translation. In the cell, a complex apparatus exists
which ensures correct processing of this raw material into the correct final product. A key character of
such apparatus is  the  ribosome,  a  megadalton-size  ribonucleoprotein  which  monitors  the  correct
matching  between mRNA codons  and tRNA anticodons  and catalyses  the  condensation  reaction
between amino acids to form polypeptides12.
The prokaryotic ribosome is constituted of two subunits of different sizes. The small subunit, or 30S,
is composed of a single ribosomal RNA (16S) associated to 21 proteins. The large subunit, or 50S,
consists  of  two  different  RNAs,  the  5S  and  the  23S  rRNAs,  and  31  additional  proteins.  When
associated together, the two subunits for the 70S ribosome. Both subunits present three distinct sites
which can accommodate tRNAs at different stages of the translation process, known as A site, P site
and E site.
Translation initiation starts when the 3'-end of the the 16S rRNA of the small subunit, which has
sequence 5'-ACCUCCUUA-3' in  E. coli, forms a base-pair interaction with a sequence of an mRNA
known as Shine-Dalgarno (SD) sequence (with canonical sequence AGGAGG). When this interaction
is established,  the translation start  codon ATG is displayed in the P site  of  the small  subunit.  A
specialised  initiator  tRNA,  fMet-tRNAfMet,  charged  with  an  N-formylated  methionine  (fMet),  is
escorted to the P site bound to the initiation factor IF2, a protein with GTPase activity. In addition,
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initiation factors 1 (IF1) and 3 (IF3) are occupy the A and P sites, respectively, in order to stabilise the
initiation complex as well as preventing premature association of the large subunit or of incoming
tRNAs12.
 GTP hydrolysis by IF2 leads to release of the initiation factors, association of the large subunit and
transition to the elongation phase. At the beginning of this phase, the P site is occupied by the fMet-
tRNAfMet and the E and A sites are empty. In order for protein synthesis to proceed, a new tRNA is
delivered  to  the  A site  of  the  ribosome bound  to  a  small  GTPase  known as  Elongation  Factor,
Thermally unstable (EF-Tu). If the tRNA anticodon correctly base pairs with the codon displayed in
the A site,  EF-Tu hydrolyses GTP and the tRNA is free to reposition its 3'-end into the peptidyl-
transferase centre (PTC), the site of the ribosome involved in peptide bond formation. At this stage,
the P-site tRNA is deacylated and the peptide chain is transferred to the A-site tRNA, leaving a free
tRNA in the P site and a peptide-bound tRNA in the A site. To allow the cycle to be repeated, EF-G
triggers  translocation  of  the  free  P-site  tRNA  to  the  E  site,  where  it  is  eventually  ejected,  and
translocation  of  the  peptidyl-tRNA to  the  P  site.  Furthermore,  the  ribosome is  moved along  the
mRNA by one codon12.
The ribosome possesses proofreading mechanisms which ensure that elongation can only take place
if the correct tRNA is present in the A site. In order to do this, some universally conserved position in
the 16S rRNA (G530, A1492 and A1493 in E. coli) form a hydrogen bond network with the first two
positions of the codon-anticodon base pairs which only allows Watson-Crick interactions in order for
elongation to proceed. At the third position of the codon-anticodon base pairs, a looser level of control
allows wobble interactions to occur, resulting in a tRNA to be able to decode more than one codon12.
The elongation process repeats until a stop codon is found in the A site. Physiologically, no tRNAs
are present in the cell  whose anticodon can base pair with the three codons UAA, UAG or UGA.
Instead, a release factor binds to the A site and leads to hydrolysis of the polypeptide from the P-site
tRNA, hence termination of translation. In bacteria, release factor 1 (RF1) and 2 (RF2) recognise stop
codons  UAG  and  UGA,  respectively,  while  both  can  recognise  the  UAA  codon.  Following
termination, the ribosome is disassembled by the action of a variety of GTPases, including RF3, RRF
and EF-G and recycled for new rounds of translation12.
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Genetic Code Expansion
In each living organisms all 64 possible RNA codons are assigned to either an amino acid (sense
codons), by the presence of a tRNA with a matching anticodon and an aminoacyl-tRNA synthetase
that can charge it, or to termination of translation (stop codon), by a corresponding release factor. The
set of rules which determine the meaning of codons for protein translation, or genetic code, is almost
universally conserved, even if few minor differences have been identified in various organisms27. The
branch  of  molecular  biology  whose  aim  is  to  increase  the  variety  of  amino  acid  which  can  be
incorporated into proteins by means of the cellular translational machinery is  called  genetic code
expansion28. In order to achieve this result in a living cell, a number of conditions must be satisfied:
i) a codon must be assigned to the newly introduced amino acid;
ii) a tRNA capable of decoding the chosen codon must be available;
iii) an aminoacyl-tRNA synthetase must exist which can selectively charge this tRNA with the
amino acid of choice.
Importantly, newly introduced amino acids, referred to as non-canonical amino acids (ncAAs) have
been shown to take part in the ribosomal peptide bond synthesis, even if with an efficiency dependent
on their structure29. Consequently, if the above conditions are met, the cell will start interpreting the
occurrences of the re-specified codon as the ncAA.
However, to make genetic code expansion possible, some additional considerations must be taken
into account. Fidelity of protein translation is ensured by the lack of cross-reactivity between cellular
aaRSs and non-cognate tRNAs from other isoacceptor classes. When introducing new aaRS/tRNA
pairs  in  a  cell,  in order to  prevent  repercussions on cellular  viability,  this  fidelity  should not  be
compromised. In fact,  erroneous mis-incorporation of a ncAA across the cellular proteome would
result in the production of aberrant proteins with impaired function and in the reduction of cellular
viability30.  To  prevent  this  erroneous  mis-incorporation of  a  ncAA,  the  aaRSs  able  to  use  it  as  a
substrate,  which we may call ncAA-RS, must not use cellular tRNAs as substrates, generating a pool
of  mis-charged tRNAs.  Enzymes  with this  property  are  referred to  as  orthogonal,  meaning they
cannot recognise and aminoacylate the tRNA pool of the organisms in which genetic code expansion
is performed, while having their cognate tRNA (tRNAncAA) as a sole substrate. Conversely, a tRNAncAA
is orthogonal if it cannot be a substrate for any cellular aaRS, while being recognised by its ncAA-RS.
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tRNA orthogonality is required to ensure accuracy in the incorporation of the ncAA at the target
codon.
The possibility to expand the endogenous pool of proteinogenic amino acid is attractive on many
regards28, 31. In fact, it should be noted that, in spite of the enormous variety of functions accomplished
by proteins,  they are  built  from an extremely  limited selection of  chemical  moieties.  Site-specific
introduction of new side chains can, for example, expand the variety of reactions which proteins can
undergo or catalyse. As an example, the introduction of groups which can take part in bio-orthogonal
reactions opens up new ways of labelling proteins to study their physiology, or of purifying them
with  new methods32,  33.  Amino acids  containing photo-reactive  groups  which can  be  activated in
response to light stimuli can be exploited to induce perturbations with high spatiotemporal control
and  resolution.  Such  ncAAs  have  been  used  to  study  protein  interactions34-36,  to  alter  cellular
physiology37, 38 etc.
Another area in which genetic code expansion can be a powerful tool is the study of post-translation
modifications (PTMs). In fact, introducing site-specific PTMs is relatively difficult, as the enzymes
involved often have a broad specificity39 or are unknown. On the other hand, the introduction of
ncAA containing PTMs can be performed regardless of any knowledge on the enzymes involved in
the  physiology  of  that  PTM   and  without  interference  on  other  proteins,  providing  superior
resolution. To date, several PTMs, like serine phosphorylation40, 41, threonine phosphorylation42, lysine
acetylation43, lysine methylation44 etc.28, 31, have been introduced by GCE.
Incorporation of a ncAA only at the desired site of interest is difficult to achieve in vivo. Even when
an orthogonal  ncAA-RS is available which is completely specific for its tRNAncAA,  the latter might
decode a codon which occurs in locations other than the site of interest of the target protein. This is
especially problematic considering that no codons are naturally unassigned to be either sense or stop
codons, with no blanks available. In the next sections early attempts to expand the genetic code will
be  discussed  to  highlight  how  the  lack  of  available  blank  codons  can  be  overcome  and  how
orthogonal aaRS/tRNA pairs can be obtained.
Amber Suppression
The TAG codon was the first one identified to induce termination of protein synthesis in mutants T4
phages irradiated with UV light. Some mutants were identified which expressed a truncated form of
the  protein  containing  the  mutation,  called  nonsense  mutation45.  Furthermore,  truncation  was
observed when the mutated protein was expressed in some strains of E. coli while other strains were
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able to suppress such mutation. The “suppressable” mutations were termed  amber46.  The molecular
cause of the truncation was the appearance of the TAG codon along the protein coding sequence,
which for this reason is known as amber stop codon. Furthermore, the genes responsible to suppress
the amber mutation in the several suppressor strains of E. coli were pinned down as mutant tRNAs
whose anticodon had mutated to 5'-CUA-3' 47. As a result, these tRNAs could decode the TAG codon,
preventing premature termination and restoring production of the full length protein.
The possibility of suppressing a stop codon with an appropriate tRNA implies that the activity of the
release factor 1 can be counteracted to some extent. In addition, among all the stop signals, the amber
codon is the one used least frequently in many organisms, including E. coli, S. cerevisiae, C. elegans and
also in humans48. Given its good efficiency, amber suppression is the technique which allows the site-
specific  incorporation  of  a  ncAA of  interest  with  the  highest  precision,  provided an  appropriate
ncAA-RS/tRNAncAA is found.
Early Work on Genetic Code Expansion
In some early attempts to direct site-specific incorporation of ncAA into proteins, Furter transplanted
the PheRS/tRNAPhe pair from S. cerevisiae (Sc), which is naturally able to use p-fluoro-phenylalanine
as a substrate, into an  E. coli strain incapable of using the ncAA as a substrate for the endogenous
synthetases49. In his experiments, the anticodon of the Sc-tRNAPhe was mutated to CUA (Sc- tRNACUA
Phe
). By using a reporter gene containing an in-frame amber stop codon, Furter observed incorporation of
p-fluoro-phenylalanine with ~70% yield, with the remaining fraction being phenylalanine and lysine.
His experiment highlighted that while mutations of the tRNA anticodon from its wild type sequence
to  CUA  did  not  disrupt  the  recognition  by  Sc-PheRS,  it  resulted  in  a tRNACUA
Phe which  was  not
orthogonal in E. coli, being charged by the E. coli LysRS.
To improve incorporation accuracy, later works by the Schultz lab focused on the identification of
fully orthogonal pairs for genetic code expansion. Once identified, orthogonal pairs could be evolved
to alter their recognition for a substrate amino acid and redirect it  towards a ncAA. In their first
attempt, they tried to generating an orthogonal pair by engineering the  E. coli GlnRS/ tRNA2
Gln  50.
While evolution of the tRNA2Gln was successful in generating a tRNA which was orthogonal to the
wild type GlnRS, no variants of the synthetase could be found which did not retain any specificity
towards the wild type tRNA2
Gln .
A  more  fruitful  strategy  to  generate  orthogonal  pairs  was  found  to  be  the  transplantation  of
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aaRS/tRNA pairs found in other organisms which have evolved distinctive features compared to the
orthologue pairs in the host, conferring them orthogonality in the recipient host. The first of these
examples was the TyrRS/tRNATyr derived from  Methanocaldococcus jannaschii  (Mj),  whose genome
was fully sequenced at the end of the 1990s51. Unlike its E. coli counterpart, this archaeal tRNA does
not display an extended variable arm and has a C1:G72 base pair, which differs from the bacterial
identity element G1:C72. In addition, the Mj− tRNACUA
Tyr  is orthogonal in E. coli and is charged by its
cognate Mj-TyrRS with tyrosine52.
The Schultz lab envisioned an experimental strategy to alter the amino acid specificity of the  Mj-
TyrRS by directed evolution53. First, a large library of mutant synthetases (>108 mutants) was built by
randomizing the residues of the enzyme lining the amino acid binding pocket. A selection marker
was generated by introducing an amber stop codon in a permissive site of the chloramphenicol acetyl-
transferase gene (cat112*). If cells expressing cat112* and Mj− tRNACUA
Tyr , are transformed with the library
and grown on chloramphenicol-  and ncAA-containing media,  only colonies  harbouring an active
synthetase  variant  could survive.  This  positive selection strategy is  not  capable  of  discriminating
synthetases which incorporate the ncAA from others which recognise other cellular amino acids. To
circumvent this limitation, a negative selection was performed using a toxic gene interrupted by an
amber stop codon instead of cat112*. When the selection was performed using the same setup but using
the toxic  marker  in  place  of  the  antibiotic  resistance  marker  and in the  absence  of  ncAA in the
medium, synthetase variants specific for other cellular amino acids were filtered out. By alternating
multiple consecutive rounds of positive and negative selection, the Schultz group initially identified a
synthetase specific for O-methyl-tyrosine, while tens of other enzymes were evolved by a variety of
groups  using  comparable  strategies  to  incorporate  a  multitude  of  ncAAs.  To  date,  this  Mj-
TyrRS/tRNATyr system remains one of the most successful one employed for genetic code expansion54.
However, its active site is mostly limited to accommodating tyrosine derivatives54.
The Pyrrolysyl-tRNA Synthetase/tRNA Pair
A major breakthrough for the advancement of genetic code expansion came when studies about
methanogenesis in some bacteria belonging to the Methanosarcina genus identified an in-frame amber
stop codon within the  mtmb1  gene coding for monomethylamine methyltransferase56,  57.  The X-ray
diffraction  pattern  of  crystals  grown  from  the  purified  protein  identified  an  electron  density
corresponding to a new amino acid in the active site of the enzyme58. Subsequent studies elucidated
the  chemical  structure  and  biosynthetic  pathway  which  produced  the  new  amino  acid,  named
pyrrolysine (Pyl), which is fundamental for methanogenesis due to its unique chemical properties59.
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These studies also clarified that pyrrolysine was not synthesised as a post-translational modification,
but instead it was incorporated within the protein sequence co-translationally thanks to the action of a
unique tRNA, tRNAPyl, encoded by the pylT gene, and a class II aminoacyl-tRNA synthetase, PylRS,
encoded  by  the  pylS gene,  located  in  the  same  operon  as  the  enzyme  involved  in  pyrrolysine
biosynthesis and composed of an N-terminal domain responsible for tRNA binding and a catalytic C-
terminal domain which performs aminoacylation60. Importantly, tRNAPyl naturally possesses the 5'-
CUA-3' anticodon required to perform amber suppression, and its interaction with the translational
machinery is not mediated by any additional components compared to the canonical tRNAs60. In this
regard, pyrrolysine can be considered a case of natural expansion of the genetic code.
The PylRS/tRNAPyl system presents some remarkable features. Unlike any of E. coli tRNAs, tRNAPyl
from Methanosarcina barkeri  (Mm) or mazei (Mb) presents a single nucleotide in between the acceptor
stem and the D stem, a D loop composed of only 5 nucleotides and lacking one of the conserved GG at
canonical positions 18-19, an acceptor stem composed of 6 base pairs instead of 5 and a variable loop
composed  of  only  3  nucleotides  (Figure  1.2a).  These  characteristics  render  the  Mm/Mb-tRNAPyl
orthogonal  in  E. coli and indeed in other  model  organisms28.  Furthermore,  as  Mm/Mb-PylRS has
adapted  to  recognise  such  an  uncommon  tRNA  (Figure  1.2b),  it  displays  no  reactivity  towards
endogenous tRNAs of those same species.  These two evidences define the PylRS/tRNAPyl pair as
orthogonal. Furthermore, like only few other aaRSs, PylRS does not interact with the anticodon of its
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Figure 1.2: a) Secondary structure of the tRNAPyl from M. barkeri highlights the unusual characteristics of this tRNA, such
as the lack of canonical position 9, the smaller size of the D loop, the extension of the anticodon arm from 5 to 6 bp and the
reduction of the variable loop to only 3 nt. b) Crystal structure of the N-terminal domain of the PylRS from M. mazei (PDB
5ud555) highlights its close proximity to the variable loop of the enzyme, which is smaller than the variable loop of any of the
E. coli tRNAs.
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cognate tRNAPyl. Instead, the N-terminal domain of the enzyme makes contact with the variable arm,
while the catalytic domain contacts the acceptor stem and the D arm55, 61.
The active site in PylRS is naturally promiscuous and can tolerate other lysine derivative beyond
pyrrolysine57, 62. Moreover, site-directed mutagenesis of the active site allowed incorporation of a very
broad range of  ncAA using  this  system57.  Among these,  a  large  number  of  lysine  derivatives  or
analogues are  present,  but  some mutants  are  capable  of  recognise  aromatic  ncAA deriving from
phenylalanine57.
More  recently,  the  expanding  availability  of  genomic  data  from  bacterial  and  archaeal  species
allowed  the  identification  of  a  new  class  of  PylRS/tRNAPyl pairs.  Interestingly,  this  class  in
characterised by synthetases lacking the N-terminal domain responsible for tRNA binding. Unlike
some bacterial PylRSs, this domain is not expressed as an independent protein from a distinct gene,
but is completely absent instead63. Heterologous expression of PylRS/tRNAPyl belonging to this class,
denoted as  ΔN class to reflect the truncation of the N-terminal domain,  into  E. coli confirmed that
these synthetases are competent in performing aminoacylation and that the tRNAs are active amber
suppressors. While displaying natural cross reactivity among themselves, the heterogeneity among
members within the ΔN class and between the two different classes allowed engineering of mutually
orthogonal pairs64.
The Phosphoseryl-tRNA Synthetase/tRNA Pair
In spite of its rather limited substrate scope, an important pair used for genetic code expansion is
represented by the phosphoseryl-tRNA synthetase (SepRS) in combination with its cognate tRNASep.
Being one of the most common and pleiotropic post-translation modification, gaining insight into the
effect of phosphorylation events at different serines of various targets is an important research topic.
However, research into this PTM is limited by the polyspecificity of protein kinases39 and by limited
understanding of the enzymes responsible for phosphorylation at specific sites of target proteins.
An important breakthrough in the production of phosphorylated proteins  by genetic code expasion
came from the observation that several archaeal genomes, such as the ones from Methanocaldococcus
jannaschii,  Methanobacterium  thermoautotrophicum  and  Methanococcus  maripaludis, lacked  any  gene
which  could  be  associated  to  a  cysteinyl-tRNA  synthetase,  in  spite  of  its  existence  in  all  other
organisms known to date and in spite of the presence of cysteine in the proteome of those archaea65.
Several  hypotheses  were  formulated  to  explain  the  biogenesis  of  cysteine  incorporation  in  those
species  lacking CysRS,  including the  involvement of  ProRS in the  process  or  the existence  of an
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unusual new type of CysRS in those archaea65. However, in 2005 the Söll group proved that synthesis
of Cys-tRNACys in M. jannaschii is a two-step process which starts with the acylation of tRNACys by a
new homotetrameric class II aaRS capable of using O-phosphoserine (Sep) as a substrate, to form Sep-
tRNACys 66. Subsequently, a PLP-dependent enzyme is able to convert Sep-tRNACys into Cys-tRNACys
by using a sulphur donor to replace the phosphate group of Sep.
Following identification of this novel mechanism for cysteine synthesis and incorporation in some
archaea, the biochemistry of the interaction between SepRS and Sep or tRNACys was investigated. The
crystal structure of the enzyme revealed that phosphoserine recognition occurs by means of a precise
hydrogen bond network  established between the  phosphate  group and the  enzyme,  without  the
involvement of charge-to-charge interactions67. The formation of a large number of weak interaction,
compared to stronger  salt  bridge interactions,  ensures  high fidelity for  the correct  substrate over
isosteric analogues, like glutamic acid, which is present in the cell at a very high concentration (e.g. up
to 100 mM in E. coli grown in minimal medium68).
The discovery of this natural SepRS/tRNACys pair capable of generating Sep-tRNACys provided an
idea starting point for the expansion of the genetic code with phosphoserine. In 2011, Park  et al.40
described the generation of the amber suppressor tRNASep by mutating the M. jannaschii (Mj) tRNACys
at  the  anticodon  (G34C,  C35U)  and  at  position  20  (C20U).  This  tRNASep was  not  detectably
aminoacylated by E. coli aaRSs. Co-expression of this tRNA together with SepRS from the mesophilic
Methanococcus  maripaludis  in  a  strain  engineered  to  have  higher  intracellular  concentration  of
phosphoserine, a natural metabolite for E. coli, resulted in the synthesis of Sep-tRNASep, but in little or
no amber suppression, due to poor delivery of the aminoacylated tRNA to the ribosome. To account
for this, the group evolved a mutant of EF-Tu, called EF-Sep, with improved binding to Sep-tRNASep,
leading for the first time to amber suppression with phosphoserine in E. coli.
The system described by Park et al. suffered from poor overall amber suppression efficiency, due to
the severe loss of activity of SepRS on the amber suppressor mutant of Mj-tRNACys. Subsequent work
substantially improved the overall  activity of the pair by engineering the interaction between the
enzyme and its cognate tRNA's anticodon41.  This result  was achieved first by mutating the tRNA
sequence  surrounding  the  anticodon  to  identify  variants  which  performed  better  in  amber
suppression assays, then by evolving SepRS in its anticodon-binding domain. In the same work, the
authors proved that non-hydrolysable analogues of phosphoserine could  be incorporated by their
improved system as well. Subsequently, orthogonality of tRNASep was improved and the active site of
SepRS was expanded to accommodate  O-phosphothreonine42.  To date,  this pair  has been used to
elucidate  new  roles  for  protein  phosphorylation  in  in  vitro  and in  vivo  studies,  including  in
mammalian  cells69.
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Incorporation of Multiple ncAA into Proteins
Amber suppression represents a valuable tool for the co-translational incorporation of a single ncAA
into  a  protein.  Multiple  incorporations  of  a  single  ncAA  can  also  be  achieved  using  this  same
technology if multiple occurrences of the amber codon appear within the same open reading frame.
However,  due  to  competition  between  amber  suppression  and  protein  termination  by  RF1,  the
production  of  full-length  protein  decreases  progressively  when  increasing  the  number  of  stop
codons70.
When the experimental setup requires the incorporation of multiple distinct ncAA within the same
protein,  new  limitations  need  to  be  taken  into  account.  Firstly,  codons  availability  becomes  a
fundamental  limiting  factor.  While  intuitively  suppression  of  other  stop  codons  might  seem
reasonable, the higher frequency of TGA and TAA codons in the genome compared to TAG reduces
the fidelity of genetic code expansion using those codons, while at the same time reducing the overall
efficiency  of  suppression71.  In  fact,  TGA  suppression  by  a  mutant  tRNAPyl carrying  the  UCA
anticodon, which does not interfere with aminocylation by PylRS, is overall significantly less efficient
in E. coli while also suffering from a measurable level of natural suppression by the tRNATrp. Instead,
suppression  of  the  TAA  codon  does  not  suffer  from  background  suppression  from  endogenous
tRNAs but is the least efficient due to the double competition between the suppressor tRNA and both
cellular release factors71.
As an alternative to  suppression of  stop codons,  new black codons must  be generated to allow
incorporation of new ncAAs site-specifically. To achieve this, three approaches have been explored
which will be describe in the next paragraphs:
i) exploiting quadruplet codons;
ii) generating codons containing non canonical bases;
iii) re-assigning the sense codons at the genome-scale.
Availability  of  free  codons  represents  a  necessary  but  not  sufficient  requirement  for  the
incorporation of multiple ncAAs. In addition, a set of aaRSs/tRNA pairs must be available which can
use the ncAAs as a substrate and which are both orthogonal to the endogenous aaRSs/tRNA pairs
found in the host organism and also to each other. The problem of available orthogonal pairs will be
discussed later.
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Quadruplet Codons and Quadruplet-Reading Ribosomes
Given the four nucleotides which constitute RNA, a code composed of a combination of three of
those nucleotides will give rise to 64 possible words. However, if the code contained 4 nucleotides
instead,  a large number of new words would be generated which could be used to convey new
information. The possibility of using quadruplet codons instead of the universal triplet codons finds
its basis on the experimental observation of frameshift suppressor tRNAs containing an extended 8
nucleotide anticodon loop capable of suppressing single nucleotide insertion in Salmonella and yeast72.
Genetic code expansion using quadruplet tRNAs was explored by the Sisido group starting from
1999 in an in vitro system73,  74. They chemically acylated variants of the yeast tRNAPhe containing an
extended anticodon, including AGGU, CGGU, GGGU, CUAU, CCCU, CUCU etc. with ncAAs and
confirmed that they were effectively used during protein synthesis. These works also highlighted the
lack of cross-talk between different quadruplet codons, which was relevant to incorporate two distinct
fluorescent amino acids at two sites of calmoduline for FRET measurements75.
Later, examples of in vivo applications of genetic code expansion using quadruplets were shown by
Anderson et al.76 in 2004. Building on the knowledge that frameshift suppressors could be derived for
tRNAGln and tRNALys in  E. coli by expansion of the  anticodon loop,  they generated a  quadruplet
tRNALys with anticodon UCCU derived from Pyrococcus horikoshii and evolved it cognate synthetase to
incorporate homoglutamine. By combining this new pair with the mutant of Mj-TyrRS incorporating
O-methyl-tyrosine in response to the amber codon, they observed double incorporation of ncAAs into
myoglobin with a yield of ~15% compared to the wild type protein variant.
In spite of the possibility to perform quadruplet decoding, the wild type ribosome is not proficient at
it. Given its fundamental role in sustaining life, however, mutations affecting its activity are generally
poorly  tolerated  in  living  organisms.  In  order  to  circumvent  this  limitation,  Rackham  et  al.77
envisioned a strategy to generate an independent copy of the ribosome not involved in the translation
of cellular messengers, but directed instead towards a distinct subset of mRNAs, thus generating an
orthogonal translation system. To achieve this result, they hypothesised that mutations might exist of
the Shine-Dalgarno sequence of an mRNA which could prevent the binding of the small subunit of
the cellular ribosomes to it. At the same time, they hypothesised that an orthogonal small subunit
might contain mutations at the 3'-end of the 16S rRNA which rescues its binding to the mutant Shine-
Dalgarno sequence while minimising interactions with the wild type sequence. To achieve this goal,
they  generated  a  dual  positive-negative  selection  marker  by  fusing  in-frame  the  genes  for
chloramphenicol  acetyltransferase  (cat),  an  antibiotic  resistance  marker,  and  uracil
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phosphoribosyltransferase (upp), which confers sensitivity to 5-fluorouracil. They generated a library
of the SD sequence between positions -13 and -7 upstream of the start codon of the dual selection
marker, transformed it in cells and later grew them on 5-fluorouracil. Variants of the SD sequence
recognised  by  the  wild  type  small  subunit  resulted  in  the  translation  of  the  upp gene  and  cells
containing those variants were not viable. Subsequently, the dysfunctional variants were transformed
in  cells  together  with  a  library  of  mutants  of  the  3'-end of  the  16S  rRNA where  the  nucleotides
interacting with the SD sequence were randomised. Cells containing the two libraries were grown on
chloramphenicol to select combinations of SD sequence/16S rRNA which led to effective translation.
The selection was successful to identify more than one orthogonal SD/anti-SD sequence, an important
achievement towards the generation of an orthogonal cellular translation system.
This orthogonal small ribosomal subunit was later used as a starting point to overcome the above
mentioned limitations which are intrinsic to stop codon suppression and quadruplet decoding. First,
to improve the efficiency of amber suppression and limit the competition by the release factor, Wang
et al.78 designed a library of the 16S rRNA in the loop composed of positions 529 to 535, which was
observed to be located proximal to the A site where either the tRNAs or RF1 bind. This library was
interrogated  to  test  the  ability  of  the  variants  to  outperform  the  wild  type  ribosome  in  amber
suppression. To do this,  an orthogonal mRNA containing the  cat gene was constructed where the
gene  was  interrupted  by  the  UAGA  quadruplet  codon  to  be  decoded  by  a  tRNASer2 frameshift
suppressor  with  anticodon  UCUA,  as  a  proxy  for  amber  codon.  A  positive  selection,  using
chloramphenicol  in  a  similar  fashion  compared  to  what  described  above,  identified  Ribo-X,
containing only two mutations U531G and U534A, which significantly increases efficiency of read-
through  of  single  or  multiple  amber  stop  codons  to  allow  efficient  site-specific  incorporation  of
ncAAs.
As  a  last  step  on  engineering  for  the  16S  rRNA,  Ribo-X  was  further  optimised  for  quadruplet
decoding using different quadruplets79. Neumann et al. built several libraries of Ribo-X mutants and
performed a similar selection as before, using a reporter cat gene interrupted by an AAGA frameshift
insertion which could be suppressed by the quadruplet tRNASer2 with extended anticodon UCUU.
They hence identified a variant, named Ribo-Q1, containing two mutations, A1196G and A1197G,
which was capable of decoding quadruplet as efficiently as triplets, thus theoretically opening up a
very large number of black quadruplet codons for genetic code expansion. As a proof of principle,
Neumann  et  al. showed  that  it  was  possible  to  incorporate  two  distinct  ncAAs,  p-azido-L-
phenylalanine and Nε-[(2-propynyloxy) carbonyl]-L-lysine, at two distinct sites of calmodulin, which
could be used to perform intramolecular cycloaddition using Cu(I) catalysis.
This set of experiments demonstrated that the limitation in terms of codons availability for genetic
code  expansion can be effectively circumvented by the use of quadruplets in combination with an
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engineered ribosome. Importantly, this result  indicates that codons are not  the limiting factor for
incorporation of multiple ncAAs within one polypeptide. Furthermore, more alternative approaches
have been investigated for the same purpose, as discussed below.
Non-Canonical DNA Bases
In spite of the incredible variety of forms in which life on Earth is manifested, all biological entities,
from viruses to bacteria, archaea and eukaryotes, share a communal alphabet used to store genetic
information, composed of four different nucleotides which can interact by means of hydrogen bonds
to form two distinct base pairs (A:T and C:G). This peculiarity has led scientists to investigate whether
other types of genetic letters and genetic pairs could be useful candidates to fulfil the processes of
replication, transcription and translation which genetic material is required to undergo, or whether
only the existing ones were compatible with life as we know it.
Several investigations have been carried out in this direction. As an example, the Brenner lab tried to
develop  a  new  pair  which  would  still  rely  on  hydrogen  bonds  to  ensure  specificity  without
introducing erroneous matching.  In their first  approach80,  they noticed that the pyrimidine-purine
scaffold could theoretically accommodate 6 hydrogen bond patterns of donor/acceptor combinations
(some of which require repositioning of the nitrogens in the rings), but that only the two patterns
“donor-acceptor-acceptor”  (C:G)  “acceptor-donor-acceptor”  (T:A)  were  used.  To  add  the  pattern
“acceptor-acceptor-donor” they synthesised the bases isoC and isoG, and showed incorporation into
DNA and RNA. In addition, the lab proved that the new isoC-isoG pair could be effectively used in
ribosomal translation to guide the incorporation of the non-canonical amino acid iodo-tyrosine 81. In
their  experimental  setup,  the authors  generated an mRNA containing a “(isoC)AG” codon and a
synthetic  tRNA  with  anticodon  “CU(isoG)”.  When  the  synthetic  tRNA  was  not  aminoacylated,
skipping of the isoC base led the generation of a distinct product. However, when the synthetic tRNA
was aminoacylated with iodo-tyrosine, incorporation of this amino acid in the nascent polypeptide
was more efficient  than what could be  synthesised in  an equivalent  experiment involving amber
suppression instead.
While  being  the  first  non-canonical  bases  being  investigated,  isoC  and  isoG  were  subject  to
tautomerisation and hydrolysis, leading to undesired mis-matches. In another design82, they took into
account the evidence previously reported that natural base pairs present an electron density in the
minor groove from either the N3 of the purines or from the exocyclic oxygen of the pyrimidines, to
create  two new letters,  simply  called  Z and  P,  which  would retain this  feature  but  displaying a
hydrogen bond pattern “donor-donor-acceptor”, which is distinct from the two natural ones. In their
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work, they showed that DNA sequences containing the 6 letters ATGCZP can be replicated by a DNA
polymerase in vitro and that did not lead to unidirectional loss of the new bases, while still allowing
for occasional mutations, which are the substrate for evolution.
A different approach has been taken by the Hirao lab, that tried to identify a new pair which would
not rely on hydrogen bonds. To achieve this, they envisioned the use of hydrophobic interaction to
replace the natural hydrophilic interactions which characterise base pairing. They first designed the
two  bases  7-(2-thienyl)-imidazo[4,5-b]pyridine  (Ds)  and  pyrrole-2-carbaldehyde  (Pa)83 which  are
respectively bulkier than a purine and smaller than a pyrimidine, and showed that their unusual
hydrophobic  interaction  combined  with  unfavourable  steric  interaction  with  the  natural  bases
allowed them to form a new independent pair, while being effectively used for both replication and
transcription in vitro. This pair, however, suffered from Ds:Ds mis-matches. In a subsequent work84,
the group generated a new partner for Ds, 2-nitro-4-propynylpyrrole (Px), designed to improve shape
complementarity and electron potential complementarity, and showed that this new pair could be
effectively used for PCR.
Important progress in the attempt to incorporate non natural base pairs in a biological system came
from the Romesberg lab. Continuing in the research of pairs which would not take part in hydrogen
bonds, the group first investigated the use of nucleotides formed of two fused aromatic rings, called
d5SICS and dNaM85 and found out that this pair is capable of being used effectively for replication
with no bias for the sequence context surrounding the new pair, condition which is required to allow
encoding of the genetic material without restrictions. Later investigations from the same lab on an
updated synthetic pair of nucleotides, dNaM and dTPT3, made significant progress on the generation
of  an  organism with  an  expanded genetic  material86.  To  compensate  for  the  lack  of  biosynthetic
pathways for the production of those nucleotides, the group exploited the transporter for nucleotides
triphosphate from Phaeodactylum tricornutum to overcome the natural lack of import systems for NTPs
and dNPTs in E. coli, which is required to allow replication and transcription of the DNA containing
the non-canonical bases. By doing so, it was possible to demonstrate transcription of a reporter gene
containing a synthetic base within the middle position of a serine codon and translation of the same
reporter mediated by a tRNASer containing the anticodon with the complementary synthetic base.
Using a similar setup, incorporation of ncAAs was observed in response to the same non-canonical
codon  mediated  by  mutant  synthetases  and  adapted  tRNAs  derived  from  the  M.  jannaschii
TyrRS/tRNATyr pair or from the PylRS/tRNAPyl pair.
Overall, the progress in the development of additional DNA letters has opened the possibility of
generating  new  free  words  for  the  genetic  code.  While  this  option  is  still  in  an  early  stage  of
investigation, expansion of the base alphabet from 4 to 6 would theoretically enable a total of 63=216
codons, with a net increase of 152 new empty codons to be assigned to ncAAs at will.
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Codon Reassignment
In all organisms known the genetic code is degenerate, meaning that the number of codon is larger
than the number of amino acids it needs to encode for; nonetheless, every codon is used and no free
codons are available. A potential solution to the problem of expanding the amino acid pool for protein
synthesis would be redefining the meaning of a fraction of those codons in a genome-wide fashion.
While intuitively more straightforward, this strategy is significantly more challenging.
Since that the assignment of codons to amino acids is governed by aaRSs and their cognate tRNAs,
reassignment of a particular  triplet  to  a  different  amino acid means altering the  natural  tRNA(s)
which decode(s) that particular codon. However, it is easy to imagine how the manipulations of the
wild type set of tRNAs result in significant viability defects for the cells, due to interference with
translation of the essential  proteome.  Alternatively,  if  the endogenous tRNA are not  altered and,
instead, an extra tRNA which can be aminoacylated with a ncAAs is introduced in the host, a partial
reassignment of the codon is achieved which on the one hand limits the specificity of genetic code
expansion,  and  on  the  other  hand   might  show  various  degrees  of  toxicity  associated  with  the
production of dysfunctional proteins where the natural amino acids are replaced to some extent by
ncAAs30.
In a general sense, amber suppression represents a simple form of codon reassignment70. In this case,
however, the meaning of the TAG codon is specified by the release factor 1 rather than by a tRNA. As
such, amber suppression suffers from the limitations mentioned above in case of the addition of an
additional tRNA without alteration of the endogenous pool, although to a very minor extent. In spite
of it, the first attempts to fully reassign a codon were performed on the amber stop codon.
To obtain complete redefinition of the meaning of the TAG codon, two steps must be performed:
i) removal of all the undesired instances of this stop signal from the genome;
ii) deletion of the RF1 from the organism.
The first of these two steps is not trivial, considering the existence of over 300 annotated ORFs which
are  terminated by this  stop codon87.  In a  first  attempt  to circumvent  this  problem,  Mukai  et  al.87
generated a BAC containing the 7 known essential genes which are terminated by an amber stop
codon and edited them so that they would instead end with a TAA codon. In their experiment, they
did not  perform genomic manipulation of  the  amber-terminated genes  in  the  bacterial  host.  The
authors observed that, in the presence of this BAC, the otherwise essential prfA gene, coding for RF1,
could be knocked out to produce a mutant strain called  RFzero, but exclusively when an effective
suppressor tRNA was present in the cell. In this strain, TAG was effectively redefined to both natural
amino acids, like tyrosine, and to ncAAs like 3-iodo-L-tyrosine, however, growth was significantly
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slowed down compared to the wild type strain containing the BAC. Johnson et al.70 also investigated
the possibility to knock out RF1 in the E. coli DMS42 strain and verified that, while normally essential
in this strain, the prfA gene could indeed be deleted from the genome, but only after an alteration of
the prfB, gene coding for RF2. In fact, the authors noted that common E. coli strains derived from the
K-12 strain harbour a mutation in RF2 (Ala246Thr ) which lowers its release activity on the UAA
codon. By reverting this mutation, and by  removing the natural regulatory premature opal codon
within RF288, the authors could generated an RF1-knocked out strain, named JX3.0, where the UAG
codon  could  be  fully  reassigned  to  an  amino  acid  of  choice.  This  strain  also  allowed  multiple
incorporation of a single new amino acid in response to multiple instances (up to 6) of the amber
codon within a single CDS, without loss of efficiency.
A more systematic approach to try and edit all the instances of the amber codon was implemented
by Farren Isaacs  et al. by means of a genome editing method called  multiplex  automated  genome
engineering (MAGE)89-91. In this method, growing  E. coli cells expressing the  λ-red ssDNA-binding
protein β are electroporated with a pool of ssDNA oligonucleotides containing the desired mutations,
which are effectively used by the replication apparatus as primers for the synthesis of the lagging
strand. Due to the parallel nature of the genome editing events, MAGE could be effectively used to
induce the G to A mutation required to convert TAG codons into TAA codons. A subset of amber
codons  were mutated by this method in several different strains of  E. coli whose genome was later
combine  by  means  of  conjugative assembly  genome  engineering  (CAGE),  a  method which  takes
advantage of conjugation, to generate the new C321 strain. This was further engineered by deleting
the RF1 gene to produce the strain C321.ΔA, which displayed improved performance compared to the
previously generated strains in terms of growth speed, but still significantly slower than the starting
wild type strain.
Due to the constantly declining price for DNA synthesis, the chemical synthesis of recoded genomes
has been investigated by other groups, too. In 2016, Wang et al.92 investigated in a more methodic way
which schemes for codon reassignment would be viable in E. coli strains in which a stretch of 20 kbp
of genome, chosen to contain the highest  density of essential  genes,  was replaced with synthetic
recoded DNA. In their work, the authors designed a new  λ-Red based recombineering technology,
called REXER, in which the linear DNA substrate for recombination is generated in vivo by action of
the  CRISPR/Cas9 system and showed that it allowed efficient size-independent replacement of DNA
pieces of up to 100 kbp. They then used REXER to edit the chosen 20 kbp of the E. coli genome in 8
different ways to show that some designs were not compatible with life, while others were viable.
Later on, Fredens et al.30 implemented REXER iteratively to assemble the first synthetic E. coli, named
Syn61,  where  2  serine  codons  and  the  amber  codon  were  erased  globally.  In  their  work,  they
chemically synthesised an entire genome, recoded based on one of the reassignment schemes which
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were found to be viable in their previous work, in fragments of around 10 kbp, and hierarchically
assembled them into larger pieces to obtained 7 strains each containing between 0.5 to 1 Mbp of
recoded genome. Finally, an individual strain containing a fully recoded genome was obtained by
allowing the 7 intermediate strains to recombine following conjugation. The Syn61 strain doubles 1.6x
slower  than  MDS42  in  LB  medium  supplemented  with  glucose  at  37°C,  however,  it  is  viable 
following deletions of the tRNAs which decode the two serine codons globally removed, allowing for
the first time full reassignment of a sense codon in addition to the amber stop codon.
These works highlight how a significant effort is being made to create blank codons with the purpose
of  redefining  the  genetic  code.  This  commitment,  however,  requires  a  parallel  effort  aimed  at
expanding the availability of mutually orthogonal aaRSs/tRNA pairs. In the next sessions, the current
availability of pairs together with the difficulties connected to their discovery will be discussed.
Other Orthogonal Aminoacyl-tRNA Synthetase/tRNA Pairs
The TyrRS/tRNATyr from M. jannaschii and the PylRS/tRNAPyl from M. barkeri or M. mazei have been
extensively used for genetic code expansion due to their orthogonality and to the amenability of their
active site to be engineered to accommodate substrates different from their wild type amino acid 54.
However, the use of such a restricted number of orthogonal pairs presents some limitations. In the
first place, in spite of their versatility, both PylRS and TyrRS are mostly restricted to bulky and mostly
hydrophobic amino acids which can be recognised by means of non-specific interaction 54. Even when
mutants are known to incorporate the ncAAs of interest,  in order to incorporate multiple distinct
ncAAs  in  different  codons,  multiple  aaRS/tRNA  pairs  are  necessary,  each  of  which  should  be
composed of:
(i) a tRNA which decodes a distinct codon;
(ii) an aaRS which accepts only one of the ncAAs of interest as a substrate;
(iii) an aaRS which aminoacylates only its cognate tRNA and not any of the ones of the other pairs
or of the host's pairs.
In other words,  multiple mutually orthogonal  pairs are necessary. Lastly, even if PylRS does not
recognise the anticodon of its cognate tRNA and hence is not affected by mutations in that portion of
the tRNA, most of the other aaRS can tolerate minimal or no changes in the sequence of the anticodon
of their cognate tRNA without the need of additional engineering. For all these reasons, availability of
a  large  variety  of  mutually  orthogonal  aaRS/tRNA pairs  represents  an  important  aspect  for  the
progression of the field, as it would increase the chances of successfully evolving a ncAA-RS for a
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ncAA which differs chemically from what the currently available pairs can be engineered to accept.
This consideration is especially true as genetic code expansion progresses towards the synthesis of
polymers containing building blocks different from  α-amino acids, which for example could be  β-
amino acids, α-hydroxy acids, α-thio acids etc.28
Following  the  initial  identification  of  the  M.  jannaschii  TyrRS/tRNATyr pair  and  the  failures  of
generating  orthogonal  pairs  by  evolution  of  the  cellular  aaRS/tRNAs52,  interest  grew  for  the
possibility to identify new pairs derived from organisms evolutionarily distant from the chosen host.
One of the first of such attempts was the conversion of the yeast S. cerevisiae tRNAAsp and its cognate
S. cerevisiae  AspRS into an amber suppressing pair93. The anticodon of tRNAAsp represents a strong
recognition element  for  the  AspRS and the  activity  of  the  wild type enzyme towards the  amber
suppressor mutants of its tRNAAsp is compromised. However, the mutation of a glutamic acid residue
of the protein, which is responsible for mediating the interaction with the anticodon, to a lysine is able
to partially rescue the  aminoacylation of the tRNA. Pastrnak  et  al. observed that  the AspRSE188K/
tRNACUA
Asp
 constitute an effective orthogonal amber suppressor pair in E. coli, but that the efficiency of
suppression was very limited.
Soon after, a similar approach was used by Anderson et al. to identify an orthogonal LeuRS/tRNALeu
pair94. By speculating that archaeal pairs might have naturally diverged enough to become orthogonal
to their E. coli counterpart, the authors converted 5 known archaeal tRNALeu to amber suppressors by
mutating their anticodon, taking advantage of the lack of interactions between LeuRS and the tRNALeu
anticodon, then tested them alone or in combination to a limited selection of 6 archaeal LeuRS genes
in  an  amber  suppression  assay.  They  observed  that  the  LeuRS  from  Methanobacterium
thermoautotrophicum and tRNALeu from Halobacterium sp. NRC-1 can perform better than both the Sc-
AspRS/ tRNACUA
Asp  and the Mj-TyrRS/ tRNACUA
Tyr  in amber suppression. Another pair composed of a
tRNA and a synthetase from two different species was recently described as the Archaeoglobus fulgidus
tRNASer/Methanosarcina mazei SerRS95.  Unfortunately, no later uses of these pairs for genetic code
expansion have been reported yet.
Similarly, Chatterjee et al.96 verified whether a combination among the ones formed by a group of 6
different ProRS and 6 mutant suppressors tRNAPro of archaeal origin could constitute an effective
amber or quadruplet suppressor pair. Of those tested, they identified the Pyrococcus horikoshii ProRS
as a good partner for the Archaeoglobus fulgidus tRNAPro.
An interesting alternative, which resulted in generation of two other pairs, has been undertaken by
Santoro et al.97 and by Anderson et al.76, who generated de novo a tRNAGlu and a tRNALys, respectively,
not based on a specific existing sequence, but from the consensus sequence of a set of archaeal tRNAs
for the same isoacceptor class. Upon identification of orthogonal candidate tRNAs, the authors tested
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their performances as triplet or quadruplet suppressors when combined with synthetases for their
respective  amino  acids  whose  sequence  was  available.  Anderson  et  al. additionally  managed  to
engineer the LysRS from P. horikoshii to charge homoglutamine onto its cognate tRNA.
While several of the pairs mentioned above experienced a limited use in genetic code expansion, an
interesting case is represented by the E. coli tryoptophanyl-tRNA synthetase/tRNATrp pair. Italia et al.
showed that this pair can be successfully used to expand the genetic code of mammalian cells, but
also of E. coli itself98, provided the genomic allele coding for this protein was previously replaced with
the homologous orthogonal pair derived from S. cerevisiae99. Furthermore, it is worth noting that the
Ec-TrpRS/tRNATrp pair, in combination with the Mj-TyrRS/tRNATyr and the Mb-PylRS/tRNAPyl were
used to perform a triple incorporation of ncAA into a single protein in E. coli100. This result represents
an important expansion on the previous work in which combinations of the pairs described above
were used to perform dual incorporation of ncAAs79, 101-105.  
In all the above mentioned cases, orthogonality of the tRNA and or the synthetases was presumed
based  on  consideration  of  evolutionary  distance,  then  amber  suppression  was  used  to  verify
aminoacylation of the tRNA in the absence or presence of its cognate synthetase. In 2010 Yuan et al. 106
reported the identification of a subgroup of α-proteobacteria, among which is  Caulobacter crescentus,
that  present  a  tRNAHis missing  a  key  identity  element  normally  found  in  organisms  across  all
kingdoms  of  life,  namely  an  extra  G  at  the  5'-end  known  as  G(-1)  which  base  pairs  with  the
discriminator base C73. In light of this consideration, the authors verified that the Cc-HisRS does not
aminoacylate  E. coli tRNAs, while displaying activity towards its cognate tRNA, showing extreme
specificity for its wild type anticodon. For this reason, orthogonality of the tRNA and aminoacylation
by its cognate synthetase could not have been studied using amber suppression assays. Importantly,
the authors did not test orthogonality of Cc-tRNAHis in vivo in E. coli.
This  study highlighted that  orthogonality  and activity  of  an aaRS/tRNA pair  cannot  always be
assessed following alterations of the pair itself.  In the case above mentioned, the  Cc-HisRS would
have been mistakenly considered inactive on its tRNAHis if tested only in an amber suppression test.
Instead, the enzyme is competent for aminoacylation in E. coli, but mutations of the tRNA anticodon
abolish such interaction. Availability of this orthogonal pair, however, is valuable in itself in spite of
its inability to perform as an amber suppressor, because it cannot be excluded that its activity on the
mutant  tRNA can be restored following engineering,  as  for  the case  of  S.  cerevisiae  AspRS on its
cognate  tRNACUA
Asp ,  nor  that  the  pair  cannot  direct  incorporation  of  an  amino acid  of  interest  in
response to a different codon, being it a sense, a quadruplet or a non-natural codon. In addition, the
study highlighted how identifying tRNAs with new distinctive identity elements can successfully
identify orthogonal pairs from other classes of organisms, while previous efforts had mostly inferred
orthogonality  based  on  generic  considerations  about  phylogenetic  distance.  Furthermore,  all  the
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studies mentioned were characterised by a rather narrow focus on few aaRS/tRNA combinations
belonging to a specific isoacceptor class, and almost all of them make use suppression assays for the
investigation. In the following paragraph I will  discuss what makes the study of  orthogonality of
tRNA and synthetases difficult in vivo without relying on translation-based assays.
Testing Orthogonality of tRNAs and aaRSs
When expressed in a host organism, an orthogonal tRNA cannot be aminoacylated by any of the
host's  aaRSs,  but  it  is  substrate  for  its  cognate  synthetase.  Similarly,  an  orthogonal  synthetase
exclusively aminoacylates its cognate tRNA, but does not aminoacylate any of the host's tRNAs. For
any non-suppressor tRNA which has its native anticodon, easy-to-perform reporter assays cannot
detect its aminoacylation status. In fact, as every sense codon in  E. coli is read by the endogenous
pairs, the production of the reporter cannot be correlated with the expression or aminoacylation of the
potentially orthogonal tRNA. On the other hand, suppressor tRNAs are not natively present in the
host,  hence orthogonality of a suppressor tRNA can be deduced by the lack of production above
background of a reporter interrupted by a stop or quadruplet codon in the presence of the tRNA of
interest; production which should increase upon co-expression with its cognate synthetase.
When translation-based assays are not available, a different method needs to be used to verify the in
vivo aminoacylation status of a tRNA. An important type of analysis on tRNAs was developed by
Varshney et al. in 1991, when the authors observed that electrophoresis could be used to resolve the
aminoacyl-tRNAs from their free counterparts under appropriate conditions107. In E. coli, tRNAs range
in size from 74 to 95 bp14, which equates to a molecular weight between ~24 and ~31 kDa. Conversely,
the molecular weight of proteinogenic amino acids varies between 75 Da for glycine to 204 Da for
tryptophan. As a result, the covalent attachment of an amino acid can at most increase the weight of a
tRNA  by  <1%.  In  spite  of  this,  the  authors  reported  that  running  a  tRNA  sample  on  a  urea
polyacrylamide gel buffered at pH 5 using NaOAc was an effective way to resolve the two species
over a run of about 20 cm. Given the poor electrophoretic mobility of tRNAs under those conditions,
though, this PAGE require several hours to be completed. Furthermore, if more than one species is
present in the sample, analysis of a specific tRNA of interest requires the use of northern blotting
following the electrophoresis.
This  method allows  to  verify  in  vitro  whether  aminoacylation  occurred  in  vivo in  a  direct  way
without  relying  on  a  proxy.  In  spite  of  its  surprising  effectiveness,  this  approach  is  particularly
laborious and time consuming to implement  for  the  analysis  of  multiple  different  species.  Other
techniques developed later allowed to retrieve the sequences of the aminoacylated tRNA species by
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using a combination of NaIO4 oxidation, T4 ligation or poly-A addition and reverse transcription108, 109.
Classical biochemical studies had shown that the strong oxidiser NaIO4 is capable of reacting with the
3'-end  of  tRNAs,  where  the  only  vicinal  diol  moiety  of  the  molecule  is  present,  to  form  a
dialdehyde110. However, when an amino acid is bound to the tRNA, one of the two hydroxyl groups
at the 3'-end is esterified, hence the diol is protected from oxidation. As this reaction can be carried
out  at  acidic  pH  when  aminoacylation  is  stable,  this  oxidation  permanently  converts  the
aminoacylation status at a given time into a chemical fingerprint. Following oxidation, the amino acid
can be  cleaved off  to  expose a free 3'-end,  amenable to enzymatic modifications such as  adaptor
ligation or poly-A polymerisation, while oxidised tRNAs cannot be modified. The samples can then
be reverse transcribed and PCR amplified or sequenced to obtain information about aminoacylation.
However,  as  tRNAs  are  highly  structured  and  modified  nucleic  acids,  reverse  transcription  is
notoriously problematic on them111, and furthermore orthogonal tRNAs get fully oxidised by NaIO4,
which means they are lost  during the downstream processing if  this method is  used to measure
orthogonality, such that the method would rely on negative data. Additionally, these methods require
significant hands-on processing and have been primarily used to study the aminoacylation status of
endogenous tRNA species.
Opposite to the case of tRNAs, orthogonality of the synthetases cannot be tested conclusively in vivo
for any synthetase which recognises proteinogenic amino acids. In fact, given an aaRS for a particular
isoacceptor class (e.g.: alanine), anomalous aminoacylation of the host's tRNAs for all the remaining
classes with the incorrect amino acid (e.g.: alanine) can theoretically be investigated, but there is no
experimental  design  to  date  which  can  reveal  whether  the  synthetase  under  investigation  can
aminoacylate the endogenous tRNAs for the same isoacceptor class, because they would be always
charged  in  vivo  with  that  amino  acid  (alanine)  regardless  of  whether  the  aaRS  is  orthogonal.
Consequently,  to circumvent this limitation most researchers have opted for in vitro aminoacylation
assays, which are performed using the purified synthetase under investigation and a tRNA extract
containing  the  deacylated  host's  tRNAs  only,  or  the  deacylated  host's  tRNAs  together  with  the
deacylated orthogonal tRNA40, 93, 94, 97, 112. In a hypothetical scenario, when provided with ATP and the
appropriate amino acid, no aminoacylation reaction should occur when the synthetase is incubated
only  with  the  host's  tRNA.  However,  this  setup  does  not  take  into  account  that  in  the  cell  no
synthetase  is  challenged  with  a  high  amount  of  deacylated  tRNAs  of  many  distinct  isoacceptor
classes, as in the cell a significant fraction of them are charged by their respective synthetases which
have  to  compete  to  target  their  specific  substrates.  Consequently,  this  approach  may  potentially
underestimate orthogonality for synthetases.
The considerations above highlight why identification of orthogonal pair has been attempted on a
small scale by verification of the behaviour of a single or few combinations of tRNA/synthetase in the
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host. This led us to consider which potential routes could be envisioned to establish a general way to
identify new orthogonal pairs, independently of their isoacceptor class and of the identity of their
anticodon.
Aim of the Project
In  order  to  overcome  the  current  limitations  in  availability  of  orthogonal  aminoacyl-tRNA
synthetase/tRNA pairs, we decided to develop a new approach which would take advantage of the
knowledge of how E. coli aaRSs recognise their substrate but which could be applied on a larger scale
and on pairs belonging to any isoacceptor class. We decided to set up a hierarchical approach which
would focus on the identification of orthogonal tRNAs first, as they can be tested with greater ease,
and  later  to  the  identification  of  a  cognate  active  and  orthogonal  synthetase.  Importantly,  as
alterations of a tRNA's anticodon can interfere both with its orthogonality and with its interaction
with its cognate aaRS, we chose to perform our analysis on tRNAs with their native anticodon. It is
important to notice that identifying orthogonal pairs this way does not ensure that these pairs can
perform effectively in amber suppression,  which is  currently the most  widely used technique for
genetic code expansion, nonetheless, as the field progresses availability of new pairs will be required
for applications beyond the suppression of stop codons.
In order to identify tRNA to test, we decided to rely on the natural divergence of these sequences
among the multitude of living organisms. As next-generation sequencing becomes more and more
applied, millions of new genomes become a valuable source for tRNA sequences, and for this reason
we decided to generate an initial list of candidate tRNA starting from available databases data. As a
key requirement for tRNA orthogonality is that, when introduced in E. coli, no aminoacylation should
occur,  we  decided  to  filter  the  database  developing  a  simple  metric  which  would  relate  to  the
presence  along  the  tRNA  sequence  of  the  identity  elements  for  E.  coli (Ec)  aaRSs,  under  the
assumption that sequences lacking these identity elements would have reduced likelihood of being
aminoacylated. Having identified a list of candidates, we would experimentally test their behaviour
in live cells. For the reasons discussed before, it was immediately clear that aminoacylation could not
be tested relying on translation-based reporter assays, hence a new kind of assay had to be developed
which could satisfy our experimental requirements.
While not being recognised by any of the  Ec-aaRSs, orthogonal tRNAs must be charged by their
cognate aaRS. For tRNAs which could not be aminoacylated in vivo in E. coli, we decided to rely on
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genomic data to identify, in the genome from which the tRNA was identified, the cognate aaRS for the
same isoacceptor class as the tRNA under investigation (e.g.: AspRS for a tRNAAsp etc.). Upon co-
expression of  the  two components  of  the  pairs  together  in  the  same cells,  aminoacylation of  the
heterologous tRNA implies that the synthetase is correctly expressed in a catalytically proficient way
and that it can effectively recognise its tRNA. However, this test is not sufficient to make sure that the
heterologous  synthetase  cannot  mis-aminoacylate  any  of  the  other  endogenous  Ec-tRNAs.  We
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Figure 1.3: Schematic representation of the pipeline developed for the identification of aminoacyl-tRNA synthetase/tRNA
pairs identified in living species and orthogonal in E. coli. (1)  Generation of a list of candidate orthogonal tRNAs, selected
among the ones annotated in tRNA databases, with a higher likelihood of being orthogonal in E. coli based on preliminary
considerations. (2)  expression of the candidate tRNAs in E. coli to verify which ones can be detected in cytosolic extracts but
which cannot be aminoacylated by E. coli aaRSs. (3) Co-expression of the tRNA and cognate aaRS from the same organism
as the tRNA in E. coli to identify active pairs in which aminoacylation of the tRNA is dependent on the presence of its cognate
synthetase.  (4) Verification of the orthogonality of the exogenous aaRSs with respect to the endogenous E. coli tRNAs to
confirm orthogonality of the pair as a whole. 
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decided to test orthogonality for these enzymes  in vitro,  in spite of the limitations of this kind of
assays.
In summary, the problem of identifying orthogonal pair was divided into a sequence of steps, each of
which focused on:
i) generation of a list of candidate orthogonal tRNAs;
ii) characterisation of the interaction between the candidate tRNAs and the E. coli aaRSs; 
iii) characterisation of the interaction between the orthogonal tRNAs and their cognate aaRS;
iv) characterisation of the interaction between active aaRSs and E. coli tRNAs. (Figure 1.3).
In the next chapter I will describe how we implemented the strategy described herein to screen a
large number of tRNAs and synthetases and how this allowed us to identify new orthogonal pairs. I
will then describe how I attempted to engineer these pairs for the particular use of amber suppression
for genetic code expansion and how this engineering process improved the activity and orthogonality
of the pairs.
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As next-generation sequencing technology progresses and our capability to  read entire genomes
becomes  faster  and  cheaper,  large  collections  of  data  are  now  publicly  available  in  the  form of
annotated databases. In 2011 a group of researchers from Japan led by Takashi Abe produced a work
in which they reported the creation of a database, tRNA-DB-CE, containing the sequence information
of the tRNAs present in these deposited genomes26.  The authors decided to rely on three distinct
searching algorithms, tRNAscan-SE113, ARAGORN114 and tRNAfinder115 to maximise the accuracy of
the identification of tRNAs and furthermore they verified individually all the instances in which the
35
Daniele Cervettini Ph.D. Thesis
predictions from these three softwares differed. Their database stores information about primary and
secondary structures, anticodon, species and genome of origin for several millions of tRNAs from
bacteria, archaea, phages, chloroplasts and metagenomes.
In our study we decided to exploit the variability generated by the natural divergence among species
to  identify  tRNAs  which  lack  the  distinctive  features  recognised  by  E.  coli aaRSs,  which  we
hypothesised would make them more likely to be orthogonal in this host. In order to do this, we used
the information contained in  the  tRNA-DB-CE as  our  starting  point.  The  computational  analysis
which will be described in the following sections was performed together with Dr. Stephen Fried.
Reliable tRNAs for every isoacceptor class from complete or drafted bacterial and archaeal genomes,
together  with  those  from  phages  and  chloroplasts,  were  downloaded  and  split  based  on  their
isoacceptor class.  The database contained 2,799,231 entries as of March 2017 including tRNAs for
selenocysteine and natural suppressor tRNAs. Importantly, as the isoacceptor class is assigned to each
entry based on the sequence of its anticodon, special attention had to be paid when considering the
tRNAIle with anticodon CAU. In fact, while ATG is the methionine codon in the most widespread
genetic code, the ATA codes for isoleucine, so that the cells would require a tRNA Ile with anticodon
UAU. However, as this last anticodon would base pair with the codon ATA but also wobble with the
methionine anticodon ATG, cells have developed a remarkable post-transcriptional modification to
tRNACAU
Ile which converts C34 to lysidine, an unusual nucleotide which base pairs with A without
wobbling with G due to steric clashes. As a result,  tRNACAU
Ile annotated as tRNAMet were manually
corrected to tRNAIle. In addition, tRNAMet were divided between initiators and elongators, and only
the latter were used for the analysis. Following this initial processing of the data, all the sequences
were aligned to a standard canonical tRNA archetype, as described below.
tRNAs Alignment to Canonical Form
E. coli  genome contains 86 tRNA genes of which 48 distinct sequences used to decode for the 20
canonical amino acid and selenocysteine14. In spite of the general diversity in their primary sequence,
all of them share some features:
1. The acceptor stem is 7 base pair long for all canonical amino acids, with the selenocysteinyl-
tRNA being the only exception with a distinctive 8 base pairs long acceptor stem;
2. base 8 is always U and does not base pair, and neither does base 9;
3. the sequence GG present in the D loop is assigned always to canonical positions 18 and 19, in
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order to do so occasionally positions 17a, 20a and 20b are assigned; 
4. the anticodon stem is 5 base pairs long, the anticodon loop is 7 nucleotides long;
5. positions 54→56 are assigned to the sequence TΨC which is conserved for all of them; the
TΨC stem is 5 base pairs long and the loop is 7 nucleotides long.
6. positions 74→76 have the conserved sequence CCA across all kingdoms of life.
Given the conservation of these general features, tRNAs can be aligned to a canonical form. As the
variable loop occasionally contains only 4 nucleotides, in the alignment shown position 46 might be
not assigned. To proceed with our analysis, we decided to align all tRNAs from the database to this
canonical form. Notably, positions 74→76 are always represented by the nucleotides C, C and A even
if the tRNA gene has a different sequence for those nucleotides, as many organism, among which is E.
coli, possess a quality control apparatus able to add this 5'-CCA-3' tail to tRNAs terminating with a
different  sequence116.  As a  result,  these  positions  are  not  informative  and a  73  nt  alignment  was
generated.
The conversion to this canonical form is mostly straightforward given the secondary structure of a
tRNA, but in some circumstances decisions were taken discretionally:
• for  tRNAs with acceptor  stem 8  nucleotides  long,  the  first  7  base  pairs  were  assigned to
positions 1→7/66→72,  considering that  the only  E. coli tRNA with such feature,  tRNASeC,
aligns in such manner to the tRNASer, with which it shares the recognition by the SerRS;
• if the D arm is formed of 3 base pairs, positions 13 and 22 are assigned to the first and last
nucleotides of the D loop;
• in  E.  coli  the D  loop  presents  some  degree  of  variability,  but  every  tRNA  presents  two
distinctive Gs which are always assigned to positions 18 and 19. As the loop starts at canonical
position 14 and ends at canonical position 21, to account for the difference in length of this
loop sometimes it is necessary to assign the additional positions 17a, 20a or 20b or leave some
positions unassigned in E. coli tRNAs. Given the higher digree of variability found among the
tRNAs in the database, and given the frequent lack of G18 and G19, the alignment for this
structural  element was manually generated as  shown in  Chapter V – Appendix:  D Loop
Alignment Table. The extra positions 17a, 20a and 20b are not used in the 73 nt alignement;
• as  the  variable  loop  can  have  a  very  broad  range  of  lengths,  the  positions  44→48  were
assigned in the following order: 44→48→45→47→46. For loops longer than 5 nucleotides, the
first two positions are numbered 44 and 45, while the last three are numbered 46→48.
Following the above listed rules, all the tRNAs were converted into a multiple alignment.  As an
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example, let us consider a tRNA with the following sequence, corresponding to the tRNAArg from
Aquifex aeolicus VF5 with accession number C000013 in tRNA-DB-CE:











































































































































The top line represents the canonical numbering scheme, the bottom line is a conventional way of
representing  secondary  structures  of  nucleic  acids  when  no  knots  are  presents.  In  particular,
nucleotides in open brackets base pair with nucleotides in close brackets in the order in which the
brackets  appear  (e.g.:  the  first  closed  bracket  base  pairs  with  the  last  open  bracket).  Unpaired
nucleotides are represented by dots.
In the case above, the D loop has a length of 9, so that position 20a needs to be specified. Given the
alignment, the 73 nt form is obtained by removing positions 20a and 74→76 to obtain


































































































































After having performed this type of alignment,  the 20 isoacceptor classes were highly redundant,
both  because  the  same  tRNA can  be  annotated  in  multiple  organisms,  in  multiple  strains  or  in
multiple genome assemblies of the same organism, and because distinct tRNAs can have the same
alignment by compression of the sequence in the D and variable loops. Sequences with the same 73 nt
alignment  were  compressed  together,  then  each  unique  sequence  was  evaluated  by  a  scoring
algorithm, as described next, to highlight which one is more likely to be orthogonal.
In an attempt to develop a filter which could be applied easily, we decided to undertake a simplified
approach where each tRNA is scored for its potential to interact with each of  E. coli  aaRSs simply
counting how many of its nucleotides at the positions which are recognised as identity element by
that  particular  aaRS  match  the  nucleotides  which  are  found  on  the  aaRSs'  endogenous  tRNA
substrate. As an example, let us consider again the tRNAArg from Aquifex aeolicus VF5:


































































































































Let us now try to observe how it compares to the Ec-tRNATrp:


































































































































As mentioned before,  in  a simplified model we can hypothesise  that  Ec-TrpRS only tests  which
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The two tRNAs have the same nucleotides at positions 2, 3, 35, 70 and 71, but differ at positions 1, 34,
36, 72 and 73. If each matching position is scored +1 and each different position is scored -1, the total
score of Aquifex aeolicus VF5 tRNAArg for the identity elements of Ec-TrpRS is calculated as the average
[5(+1)+5(-1)]/10=0.
Scores thus calculated are the mean of a set of numbers which can only be -1 or +1 and for this reason
each score is contained within these boundaries. Analogously,  Aquifex aeolicus VF5  tRNAArg can be
compared to each of the 47 E. coli tRNAs for the 20 natural amino acid to verify how similar it is to
known substrates for the E. coli aaRSs, generating 47 scores. For synthetases which can aminoacylate
multiple isoacceptor tRNAs, as in the case of LeuRS or SerRS etc., the comparison was performed
between the tRNA under investigation and each of the  E. coli isoacceptors individually,  then the
scores were averaged to obtain a single score, so that eventually each tRNA received 20 scores, one for
each aaRS.
This approach evaluates every identity element with the same weight, while it is likely that not all
interactions contribute equally to the binding energy. As an example, the presence of a G in position
34 or 35 of the anticodon might completely prevent binding of a tRNA to the TrpRS due to stearic
clash  of  a  larger  purine  in  place  of  a  pyrimidine;  however  characterisation  of  these  types  of
interactions would require extensive experimental validation and cannot be effectively modelled  a
priori. We hence decided to verify if this simple scoring system could be used to model the interaction
between tRNAs and aaRSs and in order to achieve this validation we verified how the set of  E. coli
tRNAs themselves,  which  are  naturally  mutually  orthogonal,  would  be  evaluated  by  the  metric
described.
E. coli tRNAs Scoring
In the scoring system described above, the endogenous E. coli tRNAs are effectively used as model
substrates for their synthetases, while the aim of the procedure is to estimate whether a particular
tRNA of interest would be a substrate for the E. coli aaRSs. In order to validate how the score for a
given aaRS correlates with the likelihood of recognition and aminoacylation by that aaRS, we needed
a training set of tRNAs whose interaction with the  E. coli enzymes is known. In order to refine the
scoring to achieve improved predictive power within the limits of the simplifications applied, a large
training set is required. However, we reasoned that the largest set of sequences whose interactions
with E. coli synthetases is experimentally validated was constituted by the E. coli tRNAs themselves,
with the limited addition of few orthogonal tRNAs which are known not to interact with any of them.
In fact, as a requirement for the fidelity of protein synthesis, each of the endogenous tRNAs must be
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aminoacylated exclusively by its cognate aaRS while being orthogonal to the other 19 present in the
cell.
As the  E. coli tRNAs are present in the database, we retrieved the scores assigned to them by the
algorithm described (Figure 2.2a).  For each isoacceptor class containing only one tRNA, the score
attributed  to  that  tRNA  for  the  corresponding  synthetase  was  equal  to  +1  by  definition.  When
multiple isoacceptors are present,  the score can still  be +1 if no variation is present in any of the
isoacceptors at the identity elements, as in the cases for glycine, proline, threonine, tyrosine or valine.
For other classes the score for their cognate aaRS was lower than +1, nonetheless in most cases it was
the highest among the scores for all synthetases, indicating a strong correlation between the scores
and the aminoacylation in vivo. There are, however, some exceptions to this observation. For example,
the Ec− tRNACCT
Arg  has  a  higher  score  for  the  IleRS  and  for  the  LeuRS,  which  would  suggest  an
interaction which is not known to occur. Given the simplicity of the model, however, a number of
false positive and a number of false negative predictions are expected to occur. In fact, it is important
to notice that identity elements are often characterised as the positions along a tRNA which, when
mutated, abolish aminoacylation by the cognate aaRS. In this context, identity elements behave as
nucleotides necessary for aminoacylation. When studing aminoacylation of a tRNA by a non-cognate
aaRS, on the contrary, it is crucial to understand if a given set of nucleotides is  sufficient  to lead to
recognition of that tRNA by the aaRS. For this reason, it is easy to hypothesise that our knowledge on
the identity elements which are sufficient for mis-aminoacylation is incomplete, resulting in a loss of
predictive power by the algorithm. In spite of these considerations, nonetheless, higher scores were
calculated for the cognate synthetases of each tRNA, while the largest portion of the score matrix was
composed of entries ≤0 (Figure 2.2a).
The score matrix for individual isoacceptors did not identify a specific threshold above which a score
unambiguously predicted a successful interaction and below which aminoacylation could not occur.
In order to account for the variation within a given isoacceptor class, we calculated the average scores
that tRNAs from the same isoacceptor class were given for each of the E. coli aaRSs (Figure 2.2b). In
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Figure 2.2: a) Scores for each of E. coli isoacceptor tRNAs individually. b) Average scores of isoacceptor tRNAs. c) Scores
for the two known orthogonal tRNAs Mj-tRNATyr and Mb-tRNAPyl. Scores >0.50 are highlighted with a box. 
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this  new  matrix,  we  observed  that  values  of  >0.50  only  occurred  along  the  diagonal,  while
orthogonality between a tRNA and an aaRS effectively correlated with a score of ≤0.50. Notably, the
elongator tRNAMet scores only 0.33 for the MetRS, for which it is a known substrate. This is due to the
divergence in sequence between the elongator and the initiator tRNAs, however a lower score does
not imply orthogonality in this case.
In summary, the matrix of the average scores for each isoacceptor class suggested that a score of
>0.50 is a good indicator for interactions, while a score of  ≤0.50 most of the times correlated with
orthogonality. Clearly, this metric is not completely predictive, however it is important to highlight
that the primary goal of our investigation was to develop a general pipeline for the identification of
orthogonal pairs, not the validation of an algorithm with high predictive power. In particular, we
intended  to  perform  a  simple  automatic  filtering  procedure  which  would  exclude  from  a  large
starting dataset the tRNAs which are very similar to the endogenous E. coli tRNAs, hence less likely to
be  orthogonal,  while  highlighting entries  whose unusual  characteristics  might  have resulted in  a
higher chance of being orthogonal. Furthermore, the experimental characterisation of a larger number
of tRNAs is an important step to calibrate a more predictive metric. Hence, we chose to verify if a
threshold of 0.50 would correctly identify the Mj-tRNATyr and Mb-tRNAPyl as orthogonal (Figure 2.2c).
While  the  former  tRNA  sequence  is  contained  in  the  dataset,  the  latter,  being  a  natural  amber
suppressor tRNA, was not included, hence it was manually aligned taking into account the unusual
characteristics of its secondary structure, then scored by the algorithm. Importantly, none of the scores
for these two known orthogonal tRNAs were >0.50. 
Overall, the scores generated by the procedure described seemed to recapitulate quite effectively the
interaction network among Ec-tRNAs and Ec-aaRSs. Noticeably, effective interactions which result in
aminoacylation within our dataset are assigned positive scores almost always  >0.50, while in some
instances successful  interactions occur when the score is  ≤0.50 but  >0.00. Conversely, interactions
between a tRNA and a non-cognate synthetase are largely characterised by scores ≤0.50, even though
in some specific cases a high score did not correspond to incorrect recognition.
Given that the sequences available in the database were several orders of magnitude higher than the
number of tRNAs which could be experimentally tested, and in light of the observation stated above,
we  decided to  undertake  a  conservative  approach  in  the  interpretation  of  the  scoring results.  In
particular, we 
i) filtered out  of  our  dataset  all  tRNAs with  a  score  of  >0.00  for  the  Ec-aaRS for  the  same
isoacceptor class;
ii) classified the remaining tRNAs in two groups: sequences for which  any of the other scores
were  >0.50 were classified as Tier 1 candidates, while tRNAs for which all the other scores
were ≤0.50 were classified as Tier 2 candidates.
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This  process  produced  a  list  of  candidate  tRNAs  for  each  isoacceptor  class  whose  size  was
significantly reduced compared to the initial number of distinct entries in our dataset (Figure 2.3).
Among these, we chose a subset of about 10 to 30 tRNAs per isoacceptor class, mostly among the Tier
2 candidates but including some from Tier 1, which we experimentally tested for orthogonality in E.
coli. 
An in vitro Assay to Test Aminoacylation: tREX
The development of the scoring system described before tackled the first of the goals of the project
(Figure 1.3 (1)), i.e.: generating a list of candidate orthogonal tRNAs containing sequence more likely
to be orthogonal. In order to successfully identify orthogonal pairs, however, experimental validation
was  required  to  verify  whether  those  tRNAs  would  be  expressed  and/or  aminoacylated  when
introduced into our host of choice, E. coli. While methods to test the aminoacylation status of a tRNA
of  interest  were  available  (see  Testing  Orthogonality  of  tRNAs  and  aaRSs),  all  of  them  were
developed to test moderate number of samples and were laborious and time-consuming, so that none
of those were appropriate to efficiently screen a few hundred tRNAs, as we had committed to do. In
order to overcome the limitations which those techniques had, I wanted to create an assay which
would satisfy three conditions:
i) to be independent of the anticodon of the tRNA under analysis;
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Figure 2.3:  Number of  distinct  entries,  sorted based on their  isoacceptor class  and displayed on a logarithmic scale,
downloaded from the database and composing the initial dataset (grey bars), and sequences selected after the application of
the filter described in the text (black bars). The filter effectively reduced the number of entries of 2 to 3 orders of magnitude.
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ii) to be independent of the nature of the amino acid bound to the tRNA of interest;
iii) to be easily scalable to allow investigation of multiple tRNA in parallel.
To achieve such results, a new assay would have to rely on few steps of manipulation of the samples
and on a non labour-intensive detection method. Due to its widespread use, I started by analysing
what factors were limiting in the application of acidic urea PAGE to our project. This technique was
completely independent of the anticodon of the tRNA of interest – hence condition i) was satisfied –
and requires essentially no manipulation of the tRNA samples after extraction, because the difference
in electrophoretic mobility between the aminoacylated and free tRNA is given by the amino acid
itself, hence they can be immediately run on the gel. However, this direct link between amino acid
and  electrophoretic  mobility  implies  that  distinct  amino  acids  cause  variable  retardation  to  the
migration speed – thus not satisfying condition ii). Furthermore, this difference can only be observed
after  a  migration of several  tens of centimetres,  which in  those  conditions require  several  hours.
Additionally, visualisation of the specific tRNA of interest in the complex mixture of cellular tRNAs
relies  on  northern  blotting.  As  a  consequence,  the  manipulation  of  the  sample  following  the
electrophoresis was quite significant, as each tRNA needed to be assayed by a different probe on a
different  membrane,  thus not  satisfying condition  iii).  These practical  considerations excluded the
possibility  to  use  this  technique  for  our  purpose.  However,  I  reasoned  that  converting  the
aminoacylation status of a tRNA into an alteration of its electrophoretic mobility could be a fruitful
way to approach the problem. I decided to explore variations of this method in which:
a) detection would not require additional steps following electrophoresis;
b) the difference in electrophoretic mobility between the aminoacylated and free species would
be generated indirectly and would be larger than the one caused directly by the presence of
the amino acid, hence eliminating the need of running lengthy gels.
To implement variation a), I decided to alter the design of the probes used for northern, which are
normally  biotinylated,  and to  label  them using a  fluorophore  instead.  In  fact,  if  hybridisation  is
performed before electrophoresis, this variation allows to directly visualise the specific target among
all the cellular tRNAs by means of in gel fluorescence. Clearly, this approach cannot be undertaken in
the context of acidic urea PAGE, as the binding of a probe to the tRNA of interest would greatly
reduce the retardation caused by the amino acid. As nucleic acid are commonly stained with green-
fluorescent  dyes (e.g.:  SYBR Gold)  which absorb blue light  around 488 nm and emit  green light
around 520 nm, probes labelled using the cyanine 5 (Cy-5), which absorbs around 635 nm and emits
around  670  nm  allows  multi-colour  imaging  without  any  spectral  overlap  among  different
fluorophores.
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Figure 2.4: Designs for in vitro aminoacylation assays. I: probe hybridisation. II: RNAse T treatment. III: DNA polymerase
treatment.
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However,  envisioning  an experimental  design  that  would implement  the  variation  b)  was  more
challenging.  In  a  first  attempt,  I  hypothesised the use  of  a  3'-to-5'  ssRNA-specific  exonuclease  to
reduce the size of free tRNAs, under the working hypothesis that aminoacylation could serve as a
protecting group to prevent  the enzyme from digesting aminoacylated tRNAs (Figure 2.4a).  This
would result in an increase in mobility for the free species dependent on the degree of digestion of its
3'-end. Unfortunately, this design is limited by the fact that the only available RNAse presenting the
required  characteristics  is  RNAse  T,  an  enzyme naturally  involved in  trimming  of  the  3'-end of
tRNAs. This nuclease has evolved to stall when the sequence 5'-CC-3' occupies its active site, which
always occurs immediately after cleaving of the universally conserved A at the very 3'-end of any
tRNA. As a consequence, this method only allows removal of a single nucleotide from tRNAs, which
is detectable on gels, but does not constitute the significant improvement I desired.
Alternatively, I hypothesised that extension of the free 3'-end of non-aminoacylated tRNAs could be
more versatile to induce a tunable variation in electrophoretic mobility. In this idea, the DNA probe
would be annealed to the 3'-end of its target tRNA generating a protruding 5'-end of ssDNA and a
recessed 3'-end of RNA (Figure 2.4b). As DNA polymerases, like the Klenow exonuclease-deficient
fragment of E. coli DNA polymerase I, can easily use RNA as a primer, in this design the probe also
serves as a template for the extension of the tRNA with extra nucleotides. In this context, it is easy to
imagine  how  aminoacylation  would  prevent  extension,  hence  generating  an  electrophoretic
retardation which can be altered at will, since the template can be arbitrarily chosen of any length and
sequence.
While this alternative was significantly more promising than the previous one, it presented a key
limitation. In fact using the aminoacylation as a protecting group can be effective exclusively under
those conditions which preserve it,  i.e.:  at  pH 5.  At this pH, many enzymes are not  catalytically
competent, and in particular the Klenow fragment of DNA polymerases I did not display any activity.
Conversely, at a more favourable pH in which the polymerases are active, aminoacylation is labile
and full extension of the tRNA of interest is observed (see below).
A key contribution which allowed to simply modify the last design and make it functional came
from the well established NaIO4 oxidation of tRNAs, which had been previously used extensively for
example in the OXOPAP method109.  In fact, while I had experimentally observed extension of the
tRNA primer over a DNA probe/template,  in my experiment the amino acid's  role as protecting
group was compromised by the liability of the aminoacyl-tRNA ester bond. Conversely, protection of
the 3'-end of  aminoacyl-tRNA from  NaIO4 oxidation was well established and known to be both
highly effective and highly efficient, as it can be carried out at acidic pH to completion in about 1h on
ice. I hence modified my idea by performing oxidation of the tRNAs immediately following extraction
and before hybridisation with the probe and extension by the DNA polymerase (Figure 2.4c). It must
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be noticed that  this  procedure inverted the  alteration in electrophoretic  mobility compared to its
original  design  (Figure  2.4b),  meaning  that  the  high  molecular-weight  band  corresponds  to
aminoacylated species whose 3'-end had been protected from oxidation.
To verify the efficacy of the procedure, I extracted total tRNAs from E. coli cells, used as a negative
control, and from E. coli cells expressing the M. mazei PylRS and a cognate tRNAPyl from M. barkeri. I
designed a DNA probe complementary to the 3'-end of the tRNA and that invades its variable loop, T
arm and to the second strand of the acceptor stem (Figure 2.4c). Furthermore, the probe had a poly-A
tail at its 5'-end which could be used by the DNA polymerase as a template, and a cyanine 5 (Cy-5)
covalently bound to its 3'-end.
Annealing of the probe to the E. coli tRNA extracts produced a high-molecular weight band only in
the presence of tRNAPyl (Figure 2.5 lanes 3,7). Incubation of the tRNA/DNA heteroduplex with the
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Figure 2.5: Experimental validation of tREX using PylRS/tRNAPyl as a model system. In the absence of any tRNA extract
(lanes 1-2) or in the presence of tRNA extracts not containing tRNAPyl, the DNA probe for the detection of tRNAPyl did not
give non-specific signals, independently of the sample processing. In the presence of tRNAPyl, the probe generated a band in
the gel  (lane 7)  which  could be  extended  by the  DNA polymerase  to  reduce its  electrophoretic  mobility  (lane 8).  The
extension by the polymerase was inhibited by oxidation of the 3'-end of the tRNA Pyl by NaIO4 (lane 10). Aminoacylation of
tRNAPyl by PylRS, induced by the addition of Nε-boc-L-lysine to the growth medium of the cells from which tRNAs are
extracted, did not prevent extension of the tRNA/probe heteroduplex by the DNA polymerase (lane 12). However, oxidation of
the aminoacylated tRNAPyl prior to the enzymatic extension by the polymerase allowed the resolution of two bands on PAGE
(lane 14).
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exonuclease-deficient Klenow fragment of DNA polymerase I led to an decrease in the mobility of the
Cy-5 labelled species, which was easily visible in a gel of standard length (~8 cm) (Figure 2.5 lanes 7,
8).  As noted before, in the absence of NaIO4 oxidation full  extension of the tRNAs was observed
regardless  of  whether  the  cells  were  grown in  presence  or  absence  of  Nε-Boc-L-lysine  (BocK),  a
substrate for PylRS which is charged on tRNAPyl (Figure 2.5 lanes 8,12). This observation proves how
aminoacylation alone is not sufficient to protect the tRNA from extension by the DNA polymerase
under the conditions required for the assay. Importantly, treating the tRNA extract with NaIO4 before
the hybridisation procedure completely prevents free tRNAs from being extended (Figure 2.5 lanes
10), consistent with quantitative oxidation of tRNAPyl.  Instead, when the tRNA extract from  E. coli
expressing  PylRS  and  tRNAPyl and  grown  in  presence  of  1  mM  Nε-Boc-L-lysine  was  oxidised,
hybridised to the DNA probe and incubated with the DNA polymerase, two bands were resolved on
the gel (Figure 2.5 lanes 14), which migrated at the same height in the gel as the native and extended
tRNAPyl,  respectively.  These  experiment  confirms  that  my  new  assay,  which  exploits  the  probe-
templated extension by a DNA polymerase of a candidate tRNA following NaIO4 oxidation, can be
used to read in vitro the aminoacylation status in vivo of a tRNA of interest. Given its design, I named
this new technique tREX, for tRNA Extension.
The validation experiment proved that aminoacylation of tRNAPyl generated a species which was
protected from NaIO4 oxidation when assayed by tREX. This result led us to ask how the relative
intensity of the two bands resolved on the gel were modulated as a function of the aminoacylation
level of tRNAPyl. Urea PAGE analysis had revealed that even at high concentrations (4 mM) of N ε-Boc-
L-lysine, aminoacylation of tRNAPyl by PylRS is  not  complete (Figure 2.6a).  However,  the control
experiments used to validate tREX suggested that a tRNA sample which is not oxidised before tREX
behaves as a completely aminoacylated sample, thus being fully extended (Figure 2.5 lanes 10).  I
hence designed an experiment in which I used oxidised or unoxidised E. coli tRNA extracts containing
tRNAPyl as an equivalent for 0% and 100% aminoacyl-tRNAPyl over tRNAPyl, respectively. I then mixed
these samples in known ratios to obtain apparent aminoacylation levels corresponding to 0%, 5%,
15%, 25%, 50%, 75% and 100%, and used these as a calibration curve (Figure 2.6c) to estimate the
fraction of BocK-tRNAPyl present in tRNA extracts from cells grown in presence of  1 mM, 2 mM or 4
mM of BocK (Figure 2.6b).
The data showed that the relative fluorescence intensity from the upper and lower bands correlates
with the relative fraction of aminoacyl-tRNAPyl equivalents present in the sample and that the same
trend is observed when the cell extracts were tested by tREX contained increasing levels of BocK-
tRNAPyl.  Comparison  of  the  biological  samples  to  the  calibration  curve  generated  as  described
allowed me to estimate the fraction of aminoacylation as a function of the concentration of amino acid
in the medium, and these results correlated well  with the estimate made by quantification of the
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norther  blot  performed  after  urea  PAGE  (Figure  2.6d).  The  difference  in  the  absolute  numbers
obtained by the quantifications using different methods was probably due to experimental error on
the one hand, and on the fact that while tREX measurement are compared to a calibration curve,
quantification on the northern blot takes into account the nominal value of pixel intensity due to the
unavailability of  a  sample  containing only BocK-tRNAPyl required to generate  a  calibration curve
using this method. Overall, these results indicate that tREX can be used quantitatively to measure the
aminoacylation  fraction  of  a  specific  tRNA,  even  if  for  the  project  the  assay  was  used  mostly
qualitatively as described in the next section.
Overall, tREX is independent of the anticodon of the tRNA under analysis by design, is  independent
of the nature of the amino acid bound to the tRNA of interest since any amino acid confer equal
resistance to NaIO4 oxidation, and is easily scalable to allow investigation of multiple tRNA in parallel
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Figure 2.6: Amino acid-dependent fractional tRNA aminoacylation measured by northern blotting or by tREX. a) Growth of
E. coli cells expressing tRNAPyl and PylRS in presence of increasing concentrations of Nε-boc-L-lysine in the range from 0 to
4 mM of amino acid led to an increase of the fraction of aminoacylated tRNAPyl which can be observed by urea PAGE
followed by northern blot. b) The relative intensity of the extended vs. non-extended bands produced by tREX correlated with
the  level  of  aminoacylation  of  the  tRNA under  investigation.  Mixing  of  a  tRNA extract  oxidised  following  complete
deacylation  (0%  aminoacylation)  together  with  a  tRNA  extract  for  which  the  NaIO 4 oxidation  was  omitted  (100%
aminoacylation) allows the generation of a calibration curve (third degree polynomial) used as a reference to estimate the
fractional aminoacylation of tRNA extracts from cells grown in presence of variable concentrations of N ε-boc-L-lysine.  c)
Calibration curve derived from the data shown in b) to estimate the fractional aminoacylation of tRNA Pyl as a function of the
concentration of BocK. Lanes 1-7 in b) (green circles) were used to generate a curve. Lanes 8-10 in b) (orange squares) were
fitted  on  the  curve  to  estimate  the  fractional  aminoacylation  of  the  samples.  d)  Estimation  of  the  fractional  level  of
aminoacylation of tRNAPyl in extracts from cells grown in presence of variable concentrations of N ε-boc-L-lysine from the
northern blot in a) and from the tREX data in b) showed a high level of correlation. The difference in the absolute values of
aminoacylation fractions measured by the two methods might be due to the impossibility of generating a calibration curve for
northern blots, as this would require the availability of a tRNA sample fully aminoacylated. Conversely, tREX allows for the
generation of a calibration curve which can be used as a standard for quantification.
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as tRNAs only need to be oxidised before the procedure, while the probe hybridisation and tRNA
extension reactions can be  performed serially  in  one pot  with no  requirement  for  purification or
additional processing before electrophoresis.  Furthermore, the detection is performed immediately
following electrophoresis by  in gel fluorescence. Consequently, we reasoned that tREX could be a
suitable method to perform the screening to identify tRNAs which, when introduced in  E. coli, are
expressed but not aminoacylated by any of the Ec-aaRSs.
Screening for tRNA Orthogonality
Having developed an effective assay to test aminoacylation of a particular tRNA, we could proceed
to  address  the  next  goal  of  the  project,  namely  identify  new  tRNAs  which  are  expressed  and
orthogonal in E. coli (Figure 1.3 (2)). However, tREX had only been successfully used to measure the
aminoacylation of a single tRNA, hence we decided to first apply the new method to test a subset of
10 candidate tRNAs (Figure 2.7 Trp_11 to Trp_20). We purchased each of the candidate tRNA genes,
including the 5'-CCA-3' universal sequence at positions 74→76, cloned into the same position of a
standard plasmid under the control of the E. coli lpp promoter, which drives high transcription of its
downstream  genes.  For  each  candidate,  a  Cy-5  labelled  DNA  probe  was  designed  to  be
complementary to the portion of its target between positions 45 and 76 and the length of the poly-A
tail at its 5'-end of the probe was adjusted based on the length of the tRNA, in order to obtain a visible
electrophoretic retardation in every case (Chapter IV – Materials & Methods: tREX Probes Design).
Since every sample is tested with a different probe, it was necessary to verify that the signal observed
in each case was specific. For this reason, a wild type E. coli tRNA extract was oxidised and used as a
specificity control for every probe. Also, for each different tRNA tested it was important to generate
controls for the electrophoretic mobility of the tRNA/probe heteroduplex and for the fully extended
species.  In order to do this.  As discussed before, these two controls could be generated by either
oxidising a fully deacylated tRNA sample or by omitting the oxidation step altogether, respectively.
Differently  from  the  case  of  PylRS/tRNAPyl,  aminoacylation  for  the  tRNATrp under  investigation
cannot be modulated by the addition of an amino acid in the medium. For this purpose, chemical
deacylation was induced by incubating the tRNA in an alkaline environment due to the liability of the
aminoacyl  ester  bond  in  basic  pH.  Consequently,  for  each  candidate  under  analysis,  tREX  was
performed on 4 samples:
(i) the first is the wild type E. coli tRNA extract;
50
Chapter II – Identification of Orthogonal Aminoacyl-tRNA Synthetase/tRNA Pairs
(ii) the second was the tRNA extract on which oxidation was omitted (i.e. control for the mobility
of the fully extended species);
(iii) the third was the tRNA extract which oxidised following chemical deacylation (i.e. control for
mobility of the unextended species);
(iv) the fourth was the oxidised extract.
In order to identify an orthogonal tRNA, the sample (iv) must be indistinguishable from the control
(ii)  and must  lack  the  extended  band  present  in  sample  (iii).  In  addition,  for  tRNAs  which  are
expressed in E. coli and which can be detected specifically by tREX, the signal observed in samples (ii),
(iii) and (iv) must be absent from the control (i).
My first test confirmed that specific detection could be observed for all tRNATrp_11 to tRNATrp_20
with the exception of tRNATrp_18 (Figure 2.7). In this case, the signal in all the samples (i) to (iv) was
indistinguishable and I concluded that this tRNA was not detectable. Considering the high binding
energy between complementary DNA and RNA sequences, the absence of specific signal was more
likely due to the lack of expression of the tRNA, even if lack of binding could not be excluded. In the
other cases, specific bands of various degrees of fluorescence intensities could be observed in the gel,
indicating aminoacylation of all the samples to very high levels (e.g.: tRNATrp_12). In several cases, a
pattern of bands was observed rather than a single band corresponding to the tRNA of interest. These
bands could correspond to maturation intermediates of the tRNA, or degradation products which
might be generated either in vivo or in vitro during the tREX protocol. However, since every sample is
analysed  from the  comparison  to  a  set  of  controls  generated  following  the  same  procedure,  the
presence of these patterns does not affect the interpretation of the results.
Having verified that tREX had broader applicability on various heterologous tRNAs, we proceeded
by expanding the screening to 233 other candidate tRNAs in addition to the 10 test tRNA Trp above
mentioned. In order to speed up the process, a part of the screening was performed by Julian. C. W.
Willis and Louise H. Funke. A subset of the screening gels are exemplified here (Figure 2.7).  The
complete set of gels generated is also reported (Figure 5.1). A summary of the result of the screening
is shown in Table 2.1.
Overall, based on the experimental data we concluded that 75 out of 243 tRNAs (~30.9%) could not
be detected in the tRNA extract.  In these cases, no conclusions could be drawn on whether such
tRNAs would be effective substrate for E. coli  aaRSs, hence these tRNAs provide little insight about
how to refine our procedure. Of the remaining 168, 97 (~57.7%) displayed a detectable amount of
aminoacylation, while in 71 cases (~42.3%) the oxidised tRNA extract was showed a fluorescence
pattern  indistinguishable  from  the   chemically  deacylated  control  (iii)  and  was  for  this  reason
considered orthogonal.
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Isoacceptor class
Ala Arg Asn Asp Cys Gln Glu Gly His Ile Total
Undetectable 6 2 5 1 3 2 1 2 3 4 29
Aminoacylate
d
3 4 3 - 1 5 3 4 1 3 27
Orthogonal 6 4 2 8 4 3 6 4 6 3 46
Total 15 10 10 9 8 10 10 10 10 10 102
Isoacceptor class
Leu Lys Met Phe Pro Ser Thr Trp Tyr Val Total
Undetectable 14 3 1 1 3 10 3 5 3 3 46
Aminoacylate
d
14 6 9 7 3 3 2 13 6 7 70
Orthogonal - - - 2 3 12 5 2 1 - 25
Total 28 9 10 10 9 25 10 20 10 10 141
Table 2.1: Summary of the screening for tRNA orthogonality performed by tREX.
Interestingly,  the  distribution  of  orthogonal  tRNAs  among  different  isoacceptor  class  was
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Figure 2.7: Example gels containing the results of the tREX screening for tRNA orthogonality. For each tRNA, a specific
DNA probe was designed to be complementary to it. Furthermore, the specificity of each probe was tested on a tRNA extract
from wild type E. coli DH10b. For each tRNA under investigation, a control for the electrophoretic mobility of the extended
species was generated by omitting the NaIO4 oxidation, while a control for the electrophoretic mobility of the unextended
species was generated by performing NaIO4 oxidation following chemical deacylation by NaOH. Orthogonality was assessed
by verifying if the oxidised tRNA sample displayed the a band with the same electrophoretic mobility as the control for the
unextended species and no bands with the same electrophoretic mobility as the control for the extended species. In the
example shown, only the tRNATyr5 was detectable but not aminoacylated in E. coli and is highlighted by a red box.
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significantly uneven. As an example, orthogonal tRNAAsp were found in very high abundance among
the  candidates  tested  (8  out  of  9),  while  only  one  candidate  tRNATyr was  orthogonal.  For  four
isoacceptor classes (i.e.: Leu, Lys, Met and Val) none of the candidates which could be detected were
orthogonal. In spite of this, the 71 orthogonal tRNA identified were distributed among 16 distinct
isoacceptor classes, indicating that tRNAs from species on a different evolutionary line compared to
the E. coli might have developed distinct recognition mechanism by their cognate aaRS while lacking
the interaction elements required for Ec-aaRSs.
This screening represented the first type of systematic analysis of tRNA orthogonality as far as we
were  aware  of.  Importantly,  the  high  frequency  at  which  orthogonal  tRNAs  could  be  identified
provided us with a large number of candidates,  which we used to move to the third step of the
project, namely identifying aaRSs which could effectively aminoacylate these new orthogonal tRNAs
in E. coli (Figure 1.3 (3)).
Identifying Active aaRS/tRNA Pairs
For each of the tRNAs which were expressed in E. coli but could not be aminoacylated by any of its
aaRSs,  we  asked whether  the  cognate  synthetase  from the  same organism where  the  tRNA was
identified could aminoacylate this tRNA in E. coli. tRNA-DB-CE contains information about genome
ID on which the tRNAs were informatically identified, together with the name of the species to which
the genome belongs to. However, I found that in many instances this species annotation was not up-
to-date,  which  made  the  identification  of  the  aaRSs  troublesome.  In  order  to  ensure  the  highest
accuracy in the identification of the enzymes to use in combination to each tRNA, I decided not to rely
on the taxonomic information from the tRNA-DB-CE but to retrieve such information from the NCBI
databases.
I searched the genome ID on NCBI Genomes to retrieve taxonomy ID of the corresponding species
from  NCBI  Taxonomy.  This  identifier  allowed  me  to  retrieve  a  complete  and  updated  set  of
taxonomical information about the species,  and importantly it also allowed me to unambiguously
identify  a  given  organism  even  in  the  circumstance  in  which  its  phylogenetic  and  taxonomic
affiliation were modified, which is not unfrequent for newly discovered organisms. Subsequently, I
searched NCBI Proteins to identify the sequence of the enzyme annotated as the cognate aminoacyl-
tRNA synthetase in that organism. In all cases, I could find a protein annotated with the required
enzymatic activity and I did not have to perform homology searches on unannotated or predicted
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proteins.
I reverse translated the protein sequences using the canonical genetic code to obtain CDSs codon-
optimised for  E. coli using the IDT codon optimisation tool (https://www.idtdna.com/CodonOpt).
The  sequences  were  designed taking  into  account  the  additional  constraint  that  they  should  not
contain BsaI restriction site,  commonly used to perform enzymatic reverse PCR to create library. The
linear dsDNA for each synthetase was purchased from Twist Bioscience and cloned into the plasmid
containing its respective tRNA gene. No tags were fused in frame with the CDS for the aaRSs, to
prevent the possibility that alteration in the protein sequence could result in a loss of activity of the
enzyme. The resulting plasmids were transformed in  E. coli and the tRNA extracts from these cells
were tested again using tREX. In this case, for each tRNA under investigation 5 samples were tested
using tREX: 
i) the wild type E. coli tRNA extract;
ii) the tRNA extract on which oxidation was omitted (i.e. control for the mobility of the fully
extended species);
iii) the tRNA extract  oxidised following chemical  deacylation (i.e.  control for mobility of the
unextended species);
iv) the oxidised tRNA extract from cells expressing both the candidate tRNA of interest and its
cognate aaRS;
v) the oxidised tRNA extract from cells expressing the candidate tRNA alone.
The result of the screening are summarised in Table 2.2 and shown in Figure 5.2, while a subset of
gels is shown in Figure 2.8. Among all the pairs tested, the gels showed unambiguous aminoacylation
of  23  out  of  59  orthogonal  tRNAs  when  their  cognate  aaRS  was  present  in  the  cell,  but  no
aminoacylation  in  its  absence,  reproducing  the  data  shown  before.  Consequently,  I  was  able  to
identify 23 active aaRS/tRNA pairs which are active when heterologously expressed in E. coli and for
which  the  tRNA  cannot  be  recognised  by  any  of  the  cellular  Ec-aaRSs.  Interestingly,  for  some
isoacceptor classes (e.g.: Asp, Cys, Gln, Glu, Ile) all of the tested pairs showed clear activity, while for
others (e.g.: Ala, His, Ser) the success rate was very low or null. It is relevant to notice that the lack of
aminoacylation of the orthogonal tRNAs by their cognate synthetase cannot specifically be pinned
down to a particular cause, as several factors might be responsible for the lack of activity of the aaRSs.
For example, the enzymes might be expressed poorly, might not fold correctly, might be inactive at
the  particular  physiological  condition  present  in  the  E.  coli cytosol  (e.g.:  temperature,  salt
concentrations etc.), or their cognate tRNAs might be poorly folded or incorrectly modified.
Overall, the 23 active pairs were distributed among 10 different isoacceptor classes, thus covering
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half of the natural proteinogenic amino acids. This experiment further highlights the value of tREX as
a method to test in vitro the aminoacylation which happens in vivo.
Having assessed the activity of these 23 synthetases brought us closer to the identification of new
orthogonal  pairs.  However,  the experiment shown so far  were not  enough to assess  whether the
newly tested enzymes were able to effectively aminoacylate the endogenous Ec-tRNAs. As discussed
previously, it has been impossible to date to design an experiment which could assess orthogonality
for  exogenous aminoacyl-tRNA synthetases for canonical  amino acids  in  vivo under physiological
conditions.  For  this  reason,  I  performed  in  vitro aminoacylation  assays,  as  described  in  the  next
section.
Isoacceptor class
Ala Arg Asn Asp Cys Gln Glu Gly His Ile Total
Inactive pair 6 2 2 - - - - 2 5 - 17
Active pair - 2 - 3 4 3 5 1 1 2 21
Total 6 4 2 3 4 3 5 3 6 2 38
Isoacceptor class
Leu Lys Met Phe Pro Ser Thr Trp Tyr Val Total
Inactive pair - - - 2 2 10 4 1 - - 19
Active pair - - - - 1 - - - 1 - 2
Total - - - 2 3 10 4 1 1 - 21
Table 2.2: Summary of the results shown in Figure 2.8.
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Figure 2.8: Example set of gels containing the results of the tREX screening for the aminoacyltion of the orthogonal tRNA by
their cognate synthetase. For each tRNA under investigation, a control for the electrophoretic mobility of the extended  and
unextended species was generated as described before. The aminoacylation status of the tRNA was verified when it was co-
expressed in E. coli cells together with its cognate synthetase from the same organism. Samples for which a synthetase-
dependent aminoacylation was observed are highlighted by a red box.
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Testing aaRS Orthogonality
In order to successfully expand the genetic code while ensuring a high fidelity for protein translation,
the  aminoacyl-tRNA synthetases present in the cell together must all be mutually orthogonal, i.e.
they should have no overlap in the set of tRNAs which they can effectively aminoacylate. As outlined
in Figure 1.3, having successfully completed the tasks (1), (2) and (3), the last step required to verify
that the approach described was successful in identifying new orthogonal pair was the assessment of
orthogonality of the 23 synthetases which were proven active on their cognate orthogonal tRNAs.
When testing aaRS orthogonality in vitro, this effectively meant that what needed to be verified was
that the new synthetases could aminoacylate a tRNA extract from  E. coli  exclusively if the extract
contained their cognate tRNA.
To set up this experiment, I cloned 15 of the active aaRS in a commercial pET expression vector,
where the protein of interest is under the control of the strong T7 promoter and could be expressed in
E.  coli BL21 strain upon induction of  the  T7  RNA polymerase  with IPTG.  The proteins  were  N-
terminally fused in frame with a StrepTag II  sequence followed by the cleavage site  for  the TEV
protease (Chapter IV – Materials & Methods: Synthetase Purification). This design enabled one-step
purification of all the enzymes to high purities, while cleavage of the tag following purification was
performed to ensure that the activity of the enzyme was not compromised by the addition of the tag.
In addition, the M. jannaschii TyrRS was purified similarly and used as a positive control.
To  obtain  tRNAs  of  the  highest  quality  possible,  I  decided  not  to  produce  them  by  in  vitro
transcription, but to purify them from E. coli instead. This had the advantage of ensuring that all the
tRNAs were correctly folded, modified and present at the physiological relative proportions. To do
this, I transformed E. coli DH10b with the plasmids containing each tRNA/aaRS pair which I used to
perform the experiment in  Figure 2.8,  then I extracted the tRNAs, chemically deacylated them by
treatment with NaOH and then performed extensive desalting using size exclusion spin concentrator
columns (Chapter IV – Materials & Methods:  tRNA Extraction for in vitro Biochemistry).  These
extracts were effectively used as positive controls, because the activity of the synthetases for their
cognate tRNA was verified in vivo, and for this reason I expected a positive signal from the in vitro
assay. Additionally, tRNAs from wild type  E. coli  DH10b were purified in the same way and were
used to verify whether the aaRS under investigation could charge any of the endogenous tRNAs or
not. As for orthogonal tRNAs no signal was expected in this assay, the presence of the positive control
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ensured that the lack of signal wasn't due to the inactivity of the enzyme in vitro.
In my first attempts to test orthogonality, I assumed that for the well characterized orthogonal Mj-
TyrRS no aminoacylation on the wild type E. coli extract would occur after incubation with L-tyrosine
and ATP, while the reaction should occur when the tRNA extract  contains the  Mj-tRNATyr.  Since
aaRSs produce AMP and PP
i
 as a by-product of their enzymatic activity, I originally tried to measure
the production of AMP by the commercial kit AMP-Glo™ (Promega) produced in the reaction after 1
h incubation at 37°C. Unfortunately, I observed a strong signal above background from both sample
(data not shown). This indicated that while Mj-TyrRS are specific for its substrates in vivo, the basal
affinity for tRNAs is high enough so that, following a long enough incubation period, aminoacylation
of non-specific targets occurs. As a consequence, I evaluated end-point measurements as ineffective
and opted to perform a more traditional assay which allowed to measure time courses over a short
time window. Importantly, when maintaining the concentrations of the substrates equal, the relative
initial reaction rate in a time courses correlates with the affinity of the enzyme for its substrate, as
higher affinity results in higher initial reaction rate.
The assay employed to measure aminoacylation takes advantage of the difference in solubility in
acidic pH between amino acid and nucleic acids. In fact, while amino acids remain in solution upon
addition  of  strong  acids  (e.g.:  trichloroacetic  acid),  tRNAs  quickly  precipitate  out  of  solution.
Importantly,  as  the  aminoacyl  ester  bond  is  stable  at  low  pH,  acid  can  be  used  to  selectively
precipitate the amino acids bound to tRNAs, hence quantification of the amount of amino acid which
co-precipitates with the tRNAs at different time points of the aminoacylation reaction is a dynamic
measurement of the activity of the enzyme.. Radioactive amino acids were purchased to allow direct
measurement by scintillation counting.  13C-radiolabelled amino acids (Arg, Asp, Gln, Glu, Gly, Ile,
Pro, Tyr) were purchased, while histidine was purchased 3H-radiolabelled due to supply availability.
Unfortunately Cys was not available from the supplier. The reactions were set up by incubating the
appropriate tRNA extracts with each of the purified synthetases and their corresponding labelled
amino acid,  then started by adding ATP.  Aliquots  of  the  reactions  at  different  time  points  were
precipitated on glass filters soaked with TCA and the radioactivity precipitated in the filters was
measured following removal of the unbound amino acids. The reactions were monitored over the
course of 5 minutes and the results are shown (Figure 2.9a). For each enzyme, two time courses were
performed on tRNA extract lacking the cognate tRNA (grey traces) and two other time courses were
performed in its presence (black traces) as positive controls. All the samples preparations displayed
high purify  following a  single  step  of  affinity  purification  (Figure  2.9b)  and were  enzymatically
active. These experiments were performed with the assistance of Dr. Shan Tang.
Surprisingly, among all the synthetases tested, only 3 out of 15 showed an appreciable difference in
aminoacylation  kinetics  between  the  two  conditions  (Figure  2.9a,  red  boxes),  similarly  to  what
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observed for the positive control (Figure 2.9a,  green box):  the ArgRS from  Caldilinea aerophila,  the
HisRS from Afifella pfennigii and the TyrRS from Archaeoglobus fulgidus.
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This result was particularly surprising to me, in light of a few considerations. Firstly, all the enzymes
tested could be successfully expressed and purified from E. coli and the cell from these cultures did
not display any signs of a detrimental activity of these exogenous proteins. This highlighted how
these synthetases could not be recognising to a significant extent any of the E. coli tRNAs for a distinct
isoacceptor class, as this would result in a loss of fidelity in protein translation, hence a loss of fitness
for those cells. As pointed out before, though, recognition of the E. coli tRNA for the same isoacceptor
class would not induce a loss in viability of the cell,  thus being the most  likely event for  a non-
orthogonal  and  non-toxic  synthetases.  Another  important  consideration  to  make  concerned  the
mechanism of recognition between the exogenous aaRS/tRNA pair compared to the E. coli ones.
59
Figure 2.9: a) In vitro aminoacylation assays. Each aaRS was purified and its activity was assayed by measuring the time
course of the incorporation of its radioactively-labelled substrate amino acid into the acid-insoluble tRNA fraction. The
synthetases were incubated with either a tRNA extract from wild type E. coli (gray traces), or with a tRNA extract from E.
coli expressing its cognate tRNA (black traces) as a positive control. Orthogonality of the synthetases by this method was
assayed by the difference in the kinetics of the incorporation of amino acid in the presence or absence of a specific substrate
for the enzyme. Enzymes which displayed a negligible or slow aminoacylation of the wild type E. coli tRNA extract compared
to the tRNA extract containing their specific substrate were considered orthogonal (red boxes). The aminoacylation kinetic
for the known orthogonal Mj-TyrRS was measured as a positive control (green box). b) SDS-PAGE of the purified enzymes
used in the in vitro assays revealed high levels of purify following a single affinity purification step. The band corresponding
to the full-length protein is indicated by an arrow. I. Nonamiensis GlnRS could not be included as all the material was used
in the in vitro assays.
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Let us take into account the ArgRS/tRNAArg pair from  Capnocytophaga sp. oral taxon 329, a species
belonging to the phylum Bacteroidetes, hence evolutionarily distant from Proteobacteria, the phylum in
which  E.  coli is  found.  This  tRNA  was  clearly  detectable  in  E.  coli but  displays  no  sign  of
aminoacylation (Arg-04 in  Figure 2.8). This indicated that, since the last common ancestor, the  Cp-
tRNAArg and the Ec-tRNAArg had evolved and diverged in such a way that the features recognised by
Ec-ArgRS are present in the Ec-tRNAArg but not in Cp-tRNAArg. However, Figure 2.8 clearly shows that
Cp-ArgRS can aminoacylate its cognate  Cp-tRNAArg   in  E. coli. Since the features recognised by  Ec-
ArgRS are absent from  Cp-tRNAArg, then  Cp-tRNAArg must display a different set of features which
Cp-ArgRS, but not  Ec-ArgRS,  can recognise. In other words,  Cp-ArgRS must have evolved a new
recognition method to interact with its  partner  Cp-tRNAArg which relies on a new set of features,
different from the ones which  Ec-ArgRS recognises on the  Ec-tRNAArg. Under these circumstances,
and considering that Ec-ArgRS cannot recognise the Cp-tRNAArg, I considered unlikely that:
a) Cp-tRNAArg only displays the features recognised by  Cp-ArgRS;
b) Ec-tRNAArg displays both the features recognised by Ec-ArgRS and by Cp-ArgRS.
In fact, since these pairs are found in evolutionarily distant species, this would imply the existence of
an unusual asymmetry in the evolutionary path undertaken by the two different tRNA sequences. For
this reason, I imagined that the probability of identifying orthogonal synthetase from a selected pool
of pairs in which the tRNA was known to be orthogonal in E. coli should be significantly higher than
the  one  observed.  In  addition,  for  most  synthetases  there  was  no  apparent  difference  in  the
aminoacylation kinetics between the sample containing their cognate tRNA and the wild type E. coli
tRNA extract. This would suggest not only a rather counterintuitive lack of differential affinity for its
substrate rather than other tRNAs, but also that the total amount of substrates in the two sample was
equal, which was also counterintuitive due to the additional presence of a specific substrate in one of
the two samples.
Overall, the results obtained from these experiments were not completely satisfactory and posed
some questions on the possibility of deducing in vivo orthogonality from in vitro assays. However, due
to the lack of possible alternatives, we could not investigate the in vivo orthogonality of the aaRSs by
other means.
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Discussion
In the previous sections I have described how we decided to approach the problem of establishing a
general  procedure  which could allow us to  identify tRNA/synthetase  pairs  derived from known
living organisms which are orthogonal when heterologously expressed in  Escherichia coli. First, we
decided to take advantage of an annotated database of bacterial and archaeal tRNA sequences, tRNA-
DB-CE, which contained more than 2 million sequences in March 2017. Our choice to limit our search
by  excluding  pairs  derived  from eukaryotes  was  mostly  due  to  the  practical  need  to  verify  the
reliability of our newly developed pipeline on an initial set of tRNAs which wouldn't be excessively
large,  and  to  the  consideration  that  eukaryotic  synthetases  can  be  clustered  in  multi-enzymatic
complexes117, which would introduce additional complications along the pipeline. Additionally, we
did not include tRNA annotated on fragmented and only partially assembled genomes derived from
metagenomics  on environmental  samples  due  to  the  possibility  of  not  being able  to  retrieve  the
corresponding synthetase for these tRNAs. Lastly, as the tRNA genes present in the database were
derived from computational predictions, we made use of the genes which were annotated as “reliable
tRNA genes” by the database curators, which correspond to genes which were predicted to code for
tRNAs by multiple distinct computational tools.
Having selected an initial set of sequences, we decided to develop a computational filtering method
which  would  reduce  the  complexity  of  our  tRNA  set  by  identifying  the  ones  with  the  highest
likelihood of being orthogonal in the host we chose for our experiment. In order to do this, we took
advantage  of  the  knowledge  of  how  E.  coli synthetases  interact  with  their  partner  tRNAs.  In
particular, in a first approximation it is believed that each of the 20 distinct cellular aminoacyl-tRNA
synthetases  recognise and establish specific  interactions with a defined sub-set  of  the nucleotides
along the sequences of the cellular tRNAs, known as identity elements20. If the sequence of a given
tRNA at the identity elements for a given synthetase is incorrect, the model predicts the interaction to
be negated. This model clearly does not take into account the contributions to the binding energy
between a tRNA and a synthetase  given by complex three-dimensional  features,  like the relative
orientation of different portions of the tRNA and the length of some of its variable loops. However,
the simplicity of this model allowed us to generate a scoring system which, even if not predictive of
the interactions between tRNAs and the  E. coli synthetases with 100% accuracy, could increase our
chances of identifying an orthogonal tRNA compared to the chance of finding orthogonality in a
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completely random selection of tRNA genes.
Our filter compared the sequence of any given tRNA at the identity element for a specified  E. coli
aaRS with the sequence at the same positions of a known substrate for that aaRS, identified in the
cognate E. coli tRNA(s), assigning a score of +1 to all those identity elements where the tRNA matched
the synthetase's substrate, and a score of -1 to the ones which were different. We calculated the overall
score of a given tRNA for a specified E. coli aaRS as the average of its scores across all the identity
elements for that synthetase. Importantly, this procedure was possible thanks to the literature which
identified the identity elements for the synthetases present in the host organism of choice, i.e. E. coli20,
118-120. Since the enzymes present in different organisms differ in their method of substrate recognition,
the list of identity elements used by the filter would have to be adapted if the procedure was to be
repeated to identify tRNAs which are orthogonal in another organism.
Given its design, the scoring system marked with scores close to +1 tRNAs which were very similar
to the endogenous substrate for the E. coli synthetases, while tRNAs with scores close to -1 were the
most dissimilar. We could hence identify a sub-set of the original database which was enriched in
tRNA sequences which we considered more likely to be orthogonal.
To obtain experimental evidence of the orthogonality of tRNAs, I developed a new method which
would address some of the important limitations which the traditional methods display when used to
perform screening. In particular, ease of execution and scalability represented a critical concern for the
application of acidic urea PAGE followed by northern blotting, which represents to date the golden
standard to verify tRNA aminoacylation. By combining the specificity of NaIO4 oxidation on vicinal
diols with RNA detection by fluorescently labelled DNA probes, I developed a new method, which I
called tREX, which is able to induce a reduction in the electrophoretic mobility of aminoacylated
tRNA, resolving them from their free counterparts. I successfully validated the method, proving that
when measuring aminoacylation of tRNAPyl, two bands were resolved on a polyacrylamide gel whose
relative intensity depended on the fractional level of aminoacylation of the tRNA. Importantly, tREX
can be performed in PCR tubes, allowing for convenient scalability. Even if significantly easier to
perform on a few hundreds of samples than acidic urea PAGE/northern blot, tREX still required over
a  thousand  lanes  of  gels  to  be  run,  and  even  if  several  samples  were  screened  in  parallel,  the
technique requires a good amount of labour. Given its robustness, though, future improvements in
the method, like automation of some of its steps, might increase its throughput.
By using tREX, 243 different tRNAs were tested for their aminoacylation status when heterologously
expressed  in  E.  coli.  Of  those,  168  could  be  specifically  detected:  97  displayed  some  degree  of
aminoacylation,  while  for  71  no  detectable  aminoacylation  could  be  observed  (~42%)  and  were
considered orthogonal. tREX was also used to determined whether co-expression in E. coli of one of
those orthogonal tRNAs with the cognate synthetase from the same organism of origin could result in
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aminoacylation of the tRNA itself, and indeed we observed that this was the case for 23 out of the 59
pairs  (~39%)  we  tested.  To  our  knowledge,  this  was  the  first  large-scale  attempt  to  characterise
orthogonality in E. coli of tRNAs derived from natural species preserving their wild type anticodon.
Surprisingly, a substantial fraction of all the tRNAs which could be expressed in E. coli, belonging to
16 out of the 20 isoacceptor classes, were not  aminoacylated by any of its endogenous synthetases.
We hypothesised that this success rate was higher than what we would have observed by randomly
selecting a tRNA to express in our host organism. This would indicate that, in spite of its simplicity,
and of its partial predictive power, our scoring method can be effectively used to filter tRNA genes
and enrich for orthogonal sequences. Nonetheless, it is likely that a fraction of those sequences which
were filtered out by our algorithm are orthogonal in E. coli. The experimental data generated by tREX
provided  us  with  an  expanded  set  of  sequences  which  are  validated  to  be  orthogonal.  This
information will probably be used in the future to polish our computational approach and to widen
its scope to a wider set of tRNAs, taking advantage both of the progress made in the sequencing and
assembly of bacterial and archaeal genomes, and also of databases of eukaryotic tRNA genes. While
the  sequences  of  tRNAs  which  were  not  orthogonal  in  E.  coli could  represent  an  important
information towards the refinement of the algorithm as well,  no experimental  data was collected
about the amino acid with which they were charged, so that we cannot unambiguously identify the
endogenous  synthetases  by  which  they  were  recognised.  Overall,  our  data  proved  that  tRNA
orthogonality is not a rare occurrence and that the natural divergence generated a very broad plethora
of different genes with distinct features, enabling the evolution of distinct modality of recognition by
their cognate synthetases. Considered the impressive variety of sequences available to date, it is easy
to imagine how multiple orthogonal tRNAs must exist for every one of the 20 natural isoacceptor
classes.
The identification of 23 pairs composed of an orthogonal tRNA and an active synthetase implies that
close to 9.5% of all the tested tRNAs, or approximately 13.7% of all the expressed tRNA, ended up
constituting one such pair. The existence of orthogonal tRNAs which could not be aminoacylated by
their cognate synthetases suggested that, while being effectively transcribed, some of those tRNAs
might  have  been  incorrectly  folded  or  modified,  preventing  their  interaction  with  their  partner
enzyme. Alternatively, the expression, folding or multimerisation of the synthetases in E. coli could be
defective.
Given the problems in proving orthogonality for synthetases in vivo, we opted for a less conclusive in
vitro approach which had been used already before40,  93,  94,  97.  To my surprise, the assay seemed to
indicate that only three of the tested synthetases were orthogonal. The large amount of orthogonal
tRNAs identified seemed to indicate that E. coli  synthetases are relatively specific for their substrate
and cannot accept tRNAs which differ at  some key positions, hence I  was expecting a very large
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number  of  the  tested  synthetases  to  display  a  similar  selectivity  for  their  substrate  and  not  to
recognise  the  E. coli tRNAs.  This  result  could potentially be explained by the arbitrary condition
under which the in vitro test was performed, however, being unable to design an experiment capable
of producing unambiguous results indicating the orthogonality  in vivo of the active synthetases, I
could only deduced that the Ca-ArgRS, Ap-HisRS and Af-TyrRS are orthogonal.
The application of an orthogonal pair to genetic code expansion most of the times requires to re-
direct a tRNA to a codon different from its wild type codon, such as the amber stop codon,. Since the
anticodon represent a crucial interaction point for most pairs, single point mutations in that region are
enough to completely disrupt their interaction. In our case, we identified orthogonal pairs composed
of an active synthetase and a tRNA with its native anticodon. We hence decided to verify how the
identified pairs behaved upon conversion of the tRNAs to amber suppressors. Given the previous
considerations, we were expecting some of the mutant tRNAs to not be recognised any longer from
their cognate synthetases. However, since we had previously verified the activity of the wild type
pair, we could pin down the loss of interaction to the mutation in the tRNA's anticodon and use
molecular  engineering  to  evolve  the  synthetase  to  accept  its  mutant  tRNA  as  a  substrate.
Hypothetically, we could have immediately mutated the tRNAs to amber suppressor and use amber
suppression to test orthogonality of these tRNAs and activity of their cognate synthetases. However,
this approach would have resulted in a large number of inactive pairs for which no conclusion could
be drawn. Hence, while producing pairs not immediately applicable to genetic code expansion, our
decision to verify the wild type pairs provided us with a clear interpretation of our results.
Importantly, since mutations of the tRNAs and of the synthetases could alter the orthogonality of
both, I  decided to produce amber suppressors also for  pairs for which the enzyme did not  seem
orthogonal based on the in vitro data. In the next chapter I will describe my efforts to produce active
and  orthogonal  amber  suppressors  derived  from  the  active  pairs  identified  as  described  in  this
chapter.
64
Chapter III – Evolution of Orthogonal Aminoacyl-tRNA Synthetase/tRNA Pairs
Chapter III – Evolution of Orthogonal 
Aminoacyl-tRNA Synthetase/tRNA Pairs
Generation of Amber Suppressors
In the previous chapter I have described how tREX allowed me to experimentally characterise pairs
composed  of  an  orthogonal  tRNA  and  an  active  synthetase  (Figure  2.8).  However,  subsequent
experiments  aimed at  verifying orthogonality  for  the  synthetases  resulted in  the  identification of
fewer orthogonal enzymes than expected (Figure 2.9). Since the characterisation had been performed
on wild type tRNAs with their native anticodon, the identified pairs could used as a starting point to
reassign the corresponding sense codons to a new amino acid. In practice, however, in spite of the
recent progress made for genetic codon reassignment and genome recoding, the use of sense codons
for genetic code expansion is seldom a feasible option in most model organisms, since decoding the
sense  codons with non-canonical  amino acids  would poison the proteome and interfere with the
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cellular functions. In practice, then, I acknowledged that, in the time frame of my doctoral research,
applications  of  these  pairs  would  still  have  to  rely  on  conventional  methods,  such  as  amber
suppression.
Engineering  of  a  pair  to  be  an  effective  amber  suppressor,  though,  should  not  be  considered
straightforward. In fact, mutation of the tRNA's anticodon to CUA, the amber suppressor anticodon,
generates a tRNA which can lose the features of its parent tRNA, such as orthogonality. In addition,
since all of the identified active pair were composed of a synthetases which directly contacted the
tRNA's anticodon, the conversion was expected to interfere with the recognition of the tRNA by the
enzymes. Importantly, however, since all the pairs were know to be active, all the observed difference
in behaviour would be directly attributed to  the specific alteration of the anticodon and could be
tackled by means of molecular evolution. In particular, in case of loss of orthogonality of the tRNAs,
introduction  of  additional  point  mutations  would  be  attempted  to  abolish  the  newly  formed
recognition by an endogenous  E. coli. In case of loss of activity of the aaRS on the mutant tRNAs,
mutation of those residues responsible for the recognition of the anticodon could be a solution to
restore  recognition  in  the  mutant  variant  of  its  substrate.  The  generation  of  mutant  synthetases
capable of establishing specific interactions with the anti-amber anticodon, which is not present in any
of the endogenous  E. coli  tRNAs, might have the additional benefit of increasing orthogonality for
synthetases lacking a strong discrimination for their cognate tRNA. In light of this considerations, I
decided  that  I  would  also  attempt  to  generate  an  amber  suppressing  pair  from  pairs  whose
synthetases did not perform satisfactorily in the in vitro aminoacylation assay.
I selected nine distinct tRNAs, each belonging from a different isoacceptor class, as a starting point to
generate amber suppressors:
(1) tRNAGCG
Arg from Caldilinea aerophila ( Ca− tRNAGCG
Arg );
(2) tRNAGUC
Asp from Sorangium cellulosum ( Sc− tRNAGUC
Asp );
(3) tRNAGCA
Cys from Moorea producens ( Mp− tRNAGCA
Cys );
(4) tRNAUUG
Gln from Ilumatobacter nonamiensis ( In− tRNAUUG
Gln );
(5) tRNACUC
Glu from Sporolactobacillus inulinus ( Si− tRNACUC
Glu );
(6) tRNACCC
Gly from Bacteroides vulgatus ( Bv− tRNACCC
Gly );
(7) tRNAGUG
His from Afifella pfennigii ( Ap− tRNAGUG
His );
(8) tRNAUAU
Ile from Chitinophaga pinensis ( Cp− tRNAUAU
Ile );
(9) tRNAGUA
Tyr from Archaeoglobus fulgidus ( Af − tRNAGUA
Tyr ).
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I started by mutating the anticodon of each of those tRNAs to CUA, without additional mutation to
the anticodon arm nor any other part of the tRNA body. I cloned the suppressor tRNAs in plasmids
either  in   absence  or  presence  of their  cognate  synthetase.  Unfortunately,  generation of plasmids
containing  the  mutant  tRNA  (8) Cp− tRNACUA
Ile failed  repeatedly,  hence  this  tRNA  was  not
investigated  further.  The  plasmids  containing  all  the  other  pairs  were  challenged  in  an  amber
suppression assay by using a commonly used antibiotic resistance reporter, i.e.: the chloramphenicol
acetyl-transferase  gene  interrupted  at  position  112  by  a  stop  codon  (cat112*).  E.  coli DH10b  cells
containing the reporter were transformed with the plasmids containing the tRNAs alone or the tRNAs
together with their cognate synthetases.  The resulting transformants were tested for their level of
resistance to the antibiotic chloramphenicol by verifying their ability to grow on plates containing
either  0,  25,  50,  75,  100,  125,  150,  200 or  250 µg/mL of antibiotic.  The results  summarised below
indicate the highest concentration of antibiotic tolerated by the cells (Table 3.1). It is important to
notice that, while tREX represents a direct measurement of aminoacylation, reporter read-through is
an indirect measurement which is additionally influenced by how efficiently an aminoacylated tRNA
can take part in ribosomal translation. Consequently, the measurement of orthogonality by these two
means  are  not  directly  comparable.  The  experiment  summarised  below  and  the  discussion  that
follows use read-through as a proxy for aminoacylation and orthogonality.
(-) aaRS (+) aaRS (-) aaRS (+) aaRS
(1) Ca− tRNACUA
Arg 250 250 (5) Si− tRNACUA
Glu 0 0
(2) Sc− tRNACUA
Asp 0 0 (6) Bv− tRNACUA
Gly 25 25
(3) Mp− tRNACUA
Cys 75 250 (7) Ap− tRNACUA
His 250 250
(4) In− tRNACUA
Gln 0 0 (9) Af − tRNACUA
Tyr 250 250
Table 3.1: Highest chloramphenicol concentration tolerated, among the ones tested, by E. coli cells due to the read-through
of the cat112* reporter gene by the amber suppressor tRNA indicated, in the presence or absence of its cognate aaRS.
The results shown above highlighted how Sc− tRNACUA
Asp , In− tRNACUA
Gln and Si− tRNACUA
Glu  retained
complete  orthogonality  as  their  parent  tRNAs,  however,  they  completely  lost  their  ability  to
productively  interact  with  their  partner  synthetase.  This  result  was  fully  in  line  with  the
considerations which were made before.  Bv− tRNACUA
Gly  displayed only a very minor background
aminoacylation by endogenous synthetases, but did nor appear to be recognised to any extent by its
cognate synthetase either.  Mp− tRNACUA
Cys displayed a modest background level of aminoacylation,
suggesting that it had partially lost its orthogonality following alteration of its anticodon, however the
reporter production increased significantly in the presence of its cognate synthetase. Ca− tRNACUA
Arg ,
Ap− tRNACUA
His  and  Af − tRNACUA
Tyr  lost their orthogonality and their aminoacylation level did not
appear to be modulated by the presence or absence of their cognate synthetase.
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The levels of chloramphenicol resistance of some of the samples described above clearly indicated
that the newly generated amber suppressor tRNAs were not always orthogonal. Given the absence of
amber  suppressors in  E. coli DH10b, a useful way to characterise which of the endogenous  E. coli
aaRSs was  responsible for this mis-aminoacylation consisted in the determination of which amino
acid was inserted in a target protein in response to an amber stop codon in its message RNA. In our
lab and others this analysis was commonly performed by using sfGFP121 as a reporter protein, due to
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Figure 3.1: LC-MC analysis of the sfGFP150* reporter purified from cells expressing a) Ca−tRNACUA
Arg ; b) Ca−tRNACUA
Arg +Ca-
ArgRS;  c)  Ap−tRNACUA
His ;  d) Ap−tRNACUA
His +Ap-HisRS;  e) Mp−tRNACUA
Cys ;  f)  Mp−tRNACUA
Cys +Mp-CysRS;  g)  Af −tRNACUA
Tyr ;  h)
Af −tRNACUA
Tyr +Af-TyrRS. The average masses detected are indicated above each peak. The minor peaks correspond to the
removal of Met1 from the mature protein. Results are summarised in Table 3.2. No additional peaks where detected within
the detection limit of the instrument (~1 % of the total protein injected), so that a minor amount of other species might be
present.
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its high expression levels, exceptional stability, ease of purification and small size, which makes it
suitable of mass spectrometry. The position at which the amber stop codon was inserted corresponds
to the first amino acid of the 7th β-strand facing outward from the barrel, equivalent to position 150 in
our particular variant (gfp150*), as this position has been tolerant to all of the ncAAs tested in the lab.
Given the sensitivity of mass determination by the instrument, mass spectrometry on the purified
protein is suitable to discriminate the amino acids which differ in mass by more than 1 Da, i.e. all the
amino acids except the pairs ile-leu, asn-asp and the group gln-glu-lys, as their mass is too similar.
LC-MC analysis  of  the  sfGFP150*  reporter  following  amber  suppression  using  the  tRNAs  under
investigation (Figure 3.1) revealed aminoacylation by the following amino acids:
(-) aaRS (+) aaRS (-) aaRS (+) aaRS
(1) Ca− tRNACUA
Arg arg arg (3) Mp− tRNACUA
Cys gln/glu/lys cys
(7) Ap− tRNACUA
His gln/glu/lys gln/glu/lys (9) Af − tRNACUA
Tyr gln/glu/lys tyr
Table 3.2: amino acid charged onto the amber suppressor tRNA indicated,  either in the presence or the absence of its
cognate synthetase, as indicated by the mass spectrometry measurement of the total mass of the sfGFP150* reporter. Reference
masses are indicated in Chapter IV – Materials & Methods: GFP Total Mass.
Interpreting the information contained in  Table 3.1 and  Table 3.2 together, I drew the following
conclusions:
(1) Ca− tRNACUA
Arg  was aminoacylated efficiently by the endogenous E. coli ArgRS, which led to a
significant increase to chloramphenicol resistance. Experimental evidences were not enough
to support nor disprove the activity of the Ca-ArgRS on the amber suppressing mutant of its
tRNA. The presence of a background incorporation with the same amino acid as the natural
substrate  for  the  synthetase  complicated  the  possibility  to  engineer  the  pair  to  improve
orthogonality.  In  fact,  in  case  the  Ca-ArgRS  could  not  recognise  the  Ca− tRNACUA
Arg ,  the
evolution of the enzyme required to re-establish their interaction would be made difficult by
the  fact  that  the  tRNA would  be  aminoacylated  in  any  case  with  arginine.  Additionally,
reduction of  the  background recognition by the  Ec-ArgRS would require  mutation of  the
tRNA, whose effect on the interaction with the Ca-ArgRS could not be monitored for similar
reasons. Overall, these considerations led me to not pursue the goal of obtaining an efficient
amber suppressor pair from this tRNA/synthetase;
(2) Sc− tRNACUA
Asp had completely lost its ability to be recognised by the  Sc-AspRS, but retained
full orthogonality. This confirmed that recognition of the anticodon represented a key feature
of  the  interaction  and  suggested  that  engineering  the  anticodon-binding  domain  of  the
synthetase might restore it;
(3) Mp− tRNACUA
Cys displayed a moderate background, but a robust incorporation of cysteine was
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driven by the concomitant presence of Mp-CysRS in the cells. In this case, molecular evolution
of either the synthetase or the tRNA might lead to an amber suppressor pair with improved
performances;
(4) In− tRNACUA
Gln  behaved like Sc− tRNACUA
Asp and had completely lost its ability to be recognised
by the  In-GlnRS, while still being fully orthogonal. This result was unexpected, considering
that other glutaminyl pairs,  notably the one from  E. coli,  were known to be permissive to
conversion to amber  suppressors122, and suggested that the  In-GlnRS had evolved a distinct
modality of interaction with its cognate tRNA, with a stronger emphasis on the recognition of
the anticodon compared to its orthologues from other species. Also in this case, engineering of
the synthetase in its anticodon-binding domain was considered a valuable strategy to restore
the interaction;
(5) Si− tRNACUA
Glu  followed a similar pattern as  Sc− tRNACUA
Asp  and engineering of the enzyme
was considered a valuable option to restore interaction between the tRNA and the synthetase;
(6) Bv− tRNACUA
Gly displayed  only  a  minor  level  of  background  aminoacylation,  however  its
recognition  by  the  cognate  synthetase  was  completely  abolished.  Given  the  existence  of
extensive interaction between the enzyme and the tRNA, we reasoned that evolution of the
anticodon-binding domain of  the synthetase could potentially allow us to identify a variant
which can engage the mutant anticodon in a new interaction network;
(7) Ap− tRNACUA
His lost its orthogonality compared to its wild type counterpart, however, unlike
the Ca− tRNACUA
Arg , it became a substrate for one of the E. coli synthetase (either the Ec-GlnRS,
Ec-GluRS, or the  Ec-LysRS) from a different isoacceptor class. Furthermore, the experiments
highlighted unambiguously that the synthetase did not display any activity on the mutant
tRNA. We reasoned though that engineering of the synthetase might restore the interaction
and that this would lead to histidine being charged onto the tRNA, which could be monitored
by mass spectrometry;
(8) Af − tRNACUA
Tyr lost  its  orthogonality  following  the  single  point  mutation  G34C  in  its
anticodon. As a consequence, the mutant tRNA became a substrate for either  Ec-GlnRS,  Ec-
GluRS, or the Ec-LysRS. The levels of chloramphenicol resistance observed in the presence of
the Af-TyrRS did not differ from the ones observed in its absence, however mass spectrometry
indicated a qualitative difference in the incorporation which changed from gln/glu/lys to tyr,
confirming some level of activity of the synthetase towards its mutant tRNA. The absence of
background aminoacylation (up to detection limit of the instrument) in the GFP purified from
cells  containing both the  Af − tRNACUA
Tyr  and the  Af-TyrRS indicated that  competition can
effectively alter the orthogonality of a tRNA, i.e.: the  Af − tRNACUA
Tyr  was orthogonal to the
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endogenous E. coli synthetases in the presence of Af-TyrRS but not in its absence. This same
observation also implied that the E. coli synthetase which mis-charged the Af − tRNACUA
Tyr  was
orthogonal to that tRNA in the presence of Af-TyrRS but not in its absence. This experimental
evidence  further  cast  a  doubt  on  the  validity  of  in  vitro aminoacylation  assays  in  the
assessment of synthetases orthogonality. In order to improve the effectiveness of the pair as
an  amber  suppressor,  we  decided  to  both  try  to  engineer  the  synthetase  to  optimise  its
interaction with the mutant tRNA and to mutate the tRNA to improve its orthogonality in the
absence of its cognate synthetase.
In the following sections I will describe the experimental procedure which was followed to try and
engineer the pairs as described herein.
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tRNAAsp from Sorangium cellulosum
The aspartyl-tRNA synthetase from S. cellulosum (Sc) is a dimeric enzyme belonging to the class II of
aaRS. Although a structure of this protein is not available, the crystal structure of its orthologue from
Thermus  thermophilus (Tt)  (PDB  1efw123,  Figure  3.2a)  allowed  to  determine  that  the  enzyme  is
composed of a small N-terminal domain (Figure 3.2a, blue), encompassing approximately the initial
20% of its primary sequence, which contacts the anticodon of the tRNA by well defined hydrogen
bonds to positions 34, 35 and 36; and a C-terminal domain, responsible for the dimerisation and for
the catalysis itself.
While the experimental evidence (Figure 2.9, Asp_09) indicated that the Sc-AspRS was active on the
Sc− tRNAGUC
Asp , amber suppression experiments on Sc− tRNACUA
Asp  in the presence of Sc-AspRS did not
reveal any chloramphenicol resistance even at the lowest concentration tested. I concluded that the
two mutations G34C and C36A had completely impaired the recognition between the two partners.
This could be due to either the loss of a fundamental fraction of the binding energy of the pair, which
could be provided by the hydrogen bonds formed between the anticodon and the enzyme, or by a
steric clash caused by the additional hinderance caused by the transversion C36A. The crystal (Figure
3.2b)  reveals  that  only  few residues  are  responsible  for  the  establishment  of  the  hydrogen bond
network  between  the  synthetase  and  the  tRNA's  anticodon:  in  particular,  E91  in  the  Tt-AspRS
contacts the guanidine moiety of the modified G34 nucleotide of the tRNA, R78 interacted with the
carbonyl groups of both U35 and C36, while the latter was also engaged by the amide group of N82.
Notably,  the  majority  of  the  interactions  between  the  side  chains  from  the  enzyme  and  the
nucleobases from the tRNA are constituted by charge-to-dipole interactions, which are stronger then
dipole-to-dipole  interactions,  thus  potentially  providing  a  significant  contribution  to  the  binding
energy responsible to keep the partners together during aminoacylation.
Conversion of the Sc− tRNAGUC
Asp  to an amber suppression did not require mutations of the middle
position of the anticodon, however, since the only residue which interacted with U35 (i.e.: Arg78) was
also responsible for the recognition of C36, which in turn was mutated to a bulkier A36, I decided to
generate a library of variants of the  Sc-AspRS which would randomise the residues of the enzyme
corresponding to Arg78, Asn82 and Glu91 from the Tt-AspRS (Figure 3.2b). Alignment of the primary
sequence of the two proteins revealed that these residues were Asn107, Arg102 and Glu116 from Sc-
AspRS, which were then randomised to all possible natural amino acids by enzymatic inverse PCR
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(eiPCR124) to generate a library of mutant synthetases. The library was generated using a plasmid
containing both the synthetase and its cognate tRNA as a starting material. In order to verify whether
any of the generated variants could re-establish any productive interaction leading to aminoacylation
of the tRNA, I transformed the library into a reporter strain of E. coli DH10b constitutively expressing
the  cat112* reporter, which conferred resistance to chloramphenicol if  the cell  could perform amber
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Figure 3.2: Evolution of the S. cellulosum tRNAAsp/AspRS pair. a) Crystal structure of the closest orthologue of the Sc-AspRS
from T. thermophilus (PDB 1efw123). The enzyme assembles into dimers, one subunit of which is coloured as a rainbow (N-
terminal blue to C-terminal red) while the second subunit being shown in white, for clarity. tRNAs are coloured in dark grey.
b) Interaction between the tRNA anticodon (orange) and the residues at the N-terminal domain of the synthetase.  c) GFP
expression level of various combination of tRNAAsp/AspRS during the evolution of the pair.  d) Schematic structure of the
amber  suppressor  mutant  of  Sc-tRNAAsp.  The  residues  in  green  were  randomised  in  a  library  from which  the  mutant
Sc−tRNACUA
Asp (10) was selected. The mutated residues are shown in red.  e) In vitro aminoacylation experiment using the
evolved  Sc-AspRSC4 showed  a  distinct  aminoacylation  rate  in  the  absence  or  presence  of  a  specific  substrate  for  the
synthetase, supporting its orthogonality.
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suppression  effectively,  and the  gfp150* reporter  upon induction  of  the  L-arabinose  inducible  P
BAD
promoter, which made the cells visibly fluorescent when illuminated using visible blue light (488 nm).
The two reporters, expressed from the same reporter plasmid called p15A-cat112*-gfp150*, served two
distinct purposes: the antibiotic resistance marker allowed the survival on plates of only the cells
harbouring an active synthetase with restored activity for its cognate tRNA, reducing drastically the
number of cells  capable of forming colonies on solid medium.. The GFP provided a fast dynamic
measurement  of  the  efficiency  of  amber  suppression  by  the  pair.  Furthermore,  I  knew  from
experimental experience that positive selections on chloramphenicol are permissive to some extent to
the survival of clones with low or absent amber suppression activity, while the incidence of false
positive clones displaying both antibiotic resistance and  green fluorescence in the absence of effective
amber suppression is mostly negligible.
A  round  of  positive  selection  using  the  dual  reporter  cell  line  grown on plates  containing  low
concentrations of chloramphenicol (i.e.: 50 ng/mL, chosen on the basis of the results shown in Table
3.1) allowed me to identify a clone possessing moderate but reliably reproducible amber suppression
properties (Figure 3.2c).  This cloned, which was called  Sc-AspRSC4 presented only two mutations:
Arg102Asn and Glu116Arg, while retaining the wild type Asn107. I speculated that the reason why
these  mutations were  sufficient  to  restore  the  interaction between the  Sc− tRNACUA
Asp  and the  Sc-
AspRS was the generation of a new Arg116:C34 charge-to-dipole interaction which had replaced the
native Glu116:G34 interaction, since the longer side chain of arginine compared to glutamic acid could
compensate  for  the  smaller  size  of  cytosine  compared  to  guanine,  while  also  presenting  the
appropriate complementary pattern of hydrogen bonds. Additionally, the minor steric bulk of Asn102
compared to Arg102 could allow the accommodation of the larger A36 which had taken the place of
C36, while also allowing for the formation of potential hydrogen bonds.
The identification of the mutant described was very promising, however the overall efficiency of the
engineered pair as an amber suppressor remained modest,  as measured by the GFP fluorescence
induced by  the  read-through of  the  gfp150* reporter  (Figure 3.2c).  In  order  to  verify  whether  this
activity could be improved,  I  tested if  the  Sc− tRNACUA
Asp  could become a better substrate for  the
newly evolved Sc-AspRSC4. In particular, given that the interface between the tRNA anticodon and the
anticodon-binding domain of the synthetase had been entirely re-designed,  I  questioned whether
mutation of the residues of the anticodon arm surrounding the anticodon could lead to improved
performances. This approach, which had been used successfully before41 has its foundation in two
aspects: first, the anticodon arm had been observed to alter the efficiency of decoding of a specific
codon by a tRNA103;  secondly, while overall isosteric,  different base pairs sequences are known to
induce  slightly  different  conformations  to  nucleic  acids125,  such  that  mutations  might  potentially
optimise at a finer level the surface complementarity between the tRNA and the synthetase. I had to
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keep in mind, though, that any alteration to the tRNA could lead to alterations to its orthogonality, so
that lack of aminoacylation in the absence of the cognate synthetase always had to be verified. To
account for this, I altered the experimental design by generating a library of the 5 nt on either sides of
the anticodon of Sc− tRNACUA
Asp  by eiPCR on a plasmid only containing the tRNA (Figure 3.2d). The
gene coding for the  Sc-AspRSC4 was cloned in the reporter plasmid p15A-cat112*-gfp150* to generate a
new reporter known as p15A-cat112*-gfp150*-ScAspRSC4. The library was transformed in cells harbouring
the  new  reporter  plasmid  and  the  transformants  were  grown  on  selective  conditions  using  a
concentration of chloramphenicol (i.e.: 100 ng/mL) higher than the one used for the previous round
of selection,  in  order to  ensure  that  the  surviving colonies  would harbour  a  tRNA which  would
outperform its parental counterpart for amber suppression. The clones displaying the highest levels of
GFP fluorescence  were  grown individually  and the  tRNA-containing plasmid  was  purified,  then
transformed  in  reporter  cells  containing  either  the  p15A-cat112*-gfp150* or  the  p15A-cat112*-gfp150*-
ScAspRSC4 plasmid. This experiment allowed me to verify the levels of GFP expression produced in
the absence  or  presence of the  Sc-AspRSC4,  thus examining both the tRNA orthogonality and the
overall activity of the pair. This screening, performed together with Dr. Shan Tang, allowed me to
identify a new tRNA, called Sc−tRNACUA
Asp (10) , which fully preserved orthogonality while displaying
enhanced performance as an amber suppressor (Figure 3.2c). However, the experiments described did
not  allow  me  to  verify  whether  the  improvement  derived  from  higher  aminoacylation  or  better
ribosomal decoding.
The  evolution  experiments  described  highlighted  how  the  Sc− tRNACUA
Asp /Sc-AspRS  pair  was
converted from a fully inactive pair to a good amber suppressing one by mean of molecular evolution.
Furthermore  the  synthetase  was  evolved to  actively  recognise  the  CUA anticodon,  which  is  not
present  in  any of  the endogenous  E. coli  tRNAs.  For  this  reason we hypothesised that  following
evolution orthogonality of the pair might have been improved, as its discrimination for the anticodon
had changed drastically. Consequently, I purified the  Sc-AspRSC4 synthetase and tested it in an  in
vitro setting as I had done previously for its wild type counterpart. The new experiment (Figure 3.2e)
showed a  remarkable  difference  in  the  aminoacylation  dynamics  between  the  sample  containing
Sc−tRNACUA
Asp (10)  compared to the sample containing only the E. coli tRNAs, differently from what
observed before the evolution (Figure 2.9). This observation led us to conclude that evolution had
effectively generated a new orthogonal amber suppressing pair.
75
Daniele Cervettini Ph.D. Thesis
Engineering the Amino Acid Specificity for Sc-AspRSC4
Since I could evolve the  S. cellulosum tRNAAsp/AspRS pair into an effective and orthogonal amber
suppressing pair, I wondered whether I could alter its amino acid specificity in order to incorporate a
ncAA for genetic code expansion. In order to understand how the synthetase recognised its amino
acid substrate, I relied on the structure of the closest orthologue crystallised bound to aspartyl-AMP
(Figure 3.3a, AspRS from E. coli,  PDB 1c0a126). Analysis of the structure revealed that the side chain of
the aspartic acid forms a salt bridge with a very conserved arginine residue (Arg489 in E. coli AspRS),
which is in turn held in place by interactions with other side chains (Glu235 and Ser487) protruding
from  adjacent  strands  of  the  β-sheet  which  constitutes  the  catalytic  pocket.  In  addition  to  the
fundamental contribution provided from Arg489, Lys 198 established an additional salt bridge with
the side chain of the substrate, while a pair of consecutive histidines at positions 495 and 496  form
hydrogen bonds with the β-carboxyl group. In spite of its importance for substrate binding, Gln195
only interacts with the α-amine group and is for this reason not directly involved with the recognition
of the side chain. Similarly to what could be observed in the crystal structure shown, previous studies
on  the  eukaryotic  enzyme  from  S.  cerevisiae127 had  highlighted  the  conservation  of  the  residues
Arg489,  Lys198 and Glu235 (Arg485,  Lys306 and Glu344 in  S.  cerevisiae, respectively),  while  also
showing how mutation of any of these residues led to complete inactivation of the enzyme.
From these pieces of information and from the alignment of the  S. cellulosum AspRS to the  E. coli
orthologue I reasoned that Arg536 (corresponding to Arg489 in E. coli) had to play a pivotal role in the
recognition of aspartic acid as a substrate for the enzyme, hence I decided to generate a library of
mutant enzymes in which I randomised this position to all the possible canonical amino acids except
for arginine.
The reasons behind this choice were firstly the likelihood that mutants retaining arginine at this
position would most likely still recognise aspartic acid as their substrate, but also the observation that
the long side chain of arginine occupies a very large volume of the catalytic pocket of the enzyme,
such that exclusion of that residue from this position would generate a pocket of significantly larger
size, potentially enabling incorporation of ncAAs with a bulkier side chain. In order to obtain this
result  with  ease,  I  made  use  of  a  computational  tool  I  developed  in  2016,  which  expanded the
generality of the approach described by Tang  et  al. in 2012 for the generation of so-called “small
intelligent libraries”128 by identifying which combination(s) of degenerate primers for site-saturation
mutagenesis can be mixed in precise ratios to generate a mixture of sequence uniformly coding for a
specific  set  of amino acids of choice.  A complete description of this algorithm is available in my
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Master's  thesis  (Daniele  Cervettini,  Engineering the  Methanogenic-Type  Seryl-tRNA Synthetase
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Figure 3.3:  a)  Molecular structure of  the active  site  of  the  AspRS synthetase  by E.  coli  (PDB 1c0a 126)  highlights  the
mechanisms of recognition of the substrate. b) Chemical structures of the ncAAs used for the selections of mutant Sc-AspRSs.
c) Activity of the Sc-AspRSC4Glu as measured by production of the sfGFP by read-through of the sfGFP150* reporter. d) Mass
spectrometry analysis on the purified sfGFP produced by the read-through of the sfGFP150* reporter confirms incorporation
of glutamic acid by the synthetase. The minor peak corresponds to the the cleavage of Met1 from the protein.
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from Methanosarcina barkeri: a New Methodological Approach,  2006, Università di Pisa), and the
code is available in Chapter V – Appendix: PrimDesign.
In  particular,  while  in  their  paper  Tang  et  al.  only  described  the  combination  of  primers  with
sequence NDT:VMA:ATG:TGG to be mixed in ratios of 12:6:1:1 to obtain uniform coverage of all 20
amino acids, my software identified the combination VHG:WKC:NAC:KGG to be mixed in ratios of
9:4:4:2 to have uniform coverage of all the natural amino acids except for arginine.
In addition to position 536 above described, my library also randomised Lys223, Glu260 and Ser534
(corresponding to Lys198, Glu235 and Ser487 in the E. coli AspRS), respectively, to all possible amino
acids (Figure 3.3a). Having hypothesised that the removal of the wild type arginine from position 536
would expand the size of the amino acid binding pocket, I decided to perform positive selection on
the library against each of the ncAAs belonging to the set listed below, which included some polar
amino acids of similar size compared to aspartic acid, but also some others with a larger side chain
(Figure 3.3b): 
1. homoserine (hSer, (S)-2-amino-4-hydroxybutanoic acid);
2. phosphoserine (pSer, (S)-2-amino-3-(phosphonooxy)propionic acid);
3. glutamic acid γ-hydrazide (zGlu, (2S)-2-amino-5-hydrazinyl-5-oxopentanoic acid);
4. homoglutamic acid (hGlu, (S)-2-aminohexanedioic acid);
5. citrulline (Cit, (S)-2-amino-5-(carbamoylamino)pentano acid);
6. azidoalanine (N3Ala, (S)-2-amino-3-azidopropanoic acid);
7. azidoornithine (N3Orn, (S)-2-amino-5-azidopentanoic acid);
8. azidolysine (N3Lys, (S)-2-amino-5-azidohexanoic acid);
9. homoDAP (hDap, (S)-2,4-diamino-butanoic acid);
10. ornithine (Orn, (S)-2,5-diamino-pentanoic acid);
11. formyl-lysine (fLys, (S)-2-amino-6-formamidohexanoic acid);
12. homoarginine (hArg, (S)-2-amino-6-(diaminomethylideneamino)hexanoic acid);
13. homocitrulline (hCit, (S)-2-amino-6-(carbamoylamino)hexanoic acid);
14. acetyl-lysine (AcLys, (S)-6-acetamido-2-aminohexanoic acid);
15. trifluoroacetyl-lysine (F3AcLys, (S)-2-amino-6-[(2,2,2-trifluoroacetyl)amino]hexanoic acid).
I  set  up a round of  positive  selection using the  dual  reporter  system described in the previous
paragraph for each for the 15 amino acids listed above at a concentration of 2 mM on solid medium.
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Additionally,  one  positive  selection  plate  was  set  up  without  the  addition  of  any  ncAA.  After
incubation at 37°C, a similar number of GFP-positive colonies were observed on each plate, including
the negative control. Considering the special precautions taken in making the library, I hypothesises
that the colonies observed could include some new mutants incorporating a different amino acid than
aspartic acid. For this reason, I extracted the library plasmid contained in several clones grown on
different plates in order to sequence the synthetase variant and to perform amber suppression on the
sfGFP150*  reporter  for  mass  spectrometry.  The analysis  reveal  that  clones  retaining the  wild type
Lys223 and Glu260 but with the mutations Ser534Arg and Arg536Ala/Ser, or clones with the wild
type  Lys223  but  with  the  mutations  Arg536Tyr  and  with  two  small  residues  (Gly/Cys/Ser)  at
positions 260 and 534,. could retain a fraction of the activity of the wild type clone and the same
specificity for aspartic acid, as confirmed by mass spectrometry. Interestingly, though, clones were
identified which lacked the conserved Lys223 and had instead acquired the mutations (Lys223Ala,
Glu260Lys and Arg536Ala/Asn/Gly, while retaining the wild type Ser534. These samples displayed
modest  but  reproducible  amber  suppression  activity,  the  most  active  variant  being  the  mutant
Lys223Ala, Glu260Lys and Arg536Ala, called Sc-AspRSC4·Glu (Figure 3.3c), while mass spectrometry on
these samples highlighted that the specificity of these mutants had changed to glutamic acid. No
mutants were selected from this library that were able to incorporate any of the ncAAs tested.
While not representing the most desirable outcome, the identification of the  Sc-AspRSC4·Glu mutant
proved  that  the  active  site  of  the  enzyme can  indeed  be  mutated  to  accommodate  amino  acids
different from the wild type substrate of the synthetase. Even if only differing from aspartic acid by
the presence of one extra carbon, glutamic acid seemed to be recognized by a distinct mechanism, as
indicated by the loss of both the salt bridge-forming residues Lys223 and Arg536, while the negatively
charged residue Glu260 had been replaced by the positively charged Lys260, likely responsible for the
establishment of a new polar interaction pattern.
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tRNACys by Moorea producens
Cysteinyl-tRNA symthetases are a family of small monomeric enzymes belonging to the class I of
aminoacyl-tRNA synthetases, lacking any editing domain due to their high selectivity for cysteine.
The structure of the CysRS from  M. producens  has not been resolved before, however, the crystal
structure of its orthologue from E. coli (Figure 3.4a, PDB 1u0b129) shows how the enzyme is composed
of a catalytic N-terminal domain, encompassing about 85% of the whole primary sequence of the
enzyme, while the C-terminal domain is composed of the last 15% of the protein and is responsible for
the  interactions with  the  tRNA's  anticodon (Figure 3.4a,  orange and red).  In  addition  to  specific
interaction between the enzyme and the tRNA's anticodon, the structure shows a wide surface area of
contact points between the two partners.
Conversion of  the  Mp-tRNACys to  an  amber  suppressor  had not  resulted in  a  significant  loss  of
orthogonality, and furthermore the resulting amber suppressor could be still recognised  by the wild
type enzyme to induce a low but reproducible level of amber suppression of the sfGFP 150* (Figure
3.4b).  The  wild  type  anticodon  for  the  Mp-tRNACys is  GCA,  so  that  its  conversion  to  an  amber
suppressor involved the two mutations G34C and C35U. Differently from the case of  Sc-tRNAAsp,
neither of these mutations were transversion from pyrimidine to sterically bulkier purines,  which
would be more likely to disrupt interactions due to steric clashes. Furthermore, the persistence of
interaction might have been facilitated by the broad contact area mentioned before. In spite of this, I
wanted to verify whether the activity of the pair could be improved by re-optimising the interaction
at the anticodon level.
A more in-depth analysis of  the crystal structure of  E. coli CysRS (Figure 3.4c)  highlighted how
Asp436 interacts specifically with the guanidine moiety of G34 in the anticodon, while its carbonyl
group establishes  a  polar  contact  with  the  side  chain  of  Arg427.  Similarly,  C35 is  involved in  a
complex network of polar contacts with Arg439 and Asp451, the latter being held in place by a salt
bridge formed with Arg423.  Overall,  position 34 and 35 of the anticodon are recognised by both
positively and negatively charged residues, which form charge-to-dipole interactions. I generated a
library of the residues Arg455, Arg459, Asp468, Arg471 and Asp483, which correspond to Arg423,
Arg427, Asp436, Arg439 and Asp451 of the E. coli CysRS. This library underwent a round of positive
selection using the dual reporter system described before and a concentration of chloramphenicol
equal to 350 µg/mL due to the higher starting activity of the pair. Several clones among the ones
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forming colonies under selective conditions displayed a high amber-suppression level, as estimate by
observing the plates under a blue light (~488 nm). The most active 27  clones were isolated and the
enzyme  variant  they  contained  was  sequences.  In  this  case,  the  active  colonies  did  not  display
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Figure 3.4:  a) Crystal structure of the CysRS from E. coli (PDB 1u0b129) reveals the division of the enzyme into an N-
terminal catalytic domain (blue to yellow) and a C-terminal anticodon-binding domain (orange and red). b) Activity of the
amber  suppressor  mutant  of  the  M.  producens  tRNACys/CysRS  pair,  as  measured  by  the  read-through  of  the  reporter
sfGFP150*. The data indicated that while the amber suppressor tRNA retained orthogonality and while being capable of being
recognised  to  a  lesser  extent  by  its  wild  type  cognate  CysRS,  truncation  of  the  C-terminal  anticodon-binding  domain
significantly improved its performance. c) Molecular mechanism of the tRNACys anticodon recognition by the E. coli CysRS
as revealed by the crystal structure of their complex (PDB 1u0b). d) Mass spectromery analysis of the read-through product
of the sfGFP150* reporter reveals incorporation of cysteine on the  tRNACUA
Cys by all the variants of the synthetase tested.  e)
Molecular mechanism of the recognition of the amino acid substrate by the E coli CysRS (PDB 1li7130) reveals the role of the
Zn2+ ion in the active site. f) Chemical structure of the ncAA used for the selection of mutant Mp-CysRS variants.
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sequence convergence, but 11 of them showed a TAG stop codon at either position 455, 459 or 471,
including  the  clone  E1  which  showed  a  remarkable  activity  (Figure  3.4b)  and  harboured  the
mutations Arg455(TAG), Arg459Gln, Asp468Gly, Arg471Gln and Asp483Thr.
The presence of an amber stop codon at the first randomised position of the library raised a question.
In fact, as the cells containing the  Mp-CysRSE1 mutant displayed high amber suppression activity, I
could not  conclude whether the activity of the synthetase was resulting from the production of a
truncated  enzyme,  given  by  termination  at  position  455,  lacking  almost  the  entire  C-terminal
anticodon-binding domain, or whether the active variant would result form suppression of the amber
stop codon at position 455 using cysteine. In order to verify which one of the two options was correct,
I mutated the sequence of the codon 455 from TAG to either the TGT cysteine codon, or to the TAA
stop codon which cannot be suppressed, such that the two proteins would either contain or lack the
C-terminal  domain.  The  two  variants,  called  Mp-CysRSE1(TGT) and  Mp-CysRSE1(TAA) were  tested,
together with the  Mp-CysRSE1 mutant containing the amber stop codon. The read-through activity of
all the variants tested resulted completely equivalent (Figure 3.4b), and mass spectrometry analysis
on the sfGFP produced in the assay confirmed the incorporation of cysteine at position 150 from all
the variants tested, namely, the wild type  Mp-CysRS and the mutants  Mp-CysRSE1,  Mp-CysRSE1(TGT)
and Mp-CysRSE1(TAA) (Figure 3.4d). These results suggested that the C-terminal domain of the enzyme
was actually of hinderance for the optimal activity of the synthetase on the suppressor tRNA and that
it was completely disposable. Given that the activity of the truncated mutant was indistinguishable
from the mutant containing the amber stop codon and also from the mutant containing cysteine, I
hypothesised  that  the  mutant  Mp-CysRSE1(TGT) could  not  form  a  functionally  folded  C-terminal
domain, hence the equivalence to the Mp-CysRSE1(TAA) mutant.
Having generated a very active amber suppressor pair, I wanted to verify whether it could be used
to incorporate ncAAs, hence I used the structural information of the E. coli CysRS crystallised bound
to cysteine (Figure 3.4e,  PDB 1li7130) to identify the residues responsible for the recognition of the
amino acid. Interestingly, the structure highlights how the active site of the enzyme contains a Zn2+
ion which is coordinated by Cys28, Cys209, His234 and  Glu238 in the absence of the amino acid.
Upon binding, the thiol group of the free cysteine replaces Glu238 in the coordination of the Zn 2+ ion.
This recognition mechanism ensures the specificity of the enzyme without requiring the presence of
an additional editing domain. I reasoned that incorporation of any ncAAs would require the removal
of the Zn2+ ion from the active site, which would generate a new catalytic pocket of bigger size and
perhaps allow incorporation of amino acids with bulkier side chains. I identified the residues Cys29,
Cys215, His240 and Glu244 in Mp-CysRS as the ones responsible for the coordination of the Zn2+ ion.
To minimise the background, I decided to exclude cysteine from the randomisation at positions 29
and 215, to be sure that the wild type coordination shell of the metal would be destroyed. To do so, I
used my script to identify the combination of degenerate primers with sequence SVT, WHC, VWG
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and TGG to be mixed in a ratio of 6:6:6:1 which would produce uniform coverage of the other 19
amino acids excluding cysteine. Additionally, I decided to randomise residues His230 and His241 as
they are in close proximity to the active site. I decided to screen the library against the following set of
amino acids (Figure 3.4f):
1. S-methyl-cysteine (mCys, (R)-2-amino-3-(methylmercapto)propionic acid);
2. S-propargyl-cysteine (pCys, (R)-2-amino-3-prop-2-ynylsulfanylpropanoic acid);
3. S-allyl-cysteine (aCys, (R)-2-amino-3-prop-2-enylsulfanylpropanoic acid);
4. homoserine (hSer, (S)-2-amino-4-hydroxybutanoic acid);
5. DAP (Dap, (S)-2,3-diaminopropanoic acid);
6. homoDAP (hDap, (S)-2,4-diamino-butanoic acid);
7. cyanoalanine (CNAla. (S)-2-Amino-3-cyanopropanoic acid);
8. azidoalanine (N3Ala, (S)-2-amino-3-azidopropanoic acid).
Unfortunately,  none of these selections revealed any mutant  synthetase capable  of  incorporating
alternative substrates. This undesired result might be due to different factors. First of all, it might be
possible that the loss of the Zn2+ ion, required to fit any alternative substrate within the active site of
the enzyme, might destabilise the folding of the protein, resulting in inactive variants. Alternatively, a
different selection of ncAAs and/or a different library design might result in successful evolution of
the pair.
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tRNAGln from Ilumatobacter nonamiensis
Glutamine-tRNA synthetases  are  monomeric  class  I  synthetases  lacking  an  editing domain.  The
crystal structure of the  E. coli GlnRS bound to its tRNA (Figure 3.5a, PDB 1qrs131) highlights how,
differently from other synthetases, the enzyme is not composed of two distinct domains, one of which
is  responsible  for  the  catalysis  while  the  other  being responsible  for  interaction with the  tRNA's
anticodon. Instead, the enzyme folds in a single globular structure which makes contacts with the
tRNA on several points along its sequence. Importantly, the  E. coli GlnRS is known to tolerate the
mutant amber suppressor Ec− tRNACUA
Gln  which arises from the mutation of the E. coli Ec− tRNACUG
Gln
122.
In contrast to the case just mentioned, conversion of the In− tRNAUUG
Gln  to an amber suppressor did
not result in any appreciable aminoacylation of the resulting tRNA, as assessed by the complete lack
of read-through of the sfGFP150* reporter (Figure 3.5b). This information highlighted how the tRNA
recognition mechanism employed by the two enzymes should differ  significantly,  in  spite of  the
homology between the to proteins.  Due to the  existence  of  a tRNAGln with anticodon CUG in  I.
nonamiensis, I concluded that the loss of recognition of the amber suppressor tRNA would have to be
dependent on the G36A mutation. From the crystal structure of the  E. coli GlnRS I identified the
residues composing the loop Lys398, Gln399, Tyr400, Lys401 and Arg402 of the proteins as the ones
which  surround  the  third  position  of  the  anticodon (Figure  3.5c).  Among  those  residues,  the  ε-
nitrogen of the side chain of Arg402 from E. coli GlnRS is observed to establish a polar interaction to
the carbonyl group of G36, potentially providing a greater contribution towards the recognition of
this position compared to the other more distal amino acids. In the  In-GlnRS these residues are not
completely conserved and align to the amino acids Pro412, Ly413, Tyr414, Lys415, Arg416 (Figure
3.5c), respectively. Notably, In-GlnRS retains an arginine at the equivalent position to the E. coli GlnRS
Arg402.  I  generated  a  library  by  randomising  these  5  residues  of  the  loop  to  any  of  the  20
proteinogenic amino acids, and performed, together with Dr. Shan Tang, a round of positive selection
using the dual reporter system composed of cat112* and gfp150* previously described to identify active
variants of the enzyme. Due to the complete lack of activity detectable from the wild type enzyme, the
selection was carried out at low concentrations of chloramphenicol on the plate (50 µg/mL). After
overnight incubation, GFP-positive clones were identified on the selection plate. The colony showing
the highest visible level of fluorescence was isolated and the synthetase variant it harboured, named
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In-GlnRSS9, was characterised as the mutant Pro412Asp, Ly413Ser, Tyr414Ala, Lys415His, Arg416Gly,
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Figure 3.5: a) Crystal structure of the GlnRS from E. coli (PDB 1qrs131) shows how the enzyme folds into a single globular.
b) Efficiency of the In-tRNAGln/In-GlnRS pair during different stages of its evolution as an amber suppressor measured using
the reporter sfGFP150* revealed how the wild type enzyme did not interact with the amber suppressor mutant of its cognate
tRNA. The activity is rescued by the mutations present in the variant In-GlnRS S9. The activity of the pair was further boosted
by the engineering of the tRNA anticodon which generated the tRNAGln(A1).  c) Inspection of the crystal structure of the E.
coli GlnRS allowed the identification of the loop in closest proximity to position 36 of the anticodon which was randomised
to  optimise  the  interaction  between  the  synthetase  and  the  amber  suppressor  variant  of  the  tRNA.  d)  Residues  of  the
anticodon arm (green) randomised and mutation selected (red) in the tRNAGln to optimise its amber suppression efficiency. e)
Mass  spectrometry  of  the  reporter  sfGFP150* confirmed  glutamine  incorporation  by  the  GlnRSS9 mutant.  b)  In  vitro
aminoacylation by the GlnRSS9 mutant highlighted its orthogonality.
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together with the additional mutation Asp558Gly. The new mutant exhibited a small but reproducible
amber  suppression  capacity,  as  differently  from  its  wild  type  counterpart  it  could  induce  read-
through of the sfGFP150* reporter (Figure 3.5b).
Overall, this pair behaved similarly to the  Sc-AspRS, consequently we decided to try optimise the
interaction between the synthetase and its substrate tRNA by evolving its anticodon arm, since this
strategy had greatly improved the performance of the Sc− tRNACUA
Asp /Sc-AspRS pair. We generated a
library of tRNA sequences by randomising the 5 nucleotides on either sides of the anticodon of the
In− tRNACUA
Gln  (Figure 3.5d) and repeated the selection to verify which of those variants could be
effectively charged by the In-GlnRSS9. The selection plate sustained the growth of a variant, which was
called In− tRNACUA
Gln (A1) , displaying high levels of amber suppression, which was  mutated at 9 of
the 10 positions randomised and presented an unusual C30:U40 pairing (Figure 3.5d). As measured
by  the  production  of  sfGFP  from  the  amber  suppression  reporter,  the  new  evolved  pair
In− tRNACUA
Gln (A1) /In-GlnRSS9,  was  a  highly  active  pair  (Figure  3.5b),  and  additionally,  mass
spectrometry confirmed that the engineering process had not altered the activity of the pair, which
was still incorporating glutamine (Figure 3.5e).
The importance of the third letter of the anticodon in the recognition of the tRNA by the In-GlnRS,
highlighted by its complete inactivity of the In− tRNACUA
Gln ,  and the fact that the mutation G36A was
unlikely to compromise the interaction between the tRNA and the synthetase due to steric clash,
suggested that potentially the enzyme required specific interactions with all the three positions of the
anticodon  for  successful  aminoacylation.  Consequently,  it  was  possible  that  the  newly  evolved
mutant In-GlnRSS9 would recognise specifically the anticodon CUA, which is not present in any of the
endogenous E. coli tRNAs, hence would have improved orthogonality. I purified the mutant enzyme
In-GlnRSS9 and repeated the in vitro  aminoacylation assay as I had done previously for the parental
wild type enzyme (Figure 3.5f).  Consistently with the consideration expressed above, the mutant
show no detectable incorporation of the labelled amino acid when incubated with the tRNA extract
from wild type E. coli DH10b, while an increase in aminoacylation was measured over the time course
when  In− tRNACUA
Gln (A1)  was present in the reaction. These results indicated that the evolved pair
In− tRNACUA
Gln (A1) /In-GlnRSS9 is  orthogonal  in  E.  coli.  Notably,  the  generation  of  an  orthogonal
GlnRS/tRNAGln amber suppressor pair from the S. cerevisiae pair was the first attempt to be made for
the genetic code expansion in  E. coli132. Given its high activity, our new pair constitutes a valuable
starting point which might be evolved in the future to incorporate ncAAs, even if time constraints
prevented me from trying and evolve the pair further.
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tRNAGlu from Sporolactobacillus inulinus
Glutamyl-tRNA synthetases are monomeric enzymes belonging to the class I of the aaRSs. While in
eukaryotes and many prokaryotes these enzymes are exclusively responsible for the aminoacylation
of  tRNAGlu,  in  all  archaea  and  several  bacterial  families  they  are  additionally  involved with  the
synthesis of glutamine, which results from the trans-amination of the side chain of the glutamic acid-
bound tRNAGln.   Consequently, the GluRSs from those organisms are non-discriminating between
tRNAGlu and tRNAGln, and for this reason are required to tolerate both C36 found on tRNAGlu and G36
found in tRNAGln.133
The crystal structure of the non-discriminating GluRS from  Thermotoga maritima (Figure 3.6a, PDB
3akz133)  highlights  how  the  enzyme,  in  spite  of  not  being  clearly  subdivided  into  independent
domains connected by loops as  in some of the cases observed before,  is  composed of a catalytic
domain at its N-terminus, while the interaction with the anticodons are  clustered at the C-terminal
domain.  In  spite  of  the  tolerance  that  these  enzymes  must  present  in  order  to  account  for  the
variations in the anticodon sequences of their substrate tRNAs, conversion of the  Si-tRNAGlu to an
amber suppressor by introduction of the mutations C36A did not result in any appreciable amount of
amber suppression (Figure 3.6b).
Inspection of  the  crystal  structure  of  the  T.  maritima  GluRS,  which  was  crystallised  bound to  a
tRNAGln,  highlighted  how  the  synthetase  did  not  establish  clear  contacts  with  position  36  the
anticodon which could account for  the lack of aminoacylation of the mutant  tRNA (Figure 3.6c),
however,  it  allowed me to identify  which portion of the enzyme was the most  proximal  to  that
residue of the tRNA. In particular,  I  could identify  the loop formed by residues Lys369,  Val370,
Asn371 and Thr372 in the crystal,  which correspond to the residues Tyr370,  Gln371,  Glu372 and
Gln373 in the Si-GluRS. Since these residues were not conserved between the two orthologues, it was
hard to speculate whether they can establish specific interactions with G36 which would account with
the  loss  of  activity  on  the  amber  suppressor.  I  generated  a  library  by  randomising  those  four
consecutive residues of the enzyme to any of the 20 proteinogenic amino acids and used the library to
perform a step of positive selection using the dual reporter system composed of cat112* and gfp150* with
a  low  concentration  of  chloramphenicol  (50  µg/mL).  After  overnight  incubation,  GFP-positive
colonies  formed  on  the  selection  plates.  I  isolated  the  clone  which  showed  the  highest  amber
suppression activity  based on visible  green fluorescence  and verified that  it  contained a  variant,
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which  was  called  Si-GluRSD2,  harbouring  the  mutations  Tyr370Lys,  Gln371Gly,  Glu372Gly  and
Gln373Gly, together with the additional spontaneous His375Arg mutation. This mutant displayed a
reproducible amber suppression activity (Figure 3.6b). Notably, the mutation Tyr370Lys made the
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Figure 3.6: a) Crystal structure of the GluRS from T. maritima (PDB 3akz133) highlights how the enzyme is composed of an
N-terminal catalytic domain (blue to green) and a C-terminal domain interacting with the anticodon. b) Efficiency of the Si-
tRNAGlu/Si-GluRS pair during different stages of its evolution as an amber suppressor measured using the reporter sfGFP150*
revealed how the wild type enzyme did not interact with the amber suppressor mutant of its cognate tRNA. The tRNA could be
recognised by the Si-GluRSD2. The activity of the pair was further boosted by the engineering of the tRNA anticodon which
generated the tRNAGln(E4). c) Inspection of the crystal structure of the T. maritima GluRS allowed the identification of the
loop in closest proximity to position 36 of the anticodon which was randomised to optimise the interaction between the
synthetase and the amber suppressor variant  of  the tRNA.  d)  Residues of  the anticodon arm (yellow) randomised and
mutation selected (red) in the tRNAGlu to optimise its amber suppression efficiency.  e)  In vitro aminoacylation by the Si-
GluRSD2 mutant highlighted its lack of specificity.
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enzyme equal to  the crystal  structure at  this  position,  however the presence of three consecutive
glycines at positions 371-372-373 made it unlikely to believe that the restored activity would be due to
the  establishment  of  some  specific  interactions  between  the  mutated  A36  position  of  the
Si− tRNACUA
Glu  and the evolved enzyme.
Similar to the strategy implemented for the cases described in the previous sections, I decided to alter
the  sequence  of  the  tRNA  in  an  attempt  to  improve  the  efficiency  of  the  pair,  however  I  only
randomised the  positions 32, 37 and 38 in the anticodon loop, together with the base pair 3:70 and
position 17. A round of positive selection using the dual reporter system allowed me to identify a
mutant tRNA which had only acquired the three mutations G3A:C70U and U38A (Figure 3.6d). This
selected tRNA, which was named Si− tRNACUA
Glu (E4) , displayed a significantly increased capacity to
suppress the amber stop codon (Figure 3.6b). 
Given the successful cases in which engineering of the synthetase had lead to an improvement of its
orthogonality, I repeated the in vitro aminoacylation assay on the Si-GluRSD2 (Figure 3.6e). The data
highlighted how the enzyme did not seem to have a faster aminoacylation rate in the presence or
absence of the Si− tRNACUA
Glu (E4) , similarly to its wild type counterpart (Figure 2.9). This seemed to
indicate that the specificity of the enzyme had not been improved and that it was still capable of
recognising some of the endogenous E. coli tRNAs. Since the experimental evidence hinted at the fact
that the synthetase would charge multiple tRNAs, we decided that it would not be suitable for genetic
code expansion. Considering the high activity of the pair, however, alternative strategies might be
considered in the future to further evolve the pair in order to improve its orthogonality, or a similar
pipeline could be performed on another pair.
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tRNAGly form Bacteroides vulgatus and tRNAHis from 
Afifella pfennigii
As discussed previously, the Bv-GlyRS could not aminoacylate to any measurable extent the amber
mutant of the Bv-tRNAGly. The enzyme is a class II aminoacyl-tRNA synthetase which is active as a
homodimer. The structure of the closest orthologue which has been crystallised bound to its tRNA
substrate belongs to Homo sapiens (Figure 3.7a, PDB 4kr2134) highlights how the enzyme is composed
of an N-terminal catalytic domain and of a C-terminal anticodon-binding domain, similar to other
aaRS  described  in  the  previous  paragraphs.  Since  the  conversion  of  the  tRNAGly to  an  amber
suppressor  involved  the  mutations  C35U  and  C36A,  I  identified  the  residues  at  the  C-terminal
domain which are responsible to establish direct interactions with these two positions of the tRNA
anticodon.  The  crystal  reveal  an  extensive  network  of  hydrogen  bonds  and  charge-to-dipole
interactions  (Figure 3.7b).  In  particular,  Thr631 and Gln640 interact  with C35,  while  Arg548 and
Arg633 interact with C36. Additionally, Met638 is located in close proximity to C36, position which
needed to accommodate a bulkier adenine following the mutation of the anticodon. Consequently, I
generated a library of the residues of the Bv-GlyRS which correspond to the ones listed above, namely
Arg399, Thr478, Arg480, Met485 and Gln487, to evaluate whether a new pattern of interactions could
be  established  between  the  enzyme  and  the  amber  suppressor  tRNA  which  could  result  in
aminoacylation.  Unfortunately,  no  GFP-positive  colonies  grew  on  selection  plates  containing  50
µg/mL of chloramphenicol after a round of positive selection of the library using the dual reporter
system.
Alternatively, in order to restore the interaction between the tRNA and the synthetase, Dr. Shan
Tang and I tried to generate a library of tRNA sequences where the 5 nucleotides on either sides of the
anticodon were  randomised  (Figure 3.7c).  Unfortunately,  no  GFP-positive  colonies  were  selective
from this library either after a round of positive selection using the dual reporter system on plates
containing 50 µg/mL of chloramphenicol after a round of positive selection of the library.
The histidine-tRNA synthetase  is  also  a  class  II  enzyme which is  active as  a  dimer.  The crystal
structure of this enzyme from Thermus thermophilus HB27 (Figure 3.7d, PDB 4rdx135) highlights how
also  this  enzyme is  composed of an N-terminal  catalytic  domain and of a  C-terminal  anticodon-
binding domain,  which are clearly distinct  and connected by an unstructured loop (Figure 3.7d).
Analysis of the contacts between the anticodon and the C-terminal domain of the enzyme highlighted
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that G34 of the tRNA contacts the two negatively charged consecutive Asp387 and Glu388 in the
crystal,  while G36 forms polar contacts with the side chain of Lys397 (Figure 3.7e).  I generated a
library  of  the  equivalent  residues  of  the  Ap-HisRS,  namely  Asp483,  Glu484  and  Lys493  which
underwent  a  round  of  positive  selection  using  the  dual  reporter  system.  Considering  that  the
background aminoacylation of the amber suppressor mutant of Ap-tRNAHis conferred a resistance up
to 250 µg/mL of chloramphenicol,  I  had to select  the library on plates containing 300 µg/mL of
antibiotic. Unfortunately, this selection didn't allow the growth of any GFP-positive colony in which
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Figure 3.7:  a) Crystal structure of the GlyRS from H. sapiens shows the molecular organisation of the enzyme as a dimer
and its division into an N-terminal  catalytic domain (blue to green) and a C-terminal anticodon-binding domain (yellow to
red).  b) Inspection of the interaction between the H. sapiens GlyRS and its substrate tRNA reveals a complex network of
hydrogen bonds responsible for the specific recognition of the positions C35 and C36.  c) Positions of the anticodon arm
which were randomised in a library (green). No mutants displaying activity were selected.
d) Crystal structure of the His from Thermus thermophilus shows the molecular organisation of the enzyme as a dimer and its
clear division into an N-terminal catalytic domain (blue to green) and a distinct C-terminal anticodon-binding domain
(yellow to red). e) Inspection of the interaction between the T. thermophilus GlyRS and its substrate tRNA reveals hydrogen
bonds formed between the positions G34 and G36 of the tRNA anticodon and the C-terminal domain of the enzyme.  f)
Positions of the anticodon arm which were randomised in a library (green). No mutants displaying activity were selected.
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the activity of the enzyme was rescued. In another attempt to obtain an active pair, Dr. Shan Tang and
I generated a library of tRNAs in which the 5 nucleotides on either sides of the anticodon were fully
randomised which underwent a round of positive selection under the same conditions. Unfortunately
also  this  attempt  didn't  allow  me  to  identify  any  mutant  pairs  in  which  could  perform  amber
suppression using histidine.
For both of the pairs for which engineering was attempted without success, it remains possible that
the failure was connected with an incorrect choice of residues to randomise for the generation of the
libraries. It is also possible however that the recognition of the wild type nucleotides in those specific
cases cannot  be  altered to recognised the anticodon with sequence “CUA”. In future,  these pairs
might be successfully evolved to recognise different anticodons which would redirect them towards
alternative  sense  codons  made  available  thanks  to  the  efforts  to  compress  the  genetic  code  of
organisms.
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tRNATyr from Archaeoglobus fulgidus
In contrast to all the cases examined in the previous paragraphs, the tRNATyr from  Archaeoglobus
fulgidus displayed an unusual behaviour when  converted to an amber suppressor by introduction of
the single point mutation G34A. In fact, while this tRNA was able to cause read-through of the amber
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Figure 3.8: a) Mass-spectrometry analysis of the read-through product of the sfGFP150* reporter induced by the Af-tRNATyrCUA
highlighted the incorporation of either glutamine, glutamic acid or lysine. b) Mass-spectrometry analysis of the read-through
product of the sfGFP150* reporter induced by the Af-tRNATyrCUA in the presence of its cognate synthetase Af-TyrRS highlighted
the incorporation of tyrosine. c) Schematic representation of the procedure to identify the amino acid attached to a tRNA of
interest. The aminoacylated tRNA sample is isolated and annealed to a tRNA-specific biotinylated DNA probe (Annealing).
The probe is then captured onto streptavidin-coated beads (Capture), the unbound tRNAs are washed off, then the amino acid
is hydrolysed from the tRNA by alkali treatment (Hydrolysis) and analysed by LC-MS. d) Analysis of the amino acid isolated
from the Af-tRNATyrCUA revealed no signal corresponding to tyrosine (i), while a peak corresponding to the mass and retention
time for lysine was observed (ii), as verified by comparison to the relative standards (iii, iv).
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stop codon in the reporter sfGFP150* both in the absence and in the presence of its cognate synthetase,
mass spectrometry analysis revealed a qualitative difference in the type of protein produced. In fact,
while the purified sfGFP isolated from cells only containing the tRNA had an intact mass of 27.843
Da, which ambiguously identifies either glutamic acid, glutamine or lysine; the mass measured when
both the tRNA and the synthetase were present in the cells was equal to 27.875 Da, which uniquely
corresponds to the incorporation of tyrosine in response to the stop codon (Figure 3.8a-b, GFP Total
Mass,  the minor peaks correspond to removal of Met1 from the translated protein). This evidence
suggested that while the synthetase was still capable of recognising the mutant  Af − tRNACUA
Tyr , this
tRNA  behaved  somehow  as  conditionally  orthogonal  (i.e.  was  orthogonal  when  Af-TyrRS  was
expressed in the cell, but was not orthogonal in its absence).  Considering the potential risk of non-
specific incorporation of a natural amino acid by the use of a system with these properties, I decided
to first focus my attention on the incomplete orthogonality of the tRNA.
In order to minimise the recognition of the Af − tRNACUA
Tyr  by endogenous E. coli aaRSs, I first tried to
identify which one among GlnRS, GluRS or LysRS was responsible for the acylation of the amber
suppressor.  Hence,  I  developed together  with my colleague Dr.  Shan Tang an analytical  method
which allows to characterise which amino acid is bound to a specific tRNA of interest. The experience
in developing tREX had showed that extraction of tRNAs at acidic pH allows the aminoacyl ester
bond to be preserved. Additionally, tREX had showed that the probe used to detect Af-tRNATyr, which
was designed to not anneal in the proximity of the anticodon, was fully specific (Figure 2.8 - Tyr_05).
We decided to purchase a probe which would contain a biotin instead of the fluorophore Cy5 and to
anneal  it  to  a tRNA extract  containing  Af − tRNACUA
Tyr  maintaining the acidic  pH throughout the
procedure. Following annealing, streptavidin-coated sepharose beads were added to the solution and
allowed to capture the biotinylated probe together with the aminoacylated Af − tRNACUA
Tyr  bound to
it. The other tRNAs were washed off with a salt buffer at pH 5, then the solution was brought to an
alkaline pH to hydrolyse the ester bonds. The amino acids hydrolysed were then collected with the
supernatant and analysed by HPLC, while the tRNAs were not eluted from the beads (Figure 3.8c).
The  procedure  was  applied  to  the  sample  under  investigation  and  the  free  amino  acids  were
separated on the  HILIC-Z column (4.6  x  150 mm,  Agilent),  and detected using the  Agilent  6130
Quadrupole LC-MS unit, ran in SIM mode and set up to monitor either the molecular weight of 182
Da to detect tyrosine, or 147 Da to detect glutamic acid, glutamine or lysine. The chromatographic
traces showed that no tyrosine could be detected in solution (Figure 3.8d trace i), while lysine was the
only amino acid detected with a molecular weight of 147 Da (Figure 3.8d  trace  ii), as deduced by
comparison with the corresponding amino acid standards (Figure 3.8d trace iii and iv).
This result removed the ambiguity in the assignment of the amino acid found in position 150 of the
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purified sfGFP and indicated that the E. coli LysRS was recognising the Af − tRNACUA
Tyr  as a substrate.
This evidence was  somewhat surprising if considering that the mis-acylation was triggered by the he
mutation  G34C  in  spite  of  tRNALys having  anticodon  UUU,  but  an  analogous  observation  was
previously  made  when the  E.  coli LysRS was  shown to  be  able  to  weakly  mis-charge an  amber
suppressor tRNA derived from the S. cerevisiae tRNATyr 136.
In light of this evidence, I decided that I would focus my engineering efforts on two aspects: increase
the activity of the pair as an amber suppressor due to specific aminoacylation by the Af-TyrRS, and
minimise the acylation of the Af − tRNACUA
Tyr  by LysRS. The Af-TyrRS shares 56% of its sequence with
the M. jannaschii (Mj) TyrRS, a synthetase that has been extensively used for genetic code expansion.
The crystal structure of Mj-TyrRS bound to its tRNA allowed me  to identify some features of their
interactions (Figure 3.9a, PDB 1j1u137). In particular, the enzyme is a small protein composed of an N-
terminal catalytic domain and a C-terminal anticodon-binding domain. It belongs to the class I of
aaRSs but is active as a homodimer. Additionally, recognition of the tRNA anticodon occurs in trans
within a dimer with respect to the catalytic event, that is, while one monomer binds the anticodon,
aminoacylation is carried out by the other monomer. Furthermore, the structure highlights how the
contact points between the synthetase and the tRNA are clustered to either the anticodon or the upper
part of the acceptor stem. 
In order to develop an effective amber suppressor pair, I decided to start off by trying to optimise the
interaction between the synthetase and the CUA anticodon, a portion of the tRNA which would not
be subsequently modified. In fact, I hoped that the identification of a synthetase with higher activity
on the  Af − tRNACUA
Tyr  would be helpful in the event that the evolution of the tRNA to increase its
orthogonality would concomitantly result  in a reduction of its  amber suppression efficiency. This
concern was due to the fact that, even if the wild type variant of the enzyme could  recognise the
Af − tRNACUA
Tyr , the level of amber suppression was relatively low and comparable to the background
caused by the non-specific activity of the Ec-LysRS (Figure 3.9b).
In order to simplify the selection process for TyrRS variants with higher activity in a context of high
background, I  decided to adapt the reporter system in use in such a way that a signal would be
observed only  as  a  consequence  of  tyrosine  incorporation.  I  took  advantage  of  the  fact  that  the
fluorophore  of  sfGFP is  composed of  the  triad Thr-Tyr-Gly,  in  which  the  aromatic  side  chain  of
tyrosine  provides  a  fundamental  contribution  to  the  conjugation  of  the  π  orbitals  required  for
fluorescence. I hence removed the stop codon at position 150 of the sfGFP150* reporter by mutating it
back to its wild type asparagine residue (sfGFP67Tyr) then I generated a mutant in which the tyrosine in
the fluorophore was replaced by lysine (sfGFP67Lys). As expected, I observed fluorescence from cells
expressing sGFP67Tyr but not sfGFP67Lys (Figure 3.9c, black box). Consequently, I tried to generate a new
reporter  in  which  the  amber  stop  codon  would  be  replace  the  tyrosine  residue  constituting  the
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fluorophore in position 67 (sfGFP67*). Amber suppression on this reporter induced by the presence of
the Af − tRNACUA
Tyr  together with Af-TyrRS resulted in cells displaying visible green fluorescence upon
excitation with blue light (~488 nm), which was not observed in the absence of the synthetase (Figure
3.9c). This result confirmed that the reporter could be effectively used to monitor amber suppression
and  it  displayed  the  differential  fluorescence  required  which  was  not  present  in  its  predecessor
sfGFP150*  (Figure 3.9c).  Importantly,  the sfGFP67*  reporter  was used from the selections described
below, while the old sfGFP150* was used to measure the overall efficiency of amber suppression in a
format  comparable  to  previous  experiments,  which  would  also  allow  for  quantification  of  the
background.
With the  new tool  available,  I  proceeded to identify  which residues of the synthetase  might  be
mutated to optimise the interaction between the synthetase and residue C34 of the anticodon (Figure
3.9d). Analysis of the crystal structure of the TyrRS from M. jannaschii revealed that the wild type G34
is contacted by the side chain of the aspartic acid 286, while the residues Phe261 and Met285 form the
lining  of  a  pocket  where  the  nucleotide  is  accommodated.  I  hence  generated  a  library  of  the
corresponding residues Phe274, Leu298 and Asp299 of the Af-TyrRS by randomising those positions
to all the natural amino acid. The library subsequently underwent a round of positive selection on
agar plates using the dual reporter system cat112* and gfp67* and a concentration of chloramphenicol
equal to 300 µg/mL. After overnight incubation I identified the most active clones and characterised a
mutant,  Af-TyrRSG5, with the mutations Phe274Val, Leu298Gly and Asp299Arg. Concomitantly, the
plasmid harbouring this mutation had gained an extra mutation G63C in the TΨC arm of the tRNA (
Af − tRNACUA
Tyr (G5) , Figure 3.9e). This pair displayed an in improved activity and at the same time a
reduced  background  (Figure  3.9b).  I  speculated  that  the  mutation  Asp299Arg,  which  replaces  a
smaller and hydrogen bond-accepting side chain with a longer, flexible hydrogen bond-donor one,
would  allow  for  the  establishment  of  a  new  compensatory  interaction  for  the  mutation  G34C.
However,  as  the  tRNA  concomitantly  mutated,  I  could  not  unambiguously  assign  a  role  to  the
mutations  of  the  enzyme  versus  the  mutation  in  the  tRNA and  I  did  not  perform mutagenesis
experiments to confirm my hypothesis.
I  then  proceeded  by  engineering  the  tRNA  to  obtain  a  further  reduction  in  the  background
aminoacylation. I  noticed that,  differently than the  Af − tRNACUA
Tyr ,  the  Mj− tRNACUA
Tyr ,  which has
been  frequently  used  in  genetic  code  expansion,  did  not  present  a  significant  background
aminoacylation (Figure 3.9b). Considering that the identity elements for the E. coli LysRS have been
poorly characterised, I decided to verify which residues from the Af − tRNACUA
Tyr  would be identical to
the  E.  coli tRNALys while  being  different  from the  corresponding residues  of  the  Mj− tRNACUA
Tyr ,
hoping to identify the positions responsible for the mis-acylation. I hence chose the positions 7:66,
11:20 and 44-45 of the  Af − tRNACUA
Tyr (G5) as targets for randomisation for the generation of a new
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tRNA library which underwent a round of positive selection using the dual reporter system described
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Figure 3.9:  a) Crystal structure of the M. jannaschii TyrRS bound to its tRNA (PDB 1j1u 137) highlights the interaction in
trans between the two domains of the enzyme and the tRNA substrate. b) Activity of the A. fulgidus TyrRS/tRNATyr at various
stages of its evolution as an amber suppressor, compared to the activity of the amber suppressor pair from M. jannaschii. c)
E. coli cells expressing a sfGFP variant and a tRNA/aaRS pair as indicated, imaged using a 488 nm laser in a 24 well plate
and  shown as false-coloured. sfGFP  displays fluorescence when position 67 is Tyr, but not when it is Lys (black box). In
contrast to sfGFP150*, which can be read through by Af− tRNACUATyr  to produces a fluorescence signal both in presence and in
absence of the Af-TyrRS, the sfGFP67* becomes fluorescence only in the presence of Af-TyrRS..  d) Inspection of the tRNA-
binding domain of the Mj-TyrRS allowed the identification of the residues of Mj-TyrRS (equivalent residues of the Af-TyrRS
are  indicated  in  parentheses)  which  surround  position  G34  in  the  tRNA.  e)  Evolution  of  the  Af-tRNATyr as  an  amber
suppressor. The residues randomised in the first library are shown in yellow, the ones randomised in the second library in
green. The selected mutations are shown in red.
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on plates containing chloramphenicol at a concentration higher than before (400 µg/mL)(Figure 3.9e).
From this selection I isolated a clone where only the base pair U7:A66 was mutated to C7:G66, called
Af − tRNACUA
Tyr (22) ,  which  displayed  an  increased  signal  (Figure  3.9b).  The  background  for  this
tRNA, however, was not completely removed as I would have hoped. Consequently, I decided to
generate a new library following a strategy similar to the one used for previous experiments and I
fully randomised the 5 residues on either sides of the anticodon of the tRNA, then performed a round
of positive selection of plates containing 500 µg/mL of chloramphenicol. By characterising the clones
displaying the highest levels of green fluorescence after overnight incubation at 37°C, I identified a
mutant tRNA,  Af − tRNACUA
Tyr (A1) ,  where 7 out of the 10 randomised positions had been mutated
(Figure  3.9e),  which  displayed  no  appreciable  amount  of  mis-acylation  by  endogenous  E.  coli
synthetases,  while  having  an  increased  activity  as  an  amber  suppressor  in  combination  with  its
cognate synthetase (Figure 3.9b). Interestingly, the highly engineered Af − tRNACUA
Tyr (A1) /Af-TyrRSG5
displayed ~5-fold higher activity compared to the Mj− tRNACUA
Tyr /Mj-TyrRS pair.
Engineering the Amino Acid Specificity for Af-TyrRSG5
Given  that  the  evolved  Af − tRNACUA
Tyr (A1) /Af-TyrRSG5 resulted  highly  active  and  compared
favourably  with  the  activity  displayed  by  the  well-established  Mj− tRNACUA
Tyr /Mj-TyrRS  pair,  I
decided to investigate whether it could also be used as an efficient tool for the incorporation of ncAAs
in E. coli. Interestingly, and differently from all the cases of the synthetases described so far, the crystal
structure of the wild type  Af-TyrRS had been previously resolved (Figure 3.10a, PDB 2cyb138). This
information allowed to confirm that the active site of this enzyme is fully conserved between the
orthologues  from  M. jannaschii and  A.  fulgidus.  In  particular,  to  allow the  specific  recognition  of
tyrosine  as  a  substrate  and its  discrimination  from  other  amino  acids  containing  aromatic  rings
(phenylalanine  or  histidine),  the  Asp165  residue  directly  facing  the  entrance  to  the  active  site
establishes a charge-to-dipole interaction with the hydroxyl group of the tyrosine side chain, while the
Tyr36 residue also contributes to the binding of the substrate by engaging it in a hydrogen bond.
Given the similarity between the two orthologues, I decided to transplant the mutations previously
characterised for the  Mj-TyrRS onto the corresponding residues for the  Af-TyrRS to verify whether
this would transfer the capacity to incorporate ncAAs from the Mj-TyrRS to the Af-TyrRS (Table 3.3).
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Mj-TyrRS residue Tyr32 Leu65 His70 Glu107 Asp158 Ile159 Leu162
Af-TyrRS residue Tyr36 Leu69 His74 Glu114 Asp165 Ile166 Leu169
pBpaRS139 Gly Ser Thr Ser
pN3PheRS140 Thr Asn Pro Leu Gln
pB(OH)2PheRS141 Ser Ala Met Ser Glu
pIPheRS142 Leu Ser Pro Leu Glu
oNO2TyrRS143 His Cys Ser Ser Ala Arg
Table 3.3: Mutations reported in the literature which transform the Mj-TyrRS into the synthetase indicated (left column).
In spite  of  the complete  identity of  the  active  sites  between the  two enzymes,  both in terms of
sequence  and  3D geometry,  none  of  the  mutant  enzymes  containing  the  transplanted  mutations
displayed  any  activity.  This  result  was  somewhat  surprising  and  difficult  to  interpret,  and  it
furthermore implied that the previous body of literature on the evolution of the Mj-TyrRS could not
be  directly  transposed  to  my  evolved pair.  As  a  consequence,  I  decided  to  verify  whether  new
mutations could be selected directly onto the  Af-TyrRS to alter its amino acid specificity using no
further a priori knowledge. However, in order to simplify the selection process and prevent the need
of repeated cycles of positive and negative selections which were needed in previous studies140,  I
decided to verify whether the sfGFP67* reporter, which is effectively a sensor for the incorporation of
tyrosine,  could  be  adapted  to  become  a  sensor  for  the  incorporation  of  amino  acids  other  than
tyrosine, the major source of background  in the evolution of the synthetase.
Given that the fluorescence properties of the fluorophore of the mature GFP are due to the electronic
properties  of  the  electron-rich  negatively-charged  fluorophore144,  and  considering  that  mutants
fluorophores  display  markedly  reduced  or  abolished  fluorescence145,  I  speculated  that  the
incorporation of most ncAAs within the fluorophore would either interfere with the correct folding of
the  protein or  result  in  a  dysfunctional  fluorophore.  Under  this  hypothesis,  the  sfGFP67* reporter
should provide no signal if the desired outcome, i.e.: incorporation of the ncAA, is achieved. In spite
of the lack of fluorescence, however, read-through of position 67 would result in the production of a
full-length protein. I consequently modified the design of the protein by fusing in frame a short linker
followed by a far-red fluorescent protein, E2Crimon146 (Figure 3.10b). In this case, I hypothesised
that the reporter would behave in one of three possible ways:
1. If tyrosine was incorporated at position 67, a wild-type sfGFP would be produced fused in
frame with E2Crimson. Given the spectral separation between the two proteins, the reporter
should display both green fluorescence due to sfGFP when irradiated with blue light (~488
nm) and far-red fluorescence when irradiated with red light (~635 nm);
2. If  no amber suppression was performed,  only the N-terminal  portion of  sfGFP would be
translated and no fluorescence should be observed;
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3. If any amino acid other then tyrosine was incorporated at position 67, the sfGFP would be
translated with a compromised fluorophore showing either reduced or impaired fluorescence
when irradiated with blue light (~488 nm), however E2Crimson would be produced in its
wild-type form and far-red fluorescence should be produced when irradiating it with red light
(~635 nm).
In order to confirm that such design would work, I took advantage of the Mj− tRNACUA
Tyr /Mj-TyrRS
pair,  and  of  its  mutant  pB(OH)2PheRS,  capable  of  incorporating  (S)-2-amino-3-(4-
boronophenyl)propanoic  acid  (Figure  3.10c,  pB(OH)2Phe).  I  transformed cells  containing the  new
reporter  gfp67*e2crimson with a plasmid containing either the  Mj− tRNACUA
Tyr /Mj-TyrRS pair or the
Mj− tRNACUA
Tyr /Mj-pB(OH)2PheRS  pair  (Figure  3.10b).  After  overnight  incubation,  the  cells
containing the wild type  Mj-TyrRS displayed both green and far-red fluorescence, while the ones
harbouring the  pB(OH)2PheRS displayed either no fluorescence in either channels if they had been
grown in the absence of the ncAA, or far-red fluorescence only if they had been grown in its presence,
confirming that the reporter was working as predicted by its design.
I  proceeded  by  creating  a  library  of  the  Af-TyrRSG5 by  randomising  the  residues  Tyr36,  His74,
Gln116, Asp165 and Ile166 due to their proximity to the active site. I then chose the following ncAAs
as substrates to perform the selections (Figure 3.10c):
1. ortho-nitro-tyrosine (o(NO2)Tyr, (S)-2-amino-3-(4-hydroxy-3-nitrophenyl)propanoic acid));
2. para-benzyl-phenylalanine (pBpa, (S)-2-amino-3-(4-benzoylphenyl)propanoic acid);
3. O-methyl-tyrosine (OmTyr, (S)-2-amino-3-(4-methoxyphenyl)propanoic acid);
101
Figure 3.10:  a) Crystal structure of the Af-TyrRS bound to the amino acid substrate (PDB 2cyb138) highlights the residues
which form the active pocket and the side chains of Tyr36 and Asp165 as the ones directly interacting with the hydroxyl
group of the amino acid. b) Design of the sensor for the incorporation of ncAAs by evolution of the Af-TyrRS. Fusion of the
E2Crimson CDS in frame with the sfGFP67* CDS results in a protein displaying green and far-red fluorescence if tyrosine is
incorporated in response to the stop codon, but exclusively far-red fluorescence if a ncAA is incorporated instead. c) List of
the chemical structures of the ncAAs which were used for the selection of mutants of the Af-TyrRS with an altered amino acid
specificity.  d)  Activity of  the Af-TyrRS mutants G5 or H11 mutant (in which the mutation Tyr36Ile is present) when the
residues Asp165 was mutated to Ala, Asn, Ser or Glu highlighted how the presence of a negative charge in that position is
both necessary and sufficient for the incorporation of tyrosine.  e) Activity of the final version of the evolved synthetases
pIPheRS, pN3PheRS and OmTyrRS, compared to a corresponding mutant of the Mj-TyrRS described in the literature capable
of  incorporating  the  same amino  acid.  f)  Mass  spectrometry  analysis  of  sfGFP150* produced  by  the  Af− tRNACUA
Tyr /Af-
pIPheRS confirmed the incorporation of pIPhe. The minor peak corresponds to the cleavage of Met1. g) Mass spectrometry
analysis  of  sfGFP150* produced  by  the  Af− tRNACUA
Tyr /Af-pN3PheRS  confirmed  the  incorporation  of  pN3Phe.  h)  Mass
spectrometry analysis of sfGFP150* produced by the  Af− tRNACUA
Tyr /Af-OmTyrRS confirmed the incorporation of OmTyr. The
minor peak corresponds to the cleavage of Met1.
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4. para-nitro-phenylalanine (p(NO2)Phe, (S)-2-amino-3-(4-nitrophenyl)propanoic acid);
5. para-azido-phenylalanine (pN3Phe, (S)-2-amino-3-(4-azidophenyl)propanoic acid);
6. para-iodo-phenylalanine (pIPhe, (S)-2-amino-3-(4-iodophenyl)propanoic acid);
7. umbelliferyl-aminobutirric  acid  (umbAbu,  (S)-2-amino-4-(7-hydroxy-2-oxochromen-4-
yl)butanoic acid);
8. para-borono-phenylalanine (pB(OH)2Phe, (S)-2-amino-3-(4-boronophenyl)propanoic acid).
Interestingly,  sfGFP containing  pN3Phe  in  place  of  Tyr  within  the  chromophore  was  previously
expressed and crystallised147. This study confirms that the altered fluorophore is not fluorescent, but
highlights that the azido group can be accommodated within the  β-barrel. This would suggest that
other ncAA with side chains of similar size might be accommodated as well, while it seems unlikely
that pBpa and umbAbu would not destabilise the fold. This, however, should not interfere with the
functioning of the fusion reporter.
As a preliminary experiment before I performed the selections, I transformed the library into cells
containing the dual reporter system cat112* and  gfp67*e2cimson in order to verify the abundance within
the library of active clones incorporating tyrosine after selection on solid agar containing 50 µg/mL of
chloramphenicol.  After  one  overnight  growth,  the  plates  were  fully  covered  in  a  loan  of  green-
fluorescent cells. This overwhelming abundance of mutants with wild type activity explains the need
for multiple rounds of selections performed in the past  for similar selections on the Mj-TyrRS.
In order to understand if this background activity could be reduced to simplify the selections, I tried
to verify whether surviving cells  harboured the wild type  Af-TyrRSG5 or if specific mutants were
present.  To  my  surprise,  a  large  number  of  the  most  active  clones  contained  the  same  mutant
synthetase,  which  I  called  Af-TyrRSH11,  with  the  mutations  Tyr36Ile,  His74Leu,  Gln116Thr.  This
mutant only retained the amino acid Asp165 among the ones in the closest proximity to the substrate,
which seemed to be sufficient for the recognition of tyrosine. Furthermore, the mutation of Tyr36
suggested that, in spite of its direct interaction with the hydroxyl group of the substrate, this residue
was dispensable for the activity of the enzyme.
I decided to perform site-directed mutagenesis on the Af-TyrRSG5 and Af-TyrRSH11 mutants to test the
effect of mutations of residue Asp165 in a context in which Tyr36 was either present or absent (Figure
3.10d).  I  introduced  the  mutations  Asp165Ala-Asn-Ser-Glu  to  the  Af-TyrRSG5 and  the  mutations
Asp165Ala-Asn-Ser to the  Af-TyrRSH11 and compared their activity as amber suppressors using the
sfGFP150* reporter. The fluorescence pattern indicated that loss of the negative charge at position 165
would totally impair the activity of the synthetase both in the presence and in the absence of Tyr36,
indicating that  Asp165 is  both necessary  and sufficient  to  allow incorporation of tyrosine by the
102
Chapter III – Evolution of Orthogonal Aminoacyl-tRNA Synthetase/tRNA Pairs
synthetase. The only mutant which  displayed an activity was the Asp165Glu mutant, from which I
concluded that the charge-to-dipole interaction between the residue 165 and the side chain of the
amino acid substrate constitutes the major component of the binding energy between the two and that
the  reduction  in  activity  of  the  mutant  Asp165Glu was  probably  due to  a  suboptimal  geometric
conformation  adopted by the synthetase caused by the presence of an additional carbon in the side
chain of glutamic acid.
I  consequently  decided that,  instead of  performing multiple  round of  selections for  each of  the
ncAAs of  interest,  I  would have a better chance of success by generating a better starting library
depleted of aspartic and glutamic acid at position 165. To achieve this result, I made use of the script I
developed previously and which I had used already to generate a library of the Sc-AspRSC4. The script
allowed me to identify the combination of degenerate primers with sequence MHG, YRC, KYC, AWC
and KGG, to be mixed in a ratio of 6:4:4:2:2 respectively, which would randomise position 165 to all
amino acids except for Asp and Glu. I hence generated a new library which underwent a single round
of positive selection using the  dual  reporter  system cat112* gfp67*e2cimson.  The plates  displayed a
combination of colonies with no detectable fluorescence, far-red fluorescence or both green and far-
red fluorescence. Among the colonies with far-red fluorescence, I identified the following mutants
incorporating the amino acids pIPhe, pN3Phe or OmTyr.
Af-TyrRS residue Tyr36 His74 Glu114 Asp165 Ile166
Af-pIPheRS* Ile Leu Glu Thr Gly
Af-pN3PheRS* Thr Leu Glu Thr Gly
Af-OmTyrRS Ile Leu Asn Phe His
Table 3.4: List of the mutations selected for the Af-TyrRS which allowed the incorporation of  pIPhe,  pN3Phe and  OmTyr,
respectively. The synthetases indicated by * were further engineered.
The mutants selected displayed an activity comparable to the mutant  Mj-TyrRSs identified which
can incorporate the same amino acids (not shown), but lower than the activity of the wild type pair. In
order to verify if their activity could be further boosted, I performed a round of random mutagenesis
on  the  synthetases  Af-pIPheRS  and  Af-pN3PheRS and performed  a  new single  round of  positive
selection and identified the following synthetases:
Af-TyrRS residue Tyr36 Leu69 His74 Glu114 Asp165 Ile166 Asn190
Af-pIPheRS Ile Met Leu Glu Thr Gly
Af-pN3PheRS Thr Leu Glu Thr Gly Lys
Table 3.5: List of the mutations contained in the most active variants of Af-TyrRS engineered to incorporate  pIPhe and
pN3Phe.
The new evolved Af-pIPheRS and Af-pN3PheRS displayed a significant activity as amber suppressors
which was dependent on the presence of the ncAA. Furthermore, they were more active than the
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corresponding  mutants  Mj-pIPheRS  and  Mj-pN3PheRS  (Figure  3.10e).  The  Af-OmTyrRS  displayed
comparable activity compared to the Mj-OmTyrRS but was not further improved (Figure 3.10e). Mass
spectrometry analysis performed after expression of the sfGFP150* reporter with the  Af-pIPheRS,  Af-
pN3PheRS and  Af-OmTyrRS unambiguously confirmed incorporation of the correct  ncAA  (Figure
3.10f-h, the minor peaks correspond to cleavage of Met1).
This  result  confirmed  that  the  newly  engineered  pair  can  be  effectively  used  for  genetic  code
expansion   with  an  efficiency  higher  than  the  one  displayed  by  previously  described  pairs.
Furthermore, the identification of mutants capable of incorporating 3 different ncAA from the same
library after a single round of positive selection represented a promising progress which might allow
for the fast expansion of the set of ncAA which can be charged by Af-TyrRS mutants. Interestingly, the
difference in behaviour between the Af-TyrRS and the Mj-TyrRS might potentially indicate that some
amino acids for which no mutant of the  Mj-TyrRS were identified might be substrates for a Af-TyrRS
mutant.
Eight Mutually Orthogonal tRNA/aaRS Pairs
The experiments described in the previous sections explain how I attempted to generate efficient
amber suppressors from the active pairs which I had previously identified by means of tREX. Among






3. Af − tRNACUA
Tyr (A1) /Af-TyrRSG5.





I hence decided to verify if these pairs were orthogonal with respect to each other and to three other
amber suppressing pairs previously used for genetic code expansion:
6. tRNACUA
Pyl /PylRS from M. mazei ( Mm− tRNACUA
Pyl /Mm-PylRS);
7. tRNACUA
Pyl (6) /PylRS from M. alvus ( Ma− tRNACUA
Pyl (6) /Ma-PylRS)64;
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8. tRNACUA
Sep (v2.0) /SepRS from M. maripaludis ( Mm− tRNACUA
Sep (v2.0) /Mm-SepRS)42.
In order to  achieve this  goal,  starting from a set  of  plasmids each containing a  pair  of  cognate
tRNA/synthetase, I generated a new set of plasmids in which the tRNAs and aaRSs were shuffled to
every possible combination of a tRNA and a synthetase. These plasmids were transformed in E. coli
DH10b cells from which tRNAs were extracted and tested for aminoacylation using tREX (Figure
3.11).  The gels highlighted that  aminoacylation was observed exclusively when the tRNAs under
investigation  were  expressed  in  combination  with  their  cognate  synthetase,  indicating  mutual
orthogonality of all the 8 pairs tested.
In spite of the fact that 6 out of the 8 tRNA tested contained the same anticodon and cannot be used
at the same time to encode for different ncAAs, this experiment identified the largest set of exogenous
tRNA/synthetase pairs  mutually orthogonal in E. coli yet. In the future, redirection of one or more of
these tRNAs to alternative codons might enable the use of multiple of these pairs together.
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Figure 3.11: tREX analysis of the cross-amionacylation analysis of the 8 tRNAs listed in combination with each of the 8
corresponding aaRSs showed that none of the non-cognate combinations resulted in aminoacylation of the tRNAs, proving
complete cross-orthogonality of these pairs. Samples (-) to Ap-HisRS and Ma-PylRS to Af-TyrRS for each tRNA had to be run
on different gels. For this reason, a set of controls is present on each gel. The dashed line between the lanes corresponding to
Mm-SepRS and Af-TyrRS corresponds to an empty lane which was removed. 
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Discussion
In this chapter I have described my attempts to convert some of the active pairs identified in the
screening I illustrated in the previous chapter into amber suppressors. This conversion was needed
primarily  due  to  the  fact  that,  in  spite  of  the  recent  attempts  to  alter  the  genetic  code of  living
organisms to free up codons and allow genetic code expansion30, 148, the research in this field was still
at  an early  stage,  so that  amber suppression still  represented the most  common method used to
expand the genetic code. Importantly, though, re-direction of a specific tRNA to a different codon
constitutes a major alteration in its function and often it abolishes its interaction with its cognate aaRS,
while also occasionally inducing mis-charging by other of the endogenous synthetases.
Initial  experiments  showed that  direct  conversion of  the  tRNA under investigation to an amber
suppressor  caused  both  loss  of  orthogonality  and  loss  of  recognition  by  the  parent  synthetase.
However, since the parental wild type variant of those pairs had been investigated and characterised
as  functional,  these  changes  to  the  functioning  of  the  pairs  was  directly  imputable  to  the  direct
alteration of the anticodon. These occurrences should also serve as an explanation to the choice which
was  made  originally  to  investigate  the  pairs  in  their  wild  type  form  before  attempting  any
engineering on them.
I firstly focused my attempts to the evolution of the corresponding synthetases in order to rescue, or
optimise  their  capacity to  aminoacylate the amber  suppressing mutant  of  their  cognate  tRNAs.  I
consequently  managed to obtain active variants  for  the  Sc− tRNACUA
Asp /Sc-AspRS,  Mp− tRNACUA
Cys
/Mp-CysRS,  In− tRNACUA
Gln /In-GlnRS,  Si− tRNACUA
Glu /Si-GluRS  and  Af − tRNACUA
Tyr /Af-TyrRS.
Unfortunately,  Ca−tRNACUA
Arg  seemed  to  be  a  substrate  of  the  endogenous  E.  coli ArgRS,  which
prevented me from attempting to engineer the pair further. Conversely, the selections to engineer the
Bv-GlyRS and the Ap-HisRS to accept the Bv− tRNACUA
Gly  and the Ap− tRNACUA
His  did not give positive
outcomes. In these two  cases, though, I could not tell whether this result was due to the intrinsic
incapacity of any mutant of  those  synthetases to  recognise the CUA anticodon,  or  whether more
extensive mutations would allow to obtain the desired activity. Regardless, these pairs might be used
for the re-assignment of alternative sense codons which will be made available in the future thanks to
genome engineering, as discussed earlier.
The  five  pairs   Sc− tRNACUA
Asp /Sc-AspRS,   Mp− tRNACUA
Cys /Mp-CysRS,   In− tRNACUA
Gln /In-GlnRS,
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Si− tRNACUA
Glu /Si-GluRS  and  Af − tRNACUA
Tyr /Af-TyrRS  were  additionally  optimised  to  maximise
their  performances  as  amber  suppressors.  Importantly,  as  a  consequence  of  these  alterations  the
engineered  variants  of  the  two  synthetases  Sc-AspRS  and  In-GlnRS,  named  Sc-AspRSC4 and  In-
GlnRSS9 respectively,  showed  a  marked  improvement  to  their  orthogonality  with  respect  to  the
endogenous E. coli tRNAs. On the other hand,  Si-GluRSD2 displayed the same lack of discrimination
as its parental counterpart, while neither Mp-CysRS nor its active truncation product could be tested.
In  addition  to  optimisations  of  the  pairs  as  amber  suppressors,  extensive  investigations  were
performed on the possibility to alter the amino acid specificity for several of the synthetases indicated.
Among those,  engineering of  the  Sc-AspRSC4 made  possible  by  a  clever  design  of  the  library  of
mutants  allowed the identification of  a variant  capable  of  incorporating glutamic acid instead of
aspartic acid. Even if the difference between these two amino acids is small and even if glutamic acid
is  a  natural  proteinogenic  amino  acid,  this  result  was  a  proof  of  principle  indicating  that  the
synthetase can be modified to alter its amino acid recognition. Future attempts will be performed to
incorporate ncAAs using this system.
Another important achievement which resulted from the work described was the evolution of three
ncAA-RS redived from Af-TyrRSG5. In spite of its similarity with the well-characterised Mj-TyrRS and
the complete three-dimensional conservation of the residues forming its active pocket, this enzyme
behaved  differently  from  the  M.  jannaschii  orthologue  as  none  of  the  attempts  of  transplanting
mutations  described  on  the  Mj-TyrRS  onto  the  Af-TyrRSG5 resulted  in  active  mutants.  As  a
consequence, a  de novo search for variants capable of incorporating ncAAs was performed, taking
advantage of  an improved design for  the  library  generation  and of  a  dedicated reporter  system
capable of discriminating the incorporation of a ncAA from the incorporation of tyrosine, the wild
type substrate for the synthetase. As a result, mutants were found from the same library which could
incorporate three distinct amino acids, namely p-iodo-L-phenylalanine, p-azido-L-phenylalanine, and
O-methyl-L-tyrosine.  The  first  two  were  further  optimised  to  achieve  incorporation  efficiencies
significantly higher than the ones achieved using the  Mj-TyrRS mutant described in the literature
capable of incorporating the same amino acids. Importantly, in all likelihood the pool of ncAAs which
can be incorporated using the Af-TyrRSG5 will be expanded in the future by screening of libraries with
alternative designs.
Finally,  I  verified  that  the  three  evolved  amber  suppressor  pairs Sc− tRNACUA
Asp /Sc-AspRSC4,
In− tRNACUA
Gln /In-GlnRSS9,  Af − tRNACUA
Tyr /Af-TyrRSG5,  the  two  native  orthogonal  pairs
Ca− tRNAGCG
Arg /Ca-ArgRS and  Ap− tRNAGUG
His /Ap-HisRS and the three previously described amber
suppressor  pairs  Mm− tRNACUA
Pyl /Mm-PylRS,  Ma− tRNACUA
Pyl (6) /Ma-PylRS  and
Mm− tRNACUA
Sep (v2.0) /Mm-SepRS display no cross-reactivity to one another and could in principle
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be used at the same time within a cell.  While constituting the largest set  of  mutually orthogonal
exogenous pairs of tRNA/synthetase in E. coli described so far, the actual concomitant use of multiple
of these pairs within a cell will depend on future efforts to re-direct the tRNAs to distinct codons.
Overall, during my project I managed to establish a procedure which enabled us to experimentally
test the behaviour of exogenous aaRS/tRNA pairs transplanted into E. coli. This pipeline allowed us
to identify several new active pairs, some of which were further engineered as amber suppressors.
The evolution of aminoacyl-tRNA synthetases to incorporate ncAA was successful for the tyrosyl-
tRNA synthetase from A. fulgidus, which could be mutated to accept amino acids containing mostly
hydrophobic side chains with an efficiency comparable or higher than previously described systems.
This  result  confirmed  that  engineering  specific  hydrophilic  interaction  is  significantly  more
challenging,  while  more  hydrophobic  active  sites  display  more  flexibility  in  their  tolerance  for
substrates. The methodology developed will allow future identification of orthogonal pairs for any of
the desired isoacceptor classes. 
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Chapter IV – Materials & Methods
The following sections are adapted from my publication, “Cervettini, D., Tang, S., Fried, S.D.  et al.
Rapid discovery and evolution of orthogonal aminoacyl-tRNA synthetase–tRNA pairs. Nat Biotechnol
38, 989–999 (2020).“
Materials
Arabinose, antibiotics, IPTG, liquefied phenol, chloroform, p-iodo-L-phenylalanine (CAS 24250-85-9,
cat.  No.  I8757-1G),  and  O-methyl-L-tyrosine  (CAS 6230-11-1,  cat.  No.  158259-1G) were  purchased
from Sigma-Aldrich. p-azido-L-phenylalanine (CAS 33173-53-4, cat. No. 4020250.0005) was purchased
from  Bachem.  All  14C-labelled  radiochemicals  (arginine:  cat.  No.  MC137;  aspartic  acid:  cat.  No.
MC139;  glutamic  acid:  cat.  No.  MC  156;  glutamine:  at.  No  MC1124;  glycine:  cat.  No.  MC163;
isoleucine:  cat.  No.  MC174;  proline:  cat.  No.  MC263;  tyrosine:  cat.  No.  MC275)  and  3H-labelled
histidine (cat. No. MT905) were purchased from Moravek Inc.
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tRNA Alignment
tRNA sequences  were  downloaded from tRNA-DB-CE together  with  the  information  about  the
secondary structure of the candidate tRNAs, which constituted the basis for the alignment performed
(http://trna.ie.niigata-u.ac.jp/cgi-bin/trnadb/index.cgi). The sequences were sorted based on their
isoacceptor classes. The database contains the following structural information:
1→7 Acceptor stem, first strand 39→43 Anticodon stem, second strand
8→9 Unpaired bases 44→48 Variable loop
10→13 D arm, first strand 49→53 TΨC stem, first strand
14→21 D loop 54→60 TΨC loop
22→25 D arm, second strand 61→65 TΨC stem, second strand
26 Unpaired base 66→72 Acceptor stem, second strand
27→31 Anticodon stem, first strand 73 Discriminator base
32→38 Anticodon loop
To convert this information into an alignment of tRNAs composed of canonical positions 1 to 76, the
following procedure was performed: 
i) for tRNAs with an 8-nucleotide acceptor stem, the first 7 base pairs were assigned to positions
1→7/66→72. The only E. coli tRNA with such feature, tRNASeC, aligns in such manner to the
tRNASers, with which it shares the recognition by the seryl-tRNA synthetase; 
ii) if the D arm is formed of 3 base pairs, positions 13 and 22 are assigned to the first and last
nucleotides of the D loop;
iii) the D loop presents a very high degree of variability, and commonly lacks the two distinctive
Gs at  positions 18 and 19 found in  E. coli  tRNAs. For these positions,  the alignment was
manually generated as shown in Chapter V – Appendix: D Loop Alignment Table;
iv) as  the  variable  loop  can  have  a  very  broad  range  of  lengths,  the  positions  44→48  were
assigned in the following order: 44→48→45→47→46. For loops longer than 5 nucleotides, the
first two positions are numbered 44 and 45, while the last three are numbered 46→48;
v) positions 74→76 always have sequence CCA, either because the tRNA gene natively has such
sequence, or because the tRNA processing enzymes edit the original sequence and a posteriori
add it.
110
Chapter IV – Materials & Methods
 The sequence alignment of E. coli tRNAs is shown in Figure 2.1.
Computational Analysis
Candidate tRNAs, aligned as described above, were compared individually to each of the distinct 47
E. coli isoacceptor  tRNAs,  which were also aligned as described above (see  Figure 2.1).  For  each
candidate  tRNA  (tRNAX)  and  E.  coli isoacceptor  (e.g.:  E.  coli tRNAGGC
Ala ),  the  nucleotides  of  the
candidate tRNAX at the positions of the identity elements for the E. coli isoacceptor (e.g: positions 2, 3,
4, 20, 69, 70, 71, 73 for E. coli alanine isoacceptors) are scored. Each position of tRNAX is scored +1 if it
matches the nucleotide at that position of that E. coli (e.g.: E. coli tRNAGGC
Ala ) isoacceptor, otherwise it
is scored -1.  The final  score for this pairwise comparison (e.g: tRNAX to  E. coli tRNAGGC
Ala )  is  the
average of the individual scores across the positions of the identity elements. The score of tRNAX for
E. coli AlaRS is the average score of tRNAX for each of the  E. coli tRNAAla isoacceptors (e.g:  E. coli
tRNAGGC
Ala  and tRNATGC
Ala ). The complete list of identity elements for E. coli aaRSs used in this work is
shown in the next section. Following the scoring procedure, tRNAs with a score for the same E. coli
aaRS as their isoacceptor class greater than 0.0 were filtered out. A subset of the remaining tRNAs
were  chosen  for  experimental  characterisation  (Chapter  V  –  Appendix:   tRNA  Experimentally
Tested).  tRNAs  for  selenocysteine  and  natural  suppressor  tRNAs  were  not  considered  for
experimental characterisation.
Table of Identity Elements
Below is the list of all the identity elements used from the scoring algorithm in this work, derived
from analysis of the literature20, 118-120.
Identity elements for E. coli aaRSs
AlaRS 2, 3, 4, 20, 69, 70, 71, 73
ArgRS 20, 35, 36, 38, 73
AsnRS 34, 35, 36, 73
AspRS 2, 10, 34, 35, 36, 38, 71, 73
CysRS 2, 3, 13, 15, 22, 34, 35, 36, 48, 70, 71, 73 
GlnRS 1, 2, 3, 10, 34, 35, 36, 37, 38, 70, 71, 72, 73
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GluRS 1, 2, 11, 13, 22, 24, 34, 35, 37, 46, 71, 72
GlyRS 1, 2, 3, 35, 36, 70, 71, 72, 73
HisRS 4, 34, 35, 36, 69, 73
IleRS 4, 12, 23, 29, 34, 35, 36, 37, 38, 41, 69, 73
LeuRS 14, 15, 16, 47, 48, 73
LysRS 34, 35, 36, 73
MetRS 4, 5, 34, 35, 36, 68, 69, 73
PheRS 20, 27, 28, 34, 35, 36, 42, 43, 44, 45, 59, 60, 73
ProRS 15, 35, 36, 48, 72, 73
SerRS 2, 3, 4, 11, 24, 69, 70, 71, 72, 73
ThrRS 1, 2, 35, 36, 71, 72 
TrpRS 1, 2, 3, 34, 35, 36, 70, 71, 72, 73
TyrRS 1, 34, 35, 46, 72, 73
ValRS 3, 4, 35, 36, 69, 70, 73
Plasmid Generation
Our  standard  expression  plasmid  for  tRNA/synthetase  pairs  consists  of  the  pBR322  origin  of
replication (high copy number); the constitutive E. coli glnS promoter which controls the expression of
the aminoacyl-tRNA synthetase of interest followed by a spacer; the strong constitutive  E. coli lpp
promoter which controls expression of the tRNA of interest and an  rrnC terminator following the
tRNA. All plasmids were constructed starting from the plasmid containing PylRS and tRNAPyl from
M. mazei and removing the coding sequence of the synthetase from the start ATG codon to the last
codon of the CDS (the TAA stop codon was left in place) by NEB HiFi DNA assembly (Cat. No.
E2621L). The remaining plasmid containing only a tRNA was used as a template in which tRNAPyl
was systematically replaced by the tRNA under investigation (tRNAX).  These plasmids are called
pKW-(tRNAX) (e.g. pKW-Af-tRNATyr). For those tRNAs which were investigated together with their
cognate  synthetase,  this  synthetase  was  re-introduced  where  the  PylRS  CDS was  located.  These
plasmids are called pRST-tRNAX-aaRS (e.g. pRST-Af-tRNATyr-Af-TyrRS). All tRNAs libraries were
generated on pKW plasmids and all synthetases libraries were generated on pRST plasmids.
The reporter plasmid p15A-cat112*-gfp150* contains the p15A origin or replication, a constitutively
expressed tetracycline resistance gene, in addition to the constitutive positive selection marker cat112*
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(chloramphenicol acetyl transferase gene interrupted by an amber stop codon at position 112) and the
fluorescent reporter  gfp150* (the sfGFP gene containing the amber stop codon at position 150) under
the control of the L-arabinose-inducible PBAD promoter. This plasmid is used for selections, unless
otherwise stated.
The  p15A-cat112*-gfp67* reporter  plasmid  was  derived  from  the  p15A-cat112*-gfp150* plasmid  by
mutating codon 150 to AAG (Asn codon) and codon 67 to TAG.
The p15A-cat112*-gfp67*e2crimson plasmid was derived from the p15A-cat112*-gfp67* plasmid by fusing
the gfp gene in frame with a linker and the e2crimson gene.
tRNA Extraction
The tRNA extraction described below was adapted from a previous method149. A pre-culture of the
desired strain was incubated overnight at 37°C with shaking at 220 rpm. 2 ml of pre-culture was
diluted into 50 ml of pre-warmed rich medium (2xYT) and the cells were incubated at 37°C with
shaking  at  220  rpm for  1-2h.  At  OD600=0.5~1.0,  cells  were  pelleted  (5  min  at  5,000  rcf)  and the
supernatant removed. The cell pellet was resuspended in 800 µl of buffer D (composition below) and
transferred to a 2 ml tube. Cells were pelleted again (2 min at 5,000 rcf), the supernatant discarded
and the pellet was resuspended in 450 µl of buffer D. 50 µl of liquefied phenol (90% phenol in water
from Sigma Aldrich,  cat.  No.  P9346) was added to the cells  as  a lysing agent,  and the lysis was
performed by  head-over-tail  rotation  (15  rpm,  15  min,  room temperature).  The  lysed  cells  were
pelleted (25 min, >20,000 rcf, 4°C) and ~500 µl of supernatant containing the tRNAs was recovered
and transferred to a clean tube. 500 µl of chloroform was added to the solution and the tube was
thoroughly vortexed for 1 min until a cloudy emulsion was formed. The emulsion was separated by
centrifugation (1 min at >20,000 rcf). The top layer containing the tRNAs was recovered (~480 µl). This
solution was either frozen at -20°C or immediately processed as described in tREX Protocol.
Buffer D composition
NaOAc 50 mM pH 5 NaCl 150 mM MgCl2 10 mM EDTA 0.1 mM
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tREX Probes Design
The tREX probes are DNA probes composed of two sections. The 3’-section of the probes is  the
reverse complement of the sequence of the tRNA of interest between canonical position 45 (e.g: from
the second nucleotide of the variable loop) to canonical position 76 (e.g: to the 3’-CCA end of the





30 to 31 32 to 33 34 to 36 37 to 38 39 to 41 42 to 43 44 to 46 47 to 48 49 to 51
Number of 
As
12 13 14 15 16 17 18 19 20
Probes were purchased from Sigma Aldrich as PAGE-purified oligos and were labelled at the 3’-OH
with the cyanine 5 (Cy5) dye. The sequence of all the probes used for the screening is reported in
Chapter V – Appendix: tRNA Experimentally Tested.
tREX Protocol
The tRNA extract was aliquoted into 3x136 µl samples (A, B and C).
Sample A (positive control for full  extension) was brought to 160 µl with buffer D (composition
below) and the tRNAs were precipitated with 375 µl of absolute ethanol. After incubation (1h, 10°C)
the sample was centrifuged (25 min at >16,100 rcf), the supernatant removed and the pellet dried. The
pellet was then resuspended in buffer D to a final concentration of 1 µg/µl, as measured by nanodrop.
Sample B (negative control for lack of extension) was deacylated by adding 8 µl of NaOH 300 mM
(42°C, 1h), then neutralized by addition of 8 µl NaOAc 3 M, pH 5, and oxidized by addition of 8 µl of
NaIO4 100 mM (1h, 10°C). Next, 375 µl of absolute ethanol was added and the tRNA was precipitated
and resuspended as for sample A.
Sample C was brought to 152 µl with buffer D, then oxidized by addition of 8 µl of NaIO4 100 mM
(1h,  10°C).  Next,  the  tRNAs  were  ethanol  precipitated  with  375  µl  of  absolute  ethanol  and
resuspended as sample A and B.
The enzymatic reactions were assembled as follows:
114









2 µl 1 µl 4.5 µl 1 µl 36.5 µl
One reaction was assembled using each of the tRNAs from samples A, B, C, or a control for probe
specificity, which consisted of a tRNA extract from wild type E. coli DH10b treated like sample C. The








1 min 2 min 2 min ∞
After annealing,  the following mix containing the Klenow Fragment (3'→5'  exo-)  of  E. coli  DNA
polymerase I (NEB M0212S) was added to each reaction. 
Klenow exo- NEBuffer 2.1 ddH2O
0.5 µl 0.5 µl 4 µl
The samples were incubated at 37°C for 20 min.
Next, each reaction was mixed with 50 µl of loading dye 2x (8 M urea, 0.04% Orange G) and 10 µl
was run on an acrylamide gel (200 V, approximately 45 min). 
Acrylamide 19:1 TBE TEMED (NH4)2S2O8
8% 1x 0.1% 0.1%
Gels were imaged on the RGB Typhoon Imager using the red laser (635 nm).
Northern Blot of Aminoacylated tRNAs
tRNA extracts  containing the  tRNA of  interest  (see  Chapter  IV –  Materials  & Methods:  tRNA
Extraction) were ethanol-precipitated by adding 7/3 volumes of absolute ethanol (1h,  10°C), then
resuspended in buffer  D (composition below) to a final  concentration of 1 µg/µl,  as assessed by
nanodrop. 2 µg of the tRNA sample was run for 4.5h at 4°C on a 15 cm long acidic urea PAGE
(composition below) using 300 mM NaOAc, pH 5, as running buffer and 12 W constant power (~140
V, ~85 mA). The composition of the loading dye (2x) used is provided below.
Following electrophoresis, the gel was stained with SYBR Gold to identify the position of tRNAs. An
appropriate  section  of  the  gel  was  cut  out  and  transferred  onto  nylon  membrane  (Ambion®
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BrightStar®-Plus Positively Charged Nylon Membrane)  using the iBlot™ DNA Transfer  Stack  for
iBlot® Dry Blotting System (the membrane contained in the transfer stack is replaced). The tRNAs
were cross-linked onto the membrane (Stratalinker® UV Crosslinker 2400), which was later immersed
for 20 min in Ambion® ULTRAhyb®-Oligo buffer for blocking. The biotinylated DNA probe with
sequence 5’-TGGCGGAAACCCCGGGAATCTAACC CGGCT-3’ to detect tRNAPyl was then added to
a final concentration of 3 ng/µl and hybridised overnight at 37°C. Excess probe was washed off using
2xSSC buffer and then blotting was performed using the Thermo Scientific Pierce Chemiluminescent
Nucleic Acid Detection Module.
Buffer D composition






8 M urea 0.1% TEMED 0.1% (NH4)2S2O8
Loading dye (2x)
100 mM NaOAc pH 5 8 M urea 0.1% xylene cyanol FF 0.1% bromophenol blue
Synthetase Purification
The  synthetases  of  interest were  cloned  in  a  pET  expression  vector  under  the  control  of  a  T7
promoter. To allow for a one-step affinity purification, a StrepTag followed by the TEV cleavage site
were  both  added  after  the  initial  methionine  (e.g:  MWSHPQFEKGSENLYFQG[...])  by  using  the
nucleotide sequence (the StrepTag sequence is underlined, the TEV cleavage side in italics.):
ATG TGG AGC CAC CCG CAG TTC GAA AAA GGG AGT GAA AAC CTG TAC TTC CAA GGT […]
Met Trp Ser Bis Pro Gln Phe Glu Lys Gly Ser Glu Asn Leu Tyr Phe Gln Gly […]
The synthetase expression plasmids were transformed in E. coli BL21 (DE3) cells. 1 L of cell culture
was grown in 2xYT after overnight expression at 20°C with shaking at 220 rpm and induction at OD 600
= 0.5 with 0.2 mM IPTG. Cells were harvested at 5,000 rcf for 10 min, resuspended in 2 volumes of
wash buffer containing cOmplete™ Protease Inhibitor Cocktail  (Roche) and sonicated. The debris
were sedimented at 18,000 rcf and the supernatant was mixed with 1 mg of avidin and loaded onto a
StrepTrap HP column (GE) for affinity purification of synthetase protein. The column was washed
with Wash buffer until the UV trace at 280 nm of the measured flow-through returned to baseline,
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then the column was equilibrated in Elution Buffer minus desthiobiotin before the protein of interest
was eluted with Elution Buffer and concentrated. The composition of the buffers was as follows:
Wash Buffer Elution Buffer
50 mM sodium phosphate buffer pH 8 20 mM sodium phosphate buffer pH 7.2
250 mM NaCl
50 mM KCl 100 mM KCl
2 mM MgCl2 2 mM MgCl2
1 mM DTT 1 mM DTT
1.5 mM desthiobiotin
tRNA Extraction for in vitro Biochemistry
A pre-culture of the desired strain was incubated overnight at 37°C with vigorous shaking. 5 mL of
pre-culture was diluted in 100 ml of pre-warmed rich medium (2xYT) and the cells ware incubated at
37°C (1-2h, 220 rpm). When OD600=0.5~1.0, cells were pelleted (5 min, 5,000 rcf), the supernatant was
discarded  and  the  cell  pellet  was  resuspended  in  1.5  mL  of  Buffer  D (composition  below)  and
transferred to a 2 ml tube. 
The cells were pelleted (2 min, 5,000 rcf), the supernatant completely removed and the cell pellet
resuspended in 900 µL of Buffer D, then 100 µL of liquefied phenol (90% phenol in water from Sigma
Aldrich,  cat.  No.  P9346)  was added to the cells  and the lysis was performed on a head-over-tail
rotation (15 min, 15 rpm, room temperature).
The lysed cells were centrifuged (25 min, >20,000 rcf,  4°C). ~1 mL of supernatant containing the
tRNAs  was  recovered  and  transferred  to  a  new  tube.  The  solution  should  not  display  phase
separation. 1 mL of chloroform was added to the solution and the tube was thoroughly vortexed for 1
min until a cloudy emulsion was formed.
The emulsion was separated by centrifuging (1 min, >20,000 rcf) and the top aqueous layer contains
the tRNAs and was recovered (~950 µl).
The extracted tRNA solution was deacylated by addition of 56 µL of NaOH 300 mM (42°C, 1h), then
neutralized with 56 µL of NaOAc 3 M pH 5. The solution was  brought to 70% EtOH using absolute
ethanol and incubated at 4°C for 1h, then the precipitated tRNAs were centrifuged (>16,000 rcf, 20
min). The supernatant was removed and the pellet was left to dry, then resuspended in water and
abundantly washed with water by means of Sartorius Vivaspin® 2 with 3kDa cutoff spin column until
the solution was totally clear.
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tRNAs are diluted to a final concentration of 2 µg/µL and frozen at -20°C.
Buffer D
NaOAc 50 mM pH 5 NaCl 150 mM MgCl2 10 mM EDTA 0.1 mM
In vitro Aminoacylation
14C-labelled amino acids were purchased from Moravek Inc. (500 µl solution, 100 µCi/mL, variable
specific  concentration).  Each  amino  acid  was  then  diluted  with  cold  amino  acid  to  a  final
concentration of 75 µCi/mL and a specific activity of 60 mCi/mmol (1.25 mM, Amino Acid Stock 5x).
In the case of histidine, the amino acid stock 5x was prepared by diluting the 3H-labelled amino acid,
purchased by the same supplier at a concentration of 1.0 mCi/mL, to a final concentration of 0.75
mCi/mL and a specific concentration of 600 mCi/mmol (1.25 mM). The reaction was performed in
Aminoacylation  buffer  1x  (composition  below).  tRNA Stock  was  prepared  at  2  µg/µl,  while  the
Enzyme Stock was prepared at concentrations between 4 and 12.5 µM. Before the reaction is started,
Whatman glass microfiber filters GF/B (21 mm, CAT No. 1821-021) were wetted with 250 µL of cold
trichloroacetic acid 5%. For each enzyme, a 2x Master Mix (2xMM) was assembled as follows:
Aminoacylation Buffer 10x DTT 20 mM Amino Acid Stock 5x Enzyme Stock ddH2O
32 µl 12.8 µL 64 µL 3.84 µL 15.36 µL
30 µL of the 2xMM was mixed with 37.5 µL of tRNA Stock 2x. 9 µL was spotted on a wet glass filter
as time 0 min. The reaction was started by adding 6.5 µL of ATP 10 mM, then 10 µL aliquots were
taken at time 0.5, 1, 2, 3 and 5 min and spotted on filters. The filters were transferred to a vacuum
filtration apparatus and washed with 1 ml of 5% TCA; then 4 ml of 1% TCA, then 1 ml of 70% ethanol
to remove the unbound amino acid. The filters were then transferred to the appropriate vial for liquid
scintillation counting. To measure total counts, 10 µL of each reaction was transferred to a dry filter
and directly transferred to a vial for liquid scintillation counting without any washing.
Aminoacylation buffer (10x)
200 mM HEPES pH 7.2 500 mM KCl 100 mM MgCl2
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tRNA Purification and Amino Acid Analysis
A biotinylated DNA probe (100 µM) was added to the tRNA solution to a final concentration of 0.1-1
µM. The mixture was heated to 75°C for 10 min to anneal the probe to the target tRNA. The extract
was then incubated on ice and the DNA/tRNA hybrid captured on high-capacity streptavidin-coated
agarose  (a  volume  of  beads  equal  to  twice  the  volume  of  100  µM  biotinylated  probe  used  for
annealing was added). The solution was shaken (30 min, 4˚C), then the beads were recovered and
transferred to a 1 mL empty chromatographic spin column (Bio-rad, cat.  No. 7326207).  The beads
were washed 5 times with 100 mM ammonium acetate pH 5, then 3 times with 20 mM ammonium
acetate pH 5.
To hydrolyse the amino acid from tRNA, 200 µL of 20 mM ammonium carbonate pH 9.6 was added
and the solution incubated (20 min, 37˚C) before collection. To maximize recovery of the amino acid,
the beads were further washed with 200 µL of water, 200 µL of 20 mM ammonium bicarbonate pH 3
twice, then 200 µL of water twice. All the washes were combined and lyophilised until dry. The amino
acid was dissolved in 40 µL of water/methanol (40:60), the solution was centrifuged (30 min, 21,000
rcf, 4˚C) to sediment precipitation. The top 20 µL of the solution was transferred into a 250 µL glass
insert (Agilent) for MS analysis.
All amino acid samples were analysed on an Agilent 1260 Infinity equipped with an Agilent 6130
Quadrupole LC-MS unit. A HILIC-Z column (4.6x150 mm) equipped with a guard column (Agilent)
with 0.5 mL/min flow rate was used to elute amino acids. Buffer A and Buffer B (compositions below)
were used for RP-HPLC. 5 µL of amino acid-containing solution was injected and eluted using a
linear gradient of 100%:0% Buffer B:buffer A to 70%:30% Buffer B:Buffer A over 10 min at 30˚C. The
mass spectrometer was set to selected-ion monitoring (SIM) mode. Pure amino acids, purchased from
Sigma Aldrich, were run as standards for comparison.
Buffer A
10 mM NH4HCO2 in H2O
Buffer B
CH3CN: H2O 9:1 (v/v), 10 mM  NH4HCO2
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GFP Expression and Mass Spectrometry
The gene encoding sfGFP is contained in a plasmid with the p15A origin of replication under the L-
arabinose-inducible PBAD promoter. The resulting protein has the following sequence, with the * at
position 150 corresponding to the amber stop codon used for ncAA incorporation:
  1 MVSKGEELFT GVVPILVELD GDVNGHKFSV RGEGEGDATN GKLTLKFICT TGKLPVPWPT
 61 LVTTLTYGVQ CFSRYPDHMK RHDFFKSAMP EGYVQERTIS FKDDGTYKTR AEVKFEGDTL
121 VNRIELKGID FKEDGNILGH KLEYNFNSH* VYITADKQKN GIKANFKIRH NVEDGSVQLA
181 DHYQQNTPIG DGPVLLPDNH YLSTQSVLSK DPNEKRDHMV LLEFVTAAGI THGMDELYKG
241 SHHHHHH-                                                         
E. coli DH10b cells harbouring this sfGFP-containing plasmid were transformed using heat shock
(42°C, 50 s, 150 ng DNA, 25 µl of cells) with a plasmid that constitutively expresses tRNA/synthetase
pair (pRST). The plasmid contained the pMB1 origin of replication. Following transformation, cells
were recovered for 1h (1 mL SOC medium, 37°C, 850 rpm). After recovery, the transformation was
diluted 100 fold in 2xYT containing antibiotics for selection of transformants, 0.2% L-arabinose and
the appropriate ncAA (2 mM) when required. After overnight expression, 5 to 50 mL of cells were
harvested by centrifugation (5,000 rcf,  10 min),  the supernatant was discarded and the pellet was
resuspended in 1 mL of lysis buffer (composition below) and incubated for 15 min on head-over-tail
rotation at room temperature. The crude lysate was centrifuged at >16,100 rcf for 20 min at 4°C, the
supernatant was recovered and 50-100 µl of 1:1 slurry of Ni-NTA Agarose beads (Qiagen) was added.
The beads were recovered by centrifugation at 200 rcf,  washed 5 times with 1 mL of wash buffer
(composition below), then sfGFP was eluted using 50 µL of elution buffer (composition below).
Mass spectra of all protein samples were acquired on an Agilent 1200 LC-MS system equipped with
a 6130 Quadrupole spectrometer. A Phenomenex Jupiter C4 column (150×2 mm, 5 μm) was used to
elute proteins. Buffer A and Buffer B (compositions below) was used for RP-HPLC. Mass spectra were
acquired in the positive mode and analysed by the MS Chemstation software (Agilent Technologies).
The deconvolution program provided in the software was used to obtain the entire mass spectra.
Lysis buffer
BugBusterTM Protein
Extraction Reagent 20 mM Tris pH 8.0 500 mM NaCl 40 mM imidazole
Wash buffer
20 mM Tris pH 8.0 500 mM NaCl 40 mM imidazole
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Elution buffer
50 mM Tris pH 8.0 50 mM NaCl 300 mM imidazole
Buffer A Buffer B
0.2% HCOOH in H2O 0.2% HCOOH in CH4CN
GFP Total Mass
The table below summarises the total mass of the reporter sfGFP150* depending on the amino acid
present at position 150.




Mass after flurophore maturation (-
Met)
gly G 27770,27 27639,07
ala A 27784.30 27653.10
ser S 27800.30 27669.10
pro P 27810,34 27679,14
val V 27812,35 27681,15
thr T 27814,32 27683,12
cys C 27816,36 27685,16
ile I 27826,38 27695,18
leu L 27826,38 27695,18
asn N 27827,32 27696,12
asp D 27828,31 27697,11
gln Q 27841,35 27710,15
lys K 27841,39 27710,19
glu E 27842,33 27711,13
met M 27844,41 27713,21
his H 27850,36 27719,16
phe F 27860.40 27729.20
arg R 27869,41 27738,21
tyr Y 27876.40 27745.20
O-methyl-L-tyrosine 27890,42 27759,22
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GFP Expression for Fluorescence Quantification
E. coli DH10b cells containing the sfGFP gene with an in-frame amber stop codon at position 150 (see
above) were transformed with a pWK or pRST plasmid using heat shock. Recovery medium was
added (1 ml, SOC medium) and the transformation was divided into 3 aliquots (biological replicates).
After recovery (1h, 37°C, 850 rpm), 50 µl of each transformation was added to a different well of a 24
deep well plate (Riplate®SW 24, PP, 10 ml) containing 5 ml of 2xYT medium supplemented with the
appropriate antibiotics for selection, 0.2% arabinose to induce expression of GFP and 2 mM of ncAA,
as necessary. Cells were incubated at 37°C (22h, 220 rpm), then 500 µL of medium was transferred
into clear-bottom 24 well plates and the GFP fluorescence in this standard volume was measured.
Measurements were performed on each sample grown in individual wells. In each graph, individual
data points are shown together with the standard deviation.
Site-Saturation Mutagenesis
Site saturation mutagenesis on aaRSs or tRNAs was carried out by enzymatic inverse PCR (eiPCR)124.
Primers were designed to contain the BsaI or SapI restriction sites. PCRs were performed using Q5 ®









5x Q5 Buffer Q5 Polymerase H20
1 µL 0.8 µL 0.4 µL 4 µL 0.2 µL 13.6 µL











30 s 10 s 10 s 30 s/kpb ∞









5x Q5 Buffer Q5 Polymerase H20
1 µL 0.8 µL 0.4 µL 4 µL 0.4 µL 13.4 µL
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30 s 10 s 10 s 60 s/kpb ∞
Following amplification, the PCRs were purified by adding 3 volumes of buffer PB (Qiagen) before
using the QIAprep 2.0 Spin Miniprep Columns (Qiagen) to bind the DNA. The column were washed
with PE buffer (Qiagen), then the DNA was eluted using EB buffer (Qiagen) and its concentration
measured using a nanodrop.
Restriction digest was performed as follows (indicated for a 50 µL reaction):
DNA BsaI/SapI DpnI CutSmart H20
50 ng/µL 1 µL 0.5 µL 5 µL to 50 µL
After 2h incubation at 37°C, the DNA was purified as indicated above, then ligation was performed
as indicated below (indicated for a 20 µL reaction):
DNA T4 ligase T4 ligase buffer H20
10 ng/µL 1 µL 2 µL to 20 µL
The reaction volumes indicated above were scaled based on the total amount of DNA processed.
Following overnight incubation at 18°C, the DNA was purified as indicated above and transformed
into  electrocompetend  E.  coli DH10b cells.  Libraries  were  produced to  contain >2x108 individual
transformants.
Mutagenesis by Error-Prone PCR
The  gene  coding for  the  synthetase  targeted for  evolution was  amplified  by  PCR using primer
immediately flanking the CDS. The DNA obtained was subsequently purified and used as a template
for random mutagenesis by error-prone PCR, which was carried out using the GeneMorph II Random
Mutagenesis  Kit  (Agilent  Technologies).  Amplification  was  carried  out  according  to  the
manufacturer’s instructions to achieve medium mutation frequency (4.5-9 mutations/kb). 30 cycles
were performed with 250 ng of initial target DNA. Random mutagenesis libraries were generated by
assembly of the mutagenised synthetase with the plasmid backbone, which was amplified using Q5®
Hot Start High-Fidelity DNA Polymerase (NEB, Cat. No. M0493S). Assembly was performed for 1h at
50°C using NEBuilder HiFi DNA Assembly Master Mix, followed by transformation to homemade
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electrocompetent cells. The transformation efficiency was >3x107. 
aaRS Library Selections
pRST plasmids containing the synthetase of interest together with its cognate tRNA were used to
build the libraries. Ten aliquots of 1 µg of library DNA was transformed into ten aliquots of 100 µL of
homemade electrocompetent  E. coli  DH10b cells  containing an appropriate reporter  plasmid (e.g.:
p15A-cat112*-gfp150* , p15A-cat112*-gfp67* or p15A-cat112*-gfp67*e2crimson). To ensure high electroporation
efficiency, electro-competent cells were freshly prepared by diluting 25 fold an overnight pre-culture
of the appropriate cells into 2xYT medium containing the appropriate antibiotic. The cells were grown
to OD600=0.6~0.8. Cells were then harvested and resuspended in ice-cold 10% glycerol in water; this
procedure is repeated 3 times. Finally, the cells were harvested and the cell pellet resuspended with
10% glycerol in water (2 times the pellet volume). After electroporation, cells were recovered (1h at
37°C, SOC medium) and then were incubated overnight (37°C, 1 L of 2xYT, 220 rpm) in medium
contained the appropriate antibiotics (commonly, tetracycline to select for the reporter plasmid and
spectinomycin to select for the library plasmid). An appropriate dilution of this medium was plated
on agar plates to ensure the transformation had yielded >5x108 individual transformants (e.g.: >500
colonies on the 10-6 dilution plate).  The overnight culture of library-containing transformants was
then diluted 25-fold in 2xYT and allowed to grow to OD600=1; if necessary, the appropriate ncAA was
the added to a concentration of 2 mM. When OD600=1 was reached, 2 mL of cells were plated on
25x25 cm2 agar plates containing the appropriate antibiotics to select for the markers on the plasmids,
together with chloramphenicol, 0.2% arabinose to induce expression of the fluorescent markers (e.g.
sfGFP  or  E2Crimson),  and  the  appropriate  ncAA  (2  mM)  if  needed.  The  chloramphenicol
concentration was chosen in accordance to the desired level of activity of the synthetase (range: 25-500
µg/mL).  The plates were incubated at  37°C overnight.  For  selections using the reporter  plasmids
p15A-cat112*-gfp150*or p15A-cat112*-gfp67*, surviving colonies were illuminated with blue light (488 nm)
to test  for  GFP production.  For selections using the reporter  plasmid p15A-cat112*-gfp67*e2crimson,
surviving colonies were illuminated with blue light (488 nm) to test sfGFP production and with red
light  (635  nm)  to  test  for  E2Crimson  production.  Individual  colonies  displaying  the  correct
fluorescence pattern were grown and characterised, or the surviving cells were pooled together, the
DNA  extracted  and transformed  again  for  another  round  of  selection  or  for  a  round of  activity
screening.
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tRNA Library Selections for Improved Orthogonality and Activity
tRNA selections were performed using a two-plasmid system. A pKW plasmid, containing the tRNA
was used to build the  library  via site-saturation mutagenesis.  A second plasmid was a  modified
version  of  the  appropriate  reporter  plasmid  (e.g.:  p15A-cat112*-gfp150*  or p15A-cat112*-gfp67*)  which
additionally contained the synthetase.
1 µg of library DNA was transformed into homemade electro-competent E. coli DH10b cells (0.1 mL)
containing the appropriate synthetase-containing reporter plasmid. Following recovery (1h at 37°C,
SOC medium 220 rpm, the cells were incubated overnight (37°C, 100 mL of 2xYT, 220 rpm). The
medium contained the appropriate antibiotics (commonly, tetracycline to select for the reporter and
spectinomycin  to  select  for  the  library  plasmid).  An  appropriate  dilution  (e.g.:  10-5)  of  the
transformation was plated on agar plated to ensure the transformation efficiency was enough to yield
>5x107 individual transformants. The overnight culture was then diluted 25-fold in 2xYT and allowed
to grow to OD600=1. When OD600=1 was reached, 2 mL of cells were plated on 25x25 cm
2 agar plates
containing  the  appropriate  antibiotics  to  select  for  the  markers  on  the  plasmids,  together  with
chloramphenicol and 0.2% arabinose to induce expression of GFP. The chloramphenicol concentration
was chosen in accordance to the desired level of activity of the synthetase (range: 25-500 µg/mL). The
plates were incubated at 37°C overnight. Surviving colonies were illuminated with blue light to test
for GFP production. DNA was extracted from either individual GFP-positive colonies, or from GFP-
positive colonies pooled together. 
The  reporter  plasmid  was  selectively  digested  with  an  appropriate  restriction  enzyme  and  T5
exonuclease (NEB, cat. No. M0363S ) treatment. The now isolated tRNA library plasmid was purified
again and transformed into cells containing the appropriate selection plasmid (e.g.: p15A-cat112*-gfp150*
or p15A-cat112*-gfp67*) lacking the cognate synthetase, and the transformants are plated on agar plates
containing  0.2%  arabinose  for  GFP  screening  in  the  absence  of  chloramphenicol.  GFP-negative
colonies contain a variant of the tRNA which is selectively aminoacylated to a desired level in the
presence of the synthetase and not in its absence, thus being more active and orthogonal.
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tRNA Experimentally Tested
Below,  the compete list  of  tRNA sequences experimentally analysed is  displayed.  Each tRNA is
indicated by an arbitrary identifier, then the species of origin is indicated, together with the anticodon
sequence and the unique ID assigned to that tRNA in the tRNA-DB-CE. The tRNA sequence indicated
includes the 3'-CCA end (positions 74→76). The tREX probes designed to detect each tRNA, whose
sequence is indicated, were purchased with the cyanine 5 fluorophore bound at their 3'-end.
Arg_01from Rothia mucilaginosa, anticodon: CCG, Seq. ID: C10110712
Seq.: GCCTCTGTAGCTCAGCGGATTAGAGCACCAGTTTCCGGTACTGGGGGTCGAAGGTTCGAATCCTTTCAGGGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCCCTGAAAGGATTCGAACCTTCGACC
Arg_02from Corynebacterium accolens, anticodon: CCG, Seq. ID: W09122376
Seq.: GTCTCCGTAGCTCAGCGGATTAGAGCATCGGTTTCCGGTACCGAAGGTCGCAGGTTCGATCCCTGTCGGGGACACCA
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tREX probe:aaaaaaaaaaaaaTGGTGTCCCCGACAGGGATCGAACCTGCGACC
Arg_03from Corynebacterium aurimucosum, anticodon: CCG, Seq. ID: W09127825
Seq.: GCCCTTGTAGCTCAGCGGATTAGAGCATCGGTTTCCGGTACCGAAGGTCGCAGGTTCGATCCCTGTCAGGGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCCCTGACAGGGATCGAACCTGCGACC
Arg_04from Capnocytophaga sp. oral taxon 329, anticodon: CCG, Seq. ID: W11301568
Seq.: GGCTCCGTAGCTTAGCTGTATAGAGCGTCAGATTCCGGTTCTGAAGGTCGAGGGTTAGAATCCCTCCGGGGTCACCA
tREX probe:aaaaaaaaaaaaaTGGTGACCCCGGAGGGATTCTAACCCTCGACC
Arg_05from Fluviicola taffensis, anticodon: TCG, Seq. ID: C11300221
Seq.: GGCTCCGTAGCTCAGCTGTATAGAGCACTGGATTTCGGCTCCAGCGGTCGGGAGTTAGAATCTCTCCGGGGTCACCA
tREX probe:aaaaaaaaaaaaaTGGTGACCCCGGAGAGATTCTAACTCCCGACC
Arg_06from Amycolatopsis azurea, anticodon: TCG, Seq. ID: W131064644
Seq.: CATGGAGTGGATCAGCGGCAGATCGCCCGGCTTCGGTCCGGGAGGGCGCGGGTTCGAGTCCCGCCTCCATGTCCA
tREX probe:aaaaaaaaaaaaaTGGACATGGAGGCGGGACTCGAACCCGCGCCC
Arg_07from Caldilinea aerophila, anticodon: GCG, Seq. ID: C121001241
Seq.: GTCCCCGTAGCTCAGTGGATGAGAGCGCTTGGTTGCGGTCCAAGAGGTCAGAGGTTCGAGTCCTCTCGGGGATGCCA
tREX probe:aaaaaaaaaaaaaTGGCATCCCCGAGAGGACTCGAACCTCTGACC
Arg_08from Enterococcus faecalis, anticodon: TCG, Seq. ID: W131189827
Seq.: TGGCGTGTAGCATTGTGGTAATGCAACTTATTTCGTGTGAGATAAGATGCGGGTTCGAATCCTGTCACGCCAACCA
tREX probe:aaaaaaaaaaaaaTGGTTGGCGTGACAGGATTCGAACCCGCATCTT
Arg_09from Weeksella virosa, anticodon: TCG, Seq. ID: C11300548
Seq.: GGCCTCGTAGCTCAACTGTATAGAGCACTGGATTTCGGCTCCAGCGGTTGGGGGTTAGAATCCCTCCGAGGTCACCA
tREX probe:aaaaaaaaaaaaaTGGTGACCTCGGAGGGATTCTAACCCCCAACC
Arg_10from Corynebacterium striatum, anticodon: CCG, Seq. ID: W09122422
Seq.: GCCTCCGTAGCTCAGCGGATTAGAGCATCGGTTTCCGGTACCGAAGGTCGCAGGTTCGATCCCTGTCGGGGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCCCCGACAGGGATCGAACCTGCGACC
Asn_01from Rivularia sp. PCC 7116, anticodon: ATT, Seq. ID: C131004222
Seq.: TACATACTAGCTCATTGGTAGAGCATTCGGCTATTAACCGACTGGTAGTAGGTTCAAATCCTGCGTATGAACCCA
tREX probe:aaaaaaaaaaaaaTGGGTTCATACGCAGGATTTGAACCTACTACC
Asn_02from Chamaesiphon minutus, anticodon: ATT, Seq. ID: C131004558
Seq.: CAAAAGTTAGCTCATTAGGTAGAGCAGTTGACTATTAATCAACGTGTAACAGGTTCGATTCCTGTACTTTTCACCA
tREX probe:aaaaaaaaaaaaaTGGTGAAAAGTACAGGAATCGAACCTGTTACA
Asn_03from Oscillatoria nigro-viridis, anticodon: ATT, Seq. ID: C131004769
Seq.: ACAAAGTTAGCTCAATTGGTAGAGCGATCGACTATTAATCGATTGGTAACAGGTTCAATTCCTGTACTTTAAACCA
tREX probe:aaaaaaaaaaaaaTGGTTTAAAGTACAGGAATTGAACCTGTTACC
Asn_04from Fischerella sp. JSC-11, anticodon: ATT, Seq. ID: W11181271
Seq.: TACATACTAGCTCAATTGGTAGAGCAGTCGGCTATTAACCGATGGGTAACAGGTTCGATTCCTGTGTATAAACCCA
tREX probe:aaaaaaaaaaaaaTGGGTTTATACACAGGAATCGAACCTGTTACC
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Asn_06from Lactobacillus hominis, anticodon: ATT, Seq. ID: W141244219
Seq.: AAGCCTATAGTTCAATTGGTAGAACGCTCTACTATTACTGAAGTAGATATGAGGGTTCGAATCCCTTTAGGCTTACCA
tREX probe:aaaaaaaaaaaaaaTGGTAAGCCTAAAGGGATTCGAACCCTCATATCT
Asn_07from Serratia marcescens, anticodon: ATT, Seq. ID: C151100364
Seq.: ACGTCATTAGCTCAGCAGGAAGAGCGGCAGCGAAATATTCGTTGGCGGACTGGGGTTCGATTCCTCGATGACGTTCCA
tREX probe:aaaaaaaaaaaaTGGAACGTCATCGAGGAATCGAACCCCAGTC
Asn_08from Salmonella enterica, anticodon: GTT, Seq. ID: W1510481293
Seq.: TCCTCTGTAGTTCAGTCGGTAGAACGGGCGGACTGTTAATCCGTATGTCACTGGTTCGAGTCCAGTCAGAGGAGCCA
tREX probe:aaaaaaaaaaaaaTGGCTCCTCTGACTGGACTCGAACCAGTGACAT
Asn_09from Klebsiella pneumoniae, anticodon: ATT, Seq. ID: W1511345087
Seq.: GGGTCGTTAGCTCAGTTGGTAGAGCAGTTGACTATTAATCAATTGGTCGCAGGTTCGAATCCTGCACGACCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGGTCGTGCAGGATTCGAACCTGCGACC
Asn_10from Providencia rettgeri, anticodon: ATT, Seq. ID: W141022179
Seq.: CCGCCATTAACTCAACTGGAAGAGTATTTAGCCTTATTAAGGCTAAGAGTCGAGGTTCGATGCCTCGATGGCGGACCA
tREX probe:aaaaaaaaaaaaaTGGTCCGCCATCGAGGCATCGAACCTCGACTC
Asp_01from Allokutzneria albata, anticodon: GTC, Seq. ID: W141766821
Seq.: CCTGATGTAGATCAGCGGTAGATCGCCCGGCTGTCAACCGGGAGGGCGCGAGTTCGAATCTCGCCATCAGGTCCA
tREX probe:aaaaaaaaaaaaaTGGACCTGATGGCGAGATTCGAACTCGCGCCC
Asp_02from Bradyrhizobium sp. OHSU_III, anticodon: GTC, Seq. ID: W141063677
Seq.: GCCTCCGGACCCAGCTGGCGACGGGACTCGACTGTCGATCGAGCATTGGCGGGTTCGATTCCCGCCGGAGGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCCTCCGGCGGGAATCGAACCCGCCAAT
Asp_03from Chryseobacterium angstadtii, anticodon: ATC, Seq. ID: W1511685144
Seq.: GAAACGTTAGCTCAATGGAAGAGCTTTGACTTATCTGAACAGAGGCTGCGGGTTCGAATCCCGCACGTTTCTCCA
tREX probe:aaaaaaaaaaaaaTGGAGAAACGTGCGGGATTCGAACCCGCAGCC
Asp_04from Thiobacillus denitrificans, anticodon: GTC, Seq. ID: W131160302
Seq.: GCCTCGTTAACTCAGCGGCAGAGTGCCCGCCTGTCTAGCGGGAAGCCAGGGGTTCAAGTCCCCTACGAGGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCCTCGTAGGGGACTTGAACCCCTGGCT
Asp_05from Mycobacterium phage PegLeg, anticodon: GTC, Seq. ID: PHG14102396
Seq.: CCCGATGTCATCTAGTGGACCAGGATGCCGCCCTGTCGAGGCGGTCACGCGAGTTCGAATCTCGTCGTCGGGACCA
tREX probe:aaaaaaaaaaaaTGGTCCCGACGACGAGATTCGAACTCGCGTG
Asp_06from Listeria phage vB_LmoM_AG20, anticodon: GTC, Seq. ID: PHG14101575
Seq.: GTGCGTATGATATAATGGCTATTATACTCGACTGTCTATCGAGAAATAGGGGTTCAATTCCCCTTACGTGCGCCA
tREX probe:aaaaaaaaaaaaTGGCGCACGTAAGGGGAATTGAACCCCTATT
Asp_07from Variovorax paradoxus, anticodon: GTC, Seq. ID: C09111138
Seq.: GATCCGTTAACTCAGCGGCCAGAGTGCCTCCCTGTCCAGGAGGAAGCCAAGGGTTCAACTCCCTTACGGATCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGATCCGTAAGGGAGTTGAACCCTTGGCT
Asp_08from Bradyrhizobium oligotrophicum, anticodon: GTC, Seq. ID: C132000002
Seq.: GCCCATGTCCCCATCTGGCGAAGGGACCGGACTGTCGATCCGGAAAGGCGGGTTCGATTCCCGTCATGGGCGCCA
tREX probe:aaaaaaaaaaaaTGGCGCCCATGACGGGAATCGAACCCGCCTT
Asp_09from Sorangium cellulosum, anticodon: GTC, Seq. ID: C08012733
129
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Seq.: GCCCTCGTATGCATCTGGTGAGGCAGCCTGATTGTCGATCAGGTGAGGGGAGTTCGATCCTCCTCGGGGGCGCCA
tREX probe:aaaaaaaaaaaaTGGCGCCCCCGAGGAGGATCGAACTCCCCTC
Cys_01from Enterococcus caccae, anticodon: GCA, Seq. ID: W131028011
Seq.: GATGGTATAGCCAAGTGGTAGGGCACAGGTCTGCAAAACCTTGAGCATCGGTTCAAACCCGATTACCATCTCCA
tREX probe:aaaaaaaaaaaaTGGAGATGGTAATCGGGTTTGAACCGATGC
Cys_02from Niastella koreensis, anticodon: GCA, Seq. ID: C123000104
Seq.: GAGCAGGTACTCAATACTGACATGGAGATTGGTCTGCAAAACCAATTCAATATGGGTTTAATTCCCATCCTGCTCTCCA
tREX probe:aaaaaaaaaaaaaTGGAGAGCAGGATGGGAATTAAACCCATATTGA
Cys_03from Acinetobacter lwoffii, anticodon: GCA, Seq. ID: W121047593
Seq.: GCATGTATGGGTGAGGTGGATTAGCCAGCGGACTGCAACTCCGTTTATACAGGTTCGAGTCCTGTTACATGCTCCA
tREX probe:aaaaaaaaaaaaTGGAGCATGTAACAGGACTCGAACCTGTATA
Cys_04from Chitinophaga pinensis, anticodon: GCA, Seq. ID: C10103731
Seq.: TGAGATGTGGTCGAATCTGGAATGACGCCCCCTTGCAACGGGGGAAAAATAAGTTCGAATCTTATCTTCTCTCCCA
tREX probe:aaaaaaaaaaaaTGGGAGAGAAGATAAGATTCGAACTTATTTT
Cys_05from Moorea producens, anticodon: GCA, Seq. ID: W11143160
Seq.: GTCCAGGTCGCCTAATGGTAGGGCATTGGTCTGCAAAACCGATTGTGTGAGTTCAATTCTCACCCTGGACTCCA
tREX probe:aaaaaaaaaaaaTGGAGTCCAGGGTGAGAATTGAACTCACACA
Cys_06from Roseburia inulinivorans, anticodon: GCA, Seq. ID: W09300492
Seq.: GATGCTGTAGCCGCTGGTAGGGCATAGGTTTGCAAAACCGAAGTTGGTGGTTCGAATCCGCCCAGTATCACCA
tREX probe:aaaaaaaaaaaaTGGTGATACTGGGCGGATTCGAACCACCAAC
Cys_07from Calothrix sp. PCC 7507, anticodon: GCA, Seq. ID: C131010320
Seq.: GTCCAGGTCGCCTAATGGTAGGGTATTGGTCTGCAAAACCGACTGTGCGAGTTCAATTCTCGCCCTGGACTCCA
tREX probe:aaaaaaaaaaaaTGGAGTCCAGGGCGAGAATTGAACTCGCACA
Cys_08from Scytonema hofmannii, anticodon: GCA, Seq. ID: W131065815
Seq.: GTCCAGGTCGCCTAACGGTAGGGCGTTGGTCTGCAAAACCGACTGTGCGAGTTCAATTCTCGCCCTGGACTCCA
tREX probe:aaaaaaaaaaaaTGGAGTCCAGGGCGAGAATTGAACTCGCACA
Gln_01from Candidatus Solibacter usitatus, anticodon: TTG, Seq. ID: C024933
Seq.: TCCCCGGTCGTCTAATGGTAGGACAGCGGCCTTTGGAGCCGTGAATCGTGGTTCGAATCCATGCCGGGGAGCCA
tREX probe:aaaaaaaaaaaaTGGCTCCCCGGCATGGATTCGAACCACGATT
Gln_02from Mycobacterium abscessus, anticodon: CTG, Seq. ID: W1510544614
Seq.: CAAACACTAGCTCAATTGGCAGAGCAATCGTTTCTGGAACGGTAGGTCGCCGGTTCAAGTCCGGCGTGTTTATCCA
tREX probe:aaaaaaaaaaaaaTGGATAAACACGCCGGACTTGAACCGGCGACC
Gln_03from Propionimicrobium lymphophilum, anticodon: TTG, Seq. ID: W131002891
Seq.: TCCCCGGTTGGTCTGCTGGTAGGGCCCGCCTGACTTTGAATCAGGATTTAGCGACGCAGGTTCGATTCCTGCCCGGGGAACCA
tREX probe:aaaaaaaaaaaaaaaTGGTTCCCCGGGCAGGAATCGAACCTGCGTCGCTAAA
Gln_04from Ilumatobacter nonamiensis, anticodon: TTG, Seq. ID: W131240735
Seq.: TCCCGGGTCGTCTAACGGTAAGACAGCGGTTTTTGGTGCCGAGAATAGGGGTTCGATTCCTCTCCCGGGAACCA
tREX probe:aaaaaaaaaaaaTGGTTCCCGGGAGAGGAATCGAACCCCTATT
Gln_05from Bradyrhizobium sp. Tv2a-2, anticodon: TTG, Seq. ID: W141150373
Seq.: ACCCGCTTGGTCCAGTGGTCTAAGACGTCGGACTTTGACTCCGAAGACAGTCGTTCAAATCGACTAGCGGGTGCCA
130
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tREX probe:aaaaaaaaaaaaTGGCACCCGCTAGTCGATTTGAACGACTGTC
Gln_06from Flavihumibacter petaseus, anticodon: CTG, Seq. ID: W1510019463
Seq.: AGTTGCGTAGTGCAAAGGCAGCACATCTGAATCTGGCTCAGAAGATGTTGGTTCGAATCCAGCCGCAACGACCA
tREX probe:aaaaaaaaaaaaTGGTCGTTGCGGCTGGATTCGAACCAACATC
Gln_07from Chryseobacterium tenax, anticodon: TTG, Seq. ID: W131220961
Seq.: AGACCTATGGTGTAGCGGTAACACTACTGTTTTTGGTGCAGTCATCTGGGGTTCGAATCCCTGTGGGTCTACCA
tREX probe:aaaaaaaaaaaaTGGTAGACCCACAGGGATTCGAACCCCAGAT
Gln_08from Truepera radiovictrix, anticodon: CTG, Seq. ID: C10113751
Seq.: TCAGGAATGGTGTAACGGTAGCACGACGCACTCTGGATGCGTTAGTCCTGGTTCGAATCCAGGTTCCTGAGCCA
tREX probe:aaaaaaaaaaaaTGGCTCAGGAACCTGGATTCGAACCAGGACT
Gln_09from Rhodopirellula baltica, anticodon: CTG, Seq. ID: C016619
Seq.: GCCGGAGTAGCAGTTGTTGGTCGCTGCACCTGACTCTGAATCAGGAGTTCATTGGTTCGATTCCAATCTCCGGTGCCA
tREX probe:aaaaaaaaaaaaaTGGCACCGGAGATTGGAATCGAACCAATGAAC
Gln_10from Verrucomicrobia bacterium SCGC AAA164-O14, anticodon: CTG, Seq. ID: W141240493
Seq.: AGCCCGGTAGTGTAGTGGCAAGCATGGGGGATTCTGGATCCCTTGACCTCGGTTCGAGTCCGAGCCGGGCTACCA
tREX probe:aaaaaaaaaaaaTGGTAGCCCGGCTCGGACTCGAACCGAGGTC
Glu_01from Lactobacillus delbrueckii, anticodon: CTC, Seq. ID: C011433
Seq.: CACCCGTTGGTCAAGTGGTTAAGACGCTACCCTCTCAAGGTGGAGTCATGAGTTCAATTCTCGTACGGGTGACCA
tREX probe:aaaaaaaaaaaaTGGTCACCCGTACGAGAATTGAACTCATGAC
Glu_02from Oscillatoria nigro-viridis, anticodon: TTC, Seq. ID: C131004735
Seq.: AGTGCTGTAGGCAAATGGTTTAAGCCGCTTGGTTTTCACCCAAGTGATTGCGGGTTCAACTCCCGTCAGCACTTCCA
tREX probe:aaaaaaaaaaaaaTGGAAGTGCTGACGGGAGTTGAACCCGCAATC
Glu_03from Firmicutes bacterium M10-2, anticodon: CTC, Seq. ID: W131196120
Seq.: GGCGCGTTCGGCAAGCGGTTAAGCCACAGCCCTCTCAAGGCTGTATCACGGGTTCAAATCCCGTACGCGCTGCCA
tREX probe:aaaaaaaaaaaaTGGCAGCGCGTACGGGATTTGAACCCGTGAT
Glu_04from Enterococcus avium, anticodon: CTC, Seq. ID: W131010917
Seq.: AACCCGTTAGTCAAGGGGTCAAGACGCCGCGTTCTCAGCGCGGAGGCACGGGTTCAAATCCCGTACGGGTTACCA
tREX probe:aaaaaaaaaaaaTGGTAACCCGTACGGGATTTGAACCCGTGCC
Glu_05from Acaryochloris marina, anticodon: TTC, Seq. ID: C08000515
Seq.: AGTGGTGTACGCAAATGGTTTAAGCGACTTGATTTTCAACCAAGTGATTGCGGGTTCAAATCCCGTCACCACTCCCA
tREX probe:aaaaaaaaaaaaTGGGAGTGGTGACGGGATTTGAACCCGCAAT
Glu_06from Sporolactobacillus inulinus, anticodon: CTC, Seq. ID: W11174757
Seq.: AGGGCGTTGGGCAAGTGGTTAAGCCAATGGATTCTCATTCCATGATCGCGGGTTCAATTCCCGTACGCCCTCCCA
tREX probe:aaaaaaaaaaaaTGGGAGGGCGTACGGGAATTGAACCCGCGAT
Glu_07from Streptomyces davawensis, anticodon: CTC, Seq. ID: C131020273
Seq.: CCGGATGTGGAGCAGAGGCAGACTCGCCGCCTTCTCAGGGCGGATACGCCGGTTCGAATCCGGCCGTCCGGGCCA
tREX probe:aaaaaaaaaaaaTGGCCCGGACGGCCGGATTCGAACCGGCGTA
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Glu_09from Lactobacillus fructivorans, anticodon: CTC, Seq. ID: W11144711
Seq.: TGCCCGTTGGTCAAACTGGTTTAAGACGTCGCCCTCTCAAGGCGGAGCTATGAGTTCAAGTCTCATACGGGTAACCA
tREX probe:aaaaaaaaaaaaTGGTTACCCGTATGAGACTTGAACTCATAGC
Glu_10from Gordonia araii, anticodon: TTC, Seq. ID: W121123713
Seq.: AGTCCACTAGCTCAGTTGGCAGAGCCATTGACTTTCCATCAATCGGTCGCCGGTTCGAGTCCGGCGTGGCGTACCA
tREX probe:aaaaaaaaaaaaaTGGTACGCCACGCCGGACTCGAACCGGCGACC




Gly_02from Dactylosporangium aurantiacum, anticodon: GCC, Seq. ID: W141758047
Seq.: TGGGCCGTAGCGCAGAGGTCGACGCACCGCTTTGCCAGAGCGGAGGACGCCGGTTCGATTCCGGCCGGTCCACCCA
tREX probe:aaaaaaaaaaaaaTGGGTGGACCGGCCGGAATCGAACCGGCGTCC
Gly_03from Microscilla marina, anticodon: GCC, Seq. ID: w022708
Seq.: AGAAGGTTGGTGTAACTGGAAACACATTCGCCTGCCAAGCGAAAAATTGCAGGTTCGAGTCCTGTGCCTTCTTCCA
tREX probe:aaaaaaaaaaaaaTGGAAGAAGGCACAGGACTCGAACCTGCAATT
Gly_04from Bacteroides vulgatus, anticodon: CCC, Seq. ID: C004835
Seq.: GGACGATTAGCTCAGAGGCAGAGCATCAGCTTCCCAAGCTGAGGGTCGCGGGTTCAAGTCCCGTATCGTCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGACGATACGGGACTTGAACCCGCGACC
Gly_05from Calothrix sp. 336/3, anticodon: TCC, Seq. ID: C151081784
Seq.: CAAAAGTTAGCTCATTTGGTAGAGCAATCGACTTCCAATCGATCTGTAACAGGTTCAAATCCTGTACTTTTAACCA
tREX probe:aaaaaaaaaaaaaTGGTTAAAAGTACAGGATTTGAACCTGTTACA
Gly_06from Microcoleus sp. PCC 7113, anticodon: TCC, Seq. ID: C131004866
Seq.: TGGTGGATAGCTCAATGGGTAGAGCGCATGACTTCCAATCATGAAGTTGTTGGTTCGAGTCCAACTCCATCAGCCA
tREX probe:aaaaaaaaaaaaaTGGCTGATGGAGTTGGACTCGAACCAACAACT
Gly_07from Deinococcus sp. 2009, anticodon: GCC, Seq. ID: W131213920
Seq.: CGTCCGGTAGCTCAGGGGAAGAGCACCTCACTGCCAGTGAGGAGGCCAGCGGTTCGATTCCGTTCCGGACGTCCA
tREX probe:aaaaaaaaaaaaaTGGACGTCCGGAACGGAATCGAACCGCTGGCC
Gly_08from Methanococcoides burtonii, anticodon: GCC, Seq. ID: At0985
Seq.: ACACCAGTAGTGTAGCGGTTATCACCGGGCGTTGCCAACGCTCGAACTCGGGTTCGATTCCCGACTGGTGTACCA
tREX probe:aaaaaaaaaaaaTGGTACACCAGTCGGGAATCGAACCCGAGTT
Gly_09from Staphylococcus aureus, anticodon: GCC, Seq. ID: W141505172
Seq.: GGTCTCGTAGTGTAGCGGTTAACACGCCTGCCTGCCACGCAGGAGATCGCGGGTTCGATTCCCGTCGAGACCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGGTCTCGACGGGAATCGAACCCGCGATC
Gly_10from Spiroplasma chrysopicola, anticodon: ACC, Seq. ID: C131014728
Seq.: GATCAATTGATGGAATTGGTAGACATAGCTGATTACCAATCAGCTGTTGAAAAACGTGCGGGTTCAAGTCCCGTATTGATCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGATCAATACGGGACTTGAACCCGCACGTTTTTCAAC
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His_02from Streptomyces sp. NTK 937, anticodon: GTG, Seq. ID: W141622045
Seq.: CCTTTCGTAGCTCAATGGCAGAGCCGCGCGTTGTGGTCGCGCTGATCCCGGTTCGACTCCGGGCGGAGGGACCA
tREX probe:aaaaaaaaaaaaTGGTCCCTCCGCCCGGAGTCGAACCGGGATC
His_03from Candidatus Pelagibacter ubique, anticodon: GTG, Seq. ID: C018211
Seq.: GCCTGCGTAGTATAACGGTTAGTACGATAGTTTGTGGAACTATAGGATTTGGTTCGATTCCAAGCGCGGGTACCA
tREX probe:aaaaaaaaaaaaTGGTACCCGCGCTTGGAATCGAACCAAATCC
His_04from Afifella pfennigii, anticodon: GTG, Seq. ID: W141562735
Seq.: GCGAACGTAGCTCAGTTGGTTAGAGCGTCGGATTGTGGCTCCGAAGGTCGGTGGTTCGAATCCACCCGTTCGTACCA
tREX probe:aaaaaaaaaaaaaTGGTACGAACGGGTGGATTCGAACCACCGACC
His_05from Ottowia sp. oral taxon 894, anticodon: GTG, Seq. ID: C151090597
Seq.: TTGTTTGTGGCTCATTCGGTAGAGCAATGCACTGTGAATGCATCGGTATATCCGTAGCGGGTTCGAGTCCCGCCAAACAAACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTTTGTTTGGCGGGACTCGAACCCGCTACGGATATACC
His_06from Mycobacterium virus Bongo, anticodon: GTG, Seq. ID: PHG14101323
Seq.: CCTCTTGTAGCTCAATGGTAGAGCGCCGTTTTGTGAGACCGGTGACCTGCGTTCGATTCGCAGCAGGGGGACCA
tREX probe:aaaaaaaaaaaaTGGTCCCCCTGCTGCGAATCGAACGCAGGTC
His_07from Lyngbya confervoides, anticodon: GTG, Seq. ID: W1511400808
Seq.: GCGAACGTAGCTCAGTTGGTTAGAGCGCTGGATTGTGGCTCCAGAGGTCGGTGGTTCAAATCCACCCGTTCGTACCA
tREX probe:aaaaaaaaaaaaaTGGTACGAACGGGTGGATTTGAACCACCGACC
His_08from Bacillus cereus, anticodon: GTG, Seq. ID: W131004730
Seq.: CAGTGTGTGGCGTAATGGTAACGCAGTGGACTGTGAATCCATGAATGAGAGTTCGATTCTCTCCATGCTGACCA
tREX probe:aaaaaaaaaaaaTGGTCAGCATGGAGAGAATCGAACTCTCATT




His_10from Blastopirellula marina, anticodon: ATG, Seq. ID: w013883
Seq.: AGACCGTTAGCTCAATGGTAGAGCACCAGACTATGAATCTGGCTGTAGCAAGTTCGAATCTTGCACGGTTCACCA
tREX probe:aaaaaaaaaaaaaTGGTGAACCGTGCAAGATTCGAACTTGCTACA
Ile_01from [Clostridium] scindens, anticodon: TAT, Seq. ID: W08003134
Seq.: CGGGATGTAGCGCAGATGGTAGAGCGACTGCCTTATATGCAGCAAGCCCCTGGTTCGAGTCCAGGCATCCCGACCA
tREX probe:aaaaaaaaaaaaaTGGTCGGGATGCCTGGACTCGAACCAGGGGCT
Ile_02from Sinorhizobium fredii, anticodon: AAT, Seq. ID: W121066177
Seq.: CGCTGGGTGGAGCAGCCCGGTAGCTCGTCAGGCTAATAACCTGAAGGCCGCAGGTTCAAATCCTGCCCCCGCAACCA
tREX probe:aaaaaaaaaaaaaTGGTTGCGGGGGCAGGATTTGAACCTGCGGCC
Ile_03from Blautia hydrogenotrophica, anticodon: TAT, Seq. ID: W09117204
Seq.: CGGAACATAGCGCAGTTGGTAGAGCACCTGTCTTATACACAGCAAGTCCCTAGTTCGATTCTAGGTGTTCCGACCA
tREX probe:aaaaaaaaaaaaaTGGTCGGAACACCTAGAATCGAACTAGGGACT
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Ile_05from Clostridiales bacterium VE202-21, anticodon: TAT, Seq. ID: W131238843
Seq.: TGGGACATAGCTCAGAAGGTAGAGCACCTGGCTTATATCCAGCGTGTCACCGGTTCGAACCCGGTTGTCCCTACCA
tREX probe:aaaaaaaaaaaaaTGGTAGGGACAACCGGGTTCGAACCGGTGACA
Ile_06from Salinispora arenicola, anticodon: GAT, Seq. ID: W131169380
Seq.: GTCGTCGTGGCCAAGAAGGTGAAGGCACCGAGCTGATACCTCGGAGATGCGGTGGTTCGAACCCACCCGACGACACCA
tREX probe:aaaaaaaaaaaaaTGGTGTCGTCGGGTGGGTTCGAACCACCGCATC




Ile_08from Butyrivibrio sp. LC3010, anticodon: AAT, Seq. ID: W131233184
Seq.: TTCAGAATGGCGAAGTGGAAATCGCGCTGGGTTAATGGCCCGGAAGTCGCAGGTTCGAATCCTGCTTCTGAATCCA
tREX probe:aaaaaaaaaaaaaTGGATTCAGAAGCAGGATTCGAACCTGCGACT
Ile_09from Mycobacterium abscessus, anticodon: GAT, Seq. ID: W121060940
Seq.: CGCATTGTGGCGCAGTTGGTTAGCGCGCCGACCTGATAAGTCGGAGGCCGCAGGTTCAATCCCTGCCGATGCGACCA
tREX probe:aaaaaaaaaaaaaTGGTCGCATCGGCAGGGATTGAACCTGCGGCC
Ile_10from Chitinophaga pinensis, anticodon: TAT, Seq. ID: C10103715
Seq.: TGATCTGTAGCTCAACGGTTAGAGCAACTGCCTTATACGCAGCAGGCTACCGGTTCAAATCCGGTCAGATCAACCA
tREX probe:aaaaaaaaaaaaaTGGTTGATCTGACCGGATTTGAACCGGTAGCC
Lys_01from Salinispora arenicola, anticodon: CTT, Seq. ID: C08008478
Seq.: CCCGCCGTAGCTCAGTGGTAGAGCACCCGGCTCTTAACCGGGAGGACGTTGGTTCGAGCCCAGCCGGCGAGCCCA
tREX probe:aaaaaaaaaaaaaTGGGCTCGCCGGCTGGGCTCGAACCAACGTCC
Lys_02from Methanosarcina acetivorans, anticodon: CTT, Seq. ID: At1403
Seq.: GGGCCCGTAGCTTAGTCAGGCAGAGCGATGGACTCTTAATCCATAGGCCGGGGGTTCAAATCCCTTCGGGCCCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGGGCCCGAAGGGATTTGAACCCCCGGCC
Lys_03from Pyrobaculum aerophilum, anticodon: CTT, Seq. ID: At0204
Seq.: GGGCCCGTAGCTCAGCCTGGTAGAGCGGCGGGCTCTTAACCCGTAGGTCGTGGGTTCGAATCCCACCGGGCCCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGGGCCCGGTGGGATTCGAACCCACGACC
Lys_04from Sulfolobus acidocaldarius, anticodon: CTT, Seq. ID: At0455
Seq.: GGGCCCGTAGCTCAGCCAGGTAGAGCGGCGGGCTCTTAACCCGTAGGTCCCGGGTTCAAATCCCGGCGGGCCCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGGGCCCGCCGGGATTTGAACCCGGGACC
Lys_05from Methanoculleus marisnigri, anticodon: CTT, Seq. ID: At1273
Seq.: GGGCCTGTAGCTTAGTTGGCAGAGCGACGGACTCTTAATCCGTAGGCCAAGGGTTCAAATCCCTTCAGGCCCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGGGCCTGAAGGGATTTGAACCCTTGGCC
Lys_06from Sulfolobus solfataricus, anticodon: CTT, Seq. ID: At0490
Seq.: GGGCCCGTAGCTTAGCCAGGTAGAGCGACGGGCTCTTAACCCGTAGTCCCGGGTTCGAATCCCGGCGGGCCCGCCA
tREX probe:aaaaaaaaaaaaTGGCGGGCCCGCCGGGATTCGAACCCGGGAC
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Lys_08from Candidatus Saccharimonas aalborgensis, anticodon: CTT, Seq. ID: C131016148
Seq.: GGGCCAGTAGCTCAGCTGGTTAGAGCACCTGCCTCTTAAGCAGGGTGTCGAGAGTTCAAGTCTCTCCTGGCCCTCCA
tREX probe:aaaaaaaaaaaaaTGGAGGGCCAGGAGAGACTTGAACTCTCGACA
Lys_09from Methanospirillum hungatei, anticodon: CTT, Seq. ID: At1600
Seq.: GGGTCTGTAGCTTAGTCGGTAGAGCGGCGGACTCTTAATCCGCAGGCCAGGGGTTCGAGTCCCTTCAGGCCCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGGGCCTGAAGGGACTCGAACCCCTGGCC
Met_01from Candidatus Koribacter versatilis, anticodon: CAT, Seq. ID: C000175
Seq.: GGCGGCGTAGCTCAGCTGGTTAGAGCGACGGTCTCATAATCCGTAGGTCCGTGGTTCGAGTCCACGCGCCGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCGGCGCGTGGACTCGAACCACGGACC
Met_02from Acidiphilium cryptum, anticodon: CAT, Seq. ID: C000488
Seq.: GGCGGCGTAGCTCAGCGGTAGAGCAGGGGAATCATAATCCCTTGGTCGGTGGTTCAAATCCGCCCGCCGCTACCA
tREX probe:aaaaaaaaaaaaaTGGTAGCGGCGGGCGGATTTGAACCACCGACC
Met_03from Aquifex aeolicus, anticodon: CAT, Seq. ID: C000005
Seq.: GGCGGCGTAGCTCAGCTGGTCAGAGCGGGGATCTCATAAGTCCCAGGTCGGAGGTTCGAGTCCTCCCGCCGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCGGCGGGAGGACTCGAACCTCCGACC
Met_04from Bacteroides fragilis, anticodon: CAT, Seq. ID: C002823
Seq.: GGCGGGATAGCTCAGCTGGTTAGAGCGCATGATTCATAATCATGAGGTCCCCGGTTCAATCCCGGGTCCCGCTACCA
tREX probe:aaaaaaaaaaaaaTGGTAGCGGGACCCGGGATTGAACCGGGGACC
Met_05from Acidovorax sp. JS42, anticodon: CAT, Seq. ID: C000375
Seq.: GGTGGTATAGCTCAGTTGGTTAGAGCGCAGCATTCATAATGCTGATGTCCCAGGTTCAAGTCCCGGTACCACCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGTGGTACCGGGACTTGAACCTGGGACA
Met_06from Chlamydia abortus, anticodon: CAT, Seq. ID: C004944
Seq.: GGCGGTATAGCTCAGATGGTTAGAGCAGCAGAATCATAATCTGCGAGTCGTTGGTTCAAGTCCGACTACCGCTACCA
tREX probe:aaaaaaaaaaaaaTGGTAGCGGTAGTCGGACTTGAACCAACGACT
Met_07from Dehalococcoides mccartyi, anticodon: CAT, Seq. ID: C007625
Seq.: GGCAGCGTAGCTCAGTGGCAGAGCAGGGGACTCATAAGCCCTTGGTCGGTAGTTCAAATCTACCCGCTGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCAGCGGGTAGATTTGAACTACCGACC
Met_08from Cenarchaeum symbiosum, anticodon: CAT, Seq. ID: At0055
Seq.: GCCGGGATAGCTCAGCCGGTCAGAGTGCCAGACTCATAATCTGGAGGTCGTGGGATCAAAACCCACTCCCGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCGGGAGTGGGTTTTGATCCCACGACC
Met_09from Nostoc punctiforme, anticodon: CAT, Seq. ID: C08006893
Seq.: GTTTGATTAGCTCAGTTGGTAGAGCGATCGACTCATAATCGAAGGGTCACAGGTTCGACTCCTGTATCAAACCCCA
tREX probe:aaaaaaaaaaaaaTGGGGTTTGATACAGGAGTCGAACCTGTGACC
Met_10from Sulfurimonas denitrificans, anticodon: CAT, Seq. ID: C025436
Seq.: GTCAGGGTAGCTCAGCTGGTTAGAGCACTGGTCTCATAAGCCGGGGGTCGGGGGTTCGAGTCCCCCCTCTGACACCA
tREX probe:aaaaaaaaaaaaaTGGTGTCAGAGGGGGGACTCGAACCCCCGACC
Phe_01from Bifidobacterium animalis, anticodon: GAA, Seq. ID: C09300022
Seq.: GGCTCTGTAGCTCAGTTGGTAGAGCGAACGACTGAAAATCGTTAGGTCAGCGGATCGACGCCGCTCGGAGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCTCCGAGCGGCGTCGATCCGCTGACC
Phe_02from Kocuria rhizophila, anticodon: GAA, Seq. ID: C08012591
135
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Seq.: GGCTCTGTAGCTCAGTTGGTAGAGCGTACGACTGAAAATCGTAAGGTCACCGGATCGACGCCGGTCGGAGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCTCCGACCGGCGTCGATCCGGTGACC
Phe_03from Mobiluncus curtisii, anticodon: GAA, Seq. ID: C10300161
Seq.: GGCTCTGTAGCTCAGTTGGCAGAGCGAACGACTGAAAATCGTTAGGTCACCGGATCGACGCCGGTCGGAGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCTCCGACCGGCGTCGATCCGGTGACC
Phe_04from Candidatus Aquiluna sp. IMCC13023, anticodon: GAA, Seq. ID: W123001457
Seq.: GGCTCTGTAGCTCAGTTGGTAGAGCGAACGACTGAAAATCGTTAGGTCACCGGATCGACGCCGGTCGGAGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCTCCGACCGGCGTCGATCCGGTGACC
Phe_05from Picrophilus torridus, anticodon: GAA, Seq. ID: At1756
Seq.: GCCGTGATAGCTCAGTTGGGAGAGCGCCAGACTGAAGATCTGGAGGTCGCTGGTTCAATCCCGGCTCACGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCGTGAGCCGGGATTGAACCAGCGACC
Phe_06from Aeropyrum pernix, anticodon: GAA, Seq. ID: At0036
Seq.: GCCGCCGTAGCTCAGCGGGAGAGCGCCCGGCTGAAGACCGGGTGGTCCGGGGTTCGAATCCCCGCGGCGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCGCCGCGGGGATTCGAACCCCGGACC
Phe_07from Chitinophagaceae bacterium JGI 0001002-J12, anticodon: GAA, Seq. ID: W131214335
Seq.: GGACGAATAGCTCCAATGGCAGAGCATCACGTTGAAGCCGTGACAGTGTTGGTTCGAATCCAGCTTCGTCTACCA
tREX probe:aaaaaaaaaaaaTGGTAGACGAAGCTGGATTCGAACCAACACT
Phe_08from Actinomyces coleocanis, anticodon: GAA, Seq. ID: W09300480
Seq.: GCCTCTGTAGCTCAGTTGGTAGAGCGTTCGACTGAAAATCGAAAGGTCACCGGATCGACGCCGGTCGGAGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCTCCGACCGGCGTCGATCCGGTGACC
Phe_09from Microbacterium testaceum, anticodon: GAA, Seq. ID: C11300378
Seq.: GGCTCTGTAGCTCAGTTGGTAGAGCGCACGACTGAAAATCGTGAGGTCACGGGATCGACGCCCGTCGGAGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCTCCGACGGGCGTCGATCCCGTGACC
Phe_10from Ignicoccus hospitalis, anticodon: GAA, Seq. ID: At2227
Seq.: GCCGCCGTAGCTCAGCGGGAGAGCGCCCGGCTGAAGACCGGGTCGTCCGGGGTTCGAATCCCCGCGGCGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCGCCGCGGGGATTCGAACCCCGGACG
Pro_01from Nocardia otitidiscaviarum, anticodon: TGG, Seq. ID: W141231342
Seq.: TTGGGTGTAGTTCAATTTGGTCAGAGCACCCGCTTTGGGAGCGGGAAGTTGCGAGTTCGAGTCTCGCCACCCGAACCA
tREX probe:aaaaaaaaaaaaaTGGTTCGGGTGGCGAGACTCGAACTCGCAACT




Pro_03from Aureispira sp. CCB-QB1, anticodon: TGG, Seq. ID: W141526482
Seq.: ACGGGAGTAGCTTAACAAGGCAAAAGCACTAGGTTTGGGACTTAGGAGATGCAGGTTCAACCCCTGTCACCCGTACCA
tREX probe:aaaaaaaaaaaaaTGGTACGGGTGACAGGGGTTGAACCTGCATCT




Pro_05from Beggiatoa alba, anticodon: TGG, Seq. ID: W123000923
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Seq.: GTCCAATTAGCTCACAGGTTAGAGCGTAATTACTGGGTAATTAAGGTAGCAGGTTCAACTCCTGCATTGGACTCCA
tREX probe:aaaaaaaaaaaaaTGGAGTCCAATGCAGGAGTTGAACCTGCTACC




Pro_08from Coprobacillus sp. D7, anticodon: TGG, Seq. ID: W09119425
Seq.: TGAGAAGTAGCACAATTTGGTAGTGCTCGTGGTTTGGGACCACGGGGTTATGGGTTCAAATCCCATCTTCTCAACCA
tREX probe:aaaaaaaaaaaaaTGGTTGAGAAGATGGGATTTGAACCCATAACC
Pro_09from Lachnospiraceae bacterium A4, anticodon: TGG, Seq. ID: W131195543
Seq.: TACTTCGTAGCTCATCTGGTAGAGCAATTTGTTTGGGACAAATTTGTAGCTGGTTCGAATCCAGTCGAAGGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCCTTCGACTGGATTCGAACCAGCTACA
Pro_10from Mucilaginibacter paludis, anticodon: TGG, Seq. ID: W11138394
Seq.: AGGGTAATATATCAATTGGCAGATTACTTGCTTTGGGAGCATGAGGTTGTGGGTTCGAGTCCCGCTTACCCTACCA
tREX probe:aaaaaaaaaaaaaTGGTAGGGTAAGCGGGACTCGAACCCACAACC
Thr_01from Amycolatopsis orientalis, anticodon: CGT, Seq. ID: W131202873
Seq.: CATGGAGTAGATCAGCGGCAGATCGCCCGGCTCGTAACCGGGAGGGCGCGGGTTCGAGTCCCGCCTCCGTGTCCA
tREX probe:aaaaaaaaaaaaaTGGACACGGAGGCGGGACTCGAACCCGCGCCC
Thr_02from Chlamydia trachomatis, anticodon: CGT, Seq. ID: W1510645195
Seq.: TGCGGGGTAGTGTAACGGTAACATACCGGTTTCGTTTTCCGGTGCTGCGGGTTCGATTCCCGCCCCCGCCTCCA
tREX probe:aaaaaaaaaaaaTGGAGGCGGGGGCGGGAATCGAACCCGCAGC
Thr_03from Lyngbya sp. PCC 8106, anticodon: AGT, Seq. ID: w021635
Seq.: CGGTGGATAGCTCAATAGGTAGAGCGCATGATTAGTCATCATGAGTTGTTGGTTCGATTCCAACTCCATCAACCA
tREX probe:aaaaaaaaaaaaTGGTTGATGGAGTTGGAATCGAACCAACAAC
Thr_04from Intestinimonas butyriciproducens, anticodon: TGT, Seq. ID: W1511303119
Seq.: TGCGGGGTGGTGTAGTGGTGAACATTAGTCTCTTGTCATGACTGGCCGCTGGTTCGATTCCAGCCCCCGCACCCA
tREX probe:aaaaaaaaaaaaTGGGTGCGGGGGCTGGAATCGAACCAGCGGC
Thr_05from Lachnospiraceae bacterium AC2014, anticodon: TGT, Seq. ID: W141731478
Seq.: TACGAAGTGGCGCAATAGGTAGCGCTCATGATTTGTAATCGTGAAGTTGTAGGTTCGAGTCCTATCTTTGTAACCA
tREX probe:aaaaaaaaaaaaaTGGTTACAAAGATAGGACTCGAACCTACAACT




Thr_07from Enterococcus faecalis, anticodon: CGT, Seq. ID: W10125366
Seq.: TGGCGTGTAGCATTGTGGTAATGCAACTTACTTCGTGTGAGATAAGATGCGGGTTCGAATCCTGTCACGCCAACCA
tREX probe:aaaaaaaaaaaaaTGGTTGGCGTGACAGGATTCGAACCCGCATCT
Thr_08from Lactobacillus reuteri, anticodon: GGT, Seq. ID: W11186032
Seq.: AACACGTTAGTTTAAATGGGGAAGCACCACTATGGTAATGTGGAGATATGGGTTCGAATCCTGTACGTGTTACCA
tREX probe:aaaaaaaaaaaaTGGTAACACGTACAGGATTCGAACCCATATC
Thr_09from Alistipes putredinis, anticodon: AGT, Seq. ID: W08002770
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Seq.: TGCGGGGTAGTGCAGAGGTTACCACGGCGGGTTAGTGTCCCGCAGGCGCAAGTTCGATTCTTGCCCCCGCTACCA
tREX probe:aaaaaaaaaaaaTGGTAGCGGGGGCAAGAATCGAACTTGCGCC
Thr_10from Calothrix sp. PCC 7507, anticodon: TGT, Seq. ID: C131010288
Seq.: AGGAAGTTAGCTCACTGGTAGAGCGATCGACTTGTAATCGATTTGTTATAGGTTCGATTCCTATACTTTCAACCA
tREX probe:aaaaaaaaaaaaaTGGTTGAAAGTATAGGAATCGAACCTATAACA
Trp_01from Leucobacter musarum, anticodon: CCA, Seq. ID: W1511008762
Seq.: GTCTGCGTAGCTCAATTGGCTAGAGCACCGGTCTCCAAAACCGGAGGTTCCAGGTTCGAGTCCTGGCGCATTCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGAATGCGCCAGGACTCGAACCTGGAACC
Trp_02from Ensifer sojae, anticodon: CCA, Seq. ID: W121066370
Seq.: TACCGGTTAGCTTAGTGGTAAAGCGTCGGTCTCCAAAACCGATTACGTGGGTTCGATTCCCGCACCGGGTGCCA
tREX probe:aaaaaaaaaaaaTGGCACCCGGTGCGGGAATCGAACCCACGTA
Trp_03from Nonlabens sediminis, anticodon: CCA, Seq. ID: W141238833
Seq.: GCAGGTTTAGCTCAGTTGGTAGAGCACTGGTCTCCAAAACCAGGTGTCGGGAGTTCGAGCCTCTCAACCTGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCAGGTTGAGAGGCTCGAACTCCCGACA
Trp_04from Chryseobacterium sp. UNC8MFCol, anticodon: CCA, Seq. ID: W141168454
Seq.: ACTCCGATAGTGTAACGGCAGTATCTCAGTCTCCAAAACTGACAGTACTGGTTCGAATCCGGTTCGGAGTTCCA
tREX probe:aaaaaaaaaaaaTGGAACTCCGAACCGGATTCGAACCAGTACT
Trp_05from Achromobacter sp. DH1f, anticodon: CCA, Seq. ID: W141187535
Seq.: TCCGGGATAGTTCAGCGGTAGAACATCCGGCTCCACTCTGGATAGGCGCTGGTTCGACTCCAGCTCCCGGATCCA
tREX probe:aaaaaaaaaaaaaTGGATCCGGGAGCTGGAGTCGAACCAGCGCCT
Trp_06from Caulobacter virus Swift, anticodon: CCA, Seq. ID: PHG14101650
Seq.: GTCGGTCTAGCTCATGGGGTAGAGCGGCGGTCTCCAAAACCGCGCGTGGCAGGTTCGAGTCCTGCGACCGGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCCGGTCGCAGGACTCGAACCTGCCACG
Trp_07from Deinococcus misasensis, anticodon: CCA, Seq. ID: W141816918
Seq.: GATCTGGTAGCTCAGTCTGGTAGAGCGTGCGTCTCCAAAACGCAGGGTCGCAGGTTCAAATCCTGCCCGGATCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGATCCGGGCAGGATTTGAACCTGCGACC
Trp_08from Vibrio parahaemolyticus, anticodon: CCA, Seq. ID: W1511591459
Seq.: GATTTCGTGGCGCAATGGTAGCGCGCCTGACTCCAGATCAGGAGGTTGCGTGTTCAAATCACGTCGAGATCACCA
tREX probe:aaaaaaaaaaaaaTGGTGATCTCGACGTGATTTGAACACGCAACC
Trp_09from Mycoplasma hyorhinis, anticodon: TCA, Seq. ID: C11114494
Seq.: tAGAGGTGTAGTTCAATGGTAGAACAACGGGCTTCAACCCCGTGTGTTGCGGGTTCGACTCCTGTCACCTCTGCCCA
tREX probe:aaaaaaaaaaaaaTGGGCAGAGGTGACAGGAGTCGAACCCGCAACA
Trp_10from Mycoplasma putrefaciens, anticodon: TCA, Seq. ID: C11115064
Seq.: cAGGGGCATAGTTCAGTTGGTAGAACATCGGTCTTCAAAACCGAGTGTCACGAGTTCGAGTCTTGTTGCCCCTGCCCA
tREX probe:aaaaaaaaaaaaaTGGGCAGGGGCAACAAGACTCGAACTCGTGACA
Tyr_01from Mycobacterium abscessus, anticodon: GTA, Seq. ID: W123001397
Seq.: CGTGGGTTGGGCTTGTTGGGCAAGGCCCTCCAGACTGTAAATCTGGCGCTTCGGCTACGGGGGTTCGATTCCCTCCCTACGTCCA
tREX probe:aaaaaaaaaaaaaaaTGGACGTAGGGAGGGAATCGAACCCCCGTAGCCGAAGC
Tyr_02from Rhodobacter sphaeroides, anticodon: GTA, Seq. ID: C027996
Seq.: TGGGCGACGTGCTGCAAGGTGCGGCAGCGGACTGTAACTCCGCCGAGGCGACTCGTGCCTGGTTCGATTCCAGGGTCGCCCACCCA
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tREX probe:aaaaaaaaaaaaaaaaaTGGGTGGGCGACCCTGGAATCGAACCAGGCACGAGTCGCCTC





Tyr_04from Mycobacterium abscessus, anticodon: GTA, Seq. ID: W122000209
Seq.: CTGCGCGCGGTGACGACGGCGTGTCACGACTGACTGTAAATCAGTTGCCTTTCGGCTCAGGGGGTTCAAATCCCTCCGCGCAGACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTCTGCGCGGAGGGATTTGAACCCCCTGAGCCGAAAGGC
Tyr_05from Archaeoglobus fulgidus, anticodon: GTA, Seq. ID: At0643
Seq.: CCCGCCTTAGCTCAGAGGTAGAGCGTGGGACTGTAGATCCCATGGTCCCCGGTTCAAATCCGGGAGGCGGGACCA
tREX probe:aaaaaaaaaaaaaTGGTCCCGCCTCCCGGATTTGAACCGGGGACC
Tyr_06from Hungatella hathewayi, anticodon: GTA, Seq. ID: W09125611
Seq.: GGATGCGTAAGCCCAGCGGCGAGGGCAGGAGACTGTAAATCTCTCACATCGGAAACAACGCAGGTTCGAGTCCTGCCGCATCCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGGATGCGGCAGGACTCGAACCTGCGTTGTTTCCGATG




Tyr_08from Mycobacterium phage Catera, anticodon: GTA, Seq. ID: PHG0200041
Seq.: CCCGTACATGCCCAACTGGTGTTTGGGAGCAGGCTGTAAATCTGTGGCCTTCGGGACGGTGAGGTTCGATTCCTCAGTGCGGGACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTCCCGCACTGAGGAATCGAACCTCACCGTCCCGAAGGC
Tyr_09from Nanoarchaeum equitans, anticodon: GTA, Seq. ID: At2113
Seq.: CCGGGCGTAGCTCAGCGGCAGAGCGGCCGGCTGTAGACCGGCAGGTCGGGGGTTCGAATCCCCCCGCCCGGACCA
tREX probe:aaaaaaaaaaaaaTGGTCCGGGCGGGGGGATTCGAACCCCCGACC




Val_01from Paenibacillus dendritiformis, anticodon: GAC, Seq. ID: W121034225
Seq.: GTTCTGATAGCTCAGTAGGGAGAGCACCATCTTGACAGGGTGGGGGTCGGCGGTTCGAGCCCGTCTCAGAACACCA
tREX probe:aaaaaaaaaaaaaTGGTGTTCTGAGACGGGCTCGAACCGCCGACC
Val_02from Acetobacterium woodii, anticodon: TAC, Seq. ID: C121003905
Seq.: GGTCGCATAGCTCAGCTGGGAGAGCACCTGCCTTACAAGCAGGGGGTCACAGGTTCGAGCCCTGTTGCGACCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGTCGCAACAGGGCTCGAACCTGTGACC
Val_03from Enterococcus faecalis, anticodon: TAC, Seq. ID: W133000314
Seq.: GGAGGTTTAGCTCAGCTGGGAGAGCACCTGCCTTACAAGCAGGGGGTCAGCGGTTCGATCCCGTTAACCTTCTCCA
tREX probe:aaaaaaaaaaaaaTGGAGAAGGTTAACGGGATCGAACCGCTGACC
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Val_05from Mycoplasma anatis, anticodon: TAC, Seq. ID: W11174739
Seq.: GGAAGATTAGCTCAGTTGGGAGAGCGTTGCCCTTACAAGGCAAATGTCATGGGTTCGAGTCCCTTATCTTCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGAAGATAAGGGACTCGAACCCATGACA
Val_06from Campylobacter showae, anticodon: GAC, Seq. ID: W131099323
Seq.: GGTCCCGTAGCTCAGTTGGTAGAGTACTACCTTGACATGGTAGTGGTCGATGGTTCGAGTCCATTCGGGGCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGCCCCGAATGGACTCGAACCATCGACC
Val_07from Candidatus Mycoplasma haemolamae, anticodon: TAC, Seq. ID: C121015518
Seq.: GGAATGTTAGCTCAGCGGGAGAGCAACTGCCTTACAAGCAGTAGGTCGGGGGTTCAAATCCCTCACATTCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGAATGTGAGGGATTTGAACCCCCGACC
Val_08from Mycoplasma cynos, anticodon: TAC, Seq. ID: C151099846
Seq.: GGAAGATTAGCTCAGTTGGGAGAGCGTCGCCCTTACAAGGCGAATGTCATGGGTTCGAGTCCCTTATCTTCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGAAGATAAGGGACTCGAACCCATGACA
Val_09from Bacillus cereus, anticodon: GAC, Seq. ID: W131005331
Seq.: GATCCCGTAGCTCAGCAGGGAGAGCGCCACCTTGACAGGGTGGAGGTCGTGAGTTCGAGCCTCACTGGGGTCACCA
tREX probe:aaaaaaaaaaaaaGGTGACCCCAGTGAGGCTCGAACTCACGACC
Val_10from Butyrivibrio sp. VCD2006, anticodon: TAC, Seq. ID: W131232029
Seq.: TCCGATATAACTCAGCTGGGAGAGTGCTTCCCTTACAAGGAAGAAGCCACAGGTTCAATCCCTGTTATCGGAACCA
tREX probe:aaaaaaaaaaaaaTGGTTCCGATAACAGGGATTGAACCTGTGGCT
Trp_11from Actinosynnema mirum, anticodon: CCA, Seq. ID: C09100630
Seq.: CGTGGAGTAGCTCAGGTGGTAGAGCTCCCGGCTCCAAACCGGGAAGTCGCGGGTTCGACTCCCGCCTCCATGTCCA
tREX probe:aaaaaaaaaaaaaTGGACATGGAGGCGGGAGTCGAACCCGCGACT
Trp_12from Microcoleus vaginatus, anticodon: CCA, Seq. ID: W11164215
Seq.: GCAGGGATGGTGTAACTGGCAACACTCTGGTCTCCAAAACCAGCATTCTGAGTTCAAATCTCAGTTCCTGTGCCA
tREX probe:aaaaaaaaaaaaTGGCACAGGAACTGAGATTTGAACTCAGAAT
Trp_13from Desulfatibacillum alkenivorans, anticodon: CCA, Seq. ID: C09103670
Seq.: GTGCCCTTGGCGTCAACTGGCAGCGCAACGGACTCCAAATCCGTAGGTTGAAGGTTCGAATCCTTCAGGGTACGCCA
tREX probe:aaaaaaaaaaaaaTGGCGTACCCTGAAGGATTCGAACCTTCAACC
Trp_14from Faecalibacterium prausnitzii, anticodon: CCA, Seq. ID: W11133128
Seq.: GCCGTTTTAGCTCATGTTGGAAGAGCGCCGGTCTCCAAAGCCGGAAGCGGCAGGTTCGATCCCTGCAAACGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCGTTTGCAGGGATCGAACCTGCCGCT
Trp_15from Phycisphaera mikurensis, anticodon: CCA, Seq. ID: C121001250
Seq.: GCCGGTGTAGCTCAGTTGGTTAGAGCAGTGGATTCCAAATCCACAGGTCGCGGGTTCGAGTCCCTCCGCCGGTGCCA
tREX probe:aaaaaaaaaaaaaTGGCACCGGCGGAGGGACTCGAACCCGCGACC
Trp_16from Leptolyngbya boryana, anticodon: CCA, Seq. ID: W131036311
Seq.: GTTGGGATGGTGTAACGGTAACATTTCGGTCTCCAAAACCGACGATCTGAGTTCGAGTCTCAGTCCCTTCGCCA
tREX probe:aaaaaaaaaaaaTGGCGAAGGGACTGAGACTCGAACTCAGATC
Trp_17from Anabaena cylindrica, anticodon: CCA, Seq. ID: C131005049
Seq.: GCACAGATGGTGTAACGGAAGCATAAGGGTCTCCAAAACCTTTGGTCATGGTTCAAATCCTTGTCTGTGCGCCA
tREX probe:aaaaaaaaaaaaTGGCGCACAGACAAGGATTTGAACCATGACC
Trp_18from Acidobacteriaceae bacterium KBS 96, anticodon: CCA, Seq. ID: W131179233
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Seq.: GCCGGGATCGTTCAGCGGCTAGGACGGCTGCCTCCAGAACAGCTTACGAGGGTTCGAGTCCTTCTCCCGGTGCCA
tREX probe:aaaaaaaaaaaaTGGCACCGGGAGAAGGACTCGAACCCTCGT
Trp_19from Clostridium botulinum, anticodon: CCA, Seq. ID: W08001255
Seq.: GTAGGTATGGTGTAATGGCTAACATGATAGTCTCCAAAACTATTGATGTGGGTTCGATTCCTACTACCTATGCCA
tREX probe:aaaaaaaaaaaaTGGCATAGGTAGTAGGAATCGAACCCACATC
Trp_20from Calothrix sp. PCC 7103, anticodon: CCA, Seq. ID: W131036258
Seq.: GCAGCGATGGTGTAATTGGCTAACACGTCGGTCTCCAAAACCGAAGAATCTAGGTTCAAGCCCTAGTCGCTGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCAGCGACTAGGGCTTGAACCTAGATTC
































Ser_477from Campylobacter hominis, anticodon: TGA, Seq. ID: C08003181
Seq.:
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Daniele Cervettini Ph.D. Thesis
CGGTAGATGGCTGAGCGGTCGAAAGCGGCGGTCTTGAAAACCGTTGAGGTGCAAGCCTCCTGGGGTTCGAATCCCTATCTACCGGCCA
tREX probe:aaaaaaaaaaaaaaaaaTGGCCGGTAGATAGGGATTCGAACCCCAGGAGGCTTGCACCTC












Ser_7016from Methyloferula stellata, anticodon: TGA, Seq. ID: W131186337
Seq.: GACCGGGTGGCAGAATGGCTATGCAGGGCTCTTGAAAATCTCGCACGCCGGTTCGATTCCGGCCCCGGTCTCCA
tREX probe:aaaaaaaaaaaaTGGAGACCGGGGCCGGAATCGAACCGGCGTG




Ser_6589from Oribacterium sp. oral taxon 078, anticodon: GGA, Seq. ID: W09125722
Seq.: GACGAGGTGTGATAATGGTAGTCGGCCAGCCTGGAAAGTTGGTGCCCGTTCTGCGGGTTGTGGGTTCAAGTCCCATCCTCGTCGCCA
tREX probe:aaaaaaaaaaaaaaaaaaTGGCGACGAGGATGGGACTTGAACCCACAACCCGCAGAACGGGC












Ser_4103from Xanthomonas fuscans, anticodon: TGA, Seq. ID: W10200001
Seq.: GGGTTGTTCCGCTGCGTTGGGCGGCGAGCGGTCTTGAAAACCGTGGTGGCCGAAAGGCCAGGGGTTCGACTCCTCAACAACCCGCCA
tREX probe:aaaaaaaaaaaaaaaaaTGGCGGGTTGTTGAGGAGTCGAACCCCTGGCCTTTCGGCCAC
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Ser_2957from Granulicella mallensis, anticodon: GCT, Seq. ID: C121006521
Seq.: GAGCCAGTAGCTCAGTTGGATAGAGCATCGGACTGCTAATCTGGGGGTCGGCGGTTCGAATCCGCCCTGGCATTCCA
tREX probe:aaaaaaaaaaaaaTGGAATGCCAGGGCGGATTCGAACCGCCGACC




Ser_3103from Coprobacillus sp. 29_1, anticodon: TGA, Seq. ID: W11119494
Seq.: GCTCAGTTGTGATAATTGGTAGTCGTGCTGTCTTGAAAACAGTTGGTCTGAAAGGACTTGGGGGTTCGAGTCCCTCACTGAGCGCCA
tREX probe:aaaaaaaaaaaaaaaaaTGGCGCTCAGTGAGGGACTCGAACCCCCAAGTCCTTTCAGACC
Ser_8239from Methanosarcina acetivorans, anticodon: CGA, Seq. ID: At1411
Seq.: GCCCAGGTCGTCTAGTGGTATGGCGACGGTCTCGAAAACCGTTCCCTTTGGGATCGCAGGTTCAAATCCTGCCCTGGGCGCCA
tREX probe:aaaaaaaaaaaaaaaaTGGCGCCCAGGGCAGGATTTGAACCTGCGATCCCAAAGGG
Ala_2698from Tropheryma whipplei, anticodon: CGC, Seq. ID: W131249897
Seq.: GGGCGATTGGCGCAGTGGTAGCGCGCTTCCATCGCACGGAAGAGGTCACTGGTTCGAGTCCAGTATCGCCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGGCGATACTGGACTCGAACCAGTGACC
Ala_3524from Streptomyces sp. FXJ7.023, anticodon: CGC, Seq. ID: W131109963
Seq.: ACGCTTGTAGCTCAGTGGATAGAGCAGCCCTTTCGCGAAGGGCAGGTCGCGGGTTCGAGTCCCGCCAGGCCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGGCCTGGCGGGACTCGAACCCGCGACC
Ala_2623from Streptomyces sp. 142MFCol3.1, anticodon: GGC, Seq. ID: W131234499
Seq.: CCCGGCGTCGAGGAGGGGCGGACTCGCCGCCTTGGCGAGGCGGATACGCCGGTTCCAATCCGGTCGTCGGGGCCA
tREX probe:aaaaaaaaaaaaTGGCCCCGACGACCGGATTGGAACCGGCGTA
Ala_3269from Streptomyces purpureus, anticodon: CGC, Seq. ID: W131163902
Seq.: CCGGATGTAGCGCAGAGGCAGGCGCACCGGTCTCGCAGGCCGGGCACGCCGGTTCGAATCCGGCCGTCGGGCCCA
tREX probe:aaaaaaaaaaaaTGGGCCCGACGGCCGGATTCGAACCGGCGTG
Ala_79from Kitasatospora setae, anticodon: GGC, Seq. ID: C11111760
Seq.: CCCGGGCGTGGGCGCAGAGGCCGCCGCCGCCGTTTTGGCAAAACGGAGCACGCCGGTTCGAATCCGGCCCCCGGGACCA
tREX probe:aaaaaaaaaaaaaTGGTCCCGGGGGCCGGATTCGAACCGGCGTGC
Ala_3046from Salinispora arenicola, anticodon: AGC, Seq. ID: W131177388
Seq.: GGGCCCGTAGCGCAGAGGTAGTCGCGCCGCCATAGCGTGGCGGAGGATGCCGGTTCGAGTCCGGTCGGGTCCCCCA
tREX probe:aaaaaaaaaaaaaTGGGGGACCCGACCGGACTCGAACCGGCATCC
Ala_3581from Streptomyces sp. 351MFTsu5.1, anticodon: GGC, Seq. ID: W131185494
Seq.: GGGTCGGTAGCGCAGAGGCAGGCGCGCCTTCATGGCATGAAGGGAACGTCGGTTCGAATCCGACCCGGCCCACCA
tREX probe:aaaaaaaaaaaaTGGTGGGCCGGGTCGGATTCGAACCGACGTT
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Ala_4032from Actinoplanes sp. SE50/110, anticodon: CGC, Seq. ID: C121007290
Seq.: GGGCCGGTAGCGCAGCTGGTCGACGCACACCGTTCGCATCGGTGGGGACGCCGGTTCGAATCCGGCTCGGCTCCCCA
tREX probe:aaaaaaaaaaaaaTGGGGAGCCGAGCCGGATTCGAACCGGCGTCC
Ala_2727from Bacillus cereus, anticodon: GGC, Seq. ID: C09102186
Seq.: GATCCCGTAGCTCAGCAGGGAGAGCGCCACCTTGGCAGGGTGGAGGTCGTGAGTTCGAGCCTCTCCGGGGTCACCA
tREX probe:aaaaaaaaaaaaaTGGTGACCCCGGAGAGGCTCGAACTCACGACC
Ala_3530from Thermaerobacter marianensis, anticodon: GGC, Seq. ID: C11122791
Seq.: GCGCCGGTAGCTCAGTTGGAAGAGCGGTGTTGTGGCGAAACACCAGGTCGAGGGTTCGAGTCCCTCCCGGCGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCGCCGGGAGGGACTCGAACCCTCGACCT
Ala_2780from Gemella haemolysans, anticodon: TGC, Seq. ID: W09119662
Seq.: GCCGGCCTAGCTCAGTTGGTAGAGCAACTGACTTGCAATCAGTAGGTCGGGGGTTCAAGTCCTCTGGCCGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCGGCCAGAGGACTTGAACCCCCGACC
Ala_3354from Deinococcus sp. 2009, anticodon: GGC, Seq. ID: W131213919
Seq.: GGTCCGGTAGCTCAGTGGAAGAGCATCTCACTGGCAGTGAGGGGGCCAGCGGTTCAATTCCGCTCCGGACGACCA
tREX probe:aaaaaaaaaaaaaTGGTCGTCCGGAGCGGAATTGAACCGCTGGCC
Ala_2762from Acinetobacter baumannii, anticodon: GGC, Seq. ID: W10106539
Seq.: GCAGCGGTAGTTCAGTTGGTTAGAATACCGGCCTGGCACGCCGGGGGTCGCGGGTTCGAGCCCCGTCCGCTGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCAGCGGACGGGGCTCGAACCCGCGACC
Ala_3674from Sinorhizobium fredii, anticodon: GGC, Seq. ID: W121066281
Seq.: GCGGGTGTAGCTCAGTCGGTTAGAGTGCCGGCGTGGCCCGCAGGAGGTCGCGGGTTCGAGCCCCGTCACTCGCGCCA
tREX probe:aaaaaaaaaaaaaTGGCGCGAGTGACGGGGCTCGAACCCGCGACC
Leu_7928from Rhodobacter sphaeroides, anticodon: TAG, Seq. ID: C019351
Seq.: CCTTTCGTAGCTCAGCTGGATAGAGCACCGGTCTTAGAAACCGGAGGTCGCAGGTTCGAGTCCTGCCGGGAGATCCA
tREX probe:aaaaaaaaaaaaaTGGATCTCCCGGCAGGACTCGAACCTGCGACC




Leu_5765from Methanosphaera stadtmanae, anticodon: TAA, Seq. ID: At1577
Seq.: GCAGGGGTGCCCGAGCTGGCCAAAGGGGGTGGACTTAAGATCCTCTGGCGTAGGCCTACGTGGGTTCAAATCCCATCTCCTGCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGCAGGAGATGGGATTTGAACCCACGTAGGCCTACGCC
Leu_13580from Methanothermobacter thermautotrophicus, anticodon: TAG, Seq. ID: At1678
Seq.: GCGGGGGTGCCCGAGCTGGCCAAAGGGGACAGGCTTAGGACCTGTTGGCGTAGGCCTACCAGGGTTCGAATCCCTGCCCCCGCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGCGGGGGCAGGGATTCGAACCCTGGTAGGCCTACGCC
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Leu_10651from Holospora undulata, anticodon: GAG, Seq. ID: W131181822
Seq.: GCGGTCATGGCGAAGCTGGTAGATGCGCAACGTTGAGGTCGTTGTGGGGGAAACCCCAGGGAAGTTCGAATCTTCTTGACCGCACCA
tREX probe:aaaaaaaaaaaaaaaaaTGGTGCGGTCAAGAAGATTCGAACTTCCCTGGGGTTTCCCCC
Leu_220from Streptomyces avermitilis, anticodon: CAA, Seq. ID: C020580
Seq.: GCCCCGGTAGTCCAGCGGTAGAGACACGGTGCTCAAACCACCGACAGCGTCGGTTCGAATCCGACTCGGGGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCCCCGAGTCGGATTCGAACCGACGCTG
Leu_12217from Nocardiopsis gilva, anticodon: TAG, Seq. ID: W131055138
Seq.: GGGGCCGTAGCCCAACAGGTAGAGGCACACGGTTTAGGTCCGTGCCAGCGCGGGTTCGAATCCCGCCGGCCCTACCA
tREX probe:aaaaaaaaaaaaaTGGTAGGGCCGGCGGGATTCGAACCCGCGCTG
Leu_7094from Butyrivibrio sp. XBB1001, anticodon: TAG, Seq. ID: W131233448
Seq.: GCACGAGTGGCGAAGCTGGTAGACGCACCTGACTTAGAATCAGACGCAGTAATGCATGTGGGTTCGAATCCCACCTCGTGTACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTACACGAGGTGGGATTCGAACCCACATGCATTACTGCG




Leu_13688from Nocardioides sp. Iso805N, anticodon: TAG, Seq. ID: W131155928
Seq.: GCGCCCGTAGCCCAACTGGCAGAGGCATACGGTTTAGGTCCGTACCAGCGTGAGTTCGAATCTCACCGGGCGCACCA
tREX probe:aaaaaaaaaaaaaTGGTGCGCCCGGTGAGATTCGAACTCACGCTG
Leu_8822from Opitutus terrae, anticodon: CAG, Seq. ID: C08012631
Seq.: CGGCGAGTGGTGGAGCGTATACACACGAGTCTCAGAAACTCGCGGGCGAAAGCCCATGCAGGTGCAAGTCCTGTCTCGCCGACCA
145
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tREX probe:aaaaaaaaaaaaaaaaaTGGTCGGCGAGACAGGACTTGCACCTGCATGGGCTTTCGCCC
Leu_10255from Pseudopropionibacterium propionicum, anticodon: TAA, Seq. ID: C121002928
Seq.: GCCCCCGTAGCCCAACTGGTAGAGGCAGGCGGCTTAAACCCGCCCCAGTGCGGGTTCGAGTCCCGTCGGGGGTGCCA
tREX probe:aaaaaaaaaaaaaTGGCACCCCCGACGGGACTCGAACCCGCACTG
Leu_7797from Proteobacteria bacterium JGI 0000113-P07, anticodon: TAA, Seq. ID: W131237883
Seq.: GCGGGGGTCGCATAGTCTGGCCAATTGCGCCGGACTTAAGATCCGGTCCTTAGTGGTACGAGGGTTCGAATCCCTCCCCCCGCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGCGGGGGGAGGGATTCGAACCCTCGTACCACTAAGG
Leu_8506from Thermobispora bispora, anticodon: TAG, Seq. ID: C10113113
Seq.: GGGGTCGTAGCCCAACCGGCAGAGGCGACGGTTTTAGGTACCGTACAGCGCGAGTTCGAATCTCGCCGACCCCACCA
tREX probe:aaaaaaaaaaaaaTGGTGGGGTCGGCGAGATTCGAACTCGCGCTG
Leu_6101from Thioalkalivibrio thiocyanodenitrificans, anticodon: TAA, Seq. ID: W131163199
Seq.: GCTCCGGTGGCGAAGCTGGTAGACGCAGGGCACTTAAAATGCCCCGCCGGCAGGCATGCGGGTTCGACTCCCGCCCGGAGCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGCTCCGGGCGGGAGTCGAACCCGCATGCCTGCCGGC
















Leu_6187from Archaeoglobus fulgidus, anticodon: GAG, Seq. ID: At0608
Seq.: GCGGGGGTTGCCGAGCGGACAAAGGCGCAGGATTGAGGGTCCTGTCCCGTAGGGGTTCGAGGGTTCGAATCCCTCCCCCCGCACCA
tREX probe:aaaaaaaaaaaaaaaaTGGTGCGGGGGGAGGGATTCGAACCCTCGAACCCCTACGGG
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D Loop Alignment Table
Below, the alignment of the D loop to the canonical positions 14→21, which was manually generated,
is indicated.
AAAGCA → AA--AGCA AGCTGG → AGCTGG-- AGGGTA → AG--GGTA ATGGTG → AT--GGTG CTGGTA → CT--GGTA
GTGGCA → GT--GGCA AAAAGCA → AAA-AGCA AAAGCAG → AAA-GCAG AAAGGAA → AAA-GGAA AAAGGAT → AAA-GGAT
AAAGGCA → AAA-GGCA AAAGGCC → AAA-GGCC AAAGGCG → AAA-GGCG AAAGGCT → AAA-GGCT AAAGGGA → AAA-GGGA
AAAGGTA → AAA-GGTA AAAGGTG → AAA-GGTG AAAGGTT → AAA-GGTT AACAGCA → AAC-AGCA AACAGGA → AACAGG-A
AACAGGC → AACAGG-C AACAGTA → AAC-AGTA AACGATA → AAC-GATA AACGCAG → AAC-GCAG AACGGAA → AAC-GGAA
AACGGAT → AAC-GGAT AACGGCA → AAC-GGCA AACGGCC → AAC-GGCC AACGGCG → AAC-GGCG AACGGCT → AAC-GGCT
AACGGGA → AAC-GGGA AACGGTA → AAC-GGTA AACGGTC → AAC-GGTC AACGGTG → AAC-GGTG AACGGTT → AAC-GGTT
AACGTAG → AAC-GTAG AACTCTA → AAC-TCTA AACTGCA → AAC-TGCA AACTTTA → AAC-TTTA AAGAGTA → AAG-AGTA
AAGGATA → AA--GGAA AAGGGAA → AAG-GGAA AAGGGAG → AAG-GGAG AAGGGAT → AAG-GGAT AAGGGCA → AAG-GGCA
AAGGGGA → AAG-GGGA AAGGGTA → AAG-GGTA AAGGGTG → AAG-GGTG AAGGGTT → AAG-GGTT AAGGTCA → AA--GGTA
AATAGAA → AAT-AGAA AATAGCA → AAT-AGCA AATAGTA → AAT-AGTA AATAGTG → AAT-AGTG AATGAAG → AAT-GAAG
AATGAGA → AAT-GAGA AATGATA → AAT-GATA AATGATG → AAT-GATG AATGCAG → AAT-GCAG AATGCAT → AAT-GCAT
AATGCTA → AAT-GCTA AATGGAA → AAT-GGAA AATGGAC → AAT-GGAC AATGGAG → AAT-GGAG AATGGAT → AAT-GGAT
AATGGCA → AAT-GGCA AATGGCC → AAT-GGCC AATGGCG → AAT-GGCG AATGGCT → AAT-GGCT AATGGGA → AAT-GGGA
AATGGGT → AAT-GGGT AATGGTA → AAT-GGTA AATGGTC → AAT-GGTC AATGGTG → AAT-GGTG AATGGTT → AAT-GGTT
AATGTAG → AAT-GTAG AATGTTA → AAT-GTTA AATTATA → AAT-TATA AATTCTA → AAT-TCTA AATTGAG → AATTGA-G
AATTGGA → AATTGG-A AATTGGC → AATTGG-C AATTGGT → AATTGG-T AATTTTA → AAT-TTTA ACAGGTA → ACA-GGTA
ACCCGGA → ACCCGG-A ACCGATA → ACC-GATA ACCGGCA → ACC-GGCA ACCGGCC → ACC-GGCC ACCGGTA → ACC-GGTA
ACCGGTC → ACC-GGTC ACCGGTG → ACC-GGTG ACGGCAG → AC--GGCG ACGGGTA → ACG-GGTA ACGGGTG → ACG-GGTG
ACTGGAA → ACT-GGAA ACTGGCA → ACT-GGCA ACTGGCT → ACT-GGCT ACTGGGA → ACT-GGGA ACTGGTA → ACT-GGTA
ACTGGTT → ACT-GGTT AGAAGAT → AGA-AGAT AGAAGCA → AGA-AGCA AGAAGTA → AGA-AGTA AGAAGTC → AGA-AGTC
AGACGTA → AGA-CGTA AGAGAAA → AGA-GAAA AGAGATG → AGA-GATG AGAGGAA → AGA-GGAA AGAGGAT → AGA-GGAT
AGAGGCA → AGA-GGCA AGAGGCC → AGA-GGCC AGAGGCG → AGA-GGCG AGAGGCT → AGA-GGCT AGAGGGA → AGA-GGGA
AGAGGGT → AGA-GGGT AGAGGTA → AGA-GGTA AGAGGTC → AGA-GGTC AGAGGTG → AGA-GGTG AGAGGTT → AGA-GGTT
AGAGTTT → AGA-GTTT AGCAGCA → AGC-AGCA AGCAGCG → AGC-AGCG AGCAGTA → AGC-AGTA AGCAGTT → AGC-AGTT
AGCGACC → AGC-GACC AGCGGAA → AGC-GGAA AGCGGAT → AGC-GGAT AGCGGCA → AGC-GGCA AGCGGCC → AGC-GGCC
AGCGGCG → AGC-GGCG AGCGGCT → AGC-GGCT AGCGGGA → AGC-GGGA AGCGGGG → AGC-GGGG AGCGGGT → AGC-GGGT
AGCGGTA → AGC-GGTA AGCGGTC → AGC-GGTC AGCGGTG → AGC-GGTG AGCGGTT → AGC-GGTT AGCGTAT → AGC-GTAT
AGCGTTA → AGC-GTTA AGCTGAA → AGCTGA-A AGCTGGA → AGCTGG-A AGCTGGG → AGCTGG-G AGCTGGT → AGCTGG-T
AGCTGTA → AGC-TGTA AGGAGCA → AGG-AGCA AGGAGTA → AGG-AGTA AGGGATA → AG--GGAA AGGGGAA → AGG-GGAA
AGGGGCA → AGG-GGCA AGGGGCC → AGG-GGCC AGGGGCT → AGG-GGCT AGGGGGA → AGG-GGGA AGGGGTA → AGG-GGTA
AGGGGTC → AGG-GGTC AGGGGTG → AGG-GGTG AGGGGTT → AGG-GGTT AGGGTTA → AG--GGTA AGNGGTA → AGN-GGTA
AGTAATT → AGT-AATT AGTAGCA → AGT-AGCA AGTAGGT → AGTAGG-T AGTAGTA → AGT-AGTA AGTCCGG → AGT-CCGG
AGTGACA → AGT-GACA AGTGACC → AGT-GACC AGTGATA → AGT-GATA AGTGATC → AGT-GATC AGTGATG → AGT-GATG
AGTGATT → AGT-GATT AGTGCAA → AGT-GCAA AGTGCTA → AGT-GCTA AGTGGAA → AGT-GGAA AGTGGAG → AGT-GGAG
AGTGGAT → AGT-GGAT AGTGGCA → AGT-GGCA AGTGGCC → AGT-GGCC AGTGGCG → AGT-GGCG AGTGGCT → AGT-GGCT
AGTGGGA → AGT-GGGA AGTGGTA → AGT-GGTA AGTGGTC → AGT-GGTC AGTGGTG → AGT-GGTG AGTGGTT → AGT-GGTT
AGTGTTA → AGT-GTTA AGTTAGG → AGTTAG-G AGTTGGA → AGTTGG-A AGTTGGT → AGTTGG-T AGTTGTA → AGTTGT-A
ANCGGTA → ANC-GGTA ANGCGGT → ANGCGG-T ATAGGTA → ATA-GGTA ATAGGTG → ATA-GGTG ATAGGTT → ATA-GGTT
ATCGGAA → ATC-GGAA ATCGGAG → ATC-GGAG ATCGGAT → ATC-GGAT ATCGGCA → ATC-GGCA ATCGGCC → ATC-GGCC
ATCGGCG → ATC-GGCG ATCGGCT → ATC-GGCT ATCGGTA → ATC-GGTA ATCGGTC → ATC-GGTC ATCGGTG → ATC-GGTG
ATCGGTT → ATC-GGTT ATCTGGA → ATCTGG-A ATGGGTA → ATG-GGTA ATGGGTT → ATG-GGTT ATGGTAG → AT--GGTG
ATGGTGC → AT--GGTC ATTGGAA → ATT-GGAA ATTGGAT → ATT-GGAT ATTGGCA → ATT-GGCA ATTGGCT → ATT-GGCT
ATTGGGA → ATT-GGGA ATTGGGG → ATT-GGGG ATTGGTA → ATT-GGTA ATTGGTC → ATT-GGTC ATTGGTG → ATT-GGTG
ATTGGTT → ATT-GGTT CAAAGTA → CAA-AGTA CAAGGCG → CAA-GGCG CAAGGTG → CAA-GGTG CAATGCA → CAA-TGCA
CACGGCG → CAC-GGCG CATGGCG → CAT-GGCG CATGGTG → CAT-GGTG CCAAGTC → CCA-AGTC CCGGTGC → CC--GGTC
CGCGGCC → CGC-GGCC CGCGGTA → CGC-GGTA CGGGGTG → CGG-GGTG CGTGGTA → CGT-GGTA CTGGATG → CT--GGAG
CTGGGAG → CTG-GGAG CTGGTGC → CT--GGTC CTGGTGG → CT--GGTG CTGGTGT → CT--GGTT CTTGGTA → CTT-GGTA
GAAGGAC → GAA-GGAC GAAGGAT → GAA-GGAT GAAGGCG → GAA-GGCG GAAGGTC → GAA-GGTC GACGGCA → GAC-GGCA
GACGGCC → GAC-GGCC GACGGTA → GAC-GGTA GACGGTC → GAC-GGTC GACGGTG → GAC-GGTG GACGGTT → GAC-GGTT
GAGGGAG → GAG-GGAG GAGGGCA → GAG-GGCA GATAGGA → GATAGG-A GATGCAG → GAT-GCAG GATGGAT → GAT-GGAT
GATGGCA → GAT-GGCA GATGGCC → GAT-GGCC GATGGCG → GAT-GGCG GATGGCT → GAT-GGCT GATGGGA → GAT-GGGA
GATGGTA → GAT-GGTA GATGGTG → GAT-GGTG GCAGGCT → GCA-GGCT GCCGGAT → GCC-GGAT GCCGGTA → GCC-GGTA
GCTGGCT → GCT-GGCT GCTGGGA → GCT-GGGA GCTGGTA → GCT-GGTA GGAGGTT → GGA-GGTT GGCGGTA → GGC-GGTA
GGCGGTG → GGC-GGTG GGCGGTT → GGC-GGTT GGGAGCA → GGG-AGCA GGTGGAC → GGT-GGAC GGTGGAT → GGT-GGAT
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GGTGGTA → GGT-GGTA GGTGGTT → GGT-GGTT GGTTGTA → GGT-TGTA GTAGGTT → GTA-GGTT GTCGGTA → GTC-GGTA
GTCGGTT → GTC-GGTT GTGGCAA → GT--GGCA GTGGGAC → GT--GGGC GTGGTAG → GT--GGTG GTTAGAG → GTT-AGAG
GTTGGAT → GTT-GGAT GTTGGTA → GTT-GGTA TAAGGCA → TAA-GGCA TACGGCA → TAC-GGCA TACGGTA → TAC-GGTA
TCAGCTG → TCA-GCTG TCCGGGA → TCC-GGGA TCTGGGA → TCT-GGGA TCTGGTA → TCT-GGTA TGCGGAG → TGC-GGAG
TGCGGCA → TGC-GGCA TGCGGTG → TGC-GGTG TGTAGAT → TGT-AGAT TGTGGTA → TGT-GGTA TGTGGTG → TGT-GGTG
TGTGGTT → TGT-GGTT TTAGAAA → TTA-GAAA TTAGGTA → TTA-GGTA TTTGGCT → TTT-GGCT AAAACATA → AAAACATA
AAAAGCCA → AAAAGCCA AAAAGGGA → AAAAGGGA AAAAGGTA → AAAAGGTA AAACGGAA → AAACGGAA AAACGGCA → AAACGGCA
AAACGGCT → AAACGGCT AAACGGGA → AAACGGGA AAACGGTA → AAACGGTA AAACGTTA → AAACGTTA AAAGGAAA → AAA-GGAA
AAAGGACA → AAA-GGAA AAAGGAGA → AAA-GGAA AAAGGATA → AAA-GGAA AAAGGATC → AAA-GGAC AAAGGATT → AAA-GGAT
AAAGGCAA → AAA-GGCA AAAGGCAG → AAA-GGCG AAAGGCAT → AAA-GGCT AAAGGCCA → AAA-GGCA AAAGGCGA → AAA-GGCA
AAAGGCTA → AAA-GGCA AAAGGGAC → AAAGGGAC AAAGGGAG → AAAGGGAG AAAGGGAT → AAAGGGAT AAAGGTAA → AAA-GGTA
AAAGGTAG → AAA-GGTG AAAGGTCA → AAA-GGTA AAAGGTGA → AAA-GGTA AAAGGTTA → AAA-GGTA AAATCTCA → AAATCTCA
AAATGGAA → AAATGGAA AAATGGAC → AAATGGAC AAATGGAT → AAATGGAT AAATGGCA → AAATGGCA AAATGGCG → AAATGGCG
AAATGGCT → AAATGGCT AAATGGGA → AAATGGGA AAATGGGG → AAATGGGG AAATGGTA → AAATGGTA AAATGGTC → AAATGGTC
AAATGGTG → AAATGGTG AAATGGTT → AAATGGTT AACAGCAG → AACAGCAG AACAGCAT → AACAGCAT AACAGGAA → AACAGGAA
AACAGGCA → AACAGGCA AACAGGGA → AACAGGGA AACAGGTA → AACAGGTA AACAGGTG → AACAGGTG AACAGTAG → AACAGTAG
AACCAGCA → AACCAGCA AACCGGAA → AACCGGAA AACCGGAG → AACCGGAG AACCGGCA → AACCGGCA AACCGGCG → AACCGGCG
AACCGGGA → AACCGGGA AACCGGTA → AACCGGTA AACGAATA → AAC-GAAA AACGAGCA → AAC-GAGA AACGATGA → AAC-GATA
AACGATTA → AAC-GATA AACGATTT → AAC-GATT AACGCTCA → AAC-GCTA AACGGAAA → AAC-GGAA AACGGAAG → AAC-GGAG
AACGGAAT → AAC-GGAT AACGGACA → AAC-GGAA AACGGACG → AAC-GGAG AACGGAGA → AAC-GGAA AACGGATA → AAC-GGAA
AACGGATC → AAC-GGAC AACGGATT → AAC-GGAT AACGGCAA → AAC-GGCA AACGGCAG → AAC-GGCG AACGGCAT → AAC-GGCT
AACGGCCA → AAC-GGCA AACGGCCG → AAC-GGCG AACGGCGA → AAC-GGCA AACGGCTA → AAC-GGCA AACGGCTG → AAC-GGCG
AACGGCTT → AAC-GGCT AACGGGAA → AACGGGAA AACGGGAC → AACGGGAC AACGGGAG → AACGGGAG AACGGGCA → AACGGGCA
AACGGGCT → AACGGGCT AACGGGTA → AACGGGTA AACGGTAA → AAC-GGTA AACGGTAG → AAC-GGTG AACGGTAT → AAC-GGTT
AACGGTCA → AAC-GGTA AACGGTGA → AAC-GGTA AACGGTTA → AAC-GGTA AACGGTTC → AAC-GGTC AACGGTTG → AAC-GGTG
AACGGTTT → AAC-GGTT AACTCTAA → AACTCTAA AACTCTCA → AACTCTCA AACTCTTA → AACTCTTA AACTGATA → AACTGATA
AACTGCCA → AACTGCCA AACTGGAA → AACTGGAA AACTGGAC → AACTGGAC AACTGGAT → AACTGGAT AACTGGCA → AACTGGCA
AACTGGCC → AACTGGCC AACTGGCG → AACTGGCG AACTGGCT → AACTGGCT AACTGGGA → AACTGGGA AACTGGGT → AACTGGGT
AACTGGTA → AACTGGTA AACTGGTC → AACTGGTC AACTGGTT → AACTGGTT AACTGTCA → AACTGTCA AACTGTTA → AACTGTTA
AACTTGTA → AACTTGTA AACTTTCA → AACTTTCA AACTTTTA → AACTTTTA AAGAGCTA → AAGAGCTA AAGAGTTA → AAGAGTTA
AAGCGGAA → AAGCGGAA AAGCGGCA → AAGCGGCA AAGCGGTA → AAGCGGTA AAGGGAAA → AAG-GGAA AAGGGACA → AAG-GGAA
AAGGGACT → AAG-GGAT AAGGGATA → AAG-GGAA AAGGGATG → AAG-GGAG AAGGGCAG → AAG-GGCG AAGGGCAT → AAG-GGCT
AAGGGCTA → AAG-GGCA AAGGGCTG → AAG-GGCG AAGGGCTT → AAG-GGCT AAGGGGTA → AAGGGGTA AAGGGTAA → AAG-GGTA
AAGGGTAG → AAG-GGTG AAGGGTTA → AAG-GGTA AAGTGGAA → AAGTGGAA AAGTGGAT → AAGTGGAT AAGTGGCA → AAGTGGCA
AAGTGGCG → AAGTGGCG AAGTGGGA → AAGTGGGA AAGTGGTA → AAGTGGTA AAGTGGTT → AAGTGGTT AANTGGTA → AANTGGTA
AATAGAAA → AATAGAAA AATAGCAG → AATAGCAG AATAGCCA → AATAGCCA AATAGCTA → AATAGCTA AATAGGAA → AATAGGAA
AATAGGCA → AATAGGCA AATAGGGA → AATAGGGA AATAGGTA → AATAGGTA AATAGTCA → AATAGTCA AATAGTTA → AATAGTTA
AATCAGCA → AATCAGCA AATCGCTA → AATCGCTA AATCGGAA → AATCGGAA AATCGGCA → AATCGGCA AATCGGGA → AATCGGGA
AATCGGTA → AATCGGTA AATCGGTG → AATCGGTG AATGAATA → AAT-GAAA AATGACCA → AAT-GACA AATGACTA → AAT-GACA
AATGATTA → AAT-GATA AATGGAAA → AAT-GGAA AATGGAAC → AAT-GGAC AATGGAAG → AAT-GGAG AATGGAAT → AAT-GGAT
AATGGACA → AAT-GGAA AATGGAGA → AAT-GGAA AATGGAGC → AAT-GGAC AATGGATA → AAT-GGAA AATGGATC → AAT-GGAC
AATGGATG → AAT-GGAG AATGGATT → AAT-GGAT AATGGCAA → AAT-GGCA AATGGCAG → AAT-GGCG AATGGCAT → AAT-GGCT
AATGGCCA → AAT-GGCA AATGGCGA → AAT-GGCA AATGGCGG → AAT-GGCG AATGGCTA → AAT-GGCA AATGGCTC → AAT-GGCC
AATGGCTG → AAT-GGCG AATGGCTT → AAT-GGCT AATGGGAA → AATGGGAA AATGGGAG → AATGGGAG AATGGGAT → AATGGGAT
AATGGGCA → AATGGGCA AATGGGGA → AATGGGGA AATGGGTA → AAT-GGGA AATGGTAA → AAT-GGTA AATGGTAG → AAT-GGTG
AATGGTAT → AAT-GGTT AATGGTCA → AAT-GGTA AATGGTGA → AAT-GGTA AATGGTGT → AAT-GGTT AATGGTTA → AAT-GGTA
AATGGTTC → AAT-GGTC AATGGTTG → AAT-GGTG AATGGTTT → AAT-GGTT AATGTCAG → AAT-GTCG AATGTCTA → AAT-GTCA
AATGTGTA → AATGTGTA AATTACAA → AATTACAA AATTACCA → AATTACCA AATTAGCA → AATTAGCA AATTAGTA → AATTAGTA
AATTCTTA → AATTCTTA AATTGACA → AATTGACA AATTGATA → AATTGATA AATTGCAG → AATTGCAG AATTGGAA → AATTGGAA
AATTGGAT → AATTGGAT AATTGGCA → AATTGGCA AATTGGCG → AATTGGCG AATTGGCT → AATTGGCT AATTGGGA → AATTGGGA
AATTGGTA → AATTGGTA AATTGGTC → AATTGGTC AATTGGTG → AATTGGTG AATTGGTT → AATTGGTT AATTGTTA → AATTGTTA
AATTTCTA → AATTTCTA AATTTGTA → AATTTGTA AATTTTTA → AATTTTTA ACAAGGTA → ACAAGGTA ACAGGCAG → ACA-GGCG
ACAGGTTA → ACA-GGTA ACCAGGCA → ACCAGGCA ACCAGGTA → ACCAGGTA ACCCGGCA → ACCCGGCA ACCCGGTA → ACCCGGTA
ACCCGGTG → ACCCGGTG ACCGGCGA → ACC-GGCA ACCGGCTA → ACC-GGCA ACCGGGAA → ACCGGGAA ACCGGGTA → ACCGGGTA
ACCGGTCA → ACC-GGTA ACCGGTGA → ACC-GGTA ACCGGTGT → ACC-GGTT ACCGGTTA → ACC-GGTA ACCTGGCA → ACCTGGCA
ACCTGGCT → ACCTGGCT ACCTGGGA → ACCTGGGA ACCTGGTA → ACCTGGTA ACCTGGTT → ACCTGGTT ACGAGGTA → ACGAGGTA
ACGCGGTA → ACGCGGTA ACGGGATA → ACG-GGAA ACGGGTTA → ACG-GGTA ACGTGGAA → ACGTGGAA ACTAGGCA → ACTAGGCA
ACTAGGTA → ACTAGGTA ACTCGGTA → ACTCGGTA ACTGGAGA → ACT-GGAA ACTGGATA → ACT-GGAA ACTGGCAG → ACT-GGCG
ACTGGCGT → ACT-GGCT ACTGGCTA → ACT-GGCA ACTGGGGT → ACTGGGGT ACTGGTAA → ACT-GGTA ACTGGTGT → ACT-GGTT
ACTGGTTT → ACT-GGTT ACTTGGCA → ACTTGGCA ACTTGGGA → ACTTGGGA ACTTGGTA → ACTTGGTA AGAAGCTC → AGAAGCTC
AGAAGGAA → AGAAGGAA AGAAGGTA → AGAAGGTA AGACGGAA → AGACGGAA AGACGGCA → AGACGGCA AGACGGGA → AGACGGGA
AGACGGTA → AGACGGTA AGACGGTC → AGACGGTC AGACGTTT → AGACGTTT AGAGAGAT → AGA-GAGT AGAGCCTA → AGA-GCCA
AGAGGAAA → AGA-GGAA AGAGGACA → AGA-GGAA AGAGGAGA → AGA-GGAA AGAGGATA → AGA-GGAA AGAGGATC → AGA-GGAC
AGAGGCAA → AGA-GGCA AGAGGCAG → AGA-GGCG AGAGGCCA → AGA-GGCA AGAGGCCC → AGA-GGCC AGAGGCCG → AGA-GGCG
AGAGGCCT → AGA-GGCT AGAGGCGG → AGA-GGCG AGAGGCTA → AGA-GGCA AGAGGCTC → AGA-GGCC AGAGGCTG → AGA-GGCG
AGAGGCTT → AGA-GGCT AGAGGGTA → AGA-GGGA AGAGGTAA → AGA-GGTA AGAGGTAG → AGA-GGTG AGAGGTCA → AGA-GGTA
AGAGGTCG → AGA-GGTG AGAGGTGA → AGA-GGTA AGAGGTGG → AGA-GGTG AGAGGTTA → AGA-GGTA AGAGGTTC → AGA-GGTC
AGAGGTTG → AGA-GGTG AGAGGTTT → AGA-GGTT AGAGTGTA → AGAGTGTA AGATAGCA → AGATAGCA AGATCGGA → AGATGG-A
AGATGGAA → AGATGGAA AGATGGAG → AGATGGAG AGATGGAT → AGATGGAT AGATGGCA → AGATGGCA AGATGGGA → AGATGGGA
AGATGGTA → AGATGGTA AGATGGTC → AGATGGTC AGATGGTT → AGATGGTT AGCAGCAA → AGCAGCAA AGCAGCCA → AGCAGCCA
AGCAGCGA → AGCAGCGA AGCAGCTA → AGCAGCTA AGCAGCTC → AGCAGCTC AGCAGGAA → AGCAGGAA AGCAGGCA → AGCAGGCA
AGCAGGCG → AGCAGGCG AGCAGGGA → AGCAGGGA AGCAGGTA → AGCAGGTA AGCAGGTG → AGCAGGTG AGCAGTCA → AGCAGTCA
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AGCAGTGA → AGCAGTGA AGCCAGGA → AGCCGG-A AGCCGGAA → AGCCGGAA AGCCGGCA → AGCCGGCA AGCCGGCG → AGCCGGCG
AGCCGGGA → AGCCGGGA AGCCGGTA → AGCCGGTA AGCCTGGA → AGCCGG-A AGCCTGGC → AGCCGG-C AGCCTGGT → AGCCGG-T
AGCCTGTA → AGCCTGTA AGCGAACA → AGC-GAAA AGCGAGAA → AGC-GAGA AGCGATTA → AGC-GATA AGCGCACA → AGC-GCAA
AGCGGAAA → AGC-GGAA AGCGGAAC → AGC-GGAC AGCGGAAG → AGC-GGAG AGCGGAAT → AGC-GGAT AGCGGACA → AGC-GGAA
AGCGGAGA → AGC-GGAA AGCGGAGT → AGC-GGAT AGCGGATA → AGC-GGAA AGCGGATC → AGC-GGAC AGCGGATG → AGC-GGAG
AGCGGATT → AGC-GGAT AGCGGCAA → AGC-GGCA AGCGGCAC → AGC-GGCC AGCGGCAG → AGC-GGCG AGCGGCCA → AGC-GGCA
AGCGGCCC → AGC-GGCC AGCGGCGA → AGC-GGCA AGCGGCTA → AGC-GGCA AGCGGCTC → AGC-GGCC AGCGGCTG → AGC-GGCG
AGCGGCTT → AGC-GGCT AGCGGGAG → AGCGGGAG AGCGGGCA → AGCGGGCA AGCGGGGA → AGCGGGGA AGCGGGTA → AGC-GGGA
AGCGGGTG → AGC-GGGG AGCGGTAA → AGC-GGTA AGCGGTAC → AGC-GGTC AGCGGTAG → AGC-GGTG AGCGGTCA → AGC-GGTA
AGCGGTCG → AGC-GGTG AGCGGTGA → AGC-GGTA AGCGGTGG → AGC-GGTG AGCGGTGT → AGC-GGTT AGCGGTTA → AGC-GGTA
AGCGGTTC → AGC-GGTC AGCGGTTG → AGC-GGTG AGCGGTTT → AGC-GGTT AGCGTAGA → AGC-GTAA AGCGTGTA → AGCGTGTA
AGCTAGTA → AGCTAGTA AGCTGAGA → AGCTGAGA AGCTGATA → AGCTGATA AGCTGGAA → AGCTGGAA AGCTGGAG → AGCTGGAG
AGCTGGCA → AGCTGGCA AGCTGGCT → AGCTGGCT AGCTGGGA → AGCTGGGA AGCTGGGC → AGCTGGGC AGCTGGGG → AGCTGGGG
AGCTGGGT → AGCTGGGT AGCTGGTA → AGCTGGTA AGCTGGTG → AGCTGGTG AGCTGGTN → AGCTGGTN AGCTGGTT → AGCTGGTT
AGCTGTGA → AGCTGTGA AGCTGTTA → AGCTGTTA AGCTTGGA → AGCTGG-A AGGAGATA → AGGAGATA AGGAGGAA → AGGAGGAA
AGGAGGCA → AGGAGGCA AGGAGGTA → AGGAGGTA AGGCAGCG → AGGCAGCG AGGCAGTA → AGGCAGTA AGGCGGCA → AGGCGGCA
AGGCGGGA → AGGCGGGA AGGCGGTA → AGGCGGTA AGGCGGTG → AGGCGGTG AGGCGGTT → AGGCGGTT AGGGCTTA → AG--GGCA
AGGGGAAA → AGG-GGAA AGGGGACA → AGG-GGAA AGGGGAGA → AGG-GGAA AGGGGATA → AGG-GGAA AGGGGCAG → AGG-GGCG
AGGGGCCA → AGG-GGCA AGGGGCGG → AGG-GGCG AGGGGCTA → AGG-GGCA AGGGGCTT → AGG-GGCT AGGGGGAA → AGGGGGAA
AGGGGGAC → AGGGGGAC AGGGGGAT → AGGGGGAT AGGGGGCA → AGGGGGCA AGGGGGTA → AGGGGGTA AGGGGTAA → AGG-GGTA
AGGGGTAC → AGG-GGTC AGGGGTCA → AGG-GGTA AGGGGTGA → AGG-GGTA AGGGGTTA → AGG-GGTA AGGGGTTT → AGG-GGTT
AGGGTTTA → AG--GGTA AGGNGGTA → AGGNGGTA AGGTAGTA → AGGTAGTA AGGTGGAA → AGGTGGAA AGGTGGCA → AGGTGGCA
AGGTGGCG → AGGTGGCG AGGTGGCT → AGGTGGCT AGGTGGGA → AGGTGGGA AGGTGGTA → AGGTGGTA AGGTGGTC → AGGTGGTC
AGGTGGTG → AGGTGGTG AGGTGGTT → AGGTGGTT AGGTGTGA → AGGTGTGA AGKTGGTA → AGKTGGTA AGNTGGGA → AGNTGGGA
AGNTGGTA → AGNTGGTA AGTAGAGA → AGTAGAGA AGTAGCAA → AGTAGCAA AGTAGCTA → AGTAGCTA AGTAGGAA → AGTAGGAA
AGTAGGAG → AGTAGGAG AGTAGGCA → AGTAGGCA AGTAGGCG → AGTAGGCG AGTAGGGA → AGTAGGGA AGTAGGTA → AGTAGGTA
AGTAGGTG → AGTAGGTG AGTAGGTT → AGTAGGTT AGTAGTAA → AGTAGTAA AGTAGTCA → AGTAGTCA AGTAGTTA → AGTAGTTA
AGTATGGA → AGTAGG-A AGTCAGCA → AGTCGC-A AGTCAGTA → AGTCGT-A AGTCCGTA → AGTCGT-A AGTCGACA → AGTCGACA
AGTCGATA → AGTCGATA AGTCGCTA → AGTCGCTA AGTCGGAA → AGTCGGAA AGTCGGCA → AGTCGGCA AGTCGGCG → AGTCGGCG
AGTCGGGA → AGTCGGGA AGTCGGTA → AGTCGGTA AGTCGGTG → AGTCGGTG AGTCGGTT → AGTCGGTT AGTCTGTA → AGTCTGTA
AGTGAATA → AGT-GAAA AGTGATTA → AGT-GATA AGTGATTT → AGT-GATT AGTGCCAA → AGT-GCCA AGTGCGTA → AGT-GCGA
AGTGCTCA → AGT-GCTA AGTGCTGA → AGT-GCTA AGTGGAAA → AGT-GGAA AGTGGAAC → AGT-GGAC AGTGGAAT → AGT-GGAT
AGTGGACA → AGT-GGAA AGTGGACG → AGT-GGAG AGTGGAGA → AGT-GGAA AGTGGAGC → AGT-GGAC AGTGGAGT → AGT-GGAT
AGTGGATA → AGT-GGAA AGTGGATC → AGT-GGAC AGTGGATG → AGT-GGAG AGTGGATT → AGT-GGAT AGTGGCAA → AGT-GGCA
AGTGGCAC → AGT-GGCC AGTGGCAG → AGT-GGCG AGTGGCCA → AGT-GGCA AGTGGCCC → AGT-GGCC AGTGGCCG → AGT-GGCG
AGTGGCCT → AGT-GGCT AGTGGCGA → AGT-GGCA AGTGGCTA → AGT-GGCA AGTGGCTC → AGT-GGCC AGTGGCTG → AGT-GGCG
AGTGGCTT → AGT-GGCT AGTGGGAA → AGTGGGAA AGTGGGAT → AGTGGGAT AGTGGGCA → AGTGGGCA AGTGGGCT → AGTGGGCT
AGTGGGGA → AGTGGGGA AGTGGGTA → AGTGGGTA AGTGGTAA → AGT-GGTA AGTGGTAG → AGT-GGTG AGTGGTAT → AGT-GGTT
AGTGGTCA → AGT-GGTA AGTGGTCG → AGT-GGTG AGTGGTCT → AGT-GGTT AGTGGTGA → AGT-GGTA AGTGGTTA → AGT-GGTA
AGTGGTTC → AGT-GGTC AGTGGTTG → AGT-GGTG AGTGGTTT → AGT-GGTT AGTGTCTA → AGT-GTCA AGTGTTCA → AGT-GTTA
AGTGTTTA → AGT-GTTA AGTTAGAA → AGTTAGAA AGTTAGCA → AGTTAGCA AGTTAGGA → AGTTGG-A AGTTAGTA → AGTTAGTA
AGTTCGTA → AGTTCGTA AGTTGATA → AGTTGATA AGTTGCTA → AGTTGCTA AGTTGGAA → AGTTGGAA AGTTGGCA → AGTTGGCA
AGTTGGGA → AGTTGGGA AGTTGGGT → AGTTGGGT AGTTGGTA → AGTTGGTA AGTTGGTC → AGTTGGTC AGTTGGTG → AGTTGGTG
AGTTGGTT → AGTTGGTT AGTTGTAA → AGTTGTAA AGTTGTTA → AGTTGTTA AGTTTGTA → AGTTTGTA AGTYGGGA → AGTYGGGA
ATAAGGTA → ATAAGGTA ATACGGAA → ATACGGAA ATACGGTA → ATACGGTA ATAGGTGA → ATA-GGTA ATAGGTGG → ATA-GGTG
ATAGGTTA → ATA-GGTA ATATGGAA → ATATGGAA ATATGGAC → ATATGGAC ATATGGAT → ATATGGAT ATATGGTA → ATATGGTA
ATCAGGAA → ATCAGGAA ATCAGGGA → ATCAGGGA ATCAGGTA → ATCAGGTA ATCAGTTA → ATCAGTTA ATCCGGCA → ATCCGGCA
ATCCGGTA → ATCCGGTA ATCGGAAA → ATC-GGAA ATCGGATA → ATC-GGAA ATCGGCAG → ATC-GGCG ATCGGCCA → ATC-GGCA
ATCGGCGA → ATC-GGCA ATCGGCTA → ATC-GGCA ATCGGCTC → ATC-GGCC ATCGGGAA → ATCGGGAA ATCGGGTA → ATCGGGTA
ATCGGGTC → ATCGGGTC ATCGGTCA → ATC-GGTA ATCGGTGT → ATC-GGTT ATCGGTTA → ATC-GGTA ATCGGTTG → ATC-GGTG
ATCGGTTT → ATC-GGTT ATCTGGCA → ATCTGGCA ATCTGGCG → ATCTGGCG ATCTGGGA → ATCTGGGA ATCTGGTA → ATCTGGTA
ATGCGGTA → ATGCGGTA ATGCGGTT → ATGCGGTT ATGGGAGA → ATG-GGAA ATGGGCTA → ATG-GGCA ATGGGGTA → ATGGGGTA
ATGGGTTA → ATG-GGTA ATGGGTTC → ATG-GGTC ATGTGGAA → ATGTGGAA ATGTGGAT → ATGTGGAT ATGTGGTG → ATGTGGTG
ATTAGGAA → ATTAGGAA ATTAGGTA → ATTAGGTA ATTCGGAA → ATTCGGAA ATTCGGTA → ATTCGGTA ATTGCTCA → ATT-GCTA
ATTGGAGA → ATT-GGAA ATTGGATA → ATT-GGAA ATTGGCAC → ATT-GGCC ATTGGCAG → ATT-GGCG ATTGGCGA → ATT-GGCA
ATTGGCGT → ATT-GGCT ATTGGCTA → ATT-GGCA ATTGGGTA → ATT-GGGA ATTGGTAA → ATT-GGTA ATTGGTAT → ATT-GGTT
ATTGGTTA → ATT-GGTA ATTGGTTC → ATT-GGTC ATTTGGCA → ATTTGGCA ATTTGGGA → ATTTGGGA ATTTGGTA → ATTTGGTA
CAAAGGTA → CAAAGGTA CAACAGCA → CAACAGCA CAACGGCA → CAACGGCA CAACGGCG → CAACGGCG CAACGGCT → CAACGGCT
CAACGGGA → CAACGGGA CAACGGTA → CAACGGTA CAACGGTG → CAACGGTG CAAGGGAG → CAAGGGAG CAAGGGCA → CAAGGGCA
CAAGGTAA → CAA-GGTA CAATGATA → CAATGATA CAATGGCA → CAATGGCA CAATGGGA → CAATGGGA CAATGGGG → CAATGGGG
CAATGGTA → CAATGGTA CAATGGTG → CAATGGTG CACGGCGA → CAC-GGCA CAGCGGCA → CAGCGGCA CAGCGGGA → CAGCGGGA
CAGCGGTA → CAGCGGTA CAGGGGTA → CAGGGGTA CAGTGGTA → CAGTGGTA CAGTGGTG → CAGTGGTG CATAGGAG → CATAGGAG
CATGGCGA → CAT-GGCA CATGGTAG → CAT-GGTG CCCGGCGG → CCC-GGCG CCCGGTGG → CCC-GGTG CCTGGTGA → CCT-GGTA
CCTGGTGG → CCT-GGTG CGATGGCA → CGATGGCA CGATGGGG → CGATGGGG CGCAGGTA → CGCAGGTA CGCGGTCA → CGC-GGTA
CGTAGGTA → CGTAGGTA CGTCGGTA → CGTCGGTA CGTGGTTA → CGT-GGTA CGTTGGCA → CGTTGGCA CGTTGGTA → CGTTGGTA
CGTTTGTA → CGTTTGTA CTCGGTAG → CTC-GGTG CTGGGAGA → CTG-GGAA CTGTGGAG → CTGTGGAG CTGTGGTG → CTGTGGTG
CTTGGTGA → CTT-GGTA CTTTGGCG → CTTTGGCG GAACGGTA → GAACGGTA GAAGGCTC → GAA-GGCC GAAGGGAC → GAAGGGAC
GAAGGTTC → GAA-GGTC GAATGGAC → GAATGGAC GAATGGCA → GAATGGCA GAATGGTA → GAATGGTA GACAGGTA → GACAGGTA
GACGGACA → GAC-GGAA GACGGCTA → GAC-GGCA GACGGTTA → GAC-GGTA GACGGTTC → GAC-GGTC GACTGGAC → GACTGGAC
GACTGGCA → GACTGGCA GACTGGTG → GACTGGTG GAGAGGTT → GAGAGGTT GAGCGGCA → GAGCGGCA GAGCGGTA → GAGCGGTA
GAGGCCTA → GA--GGCA GAGGGAAA → GAG-GGAA GAGGGGTT → GAGGGGTT GAGGGTTT → GAG-GGTT GAGTGGAG → GAGTGGAG
GAGTGGTA → GAGTGGTA GATCGGTC → GATCGGTC GATGGACA → GAT-GGAA GATGGATA → GAT-GGAA GATGGCTG → GAT-GGCG
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GATGGGAC → GAT-GGGC GATGGTTG → GAT-GGTG GATGGTTT → GAT-GGTT GCCGCGGC → GCCGGG-C GCCGGAAC → GCC-GGAC
GCCGGCAT → GCC-GGCT GCCGGTGA → GCC-GGTA GCCGGTGC → GCC-GGTC GCCGGTGT → GCC-GGTT GCCTGGTA → GCCTGGTA
GCCTGGTG → GCCTGGTG GCTCGGCG → GCTCGGCG GCTGGATA → GCT-GGAA GCTGGCCG → GCT-GGCG GCTGGCGA → GCT-GGCA
GCTGGCGC → GCT-GGCC GCTGGGTA → GCT-GGGA GCTGGTAA → GCT-GGTA GCTGGTGA → GCT-GGTA GCTGGTGC → GCT-GGTC
GCTGGTGT → GCT-GGTT GCTGGTTG → GCT-GGTG GGAGGCAG → GGA-GGCG GGAGGTCC → GGA-GGTC GGCGGATA → GGC-GGAA
GGCGGCAA → GGC-GGCA GGCGGCTA → GGC-GGCA GGCGGTCC → GGC-GGTC GGCGGTCT → GGC-GGTT GGCTGGGA → GGCTGGGA
GGGCGGAC → GGGCGGAC GGGGCTTT → GG--GGCT GGGGGAAA → GGG-GGAA GGGGTTTA → GG--GGTA GGGTGGGA → GGGTGGGA
GGGTGGTA → GGGTGGTA GGTGGAAA → GGT-GGAA GGTGGGTA → GGT-GGGA GGTGGTCC → GGT-GGTC GGTGGTCT → GGT-GGTT
GGTGGTTA → GGT-GGTA GGTTGGCA → GGTTGGCA GGTTGGTA → GGTTGGTA GGTTGGTC → GGTTGGTC GGTTGGTT → GGTTGGTT
GTCGGTTT → GTC-GGTT GTGAGGAG → GTGAGGAG GTGAGGGG → GTGAGGGG GTGGCTGA → GT--GGCA GTTGGCAG → GTT-GGCG
GTTGGTGC → GTT-GGTC GTTGGTTA → GTT-GGTA NGTCGGTA → NGTCGGTA RGGGGTTA → RGG-GGTA TAAAGGTA → TAAAGGTA
TAACGGCA → TAACGGCA TAACGGCT → TAACGGCT TAACGGGA → TAACGGGA TAACGGTA → TAACGGTA TAAGGCAA → TAA-GGCA
TAATGGAA → TAATGGAA TAATGGCA → TAATGGCA TAATGGGA → TAATGGGA TAATGGTA → TAATGGTA TACCGGAA → TACCGGAA
TACTGGCT → TACTGGCT TAGCGGTA → TAGCGGTA TAGTGGAA → TAGTGGAA TAGTGGCA → TAGTGGCA TAGTGGCG → TAGTGGCG
TAGTGGTA → TAGTGGTA TATCGGCA → TATCGGCA TCAGTGGT → TCAGGG-T TCCGGGCA → TCCGGGCA TCCGGGGA → TCCGGGGA
TCCGGTGA → TCC-GGTA TCCGGTGG → TCC-GGTG TCGGGTGA → TCG-GGTA TCTGGCGA → TCT-GGCA TCTGGGAA → TCTGGGAA
TCTGGTGA → TCT-GGTA TCTGGTGG → TCT-GGTG TCTGGTGT → TCT-GGTT TGATGGCG → TGATGGCG TGATGGTT → TGATGGTT
TGCAGGCG → TGCAGGCG TGCCGGCA → TGCCGGCA TGCGGCAA → TGC-GGCA TGCTGGCG → TGCTGGCG TGCTGGGA → TGCTGGGA
TGGCGGCG → TGGCGGCG TGTCGGCG → TGTCGGCG TGTCGGTA → TGTCGGTA TGTCGGTG → TGTCGGTG TGTGGGAA → TGTGGGAA
TGTGGTTA → TGT-GGTA TGTTGGCG → TGTTGGCG TGTTGGTA → TGTTGGTA TGTTGGTG → TGTTGGTG TTACGGAT → TTACGGAT
TTATGGAT → TTATGGAT TTCGGCAA → TTC-GGCA TTGCGGAG → TTGCGGAG TTTGGCAA → TTT-GGCA TTTGGGAA → TTTGGGAA
TTTGGTAA → TTT-GGTA TTTTGGTT → TTTTGGTT AAAAGGACA → AAAAGGAA AAAAGGATA → AAAAGGAA AAAAGGTAG → AAAAGGTG
AAAAGGTGT → AAAAGGTT AAAAGGTTA → AAAAGGTA AAACAGCAG → AAACAGCG AAACGGAGA → AAACGGAA AAACGGATA → AAACGGAA
AAACGGCAA → AAACGGCA AAACGGCAG → AAACGGCG AAACGGCTA → AAACGGCA AAACGGGAG → AAACGGGG AAACGGTAA → AAACGGTA
AAACGGTAG → AAACGGTG AAACGGTCA → AAACGGTA AAACGGTTA → AAACGGTA AAACGTGTA → AAACGTGA AAAGGAATA → AAA-GGAA
AAAGGATCA → AAA-GGAA AAAGGCAGG → AAA-GGCG AAAGGCTAA → AAA-GGCA AAAGGCTAG → AAA-GGCG AAAGGCTTA → AAA-GGCA
AAAGGGAAG → AAAGGGAG AAAGGGATA → AAAGGGAA AAAGGGTTA → AAAGGGTA AAAGGGTTC → AAAGGGTC AAAGGTATA → AAA-GGTA
AAAGGTTTA → AAA-GGTA AAAGTGGTT → AAAGGGTT AAATAGGTA → AAATGGTA AAATGGAAA → AAATGGAA AAATGGAAG → AAATGGAG
AAATGGACA → AAATGGAA AAATGGAGA → AAATGGAA AAATGGAGG → AAATGGAG AAATGGATA → AAATGGAA AAATGGATT → AAATGGAT
AAATGGCAA → AAATGGCA AAATGGCAG → AAATGGCG AAATGGCAT → AAATGGCT AAATGGCCA → AAATGGCA AAATGGCTA → AAATGGCA
AAATGGGAG → AAATGGGG AAATGGTAA → AAATGGTA AAATGGTAG → AAATGGTG AAATGGTAT → AAATGGTT AAATGGTCA → AAATGGTA
AAATGGTGA → AAATGGTA AAATGGTTA → AAATGGTA AAATTGGTA → AAATGGTA AACAAGCAA → AACAGCAA AACAAGCCA → AACAGCCA
AACAAGGTA → AACAGGTA AACAGATCA → AACAGATA AACAGCGCA → AACAGCGA AACAGGAAG → AACAGGAG AACAGGACA → AACAGGAA
AACAGGAGA → AACAGGAA AACAGGATA → AACAGGAA AACAGGCAA → AACAGGCA AACAGGCAG → AACAGGCG AACAGGCAT → AACAGGCT
AACAGGCCA → AACAGGCA AACAGGCGA → AACAGGCA AACAGGCTA → AACAGGCA AACAGGCTG → AACAGGCG AACAGGGAT → AACAGGGT
AACAGGTAA → AACAGGTA AACAGGTAG → AACAGGTG AACAGGTAT → AACAGGTT AACAGGTCA → AACAGGTA AACAGGTGA → AACAGGTA
AACAGGTTA → AACAGGTA AACAGGTTG → AACAGGTG AACAGTGAA → AACAGTGA AACAGTTCA → AACAGTTA AACATGGAA → AACAGGAA
AACATGGCA → AACAGGCA AACATGGTA → AACAGGTA AACATGTCA → AACAGTCA AACCAGGCA → AACCGGCA AACCCGATA → AACCGATA
AACCCGGCA → AACCGGCA AACCGCGCA → AACCGCGA AACCGGAAA → AACCGGAA AACCGGAAG → AACCGGAG AACCGGACA → AACCGGAA
AACCGGAGA → AACCGGAA AACCGGATA → AACCGGAA AACCGGCAA → AACCGGCA AACCGGCAG → AACCGGCG AACCGGCAT → AACCGGCT
AACCGGCCG → AACCGGCG AACCGGCTA → AACCGGCA AACCGGGAG → AACCGGGG AACCGGTAA → AACCGGTA AACCGGTAG → AACCGGTG
AACCGGTAT → AACCGGTT AACCGGTCA → AACCGGTA AACCGGTGA → AACCGGTA AACCGGTTA → AACCGGTA AACCGGTTG → AACCGGTG
AACCTGGCA → AACCGGCA AACCTGGTA → AACCGGTA AACCTGGTC → AACCGGTC AACCTGGTG → AACCGGTG AACGAGGCA → AAC-GAGA
AACGGAAGA → AAC-GGAA AACGGAATA → AAC-GGAA AACGGACGA → AAC-GGAA AACGGATCA → AAC-GGAA AACGGATGA → AAC-GGAA
AACGGATTA → AAC-GGAA AACGGCAAG → AAC-GGCG AACGGCAGG → AAC-GGCG AACGGCTCA → AAC-GGCA AACGGCTGA → AAC-GGCA
AACGGCTTA → AAC-GGCA AACGGGAGA → AACGGGAA AACGGGATA → AACGGGAA AACGGGCAG → AACGGGCG AACGGGGAT → AACGGGGT
AACGGGTAA → AACGGGTA AACGGGTAG → AACGGGTG AACGGGTTA → AACGGGTA AACGGTTAG → AAC-GGTG AACGGTTCA → AAC-GGTA
AACGGTTGA → AAC-GGTA AACGGTTTA → AAC-GGTA AACTAGATA → AACTGATA AACTAGCAG → AACTGCAG AACTAGGCA → AACTGGCA
AACTAGGTA → AACTGGTA AACTCGGAA → AACTGGAA AACTCGGCA → AACTGGCA AACTGAATA → AACTGAAA AACTGAGTA → AACTGAGA
AACTGGAAA → AACTGGAA AACTGGAAC → AACTGGAC AACTGGAAG → AACTGGAG AACTGGAAT → AACTGGAT AACTGGACA → AACTGGAA
AACTGGAGA → AACTGGAA AACTGGAGT → AACTGGAT AACTGGATA → AACTGGAA AACTGGATT → AACTGGAT AACTGGCAA → AACTGGCA
AACTGGCAC → AACTGGCC AACTGGCAG → AACTGGCG AACTGGCAT → AACTGGCT AACTGGCCA → AACTGGCA AACTGGCCG → AACTGGCG
AACTGGCCT → AACTGGCT AACTGGCTA → AACTGGCA AACTGGCTG → AACTGGCG AACTGGGAA → AACTGGGA AACTGGGAG → AACTGGGG
AACTGGGAT → AACTGGGT AACTGGGTA → AACTGGGA AACTGGTAA → AACTGGTA AACTGGTAC → AACTGGTC AACTGGTAG → AACTGGTG
AACTGGTAT → AACTGGTT AACTGGTCA → AACTGGTA AACTGGTCG → AACTGGTG AACTGGTGA → AACTGGTA AACTGGTGT → AACTGGTT
AACTGGTTA → AACTGGTA AACTGGTTC → AACTGGTC AACTGGTTG → AACTGGTG AACTGGTTT → AACTGGTT AACTGTATA → AACTGTAA
AACTTGGAA → AACTGGAA AACTTGGCA → AACTGGCA AACTTGGGA → AACTGGGA AACTTGGTA → AACTGGTA AAGAAGGCA → AAGAGGCA
AAGAGGAAA → AAGAGGAA AAGAGGATA → AAGAGGAA AAGAGGCAA → AAGAGGCA AAGAGGCAG → AAGAGGCG AAGAGGTAG → AAGAGGTG
AAGAGGTTA → AAGAGGTA AAGAGTTCT → AAGAGTTT AAGCAGGCA → AAGCGGCA AAGCAGGTA → AAGCGGTA AAGCGGATA → AAGCGGAA
AAGCGGCAG → AAGCGGCG AAGCGGCCG → AAGCGGCG AAGCGGTAG → AAGCGGTG AAGCGGTAT → AAGCGGTT AAGCGGTCA → AAGCGGTA
AAGCGGTCC → AAGCGGTC AAGCGGTCG → AAGCGGTG AAGCGGTGA → AAGCGGTA AAGCGGTGG → AAGCGGTG AAGCGGTTA → AAGCGGTA
AAGCGGTTG → AAGCGGTG AAGCTGGCA → AAGCGGCA AAGCTGGGA → AAGCGGGA AAGGGATCA → AAG-GGAA AAGGGATTA → AAG-GGAA
AAGGGGATA → AAGGGGAA AAGGGGGTA → AAGGGGGA AAGGGGTTA → AAGGGGTA AAGTAGTCA → AAGTGTCA AAGTCCGGC → AAGTGG-C
AAGTCGGTA → AAGTGGTA AAGTGGAAA → AAGTGGAA AAGTGGACA → AAGTGGAA AAGTGGACG → AAGTGGAG AAGTGGAGA → AAGTGGAA
AAGTGGAGG → AAGTGGAG AAGTGGATA → AAGTGGAA AAGTGGCAG → AAGTGGCG AAGTGGCTA → AAGTGGCA AAGTGGTAA → AAGTGGTA
AAGTGGTAC → AAGTGGTC AAGTGGTAG → AAGTGGTG AAGTGGTAT → AAGTGGTT AAGTGGTCA → AAGTGGTA AAGTGGTCG → AAGTGGTG
AAGTGGTCT → AAGTGGTT AAGTGGTTA → AAGTGGTA AAGTGGTTC → AAGTGGTC AAGTGGTTG → AAGTGGTG AAGTTCGGC → AAGTGG-C
AAGTTGGAA → AAGTGGAA AAGTTGGCA → AAGTGGCA AAGTTGGTA → AAGTGGTA AATACGCAG → AATAGCAG AATAGGAAA → AATAGGAA
AATAGGAAG → AATAGGAG AATAGGAAT → AATAGGAT AATAGGACA → AATAGGAA AATAGGATA → AATAGGAA AATAGGATG → AATAGGAG
AATAGGCAA → AATAGGCA AATAGGCAC → AATAGGCC AATAGGCAG → AATAGGCG AATAGGCAT → AATAGGCT AATAGGCTA → AATAGGCA
AATAGGGAG → AATAGGGG AATAGGTAA → AATAGGTA AATAGGTAC → AATAGGTC AATAGGTAG → AATAGGTG AATAGGTAT → AATAGGTT
AATAGGTCA → AATAGGTA AATAGGTCG → AATAGGTG AATAGGTGA → AATAGGTA AATAGGTTA → AATAGGTA AATAGGTTC → AATAGGTC
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AATAGTGCA → AATAGTGA AATATGGCA → AATAGGCA AATATGGTA → AATAGGTA AATCAGACA → AATCGACA AATCAGCCA → AATCGCCA
AATCAGGCA → AATCGGCA AATCAGGTA → AATCGGTA AATCAGGTT → AATCGGTT AATCCGGAA → AATCGGAA AATCCGGCA → AATCGGCA
AATCCGGCC → AATCGGCC AATCCGGTA → AATCGGTA AATCGATTA → AATCGATA AATCGCGCA → AATCGCGA AATCGGAAA → AATCGGAA
AATCGGAAG → AATCGGAG AATCGGACA → AATCGGAA AATCGGATA → AATCGGAA AATCGGCAA → AATCGGCA AATCGGCAC → AATCGGCC
AATCGGCAG → AATCGGCG AATCGGCAT → AATCGGCT AATCGGCCA → AATCGGCA AATCGGCTA → AATCGGCA AATCGGGAG → AATCGGGG
AATCGGGCA → AATCGGGA AATCGGGTA → AATCGGGA AATCGGTAA → AATCGGTA AATCGGTAG → AATCGGTG AATCGGTAT → AATCGGTT
AATCGGTCA → AATCGGTA AATCGGTCG → AATCGGTG AATCGGTGA → AATCGGTA AATCGGTTA → AATCGGTA AATCGGTTG → AATCGGTG
AATCGTGTA → AATCGTGA AATCGTTAG → AATCGTTG AATCTGGAA → AATCGGAA AATCTGGCA → AATCGGCA AATCTGGGA → AATCGGGA
AATCTGGTA → AATCGGTA AATGGAAGA → AAT-GGAA AATGGAATA → AAT-GGAA AATGGACCA → AAT-GGAA AATGGATAA → AAT-GGAA
AATGGATCA → AAT-GGAA AATGGATTA → AAT-GGAA AATGGCAAA → AAT-GGCA AATGGCAAG → AAT-GGCG AATGGCAGG → AAT-GGCG
AATGGCGAG → AAT-GGCG AATGGCTAA → AAT-GGCA AATGGCTAG → AAT-GGCG AATGGCTAT → AAT-GGCT AATGGCTCA → AAT-GGCA
AATGGCTGA → AAT-GGCA AATGGCTTA → AAT-GGCA AATGGGAAG → AATGGGAG AATGGGATA → AATGGGAA AATGGGCAG → AATGGGCG
AATGGGCAT → AATGGGCT AATGGGGAG → AATGGGGG AATGGGTAA → AATGGGTA AATGGGTAG → AATGGGTG AATGGGTCA → AATGGGTA
AATGGGTGA → AATGGGTA AATGGGTTA → AATGGGTA AATGGGTTG → AATGGGTG AATGGTAGG → AAT-GGTG AATGGTCAA → AAT-GGTA
AATGGTTAA → AAT-GGTA AATGGTTAG → AAT-GGTG AATGGTTAT → AAT-GGTT AATGGTTCA → AAT-GGTA AATGGTTGA → AAT-GGTA
AATGGTTTA → AAT-GGTA AATGGTTTC → AAT-GGTC AATGTGGCA → AATGGGCA AATTAGGCA → AATTGGCA AATTAGGCG → AATTGGCG
AATTAGGTA → AATTGGTA AATTAGGTG → AATTGGTG AATTAGTAG → AATTGTAG AATTCGATA → AATTGATA AATTCGCAG → AATTGCAG
AATTCGGCA → AATTGGCA AATTCGGTA → AATTGGTA AATTGAATA → AATTGAAA AATTGATAG → AATTGATG AATTGGAAA → AATTGGAA
AATTGGAAC → AATTGGAC AATTGGAAG → AATTGGAG AATTGGAAT → AATTGGAT AATTGGACA → AATTGGAA AATTGGAGA → AATTGGAA
AATTGGATA → AATTGGAA AATTGGATC → AATTGGAC AATTGGATT → AATTGGAT AATTGGCAA → AATTGGCA AATTGGCAC → AATTGGCC
AATTGGCAG → AATTGGCG AATTGGCAT → AATTGGCT AATTGGCCA → AATTGGCA AATTGGCCT → AATTGGCT AATTGGCGA → AATTGGCA
AATTGGCTA → AATTGGCA AATTGGCTG → AATTGGCG AATTGGCTT → AATTGGCT AATTGGGAA → AATTGGGA AATTGGGAG → AATTGGGG
AATTGGGAT → AATTGGGT AATTGGGTA → AATTGGGA AATTGGNTA → AATTGGNA AATTGGTAA → AATTGGTA AATTGGTAC → AATTGGTC
AATTGGTAG → AATTGGTG AATTGGTAT → AATTGGTT AATTGGTCA → AATTGGTA AATTGGTCG → AATTGGTG AATTGGTCT → AATTGGTT
AATTGGTGA → AATTGGTA AATTGGTTA → AATTGGTA AATTGGTTG → AATTGGTG AATTGGTTT → AATTGGTT AATTGTATA → AATTGTAA
AATTGTTAG → AATTGTTG AATTTGGAC → AATTGGAC AATTTGGCA → AATTGGCA AATTTGGGA → AATTGGGA AATTTGGTA → AATTGGTA
AATTTGGTC → AATTGGTC AATTTGGTT → AATTGGTT AATTTGTAG → AATTGTAG ACAAGGTAA → ACAAGGTA ACAAGGTGT → ACAAGGTT
ACAAGGTTA → ACAAGGTA ACACGGTTA → ACACGGTA ACACGGTTC → ACACGGTC ACACGGTTG → ACACGGTG ACAGGTTGT → ACA-GGTT
ACATGGTTA → ACATGGTA ACATGGTTC → ACATGGTC ACCAAGCAA → ACCAGCAA ACCAGGCGA → ACCAGGCA ACCAGGTTA → ACCAGGTA
ACCCGGATA → ACCCGGAA ACCCGGTGA → ACCCGGTA ACCCGGTGG → ACCCGGTG ACCCGGTTT → ACCCGGTT ACCGGCGCG → ACC-GGCG
ACCGGCTGT → ACC-GGCT ACCGGGATA → ACCGGGAA ACCGGTGGT → ACC-GGTT ACCTGGACA → ACCTGGAA ACCTGGATA → ACCTGGAA
ACCTGGCCA → ACCTGGCA ACCTGGCTA → ACCTGGCA ACCTGGTGA → ACCTGGTA ACCTGGTGG → ACCTGGTG ACCTGGTTA → ACCTGGTA
ACGACGGTA → ACGAGGTA ACGAGGACG → ACGAGGAG ACGCGGTGT → ACGCGGTT ACGGTGGTT → ACGGGGTT ACGTGGATA → ACGTGGAA
ACGTGGCTA → ACGTGGCA ACGTGGTCA → ACGTGGTA ACGTGGTGT → ACGTGGTT ACGTGGTTA → ACGTGGTA ACGTTGGCT → ACGTGGCT
ACTCGGATA → ACTCGGAA ACTCGGCGG → ACTCGGCG ACTCGGTAG → ACTCGGTG ACTCGGTTA → ACTCGGTA ACTGGACTA → ACT-GGAA
ACTGGGTGT → ACTGGGTT ACTGGTGAA → ACT-GGTA ACTTGGAAA → ACTTGGAA ACTTGGACA → ACTTGGAA ACTTGGCTA → ACTTGGCA
ACTTGGTAA → ACTTGGTA ACTTGGTAG → ACTTGGTG ACTTGGTGA → ACTTGGTA ACTTGGTGT → ACTTGGTT ACTTGGTTA → ACTTGGTA
AGAAAGGCA → AGAAGGCA AGAAGAGTA → AGAAGAGA AGAAGCGCA → AGAAGCGA AGAAGGATA → AGAAGGAA AGAAGGTAA → AGAAGGTA
AGAAGGTCA → AGAAGGTA AGAAGGTCT → AGAAGGTT AGAAGGTGA → AGAAGGTA AGAAGGTTA → AGAAGGTA AGAAGGTTC → AGAAGGTC
AGAATGGCA → AGAAGGCA AGACAGGTA → AGACGGTA AGACCGGCA → AGACGGCA AGACCGGGA → AGACGGGA AGACCGGTA → AGACGGTA
AGACGGATA → AGACGGAA AGACGGCAA → AGACGGCA AGACGGCAT → AGACGGCT AGACGGCCA → AGACGGCA AGACGGCTA → AGACGGCA
AGACGGGGA → AGACGGGA AGACGGTCA → AGACGGTA AGACGGTGA → AGACGGTA AGACGGTTA → AGACGGTA AGACTGGCA → AGACGGCA
AGACTGGGA → AGACGGGA AGACTGGTA → AGACGGTA AGAGACCCA → AGA-GACA AGAGACCTA → AGA-GACA AGAGACTTA → AGA-GACA
AGAGATCTA → AGA-GATA AGAGGACAA → AGA-GGAA AGAGGACCA → AGA-GGAA AGAGGACGA → AGA-GGAA AGAGGACTA → AGA-GGAA
AGAGGATCA → AGA-GGAA AGAGGATGA → AGA-GGAA AGAGGATTA → AGA-GGAA AGAGGCACG → AGA-GGCG AGAGGCCAA → AGA-GGCA
AGAGGCCCA → AGA-GGCA AGAGGCCGA → AGA-GGCA AGAGGCCGT → AGA-GGCT AGAGGCCTA → AGA-GGCA AGAGGCCTT → AGA-GGCT
AGAGGCGAG → AGA-GGCG AGAGGCTAA → AGA-GGCA AGAGGCTCA → AGA-GGCA AGAGGCTGA → AGA-GGCA AGAGGCTTA → AGA-GGCA
AGAGGGCTA → AGAGGGCA AGAGGGTTC → AGAGGGTC AGAGGTCAA → AGA-GGTA AGAGGTCCA → AGA-GGTA AGAGGTCGA → AGA-GGTA
AGAGGTCGT → AGA-GGTT AGAGGTCTA → AGA-GGTA AGAGGTGAG → AGA-GGTG AGAGGTTAA → AGA-GGTA AGAGGTTCA → AGA-GGTA
AGAGGTTGA → AGA-GGTA AGAGGTTTA → AGA-GGTA AGAGTCCTA → AGA-GTCA AGATAGGTA → AGATGGTA AGATAGTCT → AGATGTCT
AGATCGGTA → AGATGGTA AGATGAGTA → AGATGAGA AGATGGAAA → AGATGGAA AGATGGACA → AGATGGAA AGATGGAGA → AGATGGAA
AGATGGAGT → AGATGGAT AGATGGATA → AGATGGAA AGATGGCAA → AGATGGCA AGATGGCAT → AGATGGCT AGATGGCCA → AGATGGCA
AGATGGCGA → AGATGGCA AGATGGCTA → AGATGGCA AGATGGGCA → AGATGGGA AGATGGTAA → AGATGGTA AGATGGTAG → AGATGGTG
AGATGGTCA → AGATGGTA AGATGGTCT → AGATGGTT AGATGGTGA → AGATGGTA AGATGGTTA → AGATGGTA AGATGGTTC → AGATGGTC
AGATGGTTG → AGATGGTG AGATTGGGA → AGATGGGA AGATTGGTA → AGATGGTA AGCAAGGAA → AGCAGGAA AGCAAGGTA → AGCAGGTA
AGCACGGAC → AGCAGGAC AGCACGGTA → AGCAGGTA AGCACGGTC → AGCAGGTC AGCACGTTA → AGCAGTTA AGCAGACGC → AGCAGACC
AGCAGAGTA → AGCAGAGA AGCAGCCCA → AGCAGCCA AGCAGCCGA → AGCAGCCA AGCAGGAAA → AGCAGGAA AGCAGGACA → AGCAGGAA
AGCAGGATA → AGCAGGAA AGCAGGCAA → AGCAGGCA AGCAGGCAG → AGCAGGCG AGCAGGCCA → AGCAGGCA AGCAGGCGA → AGCAGGCA
AGCAGGCTA → AGCAGGCA AGCAGGCTG → AGCAGGCG AGCAGGGGA → AGCAGGGA AGCAGGGTA → AGCAGGGA AGCAGGTCA → AGCAGGTA
AGCAGGTCT → AGCAGGTT AGCAGGTGA → AGCAGGTA AGCAGGTTA → AGCAGGTA AGCAGGTTC → AGCAGGTC AGCAGGTTG → AGCAGGTG
AGCAGTCAA → AGCAGTCA AGCATGGAA → AGCAGGAA AGCATGGCA → AGCAGGCA AGCATGGGG → AGCAGGGG AGCATGGTA → AGCAGGTA
AGCCAGACA → AGCCGACA AGCCAGGAA → AGCCGGAA AGCCAGGCA → AGCCGGCA AGCCAGGGA → AGCCGGGA AGCCAGGTA → AGCCGGTA
AGCCAGGTG → AGCCGGTG AGCCCGATA → AGCCGATA AGCCCGGAA → AGCCGGAA AGCCCGGCA → AGCCGGCA AGCCCGGCG → AGCCGGCG
AGCCCGGGA → AGCCGGGA AGCCCGGTA → AGCCGGTA AGCCCGGTC → AGCCGGTC AGCCCGGTG → AGCCGGTG AGCCGCATA → AGCCGCAA
AGCCGGAAA → AGCCGGAA AGCCGGACA → AGCCGGAA AGCCGGAGA → AGCCGGAA AGCCGGATA → AGCCGGAA AGCCGGCAT → AGCCGGCT
AGCCGGCCA → AGCCGGCA AGCCGGCTA → AGCCGGCA AGCCGGGAT → AGCCGGGT AGCCGGGCA → AGCCGGGA AGCCGGGTA → AGCCGGGA
AGCCGGTAT → AGCCGGTT AGCCGGTCA → AGCCGGTA AGCCGGTGA → AGCCGGTA AGCCGGTTA → AGCCGGTA AGCCTAATA → AGCCTAAA
AGCCTAGTA → AGCCAGTA AGCCTGATA → AGCCGATA AGCCTGGAA → AGCCGGAA AGCCTGGAT → AGCCGGAT AGCCTGGCA → AGCCGGCA
AGCCTGGCC → AGCCGGCC AGCCTGGCG → AGCCGGCG AGCCTGGCT → AGCCGGCT AGCCTGGGA → AGCCGGGA AGCCTGGTA → AGCCGGTA
AGCCTGGTG → AGCCGGTG AGCCTGGTT → AGCCGGTT AGCCTTGTA → AGCCTGTA AGCGACCAA → AGC-GACA AGCGACCTA → AGC-GACA
AGCGACTTA → AGC-GACA AGCGATCTA → AGC-GATA AGCGCGGAA → AGCGGGAA AGCGGAATA → AGC-GGAA AGCGGACAA → AGC-GGAA
AGCGGACCA → AGC-GGAA AGCGGACGA → AGC-GGAA AGCGGACTA → AGC-GGAA AGCGGACTT → AGC-GGAT AGCGGAGTA → AGC-GGAA
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AGCGGATAA → AGC-GGAA AGCGGATCA → AGC-GGAA AGCGGATGA → AGC-GGAA AGCGGATTA → AGC-GGAA AGCGGCATA → AGC-GGCA
AGCGGCCAA → AGC-GGCA AGCGGCCAG → AGC-GGCG AGCGGCCCA → AGC-GGCA AGCGGCCGA → AGC-GGCA AGCGGCCTA → AGC-GGCA
AGCGGCGAG → AGC-GGCG AGCGGCTAA → AGC-GGCA AGCGGCTAG → AGC-GGCG AGCGGCTCA → AGC-GGCA AGCGGCTGA → AGC-GGCA
AGCGGCTTA → AGC-GGCA AGCGGGAAA → AGCGGGAA AGCGGGACA → AGCGGGAA AGCGGGAGA → AGCGGGAA AGCGGGAGT → AGCGGGAT
AGCGGGATA → AGCGGGAA AGCGGGCAC → AGCGGGCC AGCGGGCTA → AGCGGGCA AGCGGGGAG → AGCGGGGG AGCGGGTCA → AGCGGGTA
AGCGGGTGA → AGCGGGTA AGCGGGTTA → AGCGGGTA AGCGGTAAG → AGC-GGTG AGCGGTATA → AGC-GGTA AGCGGTCAA → AGC-GGTA
AGCGGTCCA → AGC-GGTA AGCGGTCGA → AGC-GGTA AGCGGTCTA → AGC-GGTA AGCGGTCTC → AGC-GGTC AGCGGTTAA → AGC-GGTA
AGCGGTTAG → AGC-GGTG AGCGGTTCA → AGC-GGTA AGCGGTTGA → AGC-GGTA AGCGGTTTA → AGC-GGTA AGCGRCCAA → AGC-GRCA
AGCGTGGGA → AGCGGGGA AGCGTGGTA → AGCGGGTA AGCGTTTGA → AGC-GTTA AGCMTGGTA → AGCMGGTA AGCNCGGTA → AGCNGGTA
AGCTAGGAA → AGCTGGAA AGCTAGGCA → AGCTGGCA AGCTAGGTA → AGCTGGTA AGCTAGGTG → AGCTGGTG AGCTAGTTA → AGCTGTTA
AGCTCGGAA → AGCTGGAA AGCTCGGCA → AGCTGGCA AGCTCGGGA → AGCTGGGA AGCTCGGTA → AGCTGGTA AGCTCGGTT → AGCTGGTT
AGCTCGTTA → AGCTGTTA AGCTGAATA → AGCTGAAA AGCTGCATA → AGCTGCAA AGCTGCCAA → AGCTGCCA AGCTGGAAA → AGCTGGAA
AGCTGGAAC → AGCTGGAC AGCTGGACA → AGCTGGAA AGCTGGAGA → AGCTGGAA AGCTGGAGT → AGCTGGAT AGCTGGATA → AGCTGGAA
AGCTGGATG → AGCTGGAG AGCTGGCAA → AGCTGGCA AGCTGGCAG → AGCTGGCG AGCTGGCAT → AGCTGGCT AGCTGGCCA → AGCTGGCA
AGCTGGCGA → AGCTGGCA AGCTGGCTA → AGCTGGCA AGCTGGCTG → AGCTGGCG AGCTGGGAA → AGCTGGAA AGCTGGGAC → AGCTGGGC
AGCTGGGAG → AGCTGGGG AGCTGGGAT → AGCTGGGT AGCTGGGGA → AGCTGGGA AGCTGGGTA → AGCTGGGA AGCTGGTAA → AGCTGGTA
AGCTGGTAC → AGCTGGTC AGCTGGTAG → AGCTGGTG AGCTGGTAT → AGCTGGTT AGCTGGTCA → AGCTGGTA AGCTGGTCG → AGCTGGTG
AGCTGGTCT → AGCTGGTT AGCTGGTGA → AGCTGGTA AGCTGGTGC → AGCTGGTC AGCTGGTGG → AGCTGGTG AGCTGGTGT → AGCTGGTT
AGCTGGTTA → AGCTGGTA AGCTGGTTG → AGCTGGTG AGCTGGTTT → AGCTGGTT AGCTGTATA → AGCTGTAA AGCTNGGTA → AGCTGGTA
AGCTTAGTA → AGCTAGTA AGCTTCGTA → AGCTCGTA AGCTTGGAA → AGCTGGAA AGCTTGGCA → AGCTGGCA AGCTTGGGA → AGCTGGGA
AGCTTGGKA → AGCTGGKA AGCTTGGTA → AGCTGGTA AGCTTGGTG → AGCTGGTG AGGAGGAAA → AGGAGGAA AGGAGGACA → AGGAGGAA
AGGAGGATA → AGGAGGAA AGGAGGCTA → AGGAGGCA AGGAGGTCA → AGGAGGTA AGGAGGTGA → AGGAGGTA AGGAGGTTA → AGGAGGTA
AGGAGGTTC → AGGAGGTC AGGCAGGTA → AGGCGGTA AGGCCGGCA → AGGCGGCA AGGCCGGTA → AGGCGGTA AGGCGGACA → AGGCGGAA
AGGCGGATA → AGGCGGAA AGGCGGCTA → AGGCGGCA AGGCGGTAA → AGGCGGTA AGGCGGTCA → AGGCGGTA AGGCGGTCC → AGGCGGTC
AGGCGGTTA → AGGCGGTA AGGCTGGCA → AGGCGGCA AGGCTGGGA → AGGCGGGA AGGCTGGTA → AGGCGGTA AGGGGACAA → AGG-GGAA
AGGGGACCA → AGG-GGAA AGGGGACTA → AGG-GGAA AGGGGATAA → AGG-GGAA AGGGGATCA → AGG-GGAA AGGGGATTA → AGG-GGAA
AGGGGCCAA → AGG-GGCA AGGGGCCCA → AGG-GGCA AGGGGCCGA → AGG-GGCA AGGGGCCTA → AGG-GGCA AGGGGCTGA → AGG-GGCA
AGGGGCTTA → AGG-GGCA AGGGGGGTA → AGGGGGGA AGGGGGTTA → AGGGGGTA AGGGGTCAA → AGG-GGTA AGGGGTCCA → AGG-GGTA
AGGGGTCGA → AGG-GGTA AGGGGTCTA → AGG-GGTA AGGGGTTAA → AGG-GGTA AGGGGTTCA → AGG-GGTA AGGGGTTGA → AGG-GGTA
AGGGGTTTA → AGG-GGTA AGGTAGGCA → AGGTGGCA AGGTAGGTA → AGGTGGTA AGGTCGGTA → AGGTGGTA AGGTGATTA → AGGTGATA
AGGTGGAAA → AGGTGGAA AGGTGGACA → AGGTGGAA AGGTGGAGT → AGGTGGAT AGGTGGATA → AGGTGGAA AGGTGGATT → AGGTGGAT
AGGTGGCAA → AGGTGGCA AGGTGGCCA → AGGTGGCA AGGTGGCTA → AGGTGGCA AGGTGGTAA → AGGTGGTA AGGTGGTAG → AGGTGGTG
AGGTGGTAT → AGGTGGTT AGGTGGTCA → AGGTGGTA AGGTGGTCC → AGGTGGTC AGGTGGTGA → AGGTGGTA AGGTGGTGG → AGGTGGTG
AGGTGGTTA → AGGTGGTA AGGTGGTTC → AGGTGGTC AGGTGGTTG → AGGTGGTG AGGTGGTTT → AGGTGGTT AGGTTGGTA → AGGTGGTA
AGGTTGTTA → AGGTGTTA AGNCGGTTA → AGNCGGTA AGNGGCCAA → AGN-GGCA AGNGGCTGA → AGN-GGCA AGNTAGGTA → AGNTGGTA
AGNTGGTTA → AGNTGGTA AGTAAGATA → AGTAGATA AGTAAGGCA → AGTAGGCA AGTAAGGTA → AGTAGGTA AGTACGGAA → AGTAGGAA
AGTACGGTA → AGTAGGTA AGTAGACGA → AGTAGACA AGTAGAGTA → AGTAGAGA AGTAGGAAA → AGTAGGAA AGTAGGACA → AGTAGGAA
AGTAGGAGA → AGTAGGAA AGTAGGATA → AGTAGGAA AGTAGGCAT → AGTAGGCT AGTAGGCCA → AGTAGGCA AGTAGGCTA → AGTAGGCA
AGTAGGTAA → AGTAGGTA AGTAGGTAG → AGTAGGTG AGTAGGTCA → AGTAGGTA AGTAGGTGA → AGTAGGTA AGTAGGTTA → AGTAGGTA
AGTAGTCGA → AGTAGTCA AGTATGGCA → AGTAGGCA AGTATGGGA → AGTAGGGA AGTATGGTA → AGTAGGTA AGTCAGGAA → AGTCGGAA
AGTCAGGCA → AGTCGGCA AGTCAGGGA → AGTCGGGA AGTCAGGTA → AGTCGGTA AGTCAGGTT → AGTCGGTT AGTCCGGAA → AGTCGGAA
AGTCCGGCA → AGTCGGCA AGTCCGGCG → AGTCGGCG AGTCCGGGA → AGTCGGGA AGTCCGGTA → AGTCGGTA AGTCCGGTG → AGTCGGTG
AGTCGAATG → AGTCGAAG AGTCGCGTA → AGTCGCGA AGTCGGAAA → AGTCGGAA AGTCGGACA → AGTCGGAA AGTCGGAGT → AGTCGGAT
AGTCGGATA → AGTCGGAA AGTCGGCAA → AGTCGGCA AGTCGGCAG → AGTCGGCG AGTCGGCAT → AGTCGGCT AGTCGGCCA → AGTCGGCA
AGTCGGCCG → AGTCGGCG AGTCGGCTA → AGTCGGCA AGTCGGGCA → AGTCGGGA AGTCGGGTA → AGTCGGGA AGTCGGTAA → AGTCGGTA
AGTCGGTAC → AGTCGGTC AGTCGGTAG → AGTCGGTG AGTCGGTAT → AGTCGGTT AGTCGGTCA → AGTCGGTA AGTCGGTGA → AGTCGGTA
AGTCGGTTA → AGTCGGTA AGTCGGTTG → AGTCGGTG AGTCGTGTA → AGTCGTGA AGTCTGGAA → AGTCGGAA AGTCTGGAC → AGTCGGAC
AGTCTGGCA → AGTCGGCA AGTCTGGGA → AGTCGGGA AGTCTGGNA → AGTCGGNA AGTCTGGTA → AGTCGGTA AGTCTGGTG → AGTCGGTG
AGTGAACGA → AGT-GAAA AGTGACCGA → AGT-GACA AGTGACCTA → AGT-GACA AGTGACCTG → AGT-GACG AGTGACTCA → AGT-GACA
AGTGACTGA → AGT-GACA AGTGACTTA → AGT-GACA AGTGATCGA → AGT-GATA AGTGATCTA → AGT-GATA AGTGATTTA → AGT-GATA
AGTGCCTAA → AGT-GCCA AGTGGAACA → AGT-GGAA AGTGGAATA → AGT-GGAA AGTGGACAA → AGT-GGAA AGTGGACCA → AGT-GGAA
AGTGGACGA → AGT-GGAA AGTGGACTA → AGT-GGAA AGTGGAGCA → AGT-GGAA AGTGGATAA → AGT-GGAA AGTGGATCA → AGT-GGAA
AGTGGATGA → AGT-GGAA AGTGGATGG → AGT-GGAG AGTGGATTA → AGT-GGAA AGTGGCACA → AGT-GGCA AGTGGCAGC → AGT-GGCC
AGTGGCATA → AGT-GGCA AGTGGCCAA → AGT-GGCA AGTGGCCAG → AGT-GGCG AGTGGCCCA → AGT-GGCA AGTGGCCGA → AGT-GGCA
AGTGGCCTA → AGT-GGCA AGTGGCCTC → AGT-GGCC AGTGGCGCT → AGT-GGCT AGTGGCGTA → AGT-GGCA AGTGGCTAA → AGT-GGCA
AGTGGCTCA → AGT-GGCA AGTGGCTGA → AGT-GGCA AGTGGCTTA → AGT-GGCA AGTGGCTTC → AGT-GGCC AGTGGCTTT → AGT-GGCT
AGTGGGATA → AGTGGGAA AGTGGGCAA → AGTGGGCA AGTGGGCCA → AGTGGGCA AGTGGGCGA → AGTGGGCA AGTGGGGAA → AGTGGGAA
AGTGGGTCA → AGTGGGTA AGTGGGTTA → AGTGGGTA AGTGGNCTA → AGT-GGNA AGTGGTAAG → AGT-GGTG AGTGGTCAA → AGT-GGTA
AGTGGTCAT → AGT-GGTT AGTGGTCCA → AGT-GGTA AGTGGTCGA → AGT-GGTA AGTGGTCTA → AGT-GGTA AGTGGTCTT → AGT-GGTT
AGTGGTTAA → AGT-GGTA AGTGGTTAG → AGT-GGTG AGTGGTTCA → AGT-GGTA AGTGGTTGA → AGT-GGTA AGTGGTTTA → AGT-GGTA
AGTGGTTTT → AGT-GGTT AGTGTGGTA → AGTGGGTA AGTNGGCTA → AGTNGGCA AGTNGGTTA → AGTNGGTA AGTTAGGCA → AGTTGGCA
AGTTAGGGA → AGTTGGGA AGTTAGGTA → AGTTGGTA AGTTAGTCA → AGTTGTCA AGTTAGTTA → AGTTGTTA AGTTCGCCA → AGTTGCCA
AGTTCGGCA → AGTTGGCA AGTTCGGGA → AGTTGGGA AGTTCGGTA → AGTTGGTA AGTTCGGTC → AGTTGGTC AGTTCGGTT → AGTTGGTT
AGTTCGTTA → AGTTGTTA AGTTGAATA → AGTTGAAA AGTTGATAG → AGTTGATG AGTTGATTA → AGTTGATA AGTTGCGTA → AGTTGCGA
AGTTGGAAA → AGTTGGAA AGTTGGAAC → AGTTGGAC AGTTGGAAG → AGTTGGAG AGTTGGAAT → AGTTGGAT AGTTGGACA → AGTTGGAA
AGTTGGAGA → AGTTGGAA AGTTGGAGT → AGTTGGAT AGTTGGATA → AGTTGGAA AGTTGGATT → AGTTGGAT AGTTGGCAA → AGTTGGCA
AGTTGGCAC → AGTTGGCC AGTTGGCAG → AGTTGGCG AGTTGGCAT → AGTTGGCT AGTTGGCCA → AGTTGGCA AGTTGGCCG → AGTTGGCG
AGTTGGCGA → AGTTGGCA AGTTGGCTA → AGTTGGCA AGTTGGGAA → AGTTGGGA AGTTGGGAT → AGTTGGGT AGTTGGGTA → AGTTGGGA
AGTTGGTAA → AGTTGGTA AGTTGGTAC → AGTTGGTC AGTTGGTAG → AGTTGGTG AGTTGGTAT → AGTTGGTT AGTTGGTCA → AGTTGGTA
AGTTGGTCG → AGTTGGTG AGTTGGTCT → AGTTGGTT AGTTGGTGA → AGTTGGTA AGTTGGTGG → AGTTGGTG AGTTGGTTA → AGTTGGTA
AGTTGGTTC → AGTTGGTC AGTTGGTTG → AGTTGGTG AGTTGGTTT → AGTTGGTT AGTTGTATA → AGTTGTAA AGTTGTGTA → AGTTGTGA
AGTTGTTTA → AGTTGTTA AGTTTGGAA → AGTTGGAA AGTTTGGCA → AGTTGGCA AGTTTGGGA → AGTTGGGA AGTTTGGTA → AGTTGGTA
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AGTTTGGTG → AGTTGGTG AGTTTGTTA → AGTTGTTA AGTYGGTTA → AGTYGGTA AGYTGGTTA → AGYTGGTA AKTTGGTTA → AKTTGGTA
ANCGGCCCA → ANC-GGCA ATAAGGCAT → ATAAGGCT ATAAGGTAT → ATAAGGTT ATAAGGTTA → ATAAGGTA ATACGGATA → ATACGGAA
ATACGGTTA → ATACGGTA ATAGGCCTA → ATA-GGCA ATAGGCTTA → ATA-GGCA ATATGGTAC → ATATGGTC ATATGGTTA → ATATGGTA
ATCAGGAAA → ATCAGGAA ATCAGGAAG → ATCAGGAG ATCAGGACA → ATCAGGAA ATCAGGAGA → ATCAGGAA ATCAGGATA → ATCAGGAA
ATCAGGTCA → ATCAGGTA ATCAGGTTA → ATCAGGTA ATCATGGAA → ATCAGGAA ATCCGGAAA → ATCCGGAA ATCCGGACA → ATCCGGAA
ATCCGGATA → ATCCGGAA ATCCGGCAA → ATCCGGCA ATCCGGCCA → ATCCGGCA ATCCGGCTA → ATCCGGCA ATCCGGTCA → ATCCGGTA
ATCCGGTGA → ATCCGGTA ATCCGGTTA → ATCCGGTA ATCGGCACG → ATC-GGCG ATCGGCCTT → ATC-GGCT ATCGGCGAA → ATC-GGCA
ATCGGGAAA → ATCGGGAA ATCGGGACA → ATCGGGAA ATCGGGATA → ATCGGGAA ATCGGGTTA → ATCGGGTA ATCGGTTAA → ATC-GGTA
ATCGGTTCA → ATC-GGTA ATCGGTTTA → ATC-GGTA ATCGTGACA → ATCGGACA ATCGTGATA → ATCGGATA ATCNGGATA → ATCNGGAA
ATCRGGAAA → ATCRGGAA ATCRGGATA → ATCRGGAA ATCTAGGGA → ATCTGGGA ATCTGGAAA → ATCTGGAA ATCTGGATA → ATCTGGAA
ATCTGGCCA → ATCTGGCA ATCTGGCGG → ATCTGGCG ATCTGGCTA → ATCTGGCA ATCTGGTCA → ATCTGGTA ATCTGGTGA → ATCTGGTA
ATCTGGTGG → ATCTGGTG ATCTGGTGT → ATCTGGTT ATCTGGTTA → ATCTGGTA ATCTGGTTG → ATCTGGTG ATCTTGGTA → ATCTGGTA
ATGAGGCAC → ATGAGGCC ATGCGGACA → ATGCGGAA ATGCGGATA → ATGCGGAA ATGCGGTAG → ATGCGGTG ATGTCGGAA → ATGTGGAA
ATGTGGAAA → ATGTGGAA ATGTGGTCA → ATGTGGTA ATGTGGTTA → ATGTGGTA ATGTTGGAA → ATGTGGAA ATGTTGGCT → ATGTGGCT
ATTAGGTAT → ATTAGGTT ATTATGGCA → ATTAGGCA ATTCGGATA → ATTCGGAA ATTCGGGTA → ATTCGGGA ATTCGGTAT → ATTCGGTT
ATTCGGTTA → ATTCGGTA ATTCTGGTA → ATTCGGTA ATTGGCGCA → ATT-GGCA ATTGGTTCC → ATT-GGTC ATTGGTTTC → ATT-GGTC
ATTGGTTTT → ATT-GGTT ATTTGGATA → ATTTGGAA ATTTGGCTA → ATTTGGCA ATTTGGTAA → ATTTGGTA ATTTGGTAT → ATTTGGTT
ATTTGGTTA → ATTTGGTA ATTTTGGAA → ATTTGGAA CAAAAGGCG → CAAAGGCG CAACAGGTA → CAACGGTA CAACAGTCA → CAACGTCA
CAACGGATA → CAACGGAA CAACGGCCA → CAACGGCA CAACGGCTA → CAACGGCA CAACGGTCA → CAACGGTA CAACGGTTA → CAACGGTA
CAACTGGCA → CAACGGCA CAACTGGTA → CAACGGTA CAAGAGGTG → CAAGGGTG CAAGCGGTG → CAAGGGTG CAATAGGTA → CAATGGTA
CAATCGGTC → CAATGGTC CAATCGGTG → CAATGGTG CAATGGCTA → CAATGGCA CAATGGTCA → CAATGGTA CAATGGTTA → CAATGGTA
CAATGGTTG → CAATGGTG CAATTGGCA → CAATGGCA CAATTGGTA → CAATGGTA CAATTGTCA → CAATGTCA CACCGGCGA → CACCGGCA
CACTGGCGA → CACTGGCA CACTGGTGG → CACTGGTG CACTGGTGT → CACTGGTT CAGCAGGTA → CAGCGGTA CAGCGGCAG → CAGCGGCG
CAGCGGTAA → CAGCGGTA CAGCGGTGA → CAGCGGTA CAGCGGTTA → CAGCGGTA CAGCTAGGA → CAGCGG-A CAGCTGGAA → CAGCGGAA
CAGCTGGGA → CAGCGGGA CAGCTGGTA → CAGCGGTA CAGGGGATA → CAGGGGAA CAGGTGGTA → CAGGGGTA CAGGTTGTA → CAGGTGTA
CAGTCGGTA → CAGTGGTA CAGTGGCGA → CAGTGGCA CAGTTGGCA → CAGTGGCA CAGTTGGGA → CAGTGGGA CAGTTGGTA → CAGTGGTA
CAGTTGGTG → CAGTGGTG CATTGGTTA → CATTGGTA CCATGGTGG → CCATGGTG CCCCGGTGG → CCCCGGTG CCCTGGTGG → CCCTGGTG
CCGGGGTGG → CCGGGGTG CGAATGGTA → CGAAGGTA CGCCCGGTA → CGCCGGTA CGCGGCCTA → CGC-GGCA CGCGGGATA → CGCGGGAA
CGCTGGCGA → CGCTGGCA CGCTGGTGC → CGCTGGTC CGCTGGTGG → CGCTGGTG CGGAATTGG → CGGAATTG CGGGGGTTC → CGGGGGTC
CGGTGGCAG → CGGTGGCG CGTATGGAT → CGTAGGAT CGTCTGGTA → CGTCGGTA CGTTGGCTA → CGTTGGCA CGTTGGTTA → CGTTGGTA
CGTTTGATA → CGTTGATA CTAATGGGA → CTAAGGGA CTCCGGTGA → CTCCGGTA CTCCGGTGG → CTCCGGTG CTCTGGTGA → CTCTGGTA
CTCTGGTGG → CTCTGGTG CTCTGGTGT → CTCTGGTT CTGTAGGAG → CTGTGGAG CTGTTGGCG → CTGTGGCG GAAAGGCAA → GAAAGGCA
GAAATGGTA → GAAAGGTA GAACAGTAG → GAACAGTG GAACAGTCA → GAACAGTA GAACGGCTA → GAACGGCA GAACTGGTA → GAACGGTA
GAATGGAGC → GAATGGAC GAATGGCAT → GAATGGCT GAATGGCTA → GAATGGCA GAATGGTAT → GAATGGTT GAATGGTGA → GAATGGTA
GAATGGTTA → GAATGGTA GAATTGCAG → GAATGCAG GAATTGGCA → GAATGGCA GAATTGGTA → GAATGGTA GACAGGCCC → GACAGGCC
GACCCGGTG → GACCGGTG GACCGGATA → GACCGGAA GACCGGCTA → GACCGGCA GACCTGGTG → GACCGGTG GACTGGTGC → GACTGGTC
GACTGGTGT → GACTGGTT GAGAGGCGA → GAGAGGCA GAGCGGCAA → GAGCGGCA GAGCTGGGA → GAGCGGGA GAGGGGTTA → GAGGGGTA
GAGTGGCAA → GAGTGGCA GAGTGGCGA → GAGTGGCA GATAGGTGA → GATAGGTA GATCGAGAA → GATCGAGA GATGCAGAA → GAT-GCAA
GATGGATTC → GAT-GGAC GATGGGCGA → GATGGGCA GATGTAGAA → GAT-GTAA GATTCAGAA → GATTCAGA GATTGAGAA → GATTGAGA
GATTGGAAA → GATTGGAA GATTGGCAG → GATTGGCG GATTGGGAG → GATTGGGG GATTGGTAG → GATTGGTG GATTGGTGA → GATTGGTA
GCATGGAGT → GCATGGAT GCATGGGGT → GCATGGGT GCCCGGTGG → GCCCGGTG GCCGGAATA → GCC-GGAA GCCGGATTC → GCC-GGAC
GCCTGGTGG → GCCTGGTG GCGTTGGGC → GCGTGGGC GCTAGGAGT → GCTAGGAT GCTAGGGAG → GCTAGGGG GCTAGGGGT → GCTAGGGT
GCTCGGGGT → GCTCGGGT GCTGGCAGG → GCT-GGCG GCTTGGTAA → GCTTGGTA GCTTGGTGC → GCTTGGTC GGACGGTCA → GGACGGTA
GGCAGGACA → GGCAGGAA GGCAGGATA → GGCAGGAA GGCAGGTTG → GGCAGGTG GGCGGCCTA → GGC-GGCA GGCTGGAAG → GGCTGGAG
GGCTGGACA → GGCTGGAA GGCTGGATA → GGCTGGAA GGCTGGTGA → GGCTGGTA GGCTGGTGC → GGCTGGTC GGCTGGTTA → GGCTGGTA
GGCTTGGTA → GGCTGGTA GGGCGGTGC → GGGCGGTC GGGTGGTCC → GGGTGGTC GGGTGGTTA → GGGTGGTA GGGTTGGGA → GGGTGGGA
GGTCGGTTA → GGTCGGTA GGTCTGGTA → GGTCGGTA GGTGGCTCA → GGT-GGCA GGTGGCTGA → GGT-GGCA GGTTGGTCA → GGTTGGTA
GGTTGGTTA → GGTTGGTA GGTTGGTTG → GGTTGGTG GGTTTGGTA → GGTTGGTA GTAGAGGTA → GTAGGGTA GTAGGGGTA → GTAGGGGA
GTCTGGTGA → GTCTGGTA GTCTGGTGG → GTCTGGTG GTCTGGTGT → GTCTGGTT GTTACGGAG → GTTAGGAG NGCTGGATA → NGCTGGAA
TAAAAGGTA → TAAAGGTA TAAATGGTA → TAAAGGTA TAACGGATA → TAACGGAA TAACGGCCA → TAACGGCA TAACGGCTA → TAACGGCA
TAACGGTAA → TAACGGTA TAACGGTAG → TAACGGTG TAACGGTAT → TAACGGTT TAACGGTCA → TAACGGTA TAACGGTTA → TAACGGTA
TAACTGGCA → TAACGGCA TAACTGGGA → TAACGGGA TAACTGGTA → TAACGGTA TAATAGGGA → TAATGGGA TAATCGGCA → TAATGGCA
TAATGGATA → TAATGGAA TAATGGCTA → TAATGGCA TAATGGTAA → TAATGGTA TAATTGGAA → TAATGGAA TAATTGGCA → TAATGGCA
TAATTGGGA → TAATGGGA TAATTGGTA → TAATGGTA TACTGGCTA → TACTGGCA TACTGGTGT → TACTGGTT TAGCGGAAA → TAGCGGAA
TAGCGGCGA → TAGCGGCA TAGCGGTAA → TAGCGGTA TAGTGGCGA → TAGTGGCA TAGTGGTAA → TAGTGGTA TAGTTGGTA → TAGTGGTA
TATAGGTGT → TATAGGTT TATCGGTAG → TATCGGTG TATTGGCAG → TATTGGCG TATTGGTAG → TATTGGTG TATTGGTGC → TATTGGTC
TATTGGTGT → TATTGGTT TATTGGTTG → TATTGGTG TCAAGGTGA → TCAAGGTA TCAGCGGGA → TCAGGGGA TCCCGGTGG → TCCCGGTG
TCCGGTGAG → TCC-GGTG TCCNGGTGA → TCCNGGTA TCCTGGTGG → TCCTGGTG TCTGGTAGA → TCT-GGTA TCTGGTTGA → TCT-GGTA
TGACGGTTG → TGACGGTG TGAGTCTGA → TGA-GTCA TGATGGTTG → TGATGGTG TGCAGGTAG → TGCAGGTG TGCCGGTGC → TGCCGGTC
TGCCGGTGG → TGCCGGTG TGCCTGGTA → TGCCGGTA TGCTGGATG → TGCTGGAG TGCTGGTGC → TGCTGGTC TGCTGGTGT → TGCTGGTT
TGCTTGGTG → TGCTGGTG TGTGGCCAA → TGT-GGCA TGTTGGAAG → TGTTGGAG TGTTGGTTA → TGTTGGTA TTAACGGCA → TTAAGGCA
TTAATGGCA → TTAAGGCA TTAATGGGA → TTAAGGGA TTCCGGTGA → TTCCGGTA TTCTGGTGA → TTCTGGTA TTCTGGTGT → TTCTGGTT
AAAACGGATA → AAAAGGAA AAAACGGTGA → AAAAGGTA AAAAGGATAA → AAAAGGAA AAAAGGTTTA → AAAAGGTA AAAATGGATA → AAAAGGAA
AAACAGGTAA → AAACGGTA AAACTGGTAG → AAACGGTG AAAGGGCTAT → AAAGGGCT AAATAGGATA → AAATGGAA AAATAGGTAG → AAATGGTG
AAATAGGTAT → AAATGGTT AAATCGGTAG → AAATGGTG AAATCTGGCA → AAATGGCA AAATGGAATA → AAATGGAA AAATGGAGAT → AAATGAGT
AAATGGATGA → AAATGGAA AAATGGCCAG → AAATGGCG AAATGGCTAA → AAATGGCA AAATTGGAAA → AAATGGAA AAATTGGAAG → AAATGGAG
AAATTGGCAG → AAATGGCG AAATTGGTAA → AAATGGTA AAATTGGTAG → AAATGGTG AACAAGGCAA → AACAGGCA AACAAGGTAG → AACAGGTG
AACAAGGTTA → AACAGGTA AACACGGTTA → AACAGGTA AACAGGAAAT → AACAGGAT AACAGGCAGT → AACAGGCT AACAGGTTCA → AACAGGTA
AACATGGCAG → AACAGGCG AACATGGTAG → AACAGGTG AACCAGGCAG → AACCGGCG AACCAGGCTA → AACCGGCA AACCAGGTAA → AACCGGTA
AACCAGGTAG → AACCGGTG AACCCGGCAG → AACCGGCG AACCCGGTAA → AACCGGTA AACCCGGTAT → AACCGGTT AACCCGGTTA → AACCGGTA
AACCGGCAGC → AACCGGCC AACCGGCAGG → AACCGGCG AACCGGCAGT → AACCGGCT AACCGGTTAG → AACCGGTG AACCTGGATA → AACCGGAA
AACCTGGCAA → AACCGGCA AACCTGGCAG → AACCGGCG AACCTGGTAG → AACCGGTG AACCTGGTAT → AACCGGTT AACCTGGTCA → AACCGGTA
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AACCTGGTTA → AACCGGTA AACGAGTCCA → AACGGTCA AACGGAACCA → AAC-GGAA AACGGAATTA → AAC-GGAA AACGGATTTA → AAC-GGAA
AACGGCTTCA → AAC-GGCA AACGGTATTA → AAC-GGTA AACGGTTAGG → AAC-GGTG AACGGTTATA → AAC-GGTA AACGGTTTCA → AAC-GGTA
AACGGTTTTA → AAC-GGTA AACGTGGTAG → AACGGGTG AACGTTGGCA → AACGGGCA AACTAGGCAA → AACTGGCA AACTAGGCAT → AACTGGCT
AACTAGGCTA → AACTGGCA AACTAGGTAG → AACTGGTG AACTAGGTTA → AACTGGTA AACTCGGAGA → AACTGGAA AACTCGGTTA → AACTGGTA
AACTCTGGCA → AACTGGCA AACTGGAAGA → AACTGGAA AACTGGAAGG → AACTGGAG AACTGGATAA → AACTGGAA AACTGGATAG → AACTGGAG
AACTGGATCA → AACTGGAA AACTGGATGA → AACTGGAA AACTGGCAAG → AACTGGCG AACTGGCACG → AACTGGCG AACTGGCAGC → AACTGGCC
AACTGGCAGG → AACTGGCG AACTGGCAGT → AACTGGCT AACTGGCCAG → AACTGGCG AACTGGCGAG → AACTGGCG AACTGGCGCT → AACTGGCT
AACTGGCTTT → AACTGGCT AACTGGGCAG → AACTGGGG AACTGGTAGG → AACTGGTG AACTGGTCAG → AACTGGTG AACTGGTCAT → AACTGGTT
AACTGGTGAG → AACTGGTG AACTGGTGTT → AACTGGTT AACTGGTTAG → AACTGGTG AACTGGTTAT → AACTGGTT AACTGGTTGA → AACTGGTA
AACTGGTTTA → AACTGGTA AACTGGTTTG → AACTGGTG AACTGGTTTT → AACTGGTT AACTTGGATA → AACTGGAA AACTTGGCAA → AACTGGCA
AACTTGGCAG → AACTGGCG AACTTGGCAT → AACTGGCT AACTTGGTAG → AACTGGTG AACTTGGTAT → AACTGGTT AACTTGGTTA → AACTGGTA
AACTTTGGAA → AACTGGAA AAGAAGGTCA → AAGAGGTA AAGCCGGATA → AAGCGGAA AAGCCGGTTA → AAGCGGTA AAGCGGTCAA → AAGCGGTA
AAGCTGGATA → AAGCGGAA AAGGGAATTA → AAG-GGAA AAGTGGCTAA → AAGTGGCA AAGTGGTTTG → AAGTGGTG AAGTTGGCTA → AAGTGGCA
AAGTTGGTTA → AAGTGGTA AATAAGGCAG → AATAGGCG AATAAGGCTA → AATAGGCA AATAAGGTAT → AATAGGTT AATACGGATA → AATAGGAA
AATACGGTAG → AATAGGTG AATAGGCAGC → AATAGGCC AATAGGCAGT → AATAGGCT AATAGGCGAG → AATAGGCG AATAGGCGAT → AATAGGCT
AATAGGTCAG → AATAGGTG AATAGGTGAT → AATAGGTT AATAGGTTTG → AATAGGTG AATATGGATA → AATAGGAA AATATGGTAG → AATAGGTG
AATATGGTAT → AATAGGTT AATCAGGAAG → AATCGGAG AATCAGGATA → AATCGGAA AATCAGGCAG → AATCGGCG AATCAGGTAA → AATCGGTA
AATCAGGTAG → AATCGGTG AATCAGGTAT → AATCGGTT AATCCGGAAG → AATCGGAG AATCCGGTAG → AATCGGTG AATCCGGTTA → AATCGGTA
AATCGGCAGC → AATCGGCC AATCGGCAGG → AATCGGCG AATCGGTAGC → AATCGGTC AATCGGTTAG → AATCGGTG AATCTGGATA → AATCGGAA
AATCTGGCAA → AATCGGCA AATCTGGCAG → AATCGGCG AATCTGGTAG → AATCGGTG AATCTGGTAT → AATCGGTT AATCTGGTCA → AATCGGTA
AATCTGGTTA → AATCGGTA AATGAGGTTA → AATGGGTA AATGATGGTA → AATGGGTA AATGGACCCA → AAT-GGAA AATGGACTCA → AAT-GGAA
AATGGCATCC → AAT-GGCC AATTAGGATA → AATTGGAA AATTAGGCAG → AATTGGCG AATTAGGTAA → AATTGGTA AATTAGGTAG → AATTGGTG
AATTAGGTAT → AATTGGTT AATTCGGCAA → AATTGGCA AATTCGGGCA → AATTGGGA AATTCGGTAG → AATTGGTG AATTCGGTTA → AATTGGTA
AATTGGAAAG → AATTGGAG AATTGGAAGA → AATTGGAA AATTGGAATA → AATTGGAA AATTGGACTA → AATTGGAA AATTGGATAG → AATTGGAG
AATTGGATCA → AATTGGAA AATTGGATTA → AATTGGAA AATTGGCAAG → AATTGGCG AATTGGCAAT → AATTGGCT AATTGGCACG → AATTGGCG
AATTGGCAGC → AATTGGCC AATTGGCAGG → AATTGGCG AATTGGCAGT → AATTGGCT AATTGGCATG → AATTGGCG AATTGGCCAG → AATTGGCG
AATTGGCCGA → AATTGGCA AATTGGCGAT → AATTGGCT AATTGGCTAA → AATTGGCA AATTGGCTAG → AATTGGCG AATTGGCTAT → AATTGGCT
AATTGGCTGA → AATTGGCA AATTGGGAAG → AATTGGGG AATTGGGATA → AATTGGAA AATTGGGCAG → AATTGGGG AATTGGGCAT → AATTGGGT
AATTGGGTAG → AATTGGGG AATTGGTAAT → AATTGGTT AATTGGTACG → AATTGGTG AATTGGTAGA → AATTGGTA AATTGGTAGC → AATTGGTC
AATTGGTAGG → AATTGGTG AATTGGTAGT → AATTGGTT AATTGGTCAG → AATTGGTG AATTGGTCAT → AATTGGTT AATTGGTGAG → AATTGGTG
AATTGGTGTA → AATTGGTA AATTGGTTAA → AATTGGTA AATTGGTTAG → AATTGGTG AATTGGTTAT → AATTGGTT AATTGGTTTA → AATTGGTA
AATTGGTTTT → AATTGGTT AATTGTGGCA → AATTGGCA AATTTGGATA → AATTGGAA AATTTGGCAG → AATTGGCG AATTTGGCTA → AATTGGCA
AATTTGGTAA → AATTGGTA AATTTGGTAC → AATTGGTC AATTTGGTAG → AATTGGTG AATTTGGTAT → AATTGGTT AATTTGGTCA → AATTGGTA
AATTTGGTTA → AATTGGTA ACAAGGTGTT → ACAAGGTT ACCGGATGTT → ACC-GGAT ACGAGGCCCA → ACGAGGCA ACGCCCGGTA → ACGCGGTA
ACGTTGGCAA → ACGTGGCA ACTGGGTTTA → ACTGGGTA ACTGGTTGTG → ACT-GGTG ACTTGGTCCG → ACTTGGTG AGAAGGCCGA → AGAAGGCA
AGAAGGTCGA → AGAAGGTA AGAATGGACA → AGAAGGAA AGACAGGCTA → AGACGGCA AGACAGGTCA → AGACGGTA AGACCGGTTA → AGACGGTA
AGACGGCCGA → AGACGGCA AGACGGCCTA → AGACGGCA AGACGGCGAG → AGACGGCG AGACGGCTTA → AGACGGCA AGACTGGATA → AGACGGAA
AGACTGGTCA → AGACGGTA AGACTGGTTA → AGACGGTA AGAGGAAATG → AGA-GGAG AGAGGACCTA → AGA-GGAA AGAGGCCATA → AGA-GGCA
AGAGGCCCAG → AGA-GGCG AGAGGCCCCA → AGA-GGCA AGAGGCCGTA → AGA-GGCA AGAGGCTATA → AGA-GGCA AGAGGCTGTA → AGA-GGCA
AGAGGGCCTA → AGA-GGGA AGAGGTCATA → AGA-GGTA AGAGGTCGAC → AGA-GGTC AGAGGTCGTA → AGA-GGTA AGAGGTCGTC → AGA-GGTC
AGAGGTTATA → AGA-GGTA AGAGGTTGAC → AGA-GGTC AGATAGGTTA → AGATGGTA AGATCGGCAC → AGATGGCC AGATCGGTTA → AGATGGTA
AGATGGACCA → AGATGGAA AGATGGAGAA → AGATGGAA AGATGGAGAG → AGATGGAG AGATGGATAG → AGATGGAG AGATGGATCA → AGATGGAA
AGATGGATTA → AGATGGAA AGATGGCCGA → AGATGGCA AGATGGCCTA → AGATGGCA AGATGGCTGA → AGATGGCA AGATGGCTTA → AGATGGCA
AGATGGGATA → AGATGGGA AGATGGGTTA → AGATGGTA AGATGGTCGA → AGATGGTA AGATGGTGAG → AGATGGTG AGATGGTTTA → AGATGGTA
AGATTGGCCA → AGATGGCA AGATTGGCTA → AGATGGCA AGATTGGTCA → AGATGGTA AGATTGGTGA → AGATGGTA AGATTGGTTA → AGATGGTA
AGCAAGGTTA → AGCAGGTA AGCACGGCAC → AGCAGGCC AGCACGGCCA → AGCAGGCA AGCACGGTCA → AGCAGGTA AGCACGGTTA → AGCAGGTA
AGCAGGAGAG → AGCAGGAG AGCAGGATTA → AGCAGGAA AGCAGGCCAG → AGCAGGCG AGCAGGCCGA → AGCAGGCA AGCAGGCTAG → AGCAGGCG
AGCAGGCTGA → AGCAGGCA AGCAGGTCAA → AGCAGGTA AGCAGGTCGA → AGCAGGTA AGCAGGTCTA → AGCAGGTA AGCAGGTTTA → AGCAGGTA
AGCATGGAGT → AGCAGGAT AGCATGGATA → AGCAGGAA AGCATGGCTA → AGCAGGCA AGCATGGTCA → AGCAGGTA AGCATGGTTA → AGCAGGTA
AGCATGGTTT → AGCAGGTT AGCCAGGAAA → AGCCGGAA AGCCAGGACA → AGCCGGAA AGCCAGGACG → AGCCGGAG AGCCAGGAGA → AGCCGGAA
AGCCAGGAGT → AGCCGGAT AGCCAGGATA → AGCCGGAA AGCCAGGATG → AGCCGGAG AGCCAGGCCA → AGCCGGCA AGCCAGGCTA → AGCCGGCA
AGCCAGGGTA → AGCCGGGA AGCCAGGTAA → AGCCGGTA AGCCAGGTAG → AGCCGGTG AGCCAGGTCA → AGCCGGTA AGCCAGGTCG → AGCCGGTG
AGCCAGGTGA → AGCCGGTA AGCCAGGTTA → AGCCGGTA AGCCATGGTA → AGCCGGTA AGCCCGGAAA → AGCCGGAA AGCCCGGACA → AGCCGGAA
AGCCCGGATA → AGCCGGAA AGCCCGGCAA → AGCCGGCA AGCCCGGCCA → AGCCGGCA AGCCCGGCTA → AGCCGGCA AGCCCGGTCA → AGCCGGTA
AGCCCGGTCG → AGCCGGTG AGCCCGGTGA → AGCCGGTA AGCCCGGTTA → AGCCGGTA AGCCCGGTTC → AGCCGGTC AGCCGGCCAA → AGCCGGCA
AGCCGGCCCA → AGCCGGCA AGCCGGCCGA → AGCCGGCA AGCCGGCCTA → AGCCGGCA AGCCGGCTGA → AGCCGGCA AGCCGGGTTA → AGCCGGGA
AGCCGGTCGA → AGCCGGTA AGCCGGTTCA → AGCCGGTA AGCCGGTTTA → AGCCGGTA AGCCTGATTA → AGCCGATA AGCCTGGAAA → AGCCGGAA
AGCCTGGAAT → AGCCGGAT AGCCTGGACA → AGCCGGAA AGCCTGGAGT → AGCCGGAT AGCCTGGATA → AGCCGGAA AGCCTGGATG → AGCCGGAG
AGCCTGGCAA → AGCCGGCA AGCCTGGCCA → AGCCGGCA AGCCTGGCTA → AGCCGGCA AGCCTGGCTG → AGCCGGCG AGCCTGGGAG → AGCCGGGG
AGCCTGGGTA → AGCCGGGA AGCCTGGTAA → AGCCGGTA AGCCTGGTAG → AGCCGGTG AGCCTGGTAT → AGCCGGTT AGCCTGGTCA → AGCCGGTA
AGCCTGGTGA → AGCCGGTA AGCCTGGTTA → AGCCGGTA AGCCTGGTTG → AGCCGGTG AGCCTTGGTA → AGCCGGTA AGCGAGTTCA → AGCGGTTA
AGCGCGGTCA → AGCGGGTA AGCGGAATAA → AGC-GGAA AGCGGACTTA → AGC-GGAA AGCGGATTCA → AGC-GGAA AGCGGATTTA → AGC-GGAA
AGCGGCATTA → AGC-GGCA AGCGGCCAAA → AGC-GGCA AGCGGCCATA → AGC-GGCA AGCGGCCGTA → AGC-GGCA AGCGGCTATA → AGC-GGCA
AGCGGCTCAA → AGC-GGCA AGCGGGAGAG → AGCGGGAG AGCGGGAGCG → AGCGGGAG AGCGGGCCAA → AGCGGGCA AGCGGTAAAG → AGC-GGTG
AGCGGTCACA → AGC-GGTA AGCGGTCATA → AGC-GGTA AGCGGTCGAC → AGC-GGTC AGCGGTCGTA → AGC-GGTA AGCGGTTATA → AGC-GGTA
AGCGGTTTTA → AGC-GGTA AGCGTGGATA → AGCGGGAA AGCGTGGTCA → AGCGGGTA AGCGTGGTTA → AGCGGGTA AGCTAGGAAA → AGCTGGAA
AGCTAGGAGT → AGCTGGAT AGCTAGGATA → AGCTGGAA AGCTAGGATG → AGCTGGAG AGCTAGGCTA → AGCTGGCA AGCTAGGGCT → AGCTGGGT
AGCTAGGTAA → AGCTGGTA AGCTAGGTAT → AGCTGGTT AGCTAGGTTA → AGCTGGTA AGCTCGGACA → AGCTGGAA AGCTCGGAGT → AGCTGGAT
AGCTCGGCCA → AGCTGGCA AGCTCGGTCA → AGCTGGTA AGCTCGGTTA → AGCTGGTA AGCTGAGATA → AGCTGAGA AGCTGGAATA → AGCTGGAA
AGCTGGACAA → AGCTGGAA AGCTGGACCA → AGCTGGAA AGCTGGACGA → AGCTGGAA AGCTGGACTA → AGCTGGAA AGCTGGAGAG → AGCTGGAG
AGCTGGATAG → AGCTGGAG AGCTGGATAN → AGCTGGAN AGCTGGATAT → AGCTGGAT AGCTGGATCA → AGCTGGAA AGCTGGATTA → AGCTGGAA
AGCTGGCAAG → AGCTGGCG AGCTGGCCAA → AGCTGGCA AGCTGGCCAG → AGCTGGCG AGCTGGCCCA → AGCTGGCA AGCTGGCCGA → AGCTGGCA
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AGCTGGCCTA → AGCTGGCA AGCTGGCGAG → AGCTGGCG AGCTGGCTAG → AGCTGGCG AGCTGGCTCA → AGCTGGCA AGCTGGCTGA → AGCTGGCA
AGCTGGCTGG → AGCTGGCG AGCTGGCTTA → AGCTGGCA AGCTGGGTGA → AGCTGGGA AGCTGGGTTA → AGCTGGTA AGCTGGTAGA → AGCTGGTA
AGCTGGTATA → AGCTGGTA AGCTGGTCAA → AGCTGGTA AGCTGGTCCA → AGCTGGTA AGCTGGTCGA → AGCTGGTA AGCTGGTCTA → AGCTGGTA
AGCTGGTTAG → AGCTGGTG AGCTGGTTCA → AGCTGGTA AGCTGGTTGA → AGCTGGTA AGCTGGTTTA → AGCTGGTA AGCTGTCCGA → AGCTGTCA
AGCTTGATTA → AGCTGATA AGCTTGGACA → AGCTGGAA AGCTTGGAGT → AGCTGGAT AGCTTGGATA → AGCTGGAA AGCTTGGCCA → AGCTGGCA
AGCTTGGCGA → AGCTGGCA AGCTTGGCTA → AGCTGGCA AGCTTGGCTG → AGCTGGCG AGCTTGGGCA → AGCTGGGA AGCTTGGGTA → AGCTGGGA
AGCTTGGTAA → AGCTGGTA AGCTTGGTCA → AGCTGGTA AGCTTGGTCC → AGCTGGTC AGCTTGGTTA → AGCTGGTA AGCTTGGTTG → AGCTGGTG
AGGCAGGTCA → AGGCGGTA AGGCAGGTTA → AGGCGGTA AGGCCGGTCG → AGGCGGTG AGGCGGACGA → AGGCGGAA AGGCGGTTTA → AGGCGGTA
AGGCTGGATA → AGGCGGAA AGGCTGGCCA → AGGCGGCA AGGCTGGCTA → AGGCGGCA AGGCTGGTTA → AGGCGGTA AGGGGGCTGA → AGGGGGCA
AGGGGGGGTA → AGGGGGGA AGGGGTCATA → AGG-GGTA AGGTAGGATA → AGGTGGAA AGGTCGGAGT → AGGTGGAT AGGTCGGATA → AGGTGGAA
AGGTCGGTCA → AGGTGGTA AGGTCGGTTA → AGGTGGTA AGGTGGAGAG → AGGTGGAG AGGTGGCGAG → AGGTGGCG AGGTGGCTTA → AGGTGGCA
AGGTGGTCGA → AGGTGGTA AGGTGGTTAG → AGGTGGTG AGGTGGTTTA → AGGTGGTA AGGTTGGCTA → AGGTGGCA AGGTTGGTCA → AGGTGGTA
AGGTTGGTTA → AGGTGGTA AGTAAGGTTA → AGTAGGTA AGTACGGTAA → AGTAGGTA AGTACGGTTA → AGTAGGTA AGTAGGAGAG → AGTAGGAG
AGTAGGATCA → AGTAGGAA AGTAGGCCAA → AGTAGGCA AGTAGGCCGA → AGTAGGCA AGTAGGCTCA → AGTAGGCA AGTAGGCTGA → AGTAGGCA
AGTAGGCTTA → AGTAGGCA AGTAGGTCGA → AGTAGGTA AGTAGGTTCA → AGTAGGTA AGTAGGTTGA → AGTAGGTA AGTAGGTTTA → AGTAGGTA
AGTATGGAGT → AGTAGGAT AGTATGGATA → AGTAGGAA AGTATGGTTA → AGTAGGTA AGTCAGGAAA → AGTCGGAA AGTCAGGACA → AGTCGGAA
AGTCAGGAGA → AGTCGGAA AGTCAGGAGT → AGTCGGAT AGTCAGGATA → AGTCGGAA AGTCAGGCAA → AGTCGGCA AGTCAGGCCA → AGTCGGCA
AGTCAGGCTA → AGTCGGCA AGTCAGGGGA → AGTCGGGA AGTCAGGTAA → AGTCGGTA AGTCAGGTCA → AGTCGGTA AGTCAGGTGA → AGTCGGTA
AGTCAGGTTA → AGTCGGTA AGTCCGGAAT → AGTCGGAT AGTCCGGACA → AGTCGGAA AGTCCGGAGT → AGTCGGAT AGTCCGGATA → AGTCGGAA
AGTCCGGCCA → AGTCGGCA AGTCCGGCCG → AGTCGGCG AGTCCGGCTA → AGTCGGCA AGTCCGGTCA → AGTCGGTA AGTCCGGTGA → AGTCGGTA
AGTCCGGTTA → AGTCGGTA AGTCGGAGCA → AGTCGGAA AGTCGGCCAA → AGTCGGCA AGTCGGCCCA → AGTCGGCA AGTCGGCCGA → AGTCGGCA
AGTCGGCCTA → AGTCGGCA AGTCGGCTGA → AGTCGGCA AGTCGGCTTA → AGTCGGCA AGTCGGTCAA → AGTCGGTA AGTCGGTCGA → AGTCGGTA
AGTCGGTCTA → AGTCGGTA AGTCGGTTCA → AGTCGGTA AGTCGGTTGA → AGTCGGTA AGTCGGTTTA → AGTCGGTA AGTCTGATCA → AGTCGATA
AGTCTGATTA → AGTCGATA AGTCTGCGCA → AGTCGCGA AGTCTGGAAA → AGTCGGAA AGTCTGGACA → AGTCGGAA AGTCTGGACG → AGTCGGAG
AGTCTGGAGA → AGTCGGAA AGTCTGGAGT → AGTCGGAT AGTCTGGATA → AGTCGGAA AGTCTGGCCA → AGTCGGCA AGTCTGGCTA → AGTCGGCA
AGTCTGGGCA → AGTCGGGA AGTCTGGTAA → AGTCGGTA AGTCTGGTAG → AGTCGGTG AGTCTGGTCA → AGTCGGTA AGTCTGGTCG → AGTCGGTG
AGTCTGGTGA → AGTCGGTA AGTCTGGTTA → AGTCGGTA AGTCTGGTTC → AGTCGGTC AGTGCGGTTA → AGTGGGTA AGTGGAACCA → AGT-GGAA
AGTGGAATCA → AGT-GGAA AGTGGACTCA → AGT-GGAA AGTGGAGTGA → AGT-GGAA AGTGGATAAA → AGT-GGAA AGTGGATATA → AGT-GGAA
AGTGGATGCA → AGT-GGAA AGTGGATTCA → AGT-GGAA AGTGGATTTA → AGT-GGAA AGTGGCCAAA → AGT-GGCA AGTGGCCATA → AGT-GGCA
AGTGGCCCTA → AGT-GGCA AGTGGCCGTA → AGT-GGCA AGTGGCCTAA → AGT-GGCA AGTGGCTATA → AGT-GGCA AGTGGCTGTA → AGT-GGCA
AGTGGCTTAA → AGT-GGCA AGTGGGAGAG → AGTGGGAG AGTGGGCCAA → AGTGGGCA AGTGGGCCCA → AGTGGGCA AGTGGGCTGA → AGTGGGCA
AGTGGTCACA → AGT-GGTA AGTGGTCATA → AGT-GGTA AGTGGTCGAC → AGT-GGTC AGTGGTCGCA → AGT-GGTA AGTGGTCGTA → AGT-GGTA
AGTGGTTAAA → AGT-GGTA AGTGGTTAAC → AGT-GGTC AGTGGTTATA → AGT-GGTA AGTGGTTGAA → AGT-GGTA AGTGGTTGTA → AGT-GGTA
AGTGGTTGTC → AGT-GGTC AGTGGTTTCT → AGT-GGTT AGTTAGCGTA → AGTTGCGA AGTTAGGAAA → AGTTGGAA AGTTAGGACA → AGTTGGAA
AGTTAGGAGT → AGTTGGAT AGTTAGGATA → AGTTGGAA AGTTAGGTAA → AGTTGGTA AGTTAGGTTA → AGTTGGTA AGTTATGGTA → AGTTGGTA
AGTTCCGGAA → AGTTGGAA AGTTCGGACA → AGTTGGAA AGTTCGGAGT → AGTTGGAT AGTTCGGCTA → AGTTGGCA AGTTCGGTCA → AGTTGGTA
AGTTCGGTGA → AGTTGGTA AGTTCGGTTA → AGTTGGTA AGTTGAGAGT → AGTTGAGT AGTTGGAATA → AGTTGGAA AGTTGGACAA → AGTTGGAA
AGTTGGACGA → AGTTGGAA AGTTGGAGAG → AGTTGGAG AGTTGGAGCA → AGTTGGAA AGTTGGAGTA → AGTTGGAA AGTTGGATAA → AGTTGGAA
AGTTGGATCA → AGTTGGAA AGTTGGATGA → AGTTGGAA AGTTGGATTA → AGTTGGAA AGTTGGCATA → AGTTGGCA AGTTGGCCAA → AGTTGGCA
AGTTGGCCAG → AGTTGGCG AGTTGGCCCA → AGTTGGCA AGTTGGCCGA → AGTTGGCA AGTTGGCCTA → AGTTGGCA AGTTGGCGAG → AGTTGGCG
AGTTGGCTAA → AGTTGGCA AGTTGGCTGA → AGTTGGCA AGTTGGCTTA → AGTTGGCA AGTTGGGATA → AGTTGGAA AGTTGGGTAG → AGTTGGTG
AGTTGGNTTA → AGTTGGNA AGTTGGTAGA → AGTTGGTA AGTTGGTAGT → AGTTGGTT AGTTGGTCAA → AGTTGGTA AGTTGGTCCA → AGTTGGTA
AGTTGGTCGA → AGTTGGTA AGTTGGTCTA → AGTTGGTA AGTTGGTGGG → AGTTGGTG AGTTGGTGTA → AGTTGGTA AGTTGGTTAA → AGTTGGTA
AGTTGGTTAG → AGTTGGTG AGTTGGTTCA → AGTTGGTA AGTTGGTTGA → AGTTGGTA AGTTGGTTTA → AGTTGGTA AGTTTGATCA → AGTTGATA
AGTTTGATTA → AGTTGATA AGTTTGCGTA → AGTTGCGA AGTTTGGAAG → AGTTGGAG AGTTTGGACA → AGTTGGAA AGTTTGGAGT → AGTTGGAT
AGTTTGGATA → AGTTGGAA AGTTTGGCCA → AGTTGGCA AGTTTGGCGA → AGTTGGCA AGTTTGGCTA → AGTTGGCA AGTTTGGGTA → AGTTGGGA
AGTTTGGTAA → AGTTGGTA AGTTTGGTAC → AGTTGGTC AGTTTGGTAG → AGTTGGTG AGTTTGGTAT → AGTTGGTT AGTTTGGTCA → AGTTGGTA
AGTTTGGTTA → AGTTGGTA AGTTTGGTTG → AGTTGGTG AGTTTTGGTA → AGTTGGTA AGTTTTGTTA → AGTTGTTA ATAAGGATTG → ATAAGGAG
ATAATTGGTA → ATAAGGTA ATACGGCTGG → ATACGGCG ATACGGTTTG → ATACGGTG ATACTGACAT → ATACGACT ATATGGTTGG → ATATGGTG
ATATTGGTTA → ATATGGTA ATCAGGAATA → ATCAGGAA ATCTGGATCA → ATCTGGAA ATGCTGGTTA → ATGCGGTA ATGGCGGTTA → ATGGGGTA
ATGGTGGTTA → ATGGGGTA ATGTTGGCTT → ATGTGGCT ATGTTGGTTA → ATGTGGTA ATTATGGCAA → ATTAGGCA ATTGGTCTGA → ATT-GGTA
ATTTCCTGGT → ATTTGG-T ATTTGGTGTA → ATTTGGTA ATTTTGGATA → ATTTGGAA CAAAAGGCTA → CAAAGGCA CAAATGGTTA → CAAAGGTA
CAACAGGTTA → CAACGGTA CAACGGTTCA → CAACGGTA CAACTGGATA → CAACGGAA CAACTGGCTA → CAACGGCA CAACTGGCTG → CAACGGCG
CAAGTTCGGC → CAAGGG-C CAATGGTTAA → CAATGGTA CAATTGGATA → CAATGGAA CAATTGGCAG → CAATGGCG CAATTGGTTC → CAATGGTC
CAGAGGCAGG → CAGAGGCG CAGAGGTCCA → CAGAGGTA CAGAGGTCGT → CAGAGGTT CAGCAGGTCA → CAGCGGTA CAGCCTGGTA → CAGCGGTA
CAGCGGCCTA → CAGCGGCA CAGCGGCGAG → CAGCGGCG CAGCGGTCAA → CAGCGGTA CAGCTGGATA → CAGCGGAA CAGCTGGCTA → CAGCGGCA
CAGCTTGGTA → CAGCGGTA CAGTCGGTTA → CAGTGGTA CAGTTGCGTA → CAGTGCGA CAGTTGGATA → CAGTGGAA CAGTTGGTTA → CAGTGGTA
CAGTTTGGTA → CAGTGGTA CATCCGGTGA → CATCGGTA CCGAGTGGCC → CCGAGGCC CGACGGCGAG → CGACGGCG CGACGGCGTG → CGACGGCG
CGATGGAGAG → CGATGGAG CGATGGAGCG → CGATGGAG CGATGGCGAG → CGATGGCG CGATGGCGGG → CGATGGCG CGATGGTGAG → CGATGGTG
CGCCGGAGAG → CGCCGGAG CGCGGGAGAG → CGCGGGAG CGCTGGAGAG → CGCTGGAG CGGGACGGTA → CGGGGGTA CGTAGAGGTA → CGTAGGTA
CGTCGGAGAG → CGTCGGAG CGTGGGAGAG → CGTGGGAG CGTTGGAGAG → CGTTGGAG CGTTGGAGGG → CGTTGGAG CTAACGGCCA → CTAAGGCA
CTGAAGGCAG → CTGAGGCG CTGATGGCAG → CTGAGGCG CTGCTGGTAG → CTGCGGTG CTGCTGGTGG → CTGCGGTG CTGTTGGCAG → CTGTGGCG
CTGTTGGTAG → CTGTGGTG CTGTTGGTCG → CTGTGGTG GAAATGGTAG → GAAAGGTG GAACAGGTAT → GAACGGTT GAACTGGACT → GAACGGAT
GAACTGGCAG → GAACGGCG GAACTGGCTA → GAACGGCA GAACTGGTTA → GAACGGTA GAATCAGCAG → GAATAGCG GAATCGGCTA → GAATGGCA
GAATCGGTAG → GAATGGTG GAATGGCTTT → GAATGGCT GAATTGGCAG → GAATGGCG GAATTGGCTA → GAATGGCA GAATTGGTAG → GAATGGTG
GAATTGGTCA → GAATGGTA GAATTGGTTA → GAATGGTA GACTTGGGGA → GACTGGGA GAGAGGATGA → GAGAGGAA GAGAGGATTA → GAGAGGAA
GAGAGGCTGA → GAGAGGCA GAGAGGTTTA → GAGAGGTA GAGCGGCCAA → GAGCGGCA GAGCGGCTTA → GAGCGGCA GAGCGGTCAA → GAGCGGTA
GAGCGGTCGA → GAGCGGTA GAGCGGTCTA → GAGCGGTA GAGCGGTTTA → GAGCGGTA GAGTGGCCAA → GAGTGGCA GAGTGGCCGA → GAGTGGCA
GAGTGGCTAA → GAGTGGCA GAGTGGCTGA → GAGTGGCA GAGTGGCTTA → GAGTGGCA GAGTGGTCGA → GAGTGGTA GAGTGGTCTA → GAGTGGTA
GAGTGGTTCA → GAGTGGTA GAGTGGTTGA → GAGTGGTA GAGTGGTTTA → GAGTGGTA GCTAGGGAAG → GCTAGGAG GGACCCGTAT → GGACGTAT
GGTTTGGTTA → GGTTGGTA GTAAGTGGAA → GTAAGGAA GTAAGTGGTA → GTAAGGTA GTAGATGGTA → GTAGGGTA GTAGCGGTTA → GTAGGGTA
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GTCAGGGGAG → GTCAGGGG GTCCTGGTGG → GTCCGGTG GTCTGGCTGA → GTCTGGCA GTGCTGGTAC → GTGCGGTC GTTAGGGAAG → GTTAGGAG
GTTAGGGGAG → GTTAGGGG GTTCGGCTGA → GTTCGGCA GTTCTGGTGT → GTTCGGTT TAAATGGCTA → TAAAGGCA TAACTGGATA → TAACGGAA
TAACTGGCTA → TAACGGCA TAATGGTGTA → TAATGGTA TAATGGTTCA → TAATGGTA TAATTGGCTA → TAATGGCA TAATTGGTAA → TAATGGTA
TAATTGGTTA → TAATGGTA TAGAGGCCCA → TAGAGGCA TAGAGGCCTA → TAGAGGCA TAGCGGCCTA → TAGCGGCA TAGCGGTCCA → TAGCGGTA
TAGCTGGTGC → TAGCGGTC TAGCTGGTTA → TAGCGGTA TAGTCTGGTA → TAGTGGTA TAGTGGCCCA → TAGTGGCA TAGTTGGCTA → TAGTGGCA
TAGTTGGTTA → TAGTGGTA TATCCGGTGA → TATCGGTA TATCGGCAGG → TATCGGCG TATTGGCAGT → TATTGGCT TATTGGCGAA → TATTGGCA
TATTGGTAAG → TATTGGTG TATTGGTAGG → TATTGGTG TCAGCTGGGA → TCAGGGGA TCAGTAGGTA → TCAGGGTA TCAGTCGGTA → TCAGGGTA
TCAGTTGGTA → TCAGGGTA TCCCCGGTGG → TCCCGGTG TCTCTGGTGA → TCTCGGTA TGACGGTTTG → TGACGGTG TGCCGGCAGG → TGCCGGCG
TGCCGGTAGG → TGCCGGTG TGCTGGCACG → TGCTGGCG TGCTGGCAGG → TGCTGGCG TGCTGGTAGG → TGCTGGTG TGCTGGTATG → TGCTGGTG
TGCTGGTTGC → TGCTGGTC TGTCGGCAAA → TGTCGGCA TGTCGGCAGG → TGTCGGCG TGTCGGTAGG → TGTCGGTG TGTTGGCAGG → TGTTGGCG
TGTTGGTCGC → TGTTGGTC TGTTGGTTGC → TGTTGGTC TTAACGGCAA → TTAAGGCA TTAACGGCTA → TTAAGGCA TTCCGGCAGG → TTCCGGCG
TTGCTGGTCG → TTGCGGTG TTGTTGGTCG → TTGTGGTG TTGTTGGTTG → TTGTGGTG TTTCGGTAGG → TTTCGGTG AACACTGGTAG → AACAGGTG
AACATGGCAGG → AACAGGCG AACCACGGTAG → AACCGGTG AACCGGCTAGG → AACCGGCG AACCTTGGTAG → AACCGGTG AACTCAGGTAG → AACTGGTG
AACTGGAATTA → AACTGGAA AACTGGCCAGG → AACTGGCG AACTTGGCTAA → AACTGGCA AACTTGGTCAG → AACTGGTG AACTTGGTTAA → AACTGGTA
AACTTTGGTAG → AACTGGTG AAGCGGCCCAA → AAGCGGCA AAGCGGCCGAA → AAGCGGCA AAGTAGGGTTA → AAGTGGTA AAGTGGCCTAC → AAGTGGCC
AAGTGGTCATA → AAGTGGTA AAGTGGTCTAA → AAGTGGTA AAGTTGGCCAA → AAGTGGCA AAGTTTGGTAG → AAGTGGTG AATAGGTTTAG → AATAGGTG
AATATAGGTAT → AATAGGTT AATCAAGGTAG → AATCGGTG AATCAGGCAGG → AATCGGCG AATCGGAATAA → AATCGGAA AATCGGAATTA → AATCGGAA
AATCGGATTCA → AATCGGAA AATCGGCTAGG → AATCGGCG AATCGGTCTTA → AATCGGTA AATCTGGCTAA → AATCGGCA AATGCAGGTAG → AATGGGTG
AATGGTTTTAA → AAT-GGTA AATTCAGGTAG → AATTGGTG AATTCGGCAGC → AATTGGCC AATTCGGTAGC → AATTGGTC AATTCTGGTAG → AATTGGTG
AATTGGAATTA → AATTGGAA AATTGGCAGAA → AATTGGCA AATTGGCTCAT → AATTGGCT AATTGGTTTAG → AATTGGTG AATTTCGGCAG → AATTGGCG
AATTTCGGTAG → AATTGGTG AATTTCGGTAT → AATTGGTT AATTTGGACAA → AATTGGAA AATTTGGATGA → AATTGGAA AATTTGGCAGC → AATTGGCC
AATTTGGTTAG → AATTGGTG AATTTTGGTTA → AATTGGTA ACAGCAGGCGA → ACAGGGCA ACAGTTGGTTA → ACAGGGTA ACGCGTGGTTA → ACGCGGTA
ACTCGGTCTGT → ACTCGGTT AGACAGGTCAA → AGACGGTA AGACCGGCCAA → AGACGGCA AGACTGGACAA → AGACGGAA AGACTGGCCAA → AGACGGCA
AGACTGGCCCA → AGACGGCA AGACTGGCTGA → AGACGGCA AGACTGGCTTA → AGACGGCA AGACTGGTCAA → AGACGGTA AGACTGGTCCA → AGACGGTA
AGATATGGTTA → AGATGGTA AGATGCGGTTA → AGATGGTA AGATGGATATA → AGATGGAA AGATGGTTCTA → AGATGGTA AGATTGGCCCA → AGATGGCA
AGCAAGGCTGA → AGCAGGCA AGCAAGGTCAA → AGCAGGTA AGCACGGCCAA → AGCAGGCA AGCACGGCTGA → AGCAGGCA AGCACGGTCAA → AGCAGGTA
AGCAGGAAAGA → AGCAGGAA AGCAGGAAGAG → AGCAGGAG AGCAGGATACA → AGCAGGAA AGCATGGCCCA → AGCAGGCA AGCATGGCTGA → AGCAGGCA
AGCATGGTCAA → AGCAGGTA AGCATGGTTGA → AGCAGGTA AGCATGGTTTA → AGCAGGTA AGCCAGGACAA → AGCCGGAA AGCCAGGACCA → AGCCGGAA
AGCCAGGACTA → AGCCGGAA AGCCAGGATTA → AGCCGGAA AGCCAGGCCAA → AGCCGGCA AGCCAGGCCCA → AGCCGGCA AGCCAGGCCTA → AGCCGGCA
AGCCAGGGCGA → AGCCGGGA AGCCAGGTCAA → AGCCGGTA AGCCAGGTCCA → AGCCGGTA AGCCAGGTCGA → AGCCGGTA AGCCAGGTCTA → AGCCGGTA
AGCCAGGTTAA → AGCCGGTA AGCCAGGTTGA → AGCCGGTA AGCCAGGTTTA → AGCCGGTA AGCCCGGACAA → AGCCGGAA AGCCCGGACTA → AGCCGGAA
AGCCCGGATCA → AGCCGGAA AGCCCGGCCAA → AGCCGGCA AGCCCGGCCCA → AGCCGGCA AGCCCGGCCGA → AGCCGGCA AGCCCGGCCTA → AGCCGGCA
AGCCCGGCTGA → AGCCGGCA AGCCCGGCTTA → AGCCGGCA AGCCCGGTCAA → AGCCGGTA AGCCCGGTCCA → AGCCGGTA AGCCCGGTCGA → AGCCGGTA
AGCCCGGTCTA → AGCCGGTA AGCCCGGTTCA → AGCCGGTA AGCCCGGTTCT → AGCCGGTT AGCCCGGTTGA → AGCCGGTA AGCCCGGTTTA → AGCCGGTA
AGCCTGGAATA → AGCCGGAA AGCCTGGACCA → AGCCGGAA AGCCTGGACGA → AGCCGGAA AGCCTGGACTA → AGCCGGAA AGCCTGGATTA → AGCCGGAA
AGCCTGGCAAA → AGCCGGCA AGCCTGGCCAA → AGCCGGCA AGCCTGGCCCA → AGCCGGCA AGCCTGGCCGA → AGCCGGCA AGCCTGGCCGT → AGCCGGCT
AGCCTGGCCTA → AGCCGGCA AGCCTGGCTGA → AGCCGGCA AGCCTGGCTTA → AGCCGGCA AGCCTGGTAGG → AGCCGGTG AGCCTGGTCAA → AGCCGGTA
AGCCTGGTCCA → AGCCGGTA AGCCTGGTCGA → AGCCGGTA AGCCTGGTCGT → AGCCGGTT AGCCTGGTCTA → AGCCGGTA AGCCTGGTTAA → AGCCGGTA
AGCCTGGTTGA → AGCCGGTA AGCCTGGTTTA → AGCCGGTA AGCGGCCCTAA → AGC-GGCA AGCGGCGTGGC → AGC-GGCC AGCGGTAGAGC → AGC-GGTC
AGCTAGGACAA → AGCTGGAA AGCTAGGATTA → AGCTGGAA AGCTAGGCCAA → AGCTGGCA AGCTAGGCTGA → AGCTGGCA AGCTAGGGCAA → AGCTGGGA
AGCTAGGTCAA → AGCTGGTA AGCTAGGTCCA → AGCTGGTA AGCTAGGTCGA → AGCTGGTA AGCTAGGTTAA → AGCTGGTA AGCTCAGGTTA → AGCTGGTA
AGCTCGGCCAA → AGCTGGCA AGCTCGGCCCA → AGCTGGCA AGCTCGGCCTA → AGCTGGCA AGCTCGGCTGA → AGCTGGCA AGCTCGGTCAA → AGCTGGTA
AGCTCGGTCCA → AGCTGGTA AGCTCGGTCGT → AGCTGGTT AGCTCGGTTGA → AGCTGGTA AGCTCGGTTTA → AGCTGGTA AGCTCTGGTTA → AGCTGGTA
AGCTGCGGTTA → AGCTGGTA AGCTGGCCAAG → AGCTGGCG AGCTGGCCGAA → AGCTGGCA AGCTGGCCGAG → AGCTGGCG AGCTGGCCGTA → AGCTGGCA
AGCTGGCCTAG → AGCTGGCG AGCTGGGCCGT → AGCTGGGT AGCTGGTAGAG → AGCTGGTG AGCTTAGGTTA → AGCTGGTA AGCTTCGGTTA → AGCTGGTA
AGCTTGGACAA → AGCTGGAA AGCTTGGACTA → AGCTGGAA AGCTTGGATGA → AGCTGGAA AGCTTGGATTA → AGCTGGAA AGCTTGGCCAA → AGCTGGCA
AGCTTGGCCCA → AGCTGGCA AGCTTGGCCGA → AGCTGGCA AGCTTGGCCTA → AGCTGGCA AGCTTGGCTGA → AGCTGGCA AGCTTGGCTTA → AGCTGGCA
AGCTTGGGTTA → AGCTGGGA AGCTTGGTCAA → AGCTGGTA AGCTTGGTCCA → AGCTGGTA AGCTTGGTCGA → AGCTGGTA AGCTTGGTCGT → AGCTGGTT
AGCTTGGTCTA → AGCTGGTA AGCTTGGTTAA → AGCTGGTA AGCTTGGTTGA → AGCTGGTA AGCTTGGTTTA → AGCTGGTA AGCTTTGGTTA → AGCTGGTA
AGGACGGTCGA → AGGAGGTA AGGCCGGCCCA → AGGCGGCA AGGCCGGCTGA → AGGCGGCA AGGCTGGATTA → AGGCGGAA AGGCTGGTCTA → AGGCGGTA
AGGGGGGGATA → AGGGGGAA AGGTAGGTTTA → AGGTGGTA AGGTTGGTCTA → AGGTGGTA AGTAACGGATA → AGTAGGAA AGTACGGCTGA → AGTAGGCA
AGTACGGCTTA → AGTAGGCA AGTACGGTCTA → AGTAGGTA AGTACGGTTGA → AGTAGGTA AGTACGGTTTA → AGTAGGTA AGTATGGCCAA → AGTAGGCA
AGTATGGCTAA → AGTAGGCA AGTATGGCTGA → AGTAGGCA AGTATGGTCCA → AGTAGGTA AGTATGGTCGA → AGTAGGTA AGTATGGTTAA → AGTAGGTA
AGTATGGTTGA → AGTAGGTA AGTCAGGACGA → AGTCGGAA AGTCAGGCCAA → AGTCGGCA AGTCAGGCCCA → AGTCGGCA AGTCAGGCCGA → AGTCGGCA
AGTCAGGCCGT → AGTCGGCT AGTCAGGCCTA → AGTCGGCA AGTCAGGCTAA → AGTCGGCA AGTCAGGCTCA → AGTCGGCA AGTCAGGCTGA → AGTCGGCA
AGTCAGGCTTA → AGTCGGCA AGTCAGGTCAA → AGTCGGTA AGTCAGGTCCA → AGTCGGTA AGTCAGGTCGA → AGTCGGTA AGTCAGGTCGT → AGTCGGTT
AGTCAGGTCTA → AGTCGGTA AGTCAGGTTAA → AGTCGGTA AGTCAGGTTGA → AGTCGGTA AGTCAGGTTTA → AGTCGGTA AGTCCGCCTGA → AGTCGCCA
AGTCCGGACAA → AGTCGGAA AGTCCGGATCA → AGTCGGAA AGTCCGGATTA → AGTCGGAA AGTCCGGCCAA → AGTCGGCA AGTCCGGCCCA → AGTCGGCA
AGTCCGGCCGA → AGTCGGCA AGTCCGGCCGT → AGTCGGCT AGTCCGGCCTA → AGTCGGCA AGTCCGGCTAA → AGTCGGCA AGTCCGGCTCA → AGTCGGCA
AGTCCGGCTGA → AGTCGGCA AGTCCGGCTTA → AGTCGGCA AGTCCGGTCAA → AGTCGGTA AGTCCGGTCCA → AGTCGGTA AGTCCGGTCGA → AGTCGGTA
AGTCCGGTCTA → AGTCGGTA AGTCCGGTTCA → AGTCGGTA AGTCCGGTTGA → AGTCGGTA AGTCCGGTTGT → AGTCGGTT AGTCCGGTTTA → AGTCGGTA
AGTCGGGTCGA → AGTCGGTA AGTCNGGCTGA → AGTCGGCA AGTCTCGGTTA → AGTCGGTA AGTCTGGACAA → AGTCGGAA AGTCTGGACTA → AGTCGGAA
AGTCTGGATTA → AGTCGGAA AGTCTGGCCAA → AGTCGGCA AGTCTGGCCCA → AGTCGGCA AGTCTGGCCGA → AGTCGGCA AGTCTGGCCTA → AGTCGGCA
AGTCTGGCCTT → AGTCGGCT AGTCTGGCTAA → AGTCGGCA AGTCTGGCTAT → AGTCGGCT AGTCTGGCTCA → AGTCGGCA AGTCTGGCTGA → AGTCGGCA
AGTCTGGCTTA → AGTCGGCA AGTCTGGTCAA → AGTCGGTA AGTCTGGTCCA → AGTCGGTA AGTCTGGTCGA → AGTCGGTA AGTCTGGTCGT → AGTCGGTT
AGTCTGGTCTA → AGTCGGTA AGTCTGGTTAA → AGTCGGTA AGTCTGGTTCA → AGTCGGTA AGTCTGGTTGA → AGTCGGTA AGTCTGGTTTA → AGTCGGTA
AGTGGATTTCT → AGT-GGAT AGTGGGTAGTA → AGTGGGTA AGTTAGGACAA → AGTTGGAA AGTTAGGCCCA → AGTTGGCA AGTTAGGCCTA → AGTTGGCA
AGTTAGGCTGA → AGTTGGCA AGTTAGGTTTA → AGTTGGTA AGTTCATGGTA → AGTTGGTA AGTTCCGGTCA → AGTTGGTA AGTTCGGCCGT → AGTTGGCT
AGTTCGGCCTA → AGTTGGCA AGTTCGGCTGA → AGTTGGCA AGTTCGGCTTA → AGTTGGCA AGTTCGGTCCA → AGTTGGTA AGTTCGGTCGT → AGTTGGTT
AGTTCGGTCTA → AGTTGGTA AGTTCGGTTAA → AGTTGGTA AGTTCGGTTGA → AGTTGGTA AGTTCGGTTTA → AGTTGGTA AGTTCTGGTCA → AGTTGGTA
AGTTCTGGTTA → AGTTGGTA AGTTGCGGTTA → AGTTGCGA AGTTGGATGCA → AGTTGGAA AGTTGGCCAAG → AGTTGGCG AGTTGGCCGTA → AGTTGGCA
AGTTGGGCTTA → AGTTGGGA AGTTGGTCTTA → AGTTGGTA AGTTGGTTAGA → AGTTGGTA AGTTGGTTGAA → AGTTGGTA AGTTGGTTTAG → AGTTGGTG
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AGTTTAGGTCA → AGTTGGTA AGTTTCGGTTA → AGTTGGTA AGTTTGGCCAA → AGTTGGCA AGTTTGGCCGA → AGTTGGCA AGTTTGGCCGT → AGTTGGCT
AGTTTGGCTGA → AGTTGGCA AGTTTGGCTTA → AGTTGGCA AGTTTGGTACA → AGTTGGTA AGTTTGGTCAA → AGTTGGTA AGTTTGGTCCA → AGTTGGTA
AGTTTGGTCGA → AGTTGGTA AGTTTGGTCTA → AGTTGGTA AGTTTGGTTAA → AGTTGGTA AGTTTGGTTGA → AGTTGGTA AGTTTGGTTTA → AGTTGGTA
AGTTTTGGTAA → AGTTGGTA AGTTTTGGTTA → AGTTGGTA ATACGGCTTGG → ATACGGCG ATACTGGTTGG → ATACGGTG ATACTGGTTTG → ATACGGTG
ATATTGGTTTG → ATATGGTG ATCTTGGTAGA → ATCTGGTA ATGCATGGTTA → ATGCGGTA ATGCCTGGCAA → ATGCGGCA ATGCCTGGTCA → ATGCGGTA
ATGCCTGGTTA → ATGCGGTA ATGCTTGGTTA → ATGCGGTA ATGTTGGTTTG → ATGTGGTG CAAGTGGCTGA → CAAGGGCA CAATCTGGCAG → CAATGGCG
CAGCCGGTTAG → CAGCGGTG CAGGTGGTTAG → CAGGGGTG CAGTTGGTTAG → CAGTGGTG CATGGCGGTCT → CATGGGTT CCGAGTGGCTG → CCGAGGCG
CGAGCGGCCAA → CGAGGGCA CGAGTGGCCAA → CGAGGGCA CGAGTGGCTGA → CGAGGGCA CGCAGATTGAC → CGCAGATC CGCTCGGAGAG → CGCTGGAG
CTATTGGTATG → CTATGGTG CTCAGCTGGGA → CTCAGGGA CTCAGTTGGTA → CTCAGGTA GAAATTGGTAG → GAAAGGTG GAAGAGGCTAA → GAAGGGCA
GAAGTGGTTTA → GAAGGGTA GAGCGGCCAAA → GAGCGGCA GAGCGGTTTAT → GAGCGGTT GAGCTGGTTTA → GAGCGGTA GAGTGGCTGAA → GAGTGGCA
GAGTGGCTTAT → GAGTGGCT GAGTGGTCGAA → GAGTGGTA GAGTGGTTTAT → GAGTGGTT GAGTTGGTTTA → GAGTGGTA GCAATTGGATA → GCAAGGAA
GCAGAGGCCGC → GCAGGGCC GCAGCCTGGTA → GCAGGGTA GCAGCTTGGTA → GCAGGGTA GCAGTTCGGTA → GCAGGGTA GGAATTGGCAG → GGAAGGCG
GGAATTGGTAG → GGAAGGTG GGCTTGGTAGC → GGCTGGTC GTAGGGGTAGC → GTAGGGTC GTGCTGGTTTC → GTGCGGTC GTGTTGGTCAA → GTGTGGTA
GTGTTGGTTTC → GTGTGGTC TAGCGGCCCAA → TAGCGGCA TAGGAGGCCCA → TAGGGGCA TAGTCCTGGTA → TAGTGGTA TAGTGGCCTAG → TAGTGGCG
TATATAGGTTA → TATAGGTA TATCTGGTGAT → TATCGGTT TCAGCTGGATA → TCAGGGAA TCAGCTGGTTA → TCAGGGTA TCAGGAATAGC → TCA-GGAC
TCAGGTGGTTA → TCAGGGTA TCAGTTGGTAG → TCAGGGTG TCAGTTGGTTA → TCAGGGTA TGACGGTGGTA → TGACGGTA TGAGTGGTTGA → TGAGGGTA
TGTAGCGGTTA → TGTAGGTA TGTTGGGCAAG → TGTTGGCG TTAACGGTTTA → TTAAGGTA TTGTTGGTATG → TTGTGGTG TTGTTGGTCAA → TTGTGGTA
ACTCAGTTGGGA → ACTCGTTA AGTCCGGCCGTA → AGTCGGCA AGTCCGGCTGTA → AGTCGGCA AGTCCGGTCGTA → AGTCGGTA TAGCACTGTGGGA → TAGCGTGA
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tREX Screening Gels
Complete set of tREX screening gels.
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Figure 5.1: Complete set of gels for tREX screening of tRNA orthogonality in E. coli. For each tRNA, a specific DNA probe
was designed to be complementary to it. Furthermore, the specificity of each probe was tested on a tRNA extract from wild
type E. coli DH10b. For each tRNA under investigation, a control for the electrophoretic mobility of the extended species was
generated by omitting the NaIO4 oxidation, while a control for the electrophoretic mobility of the unextended species was
generated by performing NaIO4 oxidation following chemical deacylation by NaOH. Orthogonality was assessed by verifying
if the oxidised tRNA sample displayed the a band with the same electrophoretic mobility as the control for the unextended
species and no bands with the same electrophoretic mobility as the control for the extended species.
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Figure 5.2: Complete set of gels containing the results of the tREX screening for the aminoacyltion of the orthogonal tRNA
by their cognate synthetase. For each tRNA under investigation, a control for the electrophoretic mobility of the extended
and unextended species was generated as described before. The aminoacylation status of the tRNA was verified when it was
co-expressed in E. coli cells together with its cognate synthetase from the same organism. Samples for which a synthetase-
dependent aminoacylation was observed are highlighted by a red box.
Chapter V – Appendix
PrimDesign
Below the code, written in Mathematica, of the computational tool used to design primer for site-
saturation libraries which include only the amino acids of choice.















 Button["Edit Translational Table",
  CreateDialog[{
    Panel@Grid[{



































       {Checkbox[Dynamic@att,{"***","att"}],Style["att",Bold],InputField[Dynamic@att1,String,FieldSize-
>3],Checkbox[Dynamic@act,{"***","act"}],Style["act",Bold],InputField[Dynamic@act1,String,FieldSize-
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>3],Checkbox[Dynamic@aat,{"***","aat"}],Style["aat",Bold],InputField[Dynamic@aat1,String,FieldSize-
>3],Checkbox[Dynamic@agt,{"***","agt"}],Style["agt",Bold],InputField[Dynamic@agt1,String,FieldSize->3]},















































       }, 
      Dividers->{{1->True,4->True,7->True,10->True,13->True},All}]},
   WindowTitle->"Translational Table"]],
 TranslationalTable;RareCod;]










     Button["Remove All",AminoAcid={}]},
    {Style["How many primers do you want to mix?",Bold,Medium],CheckboxBar[Dynamic[MixNo],{2,3,4,5}]}
    },Dividers->{{1,None,1},{1,None,None,1,1,1}},ItemSize-
>All],AminoAcid//Sort;ExcludedAminoAcid=Complement[TotalAminoAcid,AminoAcid]//Sort;MixNo;Panel[Grid[{{Style
["Included Amino Acid(s):", Bold],Row[AminoAcid,","]},{Style["Excluded Amino Acid(s):", 
Bold],Row[ExcludedAminoAcid,","]}},Alignment->Left]]]
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Core Software







#,Nuc[[k,2]]]&/@Outer[StringJoin, Nuc[[i,2]], Nuc[[j,2]]],2]},{i,1,15},{j,1,15},{k,1,15}],2];(*Generates 
all the possible primers using the IUPAC alphabet*)
Nprimertot=Dimensions[PrimerTot];
PrimerNoRareCodon=Table[If[Intersection[PrimerTot[[i,2]],RareCod]==={},PrimerTot[[i]],Nothing],
{i,1,Nprimertot[[1]]}];(*Removes from the list of primers the ones that code for rare codons*)
Nprimernorarecodon=Dimensions[PrimerNoRareCodon];
Table[{PrimerNoRareCodon[[i,1]],PrimerNoRareCodon[[i,2]],PrimerNoRareCodon[[i,2]]/.Transl},
{i,1,Nprimernorarecodon[[1]]}];(*Adds to the previuous table the list of the amino acids they encode for*)
PrimerNoRedundant=Table[If[CountDistinct[Part[#,2]&/@Tally[%[[i,3]]]]==1,%[[i]],Nothing],{i,1,Dimensions[%]
[[1]]}];(*keeps only the primers that cover evenly a given set of amino acid, that means each one either 





[[1]]}];(*Generate the final list of non redundant amino acids that do not contain rare codon AND do not 





For[x=1,x<=Max[PrimerL],x++,a[x]];(*Divides the list of primers based on their degeneracy*)
g[i_]:=Gather[a[i],(Sort@#1[[3]])==Sort@(#2[[3]])&];(*pools the primers of the same length that code for 




















out[2]=If[MemberQ[MixNo,2],Flatten[ParallelMap[Fold[combine,#]&,Map[blk,w2,{2}]],1],"Mixes of 2 primers 
where not searched"];
out[3]=If[MemberQ[MixNo,3],Flatten[ParallelMap[Fold[combine,#]&,Map[blk,w3,{2}]],1],"Mixes of 3 primers 
where not searched"];
out[4]=If[MemberQ[MixNo,4],Flatten[ParallelMap[Fold[combine,#]&,Map[blk,w4,{2}]],1],"Mixes of 4 primers 
where not searched"];
out[5]=If[MemberQ[MixNo,5],Flatten[ParallelMap[Fold[combine,#]&,Map[blk,w5,{2}]],1],"Mixes of 5 primers 
where not searched"];
Panel@Grid[{{Style["Mix of 2 primers",Bold],If[MemberQ[MixNo,2],If[out[2]==={},"No solutions 
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found",TableForm[Join@@@(j[2]=Transpose@Transpose[out[2]][[{1,4}]]),TableSpacing->{1,1}]],out[2]]},
   {Style["Mix of 3 primers",Bold],If[MemberQ[MixNo,3],If[out[3]==={},"No solutions 
found",TableForm[Join@@@(j[3]=Transpose@Transpose[out[3]][[{1,4}]]),TableSpacing->{1,1}]],out[3]]},
   {Style["Mix of 4 primers",Bold],If[MemberQ[MixNo,4],If[out[4]==={},"No solutions 
found",TableForm[Join@@@(j[4]=Transpose@Transpose[out[4]][[{1,4}]]),TableSpacing->{1,1}]],out[4]]},












At last, my journey as a Ph.D. student has come to an end. These years have been more valuable for
my personal development than I can acknowledge now. They have been years full of joy, but also
years during which I had to come to terms with something university doesn't train you for: failure. I
realised that the impression of scientists that books create in your head can be very deceiving. What
books  never  teach  you  is  that  the  life  of  a  scientist  is  a  constant  fight  against  mistakes,
misinterpretations, unexplainable phenomena and mysterious events which mar the beauty of your
hypotheses about how things should be, but aren't. And I must admit that, after all, I probably had an
easy time. Nonetheless, in several occasions I struggled to see the light at the end of the tunnel.
I would like to thank all the people that gave me the chance embark on this journey, and all the great
people I met along the way, for everything they did for me, for their presence, their support, their
smiles, for giving me the strength I needed to complete this journey, that would have felt so much
scarier otherwise.
I would like to thank Jason, my supervisor, for giving me the opportunity to complete a successful
Ph.D. in this very prestigious institute. I would also like to thank Emma, for being a fantastic admin
and, more importantly, a good friend.
Along my journey I also learn how good things often come to an end. I now know that all these
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lessons, for how much unpleasant they might seem, need to be learnt sooner or later, because they are
part of life.  I wish to sincerely thank all  the people that were by my side in the darkest days, in
particular Edoardo, Lisa, Jakob, Charlie, Florence, Wesley and Anne, Julian, Jing, my parents Eleonora
and Francesco, my aunt Mariella and my sister Sonia.
In spite of circumstances, I wish to thank Michele, for what he meant to me for a very big part of my
life, and everybody who made me who I am today. And lastly, I wish to thank Bruno, for making me
feel whole again after a long time and for reminding me that sometimes pearls can be found where
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